Date,Session ID,Time,Hall,Session Type,Title,Chairs,Presentation ID,Presentation Time,Presentation Title,Presenter
11 April 2025,SP1,08:30 - 10:30,0,Special Session,Antimicrobial Stewardship in Different Scenarios,Murat Akova; Türkiye); Andre Fuchs; Germany); Maddalena Giannella; Italy); Angela Huttner; Switzerland); Benedikt Huttner; Switzerland); Jose Ramon Pano-Pardo; Spain); Galadriel Pellejero-Sagastizábal; Spain); Holger Rohde; Germany); Oana Sandulescu; Romania); Jeroen Schouten; Netherlands); Valentijn Schweitzer; Netherlands); Thomas Tängdén; Sweden); Suzanne Van Asten; Netherlands); Dafna Yahav; Israel),P1,08:30,- 10:30,"Hall 0
Special Session
Antimicrobial Stewardship in Different Scenarios 
Chairs Murat Akova (Ankara, Türkiye)"
11 April 2025,EW001,08:30 - 10:30,2,Educational Session,Surgical site infections: principles and practice in the era of multidrug,Gabriel Birgand; France); Efthymia Giannitsioti; Greece),W0002,08:50,,"Role of decolonisation and bowel decontamination in 
regions of overwhelming multidrug 
resistance Prasannakumar Palanikumar (Vellore, 
India)"
11 April 2025,EW001,08:30 - 10:30,2,Educational Session,Surgical site infections: principles and practice in the era of multidrug,Gabriel Birgand; France); Efthymia Giannitsioti; Greece),W0003,09:10,Screening for MDR GNR coloniSation:,"is there 
evidence for prophylaxis Elisabeth Presterl (Vienna, 
Austria)"
11 April 2025,EW001,08:30 - 10:30,2,Educational Session,Surgical site infections: principles and practice in the era of multidrug,Gabriel Birgand; France); Efthymia Giannitsioti; Greece),W0004,09:30,,"Perioperative prophylaxis in special populations in 
the era of MDR Divyashree Shanthamurthy (Mumbai, 
India)"
11 April 2025,EW002,08:30 - 10:30,3,Educational Session,Demystifying pharmacokinetics and population pharmacokinetics: a toolkit,Shampa Das; United Kingdom); João Paulo Telles; Brazil),W0005,08:30,Pharmacokinetics 101:,"navigating the basics for 
optimal dosing Linda Aulin (Leiden, Netherlands)"
11 April 2025,EW002,08:30 - 10:30,3,Educational Session,Demystifying pharmacokinetics and population pharmacokinetics: a toolkit,Shampa Das; United Kingdom); João Paulo Telles; Brazil),W0006,08:50,,"The ABCs of population pharmacokinetic 
models Erwin Dreesen (Leuven, Belgium)"
11 April 2025,EW002,08:30 - 10:30,3,Educational Session,Demystifying pharmacokinetics and population pharmacokinetics: a toolkit,Shampa Das; United Kingdom); João Paulo Telles; Brazil),W0007,09:10,Looking into the crystal ball:,"exploring the fabulous 
world of PK-PD simulations Vincent Aranzana-Climent 
(Poitiers, France)"
11 April 2025,EW003,08:30 - 10:30,5,Educational Session,,Kerrie Davies; United Kingdom); Yann Dumont; France),W003,08:30,- 10:30,"Hall 5
Educational SessionChallenges in identification and relevance of slow-growing pathogens
Chairs Kerrie Davies (Leeds, United Kingdom)"
11 April 2025,EW003,08:30 - 10:30,5,Educational Session,,Kerrie Davies; United Kingdom); Yann Dumont; France),W0009,08:30,,"Sampling and culturing anaerobes Hugo Cruz (Porto, 
Portugal)"
11 April 2025,EW004,08:30 - 10:30,6,Educational Session,A hard nut to crack in HIV,Yoav Keynan; Canada); Justyna Kowalska; Poland),W004,08:30,- 10:30,"Hall 6
Educational Session
A hard nut to crack in HIV
Chairs Yoav Keynan (Winnipeg, Canada)"
11 April 2025,EW004,08:30 - 10:30,6,Educational Session,A hard nut to crack in HIV,Yoav Keynan; Canada); Justyna Kowalska; Poland),W0013,08:30,Viral reservoir:,"what a physician should know Ivailo 
Alexiev (Sofia, Bulgaria)"
11 April 2025,EW004,08:30 - 10:30,6,Educational Session,A hard nut to crack in HIV,Yoav Keynan; Canada); Justyna Kowalska; Poland),W0014,08:50,Non-suppressible viraemia during HIV-1 therapy:,"a 
challenge for clinicians Jose Arribas (Madrid, Spain)"
11 April 2025,EW004,08:30 - 10:30,6,Educational Session,A hard nut to crack in HIV,Yoav Keynan; Canada); Justyna Kowalska; Poland),W0016,09:30,Opportunistic infections:,"most common and most 
deadly Milena Stevanovikj (Sopje, North Macedonia, 
Republic of)"
11 April 2025,EW005,08:30 - 10:30,8,Educational Session,Diagnostic parasitology in the XXIst century: is microscopy “+” still useful?,Miriam José Álvarez-Martínez; Spain); Caroline Rönnberg; Sweden),W0017,08:30,,"Artificial Intelligence for the diagnosis of parasitic 
infections Bobbi Pritt (Rochester, United States)"
11 April 2025,EW005,08:30 - 10:30,8,Educational Session,Diagnostic parasitology in the XXIst century: is microscopy “+” still useful?,Miriam José Álvarez-Martínez; Spain); Caroline Rönnberg; Sweden),W0018,08:50,,"Histopathology of parasitic infections Richard 
Bradbury (Townsville, Australia)"
11 April 2025,EW005,08:30 - 10:30,8,Educational Session,Diagnostic parasitology in the XXIst century: is microscopy “+” still useful?,Miriam José Álvarez-Martínez; Spain); Caroline Rönnberg; Sweden),W0019,09:10,,"Molecular diagnosis vs. microscopy in the diagnosis 
of parasitic infections Sitara Sr Ajjampur (Vellore, 
India)"
11 April 2025,EW005,08:30 - 10:30,8,Educational Session,Diagnostic parasitology in the XXIst century: is microscopy “+” still useful?,Miriam José Álvarez-Martínez; Spain); Caroline Rönnberg; Sweden),W0020,09:30,Paleoparasitology: what diagnostic tools?,"Ayman El-
Badry (Cairo, Egypt)"
11 April 2025,EW006,08:30 - 10:30,9,Educational Session,Vaccine hesitancy: from issues to solutions through developing,Monia Chemais; Belgium); Petar Velikov; Bulgaria),W0021,08:30,,"Vaccine hesitancy and its consequences Noni 
Macdonald (Halifax, Canada)"
11 April 2025,EW006,08:30 - 10:30,9,Educational Session,Vaccine hesitancy: from issues to solutions through developing,Monia Chemais; Belgium); Petar Velikov; Bulgaria),W0023,09:10,,"Using social media to deal with vaccine 
hesitancy Muge Cevik (St Andrews, United Kingdom)"
11 April 2025,SP1,08:30 - 10:30,0,Special Session,Antimicrobial Stewardship in Different Scenarios,Murat Akova; Türkiye); Andre Fuchs; Germany); Maddalena Giannella; Italy); Angela Huttner; Switzerland); Benedikt Huttner; Switzerland); Jose Ramon Pano-Pardo; Spain); Galadriel Pellejero-Sagastizábal; Spain); Holger Rohde; Germany); Oana Sandulescu; Romania); Jeroen Schouten; Netherlands); Valentijn Schweitzer; Netherlands); Thomas Tängdén; Sweden); Suzanne Van Asten; Netherlands); Dafna Yahav; Israel),P1,08:30,- 10:30,"Hall 0
Special Session
Antimicrobial Stewardship in Different Scenarios 
Chairs Murat Akova (Ankara, Türkiye)"
11 April 2025,EW001,08:30 - 10:30,2,Educational Session,Surgical site infections: principles and practice in the era of multidrug,Gabriel Birgand; France); Efthymia Giannitsioti; Greece),W0002,08:50,,"Role of decolonisation and bowel decontamination in 
regions of overwhelming multidrug 
resistance Prasannakumar Palanikumar (Vellore, 
India)"
11 April 2025,EW001,08:30 - 10:30,2,Educational Session,Surgical site infections: principles and practice in the era of multidrug,Gabriel Birgand; France); Efthymia Giannitsioti; Greece),W0003,09:10,Screening for MDR GNR coloniSation:,"is there 
evidence for prophylaxis Elisabeth Presterl (Vienna, 
Austria)"
11 April 2025,EW001,08:30 - 10:30,2,Educational Session,Surgical site infections: principles and practice in the era of multidrug,Gabriel Birgand; France); Efthymia Giannitsioti; Greece),W0004,09:30,,"Perioperative prophylaxis in special populations in 
the era of MDR Divyashree Shanthamurthy (Mumbai, 
India)"
11 April 2025,EW002,08:30 - 10:30,3,Educational Session,Demystifying pharmacokinetics and population pharmacokinetics: a toolkit,Shampa Das; United Kingdom); João Paulo Telles; Brazil),W0005,08:30,Pharmacokinetics 101:,"navigating the basics for 
optimal dosing Linda Aulin (Leiden, Netherlands)"
11 April 2025,EW002,08:30 - 10:30,3,Educational Session,Demystifying pharmacokinetics and population pharmacokinetics: a toolkit,Shampa Das; United Kingdom); João Paulo Telles; Brazil),W0006,08:50,,"The ABCs of population pharmacokinetic 
models Erwin Dreesen (Leuven, Belgium)"
11 April 2025,EW002,08:30 - 10:30,3,Educational Session,Demystifying pharmacokinetics and population pharmacokinetics: a toolkit,Shampa Das; United Kingdom); João Paulo Telles; Brazil),W0007,09:10,Looking into the crystal ball:,"exploring the fabulous 
world of PK-PD simulations Vincent Aranzana-Climent 
(Poitiers, France)"
11 April 2025,EW003,08:30 - 10:30,5,Educational Session,,Kerrie Davies; United Kingdom); Yann Dumont; France),W003,08:30,- 10:30,"Hall 5
Educational SessionChallenges in identification and relevance of slow-growing pathogens
Chairs Kerrie Davies (Leeds, United Kingdom)"
11 April 2025,EW003,08:30 - 10:30,5,Educational Session,,Kerrie Davies; United Kingdom); Yann Dumont; France),W0009,08:30,,"Sampling and culturing anaerobes Hugo Cruz (Porto, 
Portugal)"
11 April 2025,EW004,08:30 - 10:30,6,Educational Session,A hard nut to crack in HIV,Yoav Keynan; Canada); Justyna Kowalska; Poland),W004,08:30,- 10:30,"Hall 6
Educational Session
A hard nut to crack in HIV
Chairs Yoav Keynan (Winnipeg, Canada)"
11 April 2025,EW004,08:30 - 10:30,6,Educational Session,A hard nut to crack in HIV,Yoav Keynan; Canada); Justyna Kowalska; Poland),W0013,08:30,Viral reservoir:,"what a physician should know Ivailo 
Alexiev (Sofia, Bulgaria)"
11 April 2025,EW004,08:30 - 10:30,6,Educational Session,A hard nut to crack in HIV,Yoav Keynan; Canada); Justyna Kowalska; Poland),W0014,08:50,Non-suppressible viraemia during HIV-1 therapy:,"a 
challenge for clinicians Jose Arribas (Madrid, Spain)"
11 April 2025,EW004,08:30 - 10:30,6,Educational Session,A hard nut to crack in HIV,Yoav Keynan; Canada); Justyna Kowalska; Poland),W0016,09:30,Opportunistic infections:,"most common and most 
deadly Milena Stevanovikj (Sopje, North Macedonia, 
Republic of)"
11 April 2025,EW005,08:30 - 10:30,8,Educational Session,Diagnostic parasitology in the XXIst century: is microscopy “+” still useful?,Miriam José Álvarez-Martínez; Spain); Caroline Rönnberg; Sweden),W0017,08:30,,"Artificial Intelligence for the diagnosis of parasitic 
infections Bobbi Pritt (Rochester, United States)"
11 April 2025,EW005,08:30 - 10:30,8,Educational Session,Diagnostic parasitology in the XXIst century: is microscopy “+” still useful?,Miriam José Álvarez-Martínez; Spain); Caroline Rönnberg; Sweden),W0018,08:50,,"Histopathology of parasitic infections Richard 
Bradbury (Townsville, Australia)"
11 April 2025,EW005,08:30 - 10:30,8,Educational Session,Diagnostic parasitology in the XXIst century: is microscopy “+” still useful?,Miriam José Álvarez-Martínez; Spain); Caroline Rönnberg; Sweden),W0019,09:10,,"Molecular diagnosis vs. microscopy in the diagnosis 
of parasitic infections Sitara Sr Ajjampur (Vellore, 
India)"
11 April 2025,EW005,08:30 - 10:30,8,Educational Session,Diagnostic parasitology in the XXIst century: is microscopy “+” still useful?,Miriam José Álvarez-Martínez; Spain); Caroline Rönnberg; Sweden),W0020,09:30,Paleoparasitology: what diagnostic tools?,"Ayman El-
Badry (Cairo, Egypt)"
11 April 2025,EW006,08:30 - 10:30,9,Educational Session,Vaccine hesitancy: from issues to solutions through developing,Monia Chemais; Belgium); Petar Velikov; Bulgaria),W0021,08:30,,"Vaccine hesitancy and its consequences Noni 
Macdonald (Halifax, Canada)"
11 April 2025,EW006,08:30 - 10:30,9,Educational Session,Vaccine hesitancy: from issues to solutions through developing,Monia Chemais; Belgium); Petar Velikov; Bulgaria),W0023,09:10,,"Using social media to deal with vaccine 
hesitancy Muge Cevik (St Andrews, United Kingdom)"
11 April 2025,SP2,11:00 - 12:00,0,Special Session,Principles of systematic reviews (with and without meta-analysis),Chiara Iaria; Italy); Miranda Langendam; Netherlands); Blin Nagavci; Kosovo); Mical Paul; Israel); Luigia Scudeller; Italy),P2,11:00,- 12:00,"Hall 0
Special Session
Principles of systematic reviews (with and without meta-analysis)"
11 April 2025,ME007,11:00 - 12:00,2,Meet-the-Expert,How to interpret resistance patterns from antibiograms,,M0025,11:00,,"Tommaso Giani (Florence, Italy)"
11 April 2025,ME007,11:00 - 12:00,2,Meet-the-Expert,How to interpret resistance patterns from antibiograms,,M0026,11:12,,"Diaz Lorena (Santiago, Chile)"
11 April 2025,ME008,11:00 - 12:00,3,Meet-the-Expert,Children are not just small adults: interactive paediatric cases,,M0027,11:00,,"Julie Toubiana (Paris, France)"
11 April 2025,ME008,11:00 - 12:00,3,Meet-the-Expert,Children are not just small adults: interactive paediatric cases,,M0028,11:12,,"Sanjay Patel (Winchester, United Kingdom)"
11 April 2025,ME009,11:00 - 12:00,5,Meet-the-Expert,How to practise WHO Guidelines for the prevention of bloodstream infections,,M0029,11:00,,"Kushlani Jayatilleke (Battaramulla, Sri Lanka)"
11 April 2025,ME009,11:00 - 12:00,5,Meet-the-Expert,How to practise WHO Guidelines for the prevention of bloodstream infections,,M0030,11:12,,"Walter Zingg (Zurich, Switzerland)"
11 April 2025,ME010,11:00 - 12:00,6,Meet-the-Expert,"Can we stop vertical transmission of syphilis, HIV and hepatitis? Regional",,M0031,11:00,,"Ecaterina Noroc (Chisinau, Moldova, Republic of)"
11 April 2025,ME010,11:00 - 12:00,6,Meet-the-Expert,"Can we stop vertical transmission of syphilis, HIV and hepatitis? Regional",,M0032,11:12,,"Fakhriddin Nizamov (Almaty, Kazakhstan)"
11 April 2025,ME011,11:00 - 12:00,8,Meet-the-Expert,Biofilm-related nontuberculous mycobacterial infections: ongoing nightmare,,M0033,11:00,,"Jaime Esteban (Madrid, Spain)"
11 April 2025,ME011,11:00 - 12:00,8,Meet-the-Expert,Biofilm-related nontuberculous mycobacterial infections: ongoing nightmare,,M0034,11:12,,"Philippe Morand (Paris, France)"
11 April 2025,ME012,11:00 - 12:00,9,Meet-the-Expert,How to understand infectious disease risks in changing climates,,M0035,11:00,,"Kimberly Fornace (Singapore, Singapore)"
11 April 2025,ME012,11:00 - 12:00,9,Meet-the-Expert,How to understand infectious disease risks in changing climates,,M0036,11:12,,"Rachel Lowe (Barcelona, Spain)"
11 April 2025,SP3,13:30 - 14:30,0,Special Session,Top five mistakes in Infection prevention and control,Maeve Doyle; Ireland); Barbara Juliane Holzknecht; Denmark); David Ong; Netherlands); Arjana Tambic Andrasevic; Croatia),P3,13:30,- 14:30,"Hall 0
Special Session
Top five mistakes in Infection prevention and control
Chairs Maeve Doyle (Waterford, Ireland)"
11 April 2025,ME013,13:30 - 14:30,2,Meet-the-Expert,Orthopaedic implant infections: new approaches for improved outcomes,,M0037,13:30,,"Marjan Wouthuyzen-Bakker (Groningen, 
Netherlands)"
11 April 2025,ME013,13:30 - 14:30,2,Meet-the-Expert,Orthopaedic implant infections: new approaches for improved outcomes,,M0038,13:42,,"Trisha Peel (Melbourne, Australia)"
11 April 2025,ME014,13:30 - 14:30,3,Meet-the-Expert,Timing of antimicrobials in sepsis and septic shock - the sooner the better?,,M0039,13:30,,"Laura Evans (Seattle, United States)"
11 April 2025,ME014,13:30 - 14:30,3,Meet-the-Expert,Timing of antimicrobials in sepsis and septic shock - the sooner the better?,,M0040,13:42,,"Evangelos Giamarellos-Bourboulis (Athens, Greece)"
11 April 2025,ME015,13:30 - 14:30,5,Meet-the-Expert,PrEP in Europe: Current gaps and solutions,,M0041,13:30,,"Teymur Noori (Stockholm, Sweden)"
11 April 2025,ME015,13:30 - 14:30,5,Meet-the-Expert,PrEP in Europe: Current gaps and solutions,,M0042,13:42,,"Milosz Parczewski (Szczecin, Poland)"
11 April 2025,ME016,13:30 - 14:30,6,Meet-the-Expert,Short regimens for treating drug-susceptible and drug-resistant tuberculosis:,,,,,
11 April 2025,SP2,11:00 - 12:00,0,Special Session,Principles of systematic reviews (with and without meta-analysis),Chiara Iaria; Italy); Miranda Langendam; Netherlands); Blin Nagavci; Kosovo); Mical Paul; Israel); Luigia Scudeller; Italy),P2,11:00,- 12:00,"Hall 0
Special Session
Principles of systematic reviews (with and without meta-analysis)"
11 April 2025,ME007,11:00 - 12:00,2,Meet-the-Expert,How to interpret resistance patterns from antibiograms,,M0025,11:00,,"Tommaso Giani (Florence, Italy)"
11 April 2025,ME007,11:00 - 12:00,2,Meet-the-Expert,How to interpret resistance patterns from antibiograms,,M0026,11:12,,"Diaz Lorena (Santiago, Chile)"
11 April 2025,ME008,11:00 - 12:00,3,Meet-the-Expert,Children are not just small adults: interactive paediatric cases,,M0027,11:00,,"Julie Toubiana (Paris, France)"
11 April 2025,ME008,11:00 - 12:00,3,Meet-the-Expert,Children are not just small adults: interactive paediatric cases,,M0028,11:12,,"Sanjay Patel (Winchester, United Kingdom)"
11 April 2025,ME009,11:00 - 12:00,5,Meet-the-Expert,How to practise WHO Guidelines for the prevention of bloodstream infections,,M0029,11:00,,"Kushlani Jayatilleke (Battaramulla, Sri Lanka)"
11 April 2025,ME009,11:00 - 12:00,5,Meet-the-Expert,How to practise WHO Guidelines for the prevention of bloodstream infections,,M0030,11:12,,"Walter Zingg (Zurich, Switzerland)"
11 April 2025,ME010,11:00 - 12:00,6,Meet-the-Expert,"Can we stop vertical transmission of syphilis, HIV and hepatitis? Regional",,M0031,11:00,,"Ecaterina Noroc (Chisinau, Moldova, Republic of)"
11 April 2025,ME010,11:00 - 12:00,6,Meet-the-Expert,"Can we stop vertical transmission of syphilis, HIV and hepatitis? Regional",,M0032,11:12,,"Fakhriddin Nizamov (Almaty, Kazakhstan)"
11 April 2025,ME011,11:00 - 12:00,8,Meet-the-Expert,Biofilm-related nontuberculous mycobacterial infections: ongoing nightmare,,M0033,11:00,,"Jaime Esteban (Madrid, Spain)"
11 April 2025,ME011,11:00 - 12:00,8,Meet-the-Expert,Biofilm-related nontuberculous mycobacterial infections: ongoing nightmare,,M0034,11:12,,"Philippe Morand (Paris, France)"
11 April 2025,ME012,11:00 - 12:00,9,Meet-the-Expert,How to understand infectious disease risks in changing climates,,M0035,11:00,,"Kimberly Fornace (Singapore, Singapore)"
11 April 2025,ME012,11:00 - 12:00,9,Meet-the-Expert,How to understand infectious disease risks in changing climates,,M0036,11:12,,"Rachel Lowe (Barcelona, Spain)"
11 April 2025,SP3,13:30 - 14:30,0,Special Session,Top five mistakes in Infection prevention and control,Maeve Doyle; Ireland); Barbara Juliane Holzknecht; Denmark); David Ong; Netherlands); Arjana Tambic Andrasevic; Croatia),P3,13:30,- 14:30,"Hall 0
Special Session
Top five mistakes in Infection prevention and control
Chairs Maeve Doyle (Waterford, Ireland)"
11 April 2025,ME013,13:30 - 14:30,2,Meet-the-Expert,Orthopaedic implant infections: new approaches for improved outcomes,,M0037,13:30,,"Marjan Wouthuyzen-Bakker (Groningen, 
Netherlands)"
11 April 2025,ME013,13:30 - 14:30,2,Meet-the-Expert,Orthopaedic implant infections: new approaches for improved outcomes,,M0038,13:42,,"Trisha Peel (Melbourne, Australia)"
11 April 2025,ME014,13:30 - 14:30,3,Meet-the-Expert,Timing of antimicrobials in sepsis and septic shock - the sooner the better?,,M0039,13:30,,"Laura Evans (Seattle, United States)"
11 April 2025,ME014,13:30 - 14:30,3,Meet-the-Expert,Timing of antimicrobials in sepsis and septic shock - the sooner the better?,,M0040,13:42,,"Evangelos Giamarellos-Bourboulis (Athens, Greece)"
11 April 2025,ME015,13:30 - 14:30,5,Meet-the-Expert,PrEP in Europe: Current gaps and solutions,,M0041,13:30,,"Teymur Noori (Stockholm, Sweden)"
11 April 2025,ME015,13:30 - 14:30,5,Meet-the-Expert,PrEP in Europe: Current gaps and solutions,,M0042,13:42,,"Milosz Parczewski (Szczecin, Poland)"
11 April 2025,ME016,13:30 - 14:30,6,Meet-the-Expert,Short regimens for treating drug-susceptible and drug-resistant tuberculosis:,,M0043,13:30,,"Daria Podlekareva (Copenhagen, Denmark)"
11 April 2025,ME016,13:30 - 14:30,6,Meet-the-Expert,Short regimens for treating drug-susceptible and drug-resistant tuberculosis:,,M0044,13:42,,"Raquel Duarte (Porto, Portugal)"
11 April 2025,ME017,13:30 - 14:30,8,Meet-the-Expert,How to navigate Risk Communication in Public Health,,M0045,13:30,,"Christina Rolfheim-Bye (Oslo, Norway)"
11 April 2025,ME017,13:30 - 14:30,8,Meet-the-Expert,How to navigate Risk Communication in Public Health,,M0046,13:42,,"Marius Gilbert (Brussels, Belgium)"
11 April 2025,ME018,13:30 - 14:30,9,Meet-the-Expert,Do we need antiviral stewardship in immunocompromised hosts? role of cell-,,M0047,13:30,,"Michelle Yong (Melbourne, Australia)"
11 April 2025,ME018,13:30 - 14:30,9,Meet-the-Expert,Do we need antiviral stewardship in immunocompromised hosts? role of cell-,,M0048,13:42,,"Genovefa Papanicolaou (New York, United States)"
11 April 2025,SP4,14:45 - 15:45,0,Special Session,Science Slam - How to Communicate Science with Clarity,Mary Horgan; Ireland); Jaroslav Hrabak; Czech Republic); Nina Khanna; Switzerland); Preeti Malani; United States); Emily G. Mcdonald; Canada); Joshua Nosanchuk; United States); Jesús Rodríguez-Baño; Spain),P4,14:45,- 15:45,"Hall 0
Special Session
Science Slam - How to Communicate Science with Clarity
Chairs Mary Horgan (Dublin, Ireland)"
11 April 2025,ME019,14:45 - 15:45,2,Meet-the-Expert,Healthcare-associated CNS infections,,M0049,14:45,,"Diederik Van De Beek (Amsterdam, Netherlands)"
11 April 2025,ME019,14:45 - 15:45,2,Meet-the-Expert,Healthcare-associated CNS infections,,M0050,14:57,,"Alexandra Mailles (Paris, France)"
11 April 2025,ME020,14:45 - 15:45,3,Meet-the-Expert,Translation of gut microbiome data to clinical practice: a guide for clinicians,,M0051,14:45,,"Aycan Gundogdu (Kayseri, Türkiye)"
11 April 2025,ME020,14:45 - 15:45,3,Meet-the-Expert,Translation of gut microbiome data to clinical practice: a guide for clinicians,,M0052,14:57,,"Niranjan Nagarajan (Singapore, Singapore)"
11 April 2025,ME021,14:45 - 15:45,5,Meet-the-Expert,"How to make sense out of guidelines and scientific evidenceM0053  14:45  Luigia Scudeller (Pavia, Italy)",,M0053,14:45,,"Luigia Scudeller (Pavia, Italy)"
11 April 2025,ME021,14:45 - 15:45,5,Meet-the-Expert,"How to make sense out of guidelines and scientific evidenceM0053  14:45  Luigia Scudeller (Pavia, Italy)",,M0054,14:57,,"Blin Nagavci (Gjakove, Kosovo)"
11 April 2025,ME022,14:45 - 15:45,6,Meet-the-Expert,Multidisciplinary management of bone and joint infections: is there a recipe,,M0055,14:45,,"Natividad Benito (Barcelona, Spain)"
11 April 2025,ME022,14:45 - 15:45,6,Meet-the-Expert,Multidisciplinary management of bone and joint infections: is there a recipe,,M0056,14:57,,"Tiziana Ascione (Naples, Italy)"
11 April 2025,ME023,14:45 - 15:45,8,Meet-the-Expert,How to manage and prevent travellers' diarrhoea,,M0057,14:45,,"Tinja Laaveri (Helsinki, Finland)"
11 April 2025,ME023,14:45 - 15:45,8,Meet-the-Expert,How to manage and prevent travellers' diarrhoea,,M0058,14:57,,"David Tribble (Bethesda, United States)"
11 April 2025,ME024,14:45 - 15:45,9,Meet-the-Expert,How to diagnose and treat infectious complications in critically ill patients,,M0059,14:45,,"Jordi Riera (Barcelona, Spain)"
11 April 2025,ME024,14:45 - 15:45,9,Meet-the-Expert,How to diagnose and treat infectious complications in critically ill patients,,M0060,14:57,,"Giacomo Grasselli (Besana In Brianza, Italy)"
11 April 2025,SP5,16:15 - 18:15,0,Special Session,Multidisciplinary approach to early sepsis management,Markus Bald; Germany); Aleksandra Davidovic; Germany); Charalambos Dokos; Germany),P5,16:15,- 18:15,"Hall 0
Special Session
Multidisciplinary approach to early sepsis management
Chairs Markus Bald (Lüdenscheid, Germany)"
11 April 2025,EW025,16:15 - 18:15,2,Educational Session,AMR surveillance: current challenges and new perspectives,,W0062,16:35,,"Networks for surveillance of AMR in animal 
pathogens Lucie Collineau (Lyon, France)"
11 April 2025,EW025,16:15 - 18:15,2,Educational Session,AMR surveillance: current challenges and new perspectives,,W0063,16:55,,"Transition to genomic-based methodology for 
surveillance and outbreak detection to effectively 
combact AMR Camilla Wiuff Coia (Copenhagen, 
Denmark)"
11 April 2025,EW025,16:15 - 18:15,2,Educational Session,AMR surveillance: current challenges and new perspectives,,M0043,13:30,,"Daria Podlekareva (Copenhagen, Denmark)"
11 April 2025,EW025,16:15 - 18:15,2,Educational Session,AMR surveillance: current challenges and new perspectives,,M0044,13:42,,"Raquel Duarte (Porto, Portugal)"
11 April 2025,ME017,13:30 - 14:30,8,Meet-the-Expert,How to navigate Risk Communication in Public Health,,M0045,13:30,,"Christina Rolfheim-Bye (Oslo, Norway)"
11 April 2025,ME017,13:30 - 14:30,8,Meet-the-Expert,How to navigate Risk Communication in Public Health,,M0046,13:42,,"Marius Gilbert (Brussels, Belgium)"
11 April 2025,ME018,13:30 - 14:30,9,Meet-the-Expert,Do we need antiviral stewardship in immunocompromised hosts? role of cell-,,M0047,13:30,,"Michelle Yong (Melbourne, Australia)"
11 April 2025,ME018,13:30 - 14:30,9,Meet-the-Expert,Do we need antiviral stewardship in immunocompromised hosts? role of cell-,,M0048,13:42,,"Genovefa Papanicolaou (New York, United States)"
11 April 2025,SP4,14:45 - 15:45,0,Special Session,Science Slam - How to Communicate Science with Clarity,Mary Horgan; Ireland); Jaroslav Hrabak; Czech Republic); Nina Khanna; Switzerland); Preeti Malani; United States); Emily G. Mcdonald; Canada); Joshua Nosanchuk; United States); Jesús Rodríguez-Baño; Spain),P4,14:45,- 15:45,"Hall 0
Special Session
Science Slam - How to Communicate Science with Clarity
Chairs Mary Horgan (Dublin, Ireland)"
11 April 2025,ME019,14:45 - 15:45,2,Meet-the-Expert,Healthcare-associated CNS infections,,M0049,14:45,,"Diederik Van De Beek (Amsterdam, Netherlands)"
11 April 2025,ME019,14:45 - 15:45,2,Meet-the-Expert,Healthcare-associated CNS infections,,M0050,14:57,,"Alexandra Mailles (Paris, France)"
11 April 2025,ME020,14:45 - 15:45,3,Meet-the-Expert,Translation of gut microbiome data to clinical practice: a guide for clinicians,,M0051,14:45,,"Aycan Gundogdu (Kayseri, Türkiye)"
11 April 2025,ME020,14:45 - 15:45,3,Meet-the-Expert,Translation of gut microbiome data to clinical practice: a guide for clinicians,,M0052,14:57,,"Niranjan Nagarajan (Singapore, Singapore)"
11 April 2025,ME021,14:45 - 15:45,5,Meet-the-Expert,"How to make sense out of guidelines and scientific evidenceM0053  14:45  Luigia Scudeller (Pavia, Italy)",,M0053,14:45,,"Luigia Scudeller (Pavia, Italy)"
11 April 2025,ME021,14:45 - 15:45,5,Meet-the-Expert,"How to make sense out of guidelines and scientific evidenceM0053  14:45  Luigia Scudeller (Pavia, Italy)",,M0054,14:57,,"Blin Nagavci (Gjakove, Kosovo)"
11 April 2025,ME022,14:45 - 15:45,6,Meet-the-Expert,Multidisciplinary management of bone and joint infections: is there a recipe,,M0055,14:45,,"Natividad Benito (Barcelona, Spain)"
11 April 2025,ME022,14:45 - 15:45,6,Meet-the-Expert,Multidisciplinary management of bone and joint infections: is there a recipe,,M0056,14:57,,"Tiziana Ascione (Naples, Italy)"
11 April 2025,ME023,14:45 - 15:45,8,Meet-the-Expert,How to manage and prevent travellers' diarrhoea,,M0057,14:45,,"Tinja Laaveri (Helsinki, Finland)"
11 April 2025,ME023,14:45 - 15:45,8,Meet-the-Expert,How to manage and prevent travellers' diarrhoea,,M0058,14:57,,"David Tribble (Bethesda, United States)"
11 April 2025,ME024,14:45 - 15:45,9,Meet-the-Expert,How to diagnose and treat infectious complications in critically ill patients,,M0059,14:45,,"Jordi Riera (Barcelona, Spain)"
11 April 2025,ME024,14:45 - 15:45,9,Meet-the-Expert,How to diagnose and treat infectious complications in critically ill patients,,M0060,14:57,,"Giacomo Grasselli (Besana In Brianza, Italy)"
11 April 2025,SP5,16:15 - 18:15,0,Special Session,Multidisciplinary approach to early sepsis management,Markus Bald; Germany); Aleksandra Davidovic; Germany); Charalambos Dokos; Germany),P5,16:15,- 18:15,"Hall 0
Special Session
Multidisciplinary approach to early sepsis management
Chairs Markus Bald (Lüdenscheid, Germany)"
11 April 2025,EW025,16:15 - 18:15,2,Educational Session,AMR surveillance: current challenges and new perspectives,,W0062,16:35,,"Networks for surveillance of AMR in animal 
pathogens Lucie Collineau (Lyon, France)"
11 April 2025,EW025,16:15 - 18:15,2,Educational Session,AMR surveillance: current challenges and new perspectives,,W0063,16:55,,"Transition to genomic-based methodology for 
surveillance and outbreak detection to effectively 
combact AMR Camilla Wiuff Coia (Copenhagen, 
Denmark)"
11 April 2025,EW025,16:15 - 18:15,2,Educational Session,AMR surveillance: current challenges and new perspectives,,W0064,17:15,,"Implementing and running hospital-wide genomic 
surveillance of pathogens Alexander Mellmann 
ESCMID Global 2025 - Programme
(Münster, Germany)"
11 April 2025,EW026,16:15 - 18:15,3,Educational Session,New insights into antifungal agents and resistance,Anuradha Chowdhary; India); Jon Salmanton-Garcia; Germany),W026,16:15,- 18:15,"Hall 3
Educational Session
New insights into antifungal agents and resistance
Chairs Anuradha Chowdhary (New Delhi, India)"
11 April 2025,EW026,16:15 - 18:15,3,Educational Session,New insights into antifungal agents and resistance,Anuradha Chowdhary; India); Jon Salmanton-Garcia; Germany),W0065,16:15,,"Emerging resistance in Candida tropicalisSharon 
Chen (Sydney, Australia)"
11 April 2025,EW026,16:15 - 18:15,3,Educational Session,New insights into antifungal agents and resistance,Anuradha Chowdhary; India); Jon Salmanton-Garcia; Germany),W0066,16:35,,"Mechanisms of resistance in Candida glabrataDavid 
Perlin (Nutley, United States)"
11 April 2025,EW026,16:15 - 18:15,3,Educational Session,New insights into antifungal agents and resistance,Anuradha Chowdhary; India); Jon Salmanton-Garcia; Germany),W0067,16:55,,"Surveillance of resistance in Aspergillus  
species Maiken Cavling Arendrup (Copenhagen, 
Denmark)"
11 April 2025,EW026,16:15 - 18:15,3,Educational Session,New insights into antifungal agents and resistance,Anuradha Chowdhary; India); Jon Salmanton-Garcia; Germany),W0068,17:15,,"Environmental surveillance for antifungal 
resistance Eveline Snelders (Wageningen, 
Netherlands)"
11 April 2025,EW027,16:15 - 18:15,5,Educational Session,Going Viral! Phage Therapy Clinical rounds,Gregory German; Canada); Ameneh Khatami; Australia),W0069,16:15,,"Clinical cases and lessons from the STAMP 
protocol Holly Sinclair (Nsw, Australia)"
11 April 2025,EW027,16:15 - 18:15,5,Educational Session,Going Viral! Phage Therapy Clinical rounds,Gregory German; Canada); Ameneh Khatami; Australia),W0070,16:35,,"Difficult cases treated with phages Ghady Haidar 
(Pittsburgh, United States)"
11 April 2025,EW027,16:15 - 18:15,5,Educational Session,Going Viral! Phage Therapy Clinical rounds,Gregory German; Canada); Ameneh Khatami; Australia),W0071,16:55,,"Challenging osteoarticular cases treated with 
phages Tristan Ferry (Lyon, France)"
11 April 2025,EW028,16:15 - 18:15,6,Educational Session,Addressing infection challenges in immunocompromised patients: a case-,Maddalena Giannella; Italy); Asma Nasim; Pakistan),W0073,16:15,,"Challenges in managing gastrointestinal infections in 
patients with primary immunodeficiency Effrossyni 
Gkrania-Klotsas (Cambridge, United Kingdom)"
11 April 2025,EW028,16:15 - 18:15,6,Educational Session,Addressing infection challenges in immunocompromised patients: a case-,Maddalena Giannella; Italy); Asma Nasim; Pakistan),W0074,16:35,,"Respiratory infections in patients receiving CAR-T 
cells or bispecific monoclonal antibodies Gemma 
Reynolds (Heidelberg, Australia)"
11 April 2025,EW028,16:15 - 18:15,6,Educational Session,Addressing infection challenges in immunocompromised patients: a case-,Maddalena Giannella; Italy); Asma Nasim; Pakistan),W0075,16:55,,"Mycobacterial infections in patients with HIV 
infection Graeme Ayton Meintjes (Observatory, South 
Africa)"
11 April 2025,EW028,16:15 - 18:15,6,Educational Session,Addressing infection challenges in immunocompromised patients: a case-,Maddalena Giannella; Italy); Asma Nasim; Pakistan),W0076,17:15,,"Breakthrough fungal infections in haematopoietic 
cancer and in stem cell transplantation Dimitrios P. 
Kontoyiannis (Houston, Tx, United States)"
11 April 2025,EW029,16:15 - 18:15,8,Educational Session,"Impact of diabetes on infectious diseases: what should we know?Chairs Mark G. J. De Boer (Leiden, Netherlands)",Mark G. J. De Boer; Netherlands); Suzanne Van Asten; Netherlands),W0077,16:15,,"The impact of diabetes and host-pathogen interaction 
and gut microbiome Reinout Van Crevel (Nijmegen, 
Netherlands)"
11 April 2025,EW029,16:15 - 18:15,8,Educational Session,"Impact of diabetes on infectious diseases: what should we know?Chairs Mark G. J. De Boer (Leiden, Netherlands)",Mark G. J. De Boer; Netherlands); Suzanne Van Asten; Netherlands),W0078,16:35,,"Diabetes and invasive fungal infections Jochem Buil 
(Nijmegen, Netherlands)"
11 April 2025,EW030,16:15 - 18:15,9,Educational Session,Primer on infection prevention and control: the crucial support by clinical,Nico Tom Mutters; Germany); Margreet C. Vos; Netherlands),W0081,16:15,Microbial fundamentals:,"building blocks of infection 
prevention and control Laurence Armand-Lefevre 
(Paris, France)"
11 April 2025,EW030,16:15 - 18:15,9,Educational Session,Primer on infection prevention and control: the crucial support by clinical,Nico Tom Mutters; Germany); Margreet C. Vos; Netherlands),W0083,16:55,,"The crucial role of molecular typing in infection 
control Stefanie Kampmeier (Würzburg, Germany)"
11 April 2025,SY036,08:30 - 10:30,15,2-hour Symposium,The quality of antibiotics used in the communities of LMICs,Thi Thuy Nga Do; Vietnam); Christina Obiero; Kenya),Y036,08:30,- 10:30,"Hall 15
2-hour Symposium
The quality of antibiotics used in the communities of LMICs
Chairs Thi Thuy Nga Do (Ha Noi, Vietnam)"
11 April 2025,SY036,08:30 - 10:30,15,2-hour Symposium,The quality of antibiotics used in the communities of LMICs,Thi Thuy Nga Do; Vietnam); Christina Obiero; Kenya),S0105,08:30,,"The quality of antibiotics and their potential impact on 
patient outcome and AMR Paul Newton (Oxford, 
United Kingdom)"
11 April 2025,SY036,08:30 - 10:30,15,2-hour Symposium,The quality of antibiotics used in the communities of LMICs,Thi Thuy Nga Do; Vietnam); Christina Obiero; Kenya),S0106,09:00,,"Community antibiotic access and use in Sub-Sahara 
Africa Samuel Afari-Asiedu (Kintampo, Ghana)"
11 April 2025,SY036,08:30 - 10:30,15,2-hour Symposium,The quality of antibiotics used in the communities of LMICs,Thi Thuy Nga Do; Vietnam); Christina Obiero; Kenya),S0107,09:30,,"Encountered challenges and reflections on 
conducting multi-country medicine quality 
studies Noudy Sengxeu (Vientiane Capital, Lao 
People's democratic republic)"
11 April 2025,SY036,08:30 - 10:30,15,2-hour Symposium,The quality of antibiotics used in the communities of LMICs,Thi Thuy Nga Do; Vietnam); Christina Obiero; Kenya),S0108,10:00,,"Confusion in appearance of common used antibiotics 
in LMICs Heiman Wertheim (Nijmegen, Netherlands)"
11 April 2025,SY031,08:30 - 10:30,6,2-hour Symposium,To screen or not to screen prior to transplant?,Laura Alicia Barcan; Argentina); Oscar Len; Spain),S0085,08:30,,"HHV-8 Screening Alessandra Mularoni (Palermo, 
Italy)"
11 April 2025,SY031,08:30 - 10:30,6,2-hour Symposium,To screen or not to screen prior to transplant?,Laura Alicia Barcan; Argentina); Oscar Len; Spain),S0086,09:00,,"TB screening and prevention in endemic 
regions Rubina Naqvi (Karachi, Pakistan)"
11 April 2025,EW026,16:15 - 18:15,3,Educational Session,New insights into antifungal agents and resistance,Anuradha Chowdhary; India); Jon Salmanton-Garcia; Germany),W026,16:15,- 18:15,"Hall 3
Educational Session
New insights into antifungal agents and resistance
Chairs Anuradha Chowdhary (New Delhi, India)"
11 April 2025,EW026,16:15 - 18:15,3,Educational Session,New insights into antifungal agents and resistance,Anuradha Chowdhary; India); Jon Salmanton-Garcia; Germany),W0065,16:15,,"Emerging resistance in Candida tropicalisSharon 
Chen (Sydney, Australia)"
11 April 2025,EW026,16:15 - 18:15,3,Educational Session,New insights into antifungal agents and resistance,Anuradha Chowdhary; India); Jon Salmanton-Garcia; Germany),W0066,16:35,,"Mechanisms of resistance in Candida glabrataDavid 
Perlin (Nutley, United States)"
11 April 2025,EW026,16:15 - 18:15,3,Educational Session,New insights into antifungal agents and resistance,Anuradha Chowdhary; India); Jon Salmanton-Garcia; Germany),W0067,16:55,,"Surveillance of resistance in Aspergillus  
species Maiken Cavling Arendrup (Copenhagen, 
Denmark)"
11 April 2025,EW026,16:15 - 18:15,3,Educational Session,New insights into antifungal agents and resistance,Anuradha Chowdhary; India); Jon Salmanton-Garcia; Germany),W0068,17:15,,"Environmental surveillance for antifungal 
resistance Eveline Snelders (Wageningen, 
Netherlands)"
11 April 2025,EW027,16:15 - 18:15,5,Educational Session,Going Viral! Phage Therapy Clinical rounds,Gregory German; Canada); Ameneh Khatami; Australia),W0069,16:15,,"Clinical cases and lessons from the STAMP 
protocol Holly Sinclair (Nsw, Australia)"
11 April 2025,EW027,16:15 - 18:15,5,Educational Session,Going Viral! Phage Therapy Clinical rounds,Gregory German; Canada); Ameneh Khatami; Australia),W0070,16:35,,"Difficult cases treated with phages Ghady Haidar 
(Pittsburgh, United States)"
11 April 2025,EW027,16:15 - 18:15,5,Educational Session,Going Viral! Phage Therapy Clinical rounds,Gregory German; Canada); Ameneh Khatami; Australia),W0071,16:55,,"Challenging osteoarticular cases treated with 
phages Tristan Ferry (Lyon, France)"
11 April 2025,EW028,16:15 - 18:15,6,Educational Session,Addressing infection challenges in immunocompromised patients: a case-,Maddalena Giannella; Italy); Asma Nasim; Pakistan),W0073,16:15,,"Challenges in managing gastrointestinal infections in 
patients with primary immunodeficiency Effrossyni 
Gkrania-Klotsas (Cambridge, United Kingdom)"
11 April 2025,EW028,16:15 - 18:15,6,Educational Session,Addressing infection challenges in immunocompromised patients: a case-,Maddalena Giannella; Italy); Asma Nasim; Pakistan),W0074,16:35,,"Respiratory infections in patients receiving CAR-T 
cells or bispecific monoclonal antibodies Gemma 
Reynolds (Heidelberg, Australia)"
11 April 2025,EW028,16:15 - 18:15,6,Educational Session,Addressing infection challenges in immunocompromised patients: a case-,Maddalena Giannella; Italy); Asma Nasim; Pakistan),W0075,16:55,,"Mycobacterial infections in patients with HIV 
infection Graeme Ayton Meintjes (Observatory, South 
Africa)"
11 April 2025,EW028,16:15 - 18:15,6,Educational Session,Addressing infection challenges in immunocompromised patients: a case-,Maddalena Giannella; Italy); Asma Nasim; Pakistan),W0076,17:15,,"Breakthrough fungal infections in haematopoietic 
cancer and in stem cell transplantation Dimitrios P. 
Kontoyiannis (Houston, Tx, United States)"
11 April 2025,EW029,16:15 - 18:15,8,Educational Session,"Impact of diabetes on infectious diseases: what should we know?Chairs Mark G. J. De Boer (Leiden, Netherlands)",Mark G. J. De Boer; Netherlands); Suzanne Van Asten; Netherlands),W0077,16:15,,"The impact of diabetes and host-pathogen interaction 
and gut microbiome Reinout Van Crevel (Nijmegen, 
Netherlands)"
11 April 2025,EW029,16:15 - 18:15,8,Educational Session,"Impact of diabetes on infectious diseases: what should we know?Chairs Mark G. J. De Boer (Leiden, Netherlands)",Mark G. J. De Boer; Netherlands); Suzanne Van Asten; Netherlands),W0078,16:35,,"Diabetes and invasive fungal infections Jochem Buil 
(Nijmegen, Netherlands)"
11 April 2025,EW030,16:15 - 18:15,9,Educational Session,Primer on infection prevention and control: the crucial support by clinical,Nico Tom Mutters; Germany); Margreet C. Vos; Netherlands),W0081,16:15,Microbial fundamentals:,"building blocks of infection 
prevention and control Laurence Armand-Lefevre 
(Paris, France)"
11 April 2025,EW030,16:15 - 18:15,9,Educational Session,Primer on infection prevention and control: the crucial support by clinical,Nico Tom Mutters; Germany); Margreet C. Vos; Netherlands),W0083,16:55,,"The crucial role of molecular typing in infection 
control Stefanie Kampmeier (Würzburg, Germany)"
11 April 2025,SY036,08:30 - 10:30,15,2-hour Symposium,The quality of antibiotics used in the communities of LMICs,Thi Thuy Nga Do; Vietnam); Christina Obiero; Kenya),Y036,08:30,- 10:30,"Hall 15
2-hour Symposium
The quality of antibiotics used in the communities of LMICs
Chairs Thi Thuy Nga Do (Ha Noi, Vietnam)"
11 April 2025,SY036,08:30 - 10:30,15,2-hour Symposium,The quality of antibiotics used in the communities of LMICs,Thi Thuy Nga Do; Vietnam); Christina Obiero; Kenya),S0105,08:30,,"The quality of antibiotics and their potential impact on 
patient outcome and AMR Paul Newton (Oxford, 
United Kingdom)"
11 April 2025,SY036,08:30 - 10:30,15,2-hour Symposium,The quality of antibiotics used in the communities of LMICs,Thi Thuy Nga Do; Vietnam); Christina Obiero; Kenya),S0106,09:00,,"Community antibiotic access and use in Sub-Sahara 
Africa Samuel Afari-Asiedu (Kintampo, Ghana)"
11 April 2025,SY036,08:30 - 10:30,15,2-hour Symposium,The quality of antibiotics used in the communities of LMICs,Thi Thuy Nga Do; Vietnam); Christina Obiero; Kenya),S0107,09:30,,"Encountered challenges and reflections on 
conducting multi-country medicine quality 
studies Noudy Sengxeu (Vientiane Capital, Lao 
People's democratic republic)"
11 April 2025,SY036,08:30 - 10:30,15,2-hour Symposium,The quality of antibiotics used in the communities of LMICs,Thi Thuy Nga Do; Vietnam); Christina Obiero; Kenya),S0108,10:00,,"Confusion in appearance of common used antibiotics 
in LMICs Heiman Wertheim (Nijmegen, Netherlands)"
11 April 2025,SY031,08:30 - 10:30,6,2-hour Symposium,To screen or not to screen prior to transplant?,Laura Alicia Barcan; Argentina); Oscar Len; Spain),S0085,08:30,,"HHV-8 Screening Alessandra Mularoni (Palermo, 
Italy)"
11 April 2025,SY031,08:30 - 10:30,6,2-hour Symposium,To screen or not to screen prior to transplant?,Laura Alicia Barcan; Argentina); Oscar Len; Spain),S0086,09:00,,"TB screening and prevention in endemic 
regions Rubina Naqvi (Karachi, Pakistan)"
11 April 2025,SY031,08:30 - 10:30,6,2-hour Symposium,To screen or not to screen prior to transplant?,Laura Alicia Barcan; Argentina); Oscar Len; Spain),S0087,09:30,,"Screening for and prevention of chagas in 
immunocompromised hosts Marcelo Victor Radisic 
(Buenos Aires, Argentina)"
11 April 2025,SY031,08:30 - 10:30,6,2-hour Symposium,To screen or not to screen prior to transplant?,Laura Alicia Barcan; Argentina); Oscar Len; Spain),S0088,10:00,,"Screening of lung donors for Molicutes Michael G Ison 
(Derwood (MD)"
11 April 2025,SY031,08:30 - 10:30,6,2-hour Symposium,To screen or not to screen prior to transplant?,Laura Alicia Barcan; Argentina); Oscar Len; Spain),F003,08:30,- 09:30,"Arena 1
ePoster Flash Session
On the frontiers of vaccine driven prevention
Chair Maria Ganczak (Zielona Gora, Poland)"
11 April 2025,SY031,08:30 - 10:30,6,2-hour Symposium,To screen or not to screen prior to transplant?,Laura Alicia Barcan; Argentina); Oscar Len; Spain),F004,08:30,- 09:30,"Arena 3
ePoster Flash Session
Pharmacology from bench to the bedside
Chair Alina Karoline Nussbaumer-Pröll (Wien, Österreich, 
Austria)"
11 April 2025,SY034,08:30 - 10:30,10,2-hour Symposium,Endoscopy: infection risks and mitigation,Elisabeth Presterl; Austria); Gordon Ramage; United Kingdom),S0098,09:00,,"Prevention of multidrug-resistant infections from 
contaminated duodenoscopes Margreet C. Vos 
(Rotterdam, Netherlands)"
11 April 2025,SY034,08:30 - 10:30,10,2-hour Symposium,Endoscopy: infection risks and mitigation,Elisabeth Presterl; Austria); Gordon Ramage; United Kingdom),S0087,09:30,,"Screening for and prevention of chagas in 
immunocompromised hosts Marcelo Victor Radisic 
(Buenos Aires, Argentina)"
11 April 2025,SY034,08:30 - 10:30,10,2-hour Symposium,Endoscopy: infection risks and mitigation,Elisabeth Presterl; Austria); Gordon Ramage; United Kingdom),S0088,10:00,,"Screening of lung donors for Molicutes Michael G Ison 
(Derwood (MD)"
11 April 2025,SY034,08:30 - 10:30,10,2-hour Symposium,Endoscopy: infection risks and mitigation,Elisabeth Presterl; Austria); Gordon Ramage; United Kingdom),F003,08:30,- 09:30,"Arena 1
ePoster Flash Session
On the frontiers of vaccine driven prevention
Chair Maria Ganczak (Zielona Gora, Poland)"
11 April 2025,SY034,08:30 - 10:30,10,2-hour Symposium,Endoscopy: infection risks and mitigation,Elisabeth Presterl; Austria); Gordon Ramage; United Kingdom),F004,08:30,- 09:30,"Arena 3
ePoster Flash Session
Pharmacology from bench to the bedside
Chair Alina Karoline Nussbaumer-Pröll (Wien, Österreich, 
Austria)"
11 April 2025,SY034,08:30 - 10:30,10,2-hour Symposium,Endoscopy: infection risks and mitigation,Elisabeth Presterl; Austria); Gordon Ramage; United Kingdom),S0098,09:00,,"Prevention of multidrug-resistant infections from 
contaminated duodenoscopes Margreet C. Vos 
(Rotterdam, Netherlands)"
11 April 2025,OS002,08:30 - 10:30,11,,,Benjamin Peter Howden; Australia); Paula Mölling; Sweden); O0011  Nanopore metagenomic sequencing for rapid; bloodstream infection diagnostics evaluated in a; prospective observational study H.L. Nielsen*; (Aalborg; Denmark); C. Thygesen; K.K. Søgaard; A.B.; Sørensen; S.M. Karst; A.L. Krarup; M. Albertsen; O0012  Interpretative Criteria for Adjudicating Clinical; Significance to Next-Generation Sequencing Results; from Bronchial-alveolar Lavage and Bronchial; Wash. J. Alexander*; United States); A.; Charles; O0013  Implementing same-day respiratory metagenomic; diagnostics in paediatric intensive care R. Hammond*; (London; United Kingdom); A. Kopec; J. Brown; J.; Hatcher; A. Alcolea-Medina; R. Batra; D. Ward; L.B.; Snell; J. Breuer; O0014  Detection of pathogenic microorganisms using; metagenomic next-generation sequencing in ICU; patients with ongoing antibiotic therapy T.; Schroeder*; Germany); M. Eliwi Alsaffan; A. Dervishi; P. Kawaletz; H. Stäudle; O0015  Analysis of metagenomic pathogen detection; compared to conventional diagnostics: clinical usage; and relevance for patient outcomes E. Siegel*; Germany); V. Bianco-Wilhelmi; S. Koch; C. Seckert; C.; Hamm; D. Teschner; O. Kriege; D. Grimm; I.; Sagoschen; D. Schreiner; M. Bodenstein; G. Cakas; S.; Hagge; S. Vieira-Silva; T. Sparwasser; O0016  Same-day pan-microbial metagenomics for; personalized therapy and pathogen surveillance on; the intensive care unit: a single-centre prospective; study L.B. Snell*; United Kingdom); A.; Alcolea-Medina; G. Humayun; N. Al-Yaakoubi; D.; Ward; C. Alder; V. Patel; F. Vivian; C. Meadows; W.; Duncan; R. Paul; N. Barrett; R. Batra; J. Edgeworth; J.; Whitehorn; G. Nebbia; O0017  Evaluation of the diagnostic efficacy of targeted next-; generation sequencing in the detection of pathogens; in bronchoalveolar lavage fluid from patients with; lower respiratory tract infections in ICU B. Ran*; (Taiyuan; China); Y. Liu; X. Wu; X. Lin; X. Li; Q. Zhan; C.; Wang; L. Huang; T. Zhai; Y. Cai; Y. Song; Q. Zhang; C.; Zhang; J. Hao; L. Jin; Z. Huang; O0018  Prognostic and diagnostic value of Next-generation; sequencing in female reproductive tract infection and; HPV persistence C. Peng*; China); S. Qi; C.; Jiachang; P. Chunyan; W. Taiquan; X. Xianru; Y.; Jianying; Y. Qirong; Z. Pengyuan; L. Jun; O0019  A promising approach to rapid; non-culture diagnosis; of invasive fungal infections; generation sequencing; (Pittsburgh; United States); H. Badrane; B.A. Stevens; S. Cheng; G. Guigon; E. Santiago; M. Rambaud; B.; Hao; E. Driscoll; W. Maynard; C. Clancy; O0020  Implementation of Clinical Metagenomics in France:; Insights from a Five-Years Study M. Dutkiewicz*; (Paris; France); T. Ghelfenstein-Ferreira; L. Feghoul; S. Mercier-Delarue; A. Senhaji; A.L. Munier; F.; Caméléna; J. Le Goff; M. Salmona,S002,08:30,- 10:30,"Hall 11
2-hour Oral Session
Translating metagenomics into clinical practice
Chairs Benjamin Peter Howden (Parkville (Victoria)"
11 April 2025,SY035,08:30 - 10:30,12,2-hour Symposium,Barriers to TB/HIV elimination in low- and high-incidence settings,,S0101,08:30,HIV and TB epidemic: the storm hasn’,"t subsided 
yetTetiana Koval (Poltava, Ukraine)"
11 April 2025,SY035,08:30 - 10:30,12,2-hour Symposium,Barriers to TB/HIV elimination in low- and high-incidence settings,,S0102,09:00,,"Approaches for latent and active TB screening in people living with HIV Raimonda Matulionyte (Vilnius, 
Lithuania)"
11 April 2025,SY035,08:30 - 10:30,12,2-hour Symposium,Barriers to TB/HIV elimination in low- and high-incidence settings,,S0103,09:30,,"Integration of HIV and TB care to improve patient 
outcome in resource-limited settings Akaki Abutidze 
(Tbilisi, Georgia)"
11 April 2025,EW041,08:30 - 10:30,13,Educational Session,"RSV infections: diagnosis, surveillance and treatment in the advent of",,W0126,08:30,"Costs of RSV infection,","compared to other 
respiratory viruses Barbara Rath (Besançon, France)"
11 April 2025,EW041,08:30 - 10:30,13,Educational Session,"RSV infections: diagnosis, surveillance and treatment in the advent of",,W0128,09:10,RSV surveillance in the EU/,"EEA in the vaccine 
eraEeva Broberg (Solna, Sweden)"
11 April 2025,EW041,08:30 - 10:30,13,Educational Session,"RSV infections: diagnosis, surveillance and treatment in the advent of",,W0129,09:30,RSV fusion inhibitors and monoclonals:,"current 
status and future developments Peter Openshaw 
(London, United Kingdom)"
11 April 2025,EW042,08:30 - 10:30,14,Educational Session,Traumatic wound infections: diagnosis and treatment options,Amparo Fernández-Rodríguez; Spain); Veroniek Saegeman; Belgium),W0130,08:30,,"Multidrug-resistant infections after trauma in 
warzone Shehan Hettiaratchy (Hampton, United 
Kingdom)"
11 April 2025,EW042,08:30 - 10:30,14,Educational Session,Traumatic wound infections: diagnosis and treatment options,Amparo Fernández-Rodríguez; Spain); Veroniek Saegeman; Belgium),W0131,08:50,,"Fungal infections during natural disasters Anuradha 
Chowdhary (New Delhi, India)"
11 April 2025,EW042,08:30 - 10:30,14,Educational Session,Traumatic wound infections: diagnosis and treatment options,Amparo Fernández-Rodríguez; Spain); Veroniek Saegeman; Belgium),W0132,09:10,,"Bacteriophage therapy for multidrug-resistant wound 
infections in trauma Tristan Ferry (Lyon, France)"
11 April 2025,EW042,08:30 - 10:30,14,Educational Session,Traumatic wound infections: diagnosis and treatment options,Amparo Fernández-Rodríguez; Spain); Veroniek Saegeman; Belgium),W0133,09:30,,"Infection of burn wounds Nur Benzonana (Istanbul, 
Türkiye)"
11 April 2025,SY037,08:30 - 10:30,16,2-hour Symposium,Unveiling the challenges: nosocomial infections in ECMO-supported patients,Antonios Katsounas; Germany); Jordi Riera; Spain),S0109,08:30,,"Source of infection and pathogens Christian Eckmann 
(Hannover, Germany)"
11 April 2025,SY037,08:30 - 10:30,16,2-hour Symposium,Unveiling the challenges: nosocomial infections in ECMO-supported patients,Antonios Katsounas; Germany); Jordi Riera; Spain),S0110,09:00,,"Prophylaxis and empiric treatment Giacomo Grasselli 
(Besana In Brianza, Italy)"
11 April 2025,SY037,08:30 - 10:30,16,2-hour Symposium,Unveiling the challenges: nosocomial infections in ECMO-supported patients,Antonios Katsounas; Germany); Jordi Riera; Spain),S0111,09:30,,"Diagnostic criteria and definitions Graeme Maclaren 
(Singapore, Singapore)"
11 April 2025,SY037,08:30 - 10:30,16,2-hour Symposium,Unveiling the challenges: nosocomial infections in ECMO-supported patients,Antonios Katsounas; Germany); Jordi Riera; Spain),S0112,10:00,,"Microbial films Marta Hernández-Meneses 
(Barcelona, Spain)"
11 April 2025,OS002,08:30 - 10:30,11,,,Benjamin Peter Howden; Australia); Paula Mölling; Sweden); O0011  Nanopore metagenomic sequencing for rapid; bloodstream infection diagnostics evaluated in a; prospective observational study H.L. Nielsen*; (Aalborg; Denmark); C. Thygesen; K.K. Søgaard; A.B.; Sørensen; S.M. Karst; A.L. Krarup; M. Albertsen; O0012  Interpretative Criteria for Adjudicating Clinical; Significance to Next-Generation Sequencing Results; from Bronchial-alveolar Lavage and Bronchial; Wash. J. Alexander*; United States); A.; Charles; O0013  Implementing same-day respiratory metagenomic; diagnostics in paediatric intensive care R. Hammond*; (London; United Kingdom); A. Kopec; J. Brown; J.; Hatcher; A. Alcolea-Medina; R. Batra; D. Ward; L.B.; Snell; J. Breuer; O0014  Detection of pathogenic microorganisms using; metagenomic next-generation sequencing in ICU; patients with ongoing antibiotic therapy T.; Schroeder*; Germany); M. Eliwi Alsaffan; A. Dervishi; P. Kawaletz; H. Stäudle; O0015  Analysis of metagenomic pathogen detection; compared to conventional diagnostics: clinical usage; and relevance for patient outcomes E. Siegel*; Germany); V. Bianco-Wilhelmi; S. Koch; C. Seckert; C.; Hamm; D. Teschner; O. Kriege; D. Grimm; I.; Sagoschen; D. Schreiner; M. Bodenstein; G. Cakas; S.; Hagge; S. Vieira-Silva; T. Sparwasser; O0016  Same-day pan-microbial metagenomics for; personalized therapy and pathogen surveillance on; the intensive care unit: a single-centre prospective; study L.B. Snell*; United Kingdom); A.; Alcolea-Medina; G. Humayun; N. Al-Yaakoubi; D.; Ward; C. Alder; V. Patel; F. Vivian; C. Meadows; W.; Duncan; R. Paul; N. Barrett; R. Batra; J. Edgeworth; J.; Whitehorn; G. Nebbia; O0017  Evaluation of the diagnostic efficacy of targeted next-; generation sequencing in the detection of pathogens; in bronchoalveolar lavage fluid from patients with; lower respiratory tract infections in ICU B. Ran*; (Taiyuan; China); Y. Liu; X. Wu; X. Lin; X. Li; Q. Zhan; C.; Wang; L. Huang; T. Zhai; Y. Cai; Y. Song; Q. Zhang; C.; Zhang; J. Hao; L. Jin; Z. Huang; O0018  Prognostic and diagnostic value of Next-generation; sequencing in female reproductive tract infection and; HPV persistence C. Peng*; China); S. Qi; C.; Jiachang; P. Chunyan; W. Taiquan; X. Xianru; Y.; Jianying; Y. Qirong; Z. Pengyuan; L. Jun; O0019  A promising approach to rapid; non-culture diagnosis; of invasive fungal infections; generation sequencing; (Pittsburgh; United States); H. Badrane; B.A. Stevens; S. Cheng; G. Guigon; E. Santiago; M. Rambaud; B.; Hao; E. Driscoll; W. Maynard; C. Clancy; O0020  Implementation of Clinical Metagenomics in France:; Insights from a Five-Years Study M. Dutkiewicz*; (Paris; France); T. Ghelfenstein-Ferreira; L. Feghoul; S. Mercier-Delarue; A. Senhaji; A.L. Munier; F.; Caméléna; J. Le Goff; M. Salmona,S002,08:30,- 10:30,"Hall 11
2-hour Oral Session
Translating metagenomics into clinical practice
Chairs Benjamin Peter Howden (Parkville (Victoria)"
11 April 2025,SY035,08:30 - 10:30,12,2-hour Symposium,Barriers to TB/HIV elimination in low- and high-incidence settings,,S0101,08:30,HIV and TB epidemic: the storm hasn’,"t subsided 
yetTetiana Koval (Poltava, Ukraine)"
11 April 2025,SY035,08:30 - 10:30,12,2-hour Symposium,Barriers to TB/HIV elimination in low- and high-incidence settings,,S0102,09:00,,"Approaches for latent and active TB screening in people living with HIV Raimonda Matulionyte (Vilnius, 
Lithuania)"
11 April 2025,SY035,08:30 - 10:30,12,2-hour Symposium,Barriers to TB/HIV elimination in low- and high-incidence settings,,S0103,09:30,,"Integration of HIV and TB care to improve patient 
outcome in resource-limited settings Akaki Abutidze 
(Tbilisi, Georgia)"
11 April 2025,EW041,08:30 - 10:30,13,Educational Session,"RSV infections: diagnosis, surveillance and treatment in the advent of",,W0126,08:30,"Costs of RSV infection,","compared to other 
respiratory viruses Barbara Rath (Besançon, France)"
11 April 2025,EW041,08:30 - 10:30,13,Educational Session,"RSV infections: diagnosis, surveillance and treatment in the advent of",,W0128,09:10,RSV surveillance in the EU/,"EEA in the vaccine 
eraEeva Broberg (Solna, Sweden)"
11 April 2025,EW041,08:30 - 10:30,13,Educational Session,"RSV infections: diagnosis, surveillance and treatment in the advent of",,W0129,09:30,RSV fusion inhibitors and monoclonals:,"current 
status and future developments Peter Openshaw 
(London, United Kingdom)"
11 April 2025,EW042,08:30 - 10:30,14,Educational Session,Traumatic wound infections: diagnosis and treatment options,Amparo Fernández-Rodríguez; Spain); Veroniek Saegeman; Belgium),W0130,08:30,,"Multidrug-resistant infections after trauma in 
warzone Shehan Hettiaratchy (Hampton, United 
Kingdom)"
11 April 2025,EW042,08:30 - 10:30,14,Educational Session,Traumatic wound infections: diagnosis and treatment options,Amparo Fernández-Rodríguez; Spain); Veroniek Saegeman; Belgium),W0131,08:50,,"Fungal infections during natural disasters Anuradha 
Chowdhary (New Delhi, India)"
11 April 2025,EW042,08:30 - 10:30,14,Educational Session,Traumatic wound infections: diagnosis and treatment options,Amparo Fernández-Rodríguez; Spain); Veroniek Saegeman; Belgium),W0132,09:10,,"Bacteriophage therapy for multidrug-resistant wound 
infections in trauma Tristan Ferry (Lyon, France)"
11 April 2025,EW042,08:30 - 10:30,14,Educational Session,Traumatic wound infections: diagnosis and treatment options,Amparo Fernández-Rodríguez; Spain); Veroniek Saegeman; Belgium),W0133,09:30,,"Infection of burn wounds Nur Benzonana (Istanbul, 
Türkiye)"
11 April 2025,SY037,08:30 - 10:30,16,2-hour Symposium,Unveiling the challenges: nosocomial infections in ECMO-supported patients,Antonios Katsounas; Germany); Jordi Riera; Spain),S0109,08:30,,"Source of infection and pathogens Christian Eckmann 
(Hannover, Germany)"
11 April 2025,SY037,08:30 - 10:30,16,2-hour Symposium,Unveiling the challenges: nosocomial infections in ECMO-supported patients,Antonios Katsounas; Germany); Jordi Riera; Spain),S0110,09:00,,"Prophylaxis and empiric treatment Giacomo Grasselli 
(Besana In Brianza, Italy)"
11 April 2025,SY037,08:30 - 10:30,16,2-hour Symposium,Unveiling the challenges: nosocomial infections in ECMO-supported patients,Antonios Katsounas; Germany); Jordi Riera; Spain),S0111,09:30,,"Diagnostic criteria and definitions Graeme Maclaren 
(Singapore, Singapore)"
11 April 2025,SY037,08:30 - 10:30,16,2-hour Symposium,Unveiling the challenges: nosocomial infections in ECMO-supported patients,Antonios Katsounas; Germany); Jordi Riera; Spain),S0112,10:00,,"Microbial films Marta Hernández-Meneses 
(Barcelona, Spain)"
11 April 2025,EW039,08:30 - 10:30,2,Educational Session,Are urinary tract infections still the same?,Suzanne Geerlings; Netherlands); Agnes Maria Sonnevend; Hungary),W0118,08:30,,"Update on paediatric UTI Michael Buettcher (Luzern, 
Switzerland)"
11 April 2025,EW039,08:30 - 10:30,2,Educational Session,Are urinary tract infections still the same?,Suzanne Geerlings; Netherlands); Agnes Maria Sonnevend; Hungary),W0119,08:50,,"Diagnosis and treatment of UTI in the era of 
antimicrobial resistance Jennifer Kranz (Aachen, 
Germany)"
11 April 2025,EW039,08:30 - 10:30,2,Educational Session,Are urinary tract infections still the same?,Suzanne Geerlings; Netherlands); Agnes Maria Sonnevend; Hungary),W0120,09:10,Can UTI be prevented?,"Chris Harding (Newcastle 
Upon Tyne, United Kingdom)"
11 April 2025,EW039,08:30 - 10:30,2,Educational Session,Are urinary tract infections still the same?,Suzanne Geerlings; Netherlands); Agnes Maria Sonnevend; Hungary),W0121,09:30,,"Fungal and parasitic infections of the urinary 
tract Gladys Mbwanji (Mwanza, Tanzania, United 
republic of)"
11 April 2025,EW040,08:30 - 10:30,3,Educational Session,OPAT: from aged wine to new vintage,Birgit Koch; Netherlands); Sonia Luque; Spain),W0122,08:30,"OPAT: principles,","practice and checklists Charlotte 
Quintens (Leuven, Belgium)"
11 April 2025,EW040,08:30 - 10:30,3,Educational Session,OPAT: from aged wine to new vintage,Birgit Koch; Netherlands); Sonia Luque; Spain),W0123,08:50,COPAT:,"complex outpatient parenteral antimicrobial 
therapy Ronald Andrew Seaton (Glasgow, United 
Kingdom)"
11 April 2025,EW040,08:30 - 10:30,3,Educational Session,OPAT: from aged wine to new vintage,Birgit Koch; Netherlands); Sonia Luque; Spain),W0125,09:30,,"New OPAT safety and efficacy data to guide 
practice Matthew Rawlins (Murdoch, Australia)"
11 April 2025,EW038,08:30 - 11:30,4,Educational Session,EUCAST Educational Workshop,Marlene Amara; France); Alasdair P. Macgowan; United Kingdom),W038,08:30,- 11:30,"Hall 4
Educational Session
EUCAST Educational Workshop
Chairs Marlene Amara (Le Chesnay Cedex, France)"
11 April 2025,EW038,08:30 - 11:30,4,Educational Session,EUCAST Educational Workshop,Marlene Amara; France); Alasdair P. Macgowan; United Kingdom),W0113,08:30,,"EUCAST update Sören G. Gatermann (Bochum, 
Germany)"
11 April 2025,EW038,08:30 - 11:30,4,Educational Session,EUCAST Educational Workshop,Marlene Amara; France); Alasdair P. Macgowan; United Kingdom),W0114,08:50,"Setting clinical breakpoints,","assessing 
evidence Anouk Edwina Muller (The Hague, 
Netherlands)"
11 April 2025,EW038,08:30 - 11:30,4,Educational Session,EUCAST Educational Workshop,Marlene Amara; France); Alasdair P. Macgowan; United Kingdom),W0115,09:10,,"Benzylpenicillin susceptibility testing of S. 
pneumoniae  by disk diffusion Gunnar Kahlmeter 
(Tävelsås, Sweden)"
11 April 2025,EW038,08:30 - 11:30,4,Educational Session,EUCAST Educational Workshop,Marlene Amara; France); Alasdair P. Macgowan; United Kingdom),W0116,09:30,,"What to do when there are no breakpoints Barbara 
Juliane Holzknecht (Copenhagen, Denmark)"
11 April 2025,EW038,08:30 - 11:30,4,Educational Session,EUCAST Educational Workshop,Marlene Amara; France); Alasdair P. Macgowan; United Kingdom),W0117,09:50,,"Detection of resistance mechanisms Christian Giske 
(Stockholm, Sweden)"
11 April 2025,OS001,08:30 - 10:30,5,,,Alessandra Carattoli; Italy); Prasannakumar Palanikumar; India)O0001  Decoding the role of bla CPE-carrying plasmids on; wings: A holistic view using the One Health; approach S.A. Martínez-Álvarez*; Spain); P. Châtre; T. Cardona-Cabrera; P. François; U.; Höfle; M. Zarazaga; J.Y. Madec; M. Haenni; C.; Torres; O0002  A novel isolation room model leveraging culture-; independent Hi-C metagenomics for tracking; antimicrobial resistance transmission between; patients and hospital environmental reservoirs V.; Koh*; Singapore); R. Cabrera; J. Chua; J.S. Lee; N.S.B. Haidi Fitri; Z.X. Tan; X. Huan; N.M.; Thevasagayam; T.K.B. Lee; K. Marimuthu; O.T. Ng; O0003  Deciphering the pathogenic potentials and; epidemiological identities of Staphylococcus; pseudintermedius  colonizing companion dogs in; Sao Paulo I.B. Moses*; Brazil); L. Sartori; D.A. Henriques; M.M. Marini; F.M. Lima; R.X.; Espinosa; I. Orlandino Da Silva; F.F. Santos; L.; Gonzaga; A.T. Ribeiro De Vasconcelos; A.C. Gales; O0004  Recent progress towards integrated surveillance of; antimicrobial resistance in France L. Collineau*; (Lyon; France); S. Bareille; G. Birgand; L. Lacmago; B. Lange; O. Lemenand; C. Chauvin; O0005  Exploring the plasmidome of 3rd generation; cephalosporin-resistant Enterobacterales in wild; birds: Insights into horizontal gene transfer and; AMR dissemination B. Timmer*; Hungary); L. Miló; B. Koleszár; C. Freytag; Á. Lovas-; Kiss; L. Laczkó; G. Kardos; O0006  Emergence of mobile colistin resistance in; Klebsiella  at human-animal-environment interface; in Bangladesh S. Rahman*; United; Kingdom); A. Pondit; J. Parkhill; S. Saha; S.M.R.; Islam; P.I. Disha; S.A. Nasreen; M.A.K. Azad; T.; Walsh; R. Farzana; O0007  Unveiling the invisible: antimicrobial resistance; genes and pathogenic microbial diversity in sewage; of North India's largest industrial hub; A; metagenomic perspective I. Singh*; India); R. Sharma; A. Arora; B. Mohan; N. Taneja; O0008  Culturomics as a tool for ONE HEALTH approach:; Unveiling the role of unknown microorganisms as; antibiotic resistance carriers in wastewater; samples E. Ouranou*; Greece); A.; Psaroulaki; D. Chochlakis; M. Malliarou; K.; Tryfinopoulou; A. Ntoula; E. Intze; I. Lagouvardos; O0009  One Health intervention impacts on antibiotic; resistance in Denmark; England and Senegal: A; mathematical model comparison G. Knight*; (London; United Kingdom); R. Booton; J.V.; Robotham; K. Aluzaite; D. Belay; J. Guitian; M.; Dione; E. Emes; O0010  Clinically important sequence types and resistance; genes in Enterobacteriaceae  from coastal; environments and gulls V. Silva*; Portugal); M. Quintelas; M. Caniça; R. Rivière; P. Poeta; G.; Igrejas,S001,08:30,- 10:30,"Hall 5
2-hour Oral Session
One Health means resistance everywhere
Chairs Alessandra Carattoli (Rome, Italy)"
11 April 2025,SY032,08:30 - 10:30,7,2-hour Symposium,New insights into Candida  pathogenesis,Aleksandra Barac; Serbia); Joshua Nosanchuk; United States),Y032,08:30,- 10:30,"Hall 7
2-hour Symposium
New insights into Candida  pathogenesis
Chairs Aleksandra Barac (Belgrade, Serbia)"
11 April 2025,SY032,08:30 - 10:30,7,2-hour Symposium,New insights into Candida  pathogenesis,Aleksandra Barac; Serbia); Joshua Nosanchuk; United States),S0089,08:30,,"Insights into the evolution of Candida  under 
antifungal pressure Attila Gacser (Szeged, Hungary)"
11 April 2025,SY032,08:30 - 10:30,7,2-hour Symposium,New insights into Candida  pathogenesis,Aleksandra Barac; Serbia); Joshua Nosanchuk; United States),S0091,09:30,The commensal to pathogen transition:,"kind to 
killer Ilse D. Jacobsen (Jena, Germany)"
11 April 2025,SY032,08:30 - 10:30,7,2-hour Symposium,New insights into Candida  pathogenesis,Aleksandra Barac; Serbia); Joshua Nosanchuk; United States),S0092,10:00,Fungal-bacterial interactions: who wins?,"Rebecca Hall 
(Canterbury, United Kingdom)"
11 April 2025,EW039,08:30 - 10:30,2,Educational Session,Are urinary tract infections still the same?,Suzanne Geerlings; Netherlands); Agnes Maria Sonnevend; Hungary),W0118,08:30,,"Update on paediatric UTI Michael Buettcher (Luzern, 
Switzerland)"
11 April 2025,EW039,08:30 - 10:30,2,Educational Session,Are urinary tract infections still the same?,Suzanne Geerlings; Netherlands); Agnes Maria Sonnevend; Hungary),W0119,08:50,,"Diagnosis and treatment of UTI in the era of 
antimicrobial resistance Jennifer Kranz (Aachen, 
Germany)"
11 April 2025,EW039,08:30 - 10:30,2,Educational Session,Are urinary tract infections still the same?,Suzanne Geerlings; Netherlands); Agnes Maria Sonnevend; Hungary),W0120,09:10,Can UTI be prevented?,"Chris Harding (Newcastle 
Upon Tyne, United Kingdom)"
11 April 2025,EW039,08:30 - 10:30,2,Educational Session,Are urinary tract infections still the same?,Suzanne Geerlings; Netherlands); Agnes Maria Sonnevend; Hungary),W0121,09:30,,"Fungal and parasitic infections of the urinary 
tract Gladys Mbwanji (Mwanza, Tanzania, United 
republic of)"
11 April 2025,EW040,08:30 - 10:30,3,Educational Session,OPAT: from aged wine to new vintage,Birgit Koch; Netherlands); Sonia Luque; Spain),W0122,08:30,"OPAT: principles,","practice and checklists Charlotte 
Quintens (Leuven, Belgium)"
11 April 2025,EW040,08:30 - 10:30,3,Educational Session,OPAT: from aged wine to new vintage,Birgit Koch; Netherlands); Sonia Luque; Spain),W0123,08:50,COPAT:,"complex outpatient parenteral antimicrobial 
therapy Ronald Andrew Seaton (Glasgow, United 
Kingdom)"
11 April 2025,EW040,08:30 - 10:30,3,Educational Session,OPAT: from aged wine to new vintage,Birgit Koch; Netherlands); Sonia Luque; Spain),W0125,09:30,,"New OPAT safety and efficacy data to guide 
practice Matthew Rawlins (Murdoch, Australia)"
11 April 2025,EW038,08:30 - 11:30,4,Educational Session,EUCAST Educational Workshop,Marlene Amara; France); Alasdair P. Macgowan; United Kingdom),W038,08:30,- 11:30,"Hall 4
Educational Session
EUCAST Educational Workshop
Chairs Marlene Amara (Le Chesnay Cedex, France)"
11 April 2025,EW038,08:30 - 11:30,4,Educational Session,EUCAST Educational Workshop,Marlene Amara; France); Alasdair P. Macgowan; United Kingdom),W0113,08:30,,"EUCAST update Sören G. Gatermann (Bochum, 
Germany)"
11 April 2025,EW038,08:30 - 11:30,4,Educational Session,EUCAST Educational Workshop,Marlene Amara; France); Alasdair P. Macgowan; United Kingdom),W0114,08:50,"Setting clinical breakpoints,","assessing 
evidence Anouk Edwina Muller (The Hague, 
Netherlands)"
11 April 2025,EW038,08:30 - 11:30,4,Educational Session,EUCAST Educational Workshop,Marlene Amara; France); Alasdair P. Macgowan; United Kingdom),W0115,09:10,,"Benzylpenicillin susceptibility testing of S. 
pneumoniae  by disk diffusion Gunnar Kahlmeter 
(Tävelsås, Sweden)"
11 April 2025,EW038,08:30 - 11:30,4,Educational Session,EUCAST Educational Workshop,Marlene Amara; France); Alasdair P. Macgowan; United Kingdom),W0116,09:30,,"What to do when there are no breakpoints Barbara 
Juliane Holzknecht (Copenhagen, Denmark)"
11 April 2025,EW038,08:30 - 11:30,4,Educational Session,EUCAST Educational Workshop,Marlene Amara; France); Alasdair P. Macgowan; United Kingdom),W0117,09:50,,"Detection of resistance mechanisms Christian Giske 
(Stockholm, Sweden)"
11 April 2025,OS001,08:30 - 10:30,5,,,Alessandra Carattoli; Italy); Prasannakumar Palanikumar; India)O0001  Decoding the role of bla CPE-carrying plasmids on; wings: A holistic view using the One Health; approach S.A. Martínez-Álvarez*; Spain); P. Châtre; T. Cardona-Cabrera; P. François; U.; Höfle; M. Zarazaga; J.Y. Madec; M. Haenni; C.; Torres; O0002  A novel isolation room model leveraging culture-; independent Hi-C metagenomics for tracking; antimicrobial resistance transmission between; patients and hospital environmental reservoirs V.; Koh*; Singapore); R. Cabrera; J. Chua; J.S. Lee; N.S.B. Haidi Fitri; Z.X. Tan; X. Huan; N.M.; Thevasagayam; T.K.B. Lee; K. Marimuthu; O.T. Ng; O0003  Deciphering the pathogenic potentials and; epidemiological identities of Staphylococcus; pseudintermedius  colonizing companion dogs in; Sao Paulo I.B. Moses*; Brazil); L. Sartori; D.A. Henriques; M.M. Marini; F.M. Lima; R.X.; Espinosa; I. Orlandino Da Silva; F.F. Santos; L.; Gonzaga; A.T. Ribeiro De Vasconcelos; A.C. Gales; O0004  Recent progress towards integrated surveillance of; antimicrobial resistance in France L. Collineau*; (Lyon; France); S. Bareille; G. Birgand; L. Lacmago; B. Lange; O. Lemenand; C. Chauvin; O0005  Exploring the plasmidome of 3rd generation; cephalosporin-resistant Enterobacterales in wild; birds: Insights into horizontal gene transfer and; AMR dissemination B. Timmer*; Hungary); L. Miló; B. Koleszár; C. Freytag; Á. Lovas-; Kiss; L. Laczkó; G. Kardos; O0006  Emergence of mobile colistin resistance in; Klebsiella  at human-animal-environment interface; in Bangladesh S. Rahman*; United; Kingdom); A. Pondit; J. Parkhill; S. Saha; S.M.R.; Islam; P.I. Disha; S.A. Nasreen; M.A.K. Azad; T.; Walsh; R. Farzana; O0007  Unveiling the invisible: antimicrobial resistance; genes and pathogenic microbial diversity in sewage; of North India's largest industrial hub; A; metagenomic perspective I. Singh*; India); R. Sharma; A. Arora; B. Mohan; N. Taneja; O0008  Culturomics as a tool for ONE HEALTH approach:; Unveiling the role of unknown microorganisms as; antibiotic resistance carriers in wastewater; samples E. Ouranou*; Greece); A.; Psaroulaki; D. Chochlakis; M. Malliarou; K.; Tryfinopoulou; A. Ntoula; E. Intze; I. Lagouvardos; O0009  One Health intervention impacts on antibiotic; resistance in Denmark; England and Senegal: A; mathematical model comparison G. Knight*; (London; United Kingdom); R. Booton; J.V.; Robotham; K. Aluzaite; D. Belay; J. Guitian; M.; Dione; E. Emes; O0010  Clinically important sequence types and resistance; genes in Enterobacteriaceae  from coastal; environments and gulls V. Silva*; Portugal); M. Quintelas; M. Caniça; R. Rivière; P. Poeta; G.; Igrejas,S001,08:30,- 10:30,"Hall 5
2-hour Oral Session
One Health means resistance everywhere
Chairs Alessandra Carattoli (Rome, Italy)"
11 April 2025,SY032,08:30 - 10:30,7,2-hour Symposium,New insights into Candida  pathogenesis,Aleksandra Barac; Serbia); Joshua Nosanchuk; United States),Y032,08:30,- 10:30,"Hall 7
2-hour Symposium
New insights into Candida  pathogenesis
Chairs Aleksandra Barac (Belgrade, Serbia)"
11 April 2025,SY032,08:30 - 10:30,7,2-hour Symposium,New insights into Candida  pathogenesis,Aleksandra Barac; Serbia); Joshua Nosanchuk; United States),S0089,08:30,,"Insights into the evolution of Candida  under 
antifungal pressure Attila Gacser (Szeged, Hungary)"
11 April 2025,SY032,08:30 - 10:30,7,2-hour Symposium,New insights into Candida  pathogenesis,Aleksandra Barac; Serbia); Joshua Nosanchuk; United States),S0091,09:30,The commensal to pathogen transition:,"kind to 
killer Ilse D. Jacobsen (Jena, Germany)"
11 April 2025,SY032,08:30 - 10:30,7,2-hour Symposium,New insights into Candida  pathogenesis,Aleksandra Barac; Serbia); Joshua Nosanchuk; United States),S0092,10:00,Fungal-bacterial interactions: who wins?,"Rebecca Hall 
(Canterbury, United Kingdom)"
11 April 2025,SY033,08:30 - 10:30,8,2-hour Symposium,Single-cell approaches to dissect cellular phenotypic heterogeneity of,Christian Stephan Lentz; Norway); Annelies Zinkernagel; Switzerland),Y033,08:30,- 10:30,"Hall 8
2-hour Symposium
Single-cell approaches to dissect cellular phenotypic heterogeneity of 
bacterial pathogen populations.
Chairs Christian Stephan Lentz (Tromsø, Norway)"
11 April 2025,SY033,08:30 - 10:30,8,2-hour Symposium,Single-cell approaches to dissect cellular phenotypic heterogeneity of,Christian Stephan Lentz; Norway); Annelies Zinkernagel; Switzerland),S0093,08:30,,"Adaptive evolution and phenotypic heterogeneity of 
bacterial pathogens during infections Christoph Ernst 
(Cologne, Germany)"
11 April 2025,SY033,08:30 - 10:30,8,2-hour Symposium,Single-cell approaches to dissect cellular phenotypic heterogeneity of,Christian Stephan Lentz; Norway); Annelies Zinkernagel; Switzerland),S0094,09:00,,"Single-cell imaging and heterogeneity in antimicrobial 
resistance Stefano Pagliara (Exeter, United Kingdom)"
11 April 2025,SY033,08:30 - 10:30,8,2-hour Symposium,Single-cell approaches to dissect cellular phenotypic heterogeneity of,Christian Stephan Lentz; Norway); Annelies Zinkernagel; Switzerland),S0095,09:30,,"Single-cell RNAseq and heterogeneity in bacterial 
transcription Anna Kuchina (Seattle, United States)"
11 April 2025,SY033,08:30 - 10:30,8,2-hour Symposium,Single-cell approaches to dissect cellular phenotypic heterogeneity of,Christian Stephan Lentz; Norway); Annelies Zinkernagel; Switzerland),S0096,10:00,,"Dissecting the function of individual bacteria in their 
spatial context Knut Drescher (Basel, Switzerland)"
11 April 2025,SY043,09:30 - 10:30,1,ePoster Flash Session,Emerging developments in antifungal pharmacology,Nico Tom Mutters; Germany); Ermira Tartari; Malta),Y043,09:30,- 10:30,"Hall 1
1-hour Symposium
Year in infection control
Chairs Nico Tom Mutters (Bonn, Germany)"
11 April 2025,SY043,09:30 - 10:30,1,ePoster Flash Session,Emerging developments in antifungal pharmacology,Nico Tom Mutters; Germany); Ermira Tartari; Malta),S0134,09:30,,"Andrew James Stewardson (Melbourne, Victoria, 
Australia)"
11 April 2025,SY043,09:30 - 10:30,1,ePoster Flash Session,Emerging developments in antifungal pharmacology,Nico Tom Mutters; Germany); Ermira Tartari; Malta),S0135,10:00,,"Kalisvar Marimuthu (Singapore, Singapore)"
11 April 2025,SY043,09:30 - 10:30,1,ePoster Flash Session,Emerging developments in antifungal pharmacology,Nico Tom Mutters; Germany); Ermira Tartari; Malta),F005,09:30,- 10:30,"Arena 2
ePoster Flash Session
It's all in the blood
Chair Colin R. Mackenzie (Neuss, Germany)"
11 April 2025,SY043,09:30 - 10:30,1,ePoster Flash Session,Emerging developments in antifungal pharmacology,Nico Tom Mutters; Germany); Ermira Tartari; Malta),F006,09:30,- 10:30,"Arena 4
ePoster Flash Session
Emerging developments in antifungal pharmacology
Chair Roger Brüggemann (Nijmegen, Netherlands)"
11 April 2025,SY043,09:30 - 10:30,1,ePoster Flash Session,Emerging developments in antifungal pharmacology,Nico Tom Mutters; Germany); Ermira Tartari; Malta),F0147,11:00,"HIV, from key population to general population:","a 
Pandora's Box Syed Faisal Mahmood (Karachi, 
Pakistan)"
11 April 2025,SY043,09:30 - 10:30,1,ePoster Flash Session,Emerging developments in antifungal pharmacology,Nico Tom Mutters; Germany); Ermira Tartari; Malta),F0148,11:10,,"Ethical considerations in preventing mother-to-child 
HIV transmission Glory Alexander (Bangalore, India)"
11 April 2025,SY033,08:30 - 10:30,8,2-hour Symposium,Single-cell approaches to dissect cellular phenotypic heterogeneity of,Christian Stephan Lentz; Norway); Annelies Zinkernagel; Switzerland),Y033,08:30,- 10:30,"Hall 8
2-hour Symposium
Single-cell approaches to dissect cellular phenotypic heterogeneity of 
bacterial pathogen populations.
Chairs Christian Stephan Lentz (Tromsø, Norway)"
11 April 2025,SY033,08:30 - 10:30,8,2-hour Symposium,Single-cell approaches to dissect cellular phenotypic heterogeneity of,Christian Stephan Lentz; Norway); Annelies Zinkernagel; Switzerland),S0093,08:30,,"Adaptive evolution and phenotypic heterogeneity of 
bacterial pathogens during infections Christoph Ernst 
(Cologne, Germany)"
11 April 2025,SY033,08:30 - 10:30,8,2-hour Symposium,Single-cell approaches to dissect cellular phenotypic heterogeneity of,Christian Stephan Lentz; Norway); Annelies Zinkernagel; Switzerland),S0094,09:00,,"Single-cell imaging and heterogeneity in antimicrobial 
resistance Stefano Pagliara (Exeter, United Kingdom)"
11 April 2025,SY033,08:30 - 10:30,8,2-hour Symposium,Single-cell approaches to dissect cellular phenotypic heterogeneity of,Christian Stephan Lentz; Norway); Annelies Zinkernagel; Switzerland),S0095,09:30,,"Single-cell RNAseq and heterogeneity in bacterial 
transcription Anna Kuchina (Seattle, United States)"
11 April 2025,SY033,08:30 - 10:30,8,2-hour Symposium,Single-cell approaches to dissect cellular phenotypic heterogeneity of,Christian Stephan Lentz; Norway); Annelies Zinkernagel; Switzerland),S0096,10:00,,"Dissecting the function of individual bacteria in their 
spatial context Knut Drescher (Basel, Switzerland)"
11 April 2025,SY043,09:30 - 10:30,1,ePoster Flash Session,Rising threats: antimicrobial resistance in STIs,Nico Tom Mutters; Germany); Ermira Tartari; Malta),Y043,09:30,- 10:30,"Hall 1
1-hour Symposium
Year in infection control
Chairs Nico Tom Mutters (Bonn, Germany)"
11 April 2025,SY043,09:30 - 10:30,1,ePoster Flash Session,Rising threats: antimicrobial resistance in STIs,Nico Tom Mutters; Germany); Ermira Tartari; Malta),S0134,09:30,,"Andrew James Stewardson (Melbourne, Victoria, 
Australia)"
11 April 2025,SY043,09:30 - 10:30,1,ePoster Flash Session,Rising threats: antimicrobial resistance in STIs,Nico Tom Mutters; Germany); Ermira Tartari; Malta),S0135,10:00,,"Kalisvar Marimuthu (Singapore, Singapore)"
11 April 2025,SY043,09:30 - 10:30,1,ePoster Flash Session,Rising threats: antimicrobial resistance in STIs,Nico Tom Mutters; Germany); Ermira Tartari; Malta),F005,09:30,- 10:30,"Arena 2
ePoster Flash Session
It's all in the blood
Chair Colin R. Mackenzie (Neuss, Germany)"
11 April 2025,SY043,09:30 - 10:30,1,ePoster Flash Session,Rising threats: antimicrobial resistance in STIs,Nico Tom Mutters; Germany); Ermira Tartari; Malta),F006,09:30,- 10:30,"Arena 4
ePoster Flash Session
Emerging developments in antifungal pharmacology
Chair Roger Brüggemann (Nijmegen, Netherlands)"
11 April 2025,SY043,09:30 - 10:30,1,ePoster Flash Session,Rising threats: antimicrobial resistance in STIs,Nico Tom Mutters; Germany); Ermira Tartari; Malta),F0147,11:00,"HIV, from key population to general population:","a 
Pandora's Box Syed Faisal Mahmood (Karachi, 
Pakistan)"
11 April 2025,SY043,09:30 - 10:30,1,ePoster Flash Session,Rising threats: antimicrobial resistance in STIs,Nico Tom Mutters; Germany); Ermira Tartari; Malta),F0148,11:10,,"Ethical considerations in preventing mother-to-child 
HIV transmission Glory Alexander (Bangalore, India)"
11 April 2025,SY043,09:30 - 10:30,1,ePoster Flash Session,Rising threats: antimicrobial resistance in STIs,Nico Tom Mutters; Germany); Ermira Tartari; Malta),F0149,11:20,HIV drug trials in Africa:,"ethical concerns Shah Reena 
ESCMID Global 2025 - Programme
(Nairobi, Kenya)"
11 April 2025,SY043,09:30 - 10:30,1,ePoster Flash Session,Rising threats: antimicrobial resistance in STIs,Nico Tom Mutters; Germany); Ermira Tartari; Malta),F0150,11:30,,"HIV-related stigma and discrimination in the 
healthcare setting Teymur Noori (Stockholm, 
Sweden)"
11 April 2025,SY043,09:30 - 10:30,1,ePoster Flash Session,Rising threats: antimicrobial resistance in STIs,Nico Tom Mutters; Germany); Ermira Tartari; Malta),F014,11:00,- 12:00,"Arena 2
ePoster Flash Session
Infection control and prevention around the World
Chair Divyashree Shanthamurthy (Mumbai, India)"
11 April 2025,SY043,09:30 - 10:30,1,ePoster Flash Session,Rising threats: antimicrobial resistance in STIs,Nico Tom Mutters; Germany); Ermira Tartari; Malta),F0150,11:30,,"HIV-related stigma and discrimination in the 
healthcare setting Teymur Noori (Stockholm, 
Sweden)"
11 April 2025,SY043,09:30 - 10:30,1,ePoster Flash Session,Rising threats: antimicrobial resistance in STIs,Nico Tom Mutters; Germany); Ermira Tartari; Malta),F014,11:00,- 12:00,"Arena 2
ePoster Flash Session
Infection control and prevention around the World
Chair Divyashree Shanthamurthy (Mumbai, India)"
11 April 2025,KN044,11:00 - 12:00,1,,,Giulia De Angelis; Italy); Robert Leo Skov; Denmark),K0136,11:00,,"David L. Paterson (Singapore, Singapore)"
11 April 2025,OS010,11:00 - 12:00,10,,,Katy Jeannot; France); Timothy R. Walsh; United Kingdom); O0072  In vivo cefiderocol resistance due to cirA  modification; during treatment E. Carretto*; Italy); P.; Pini; R. Farzana; C. Bedogni; R. Marrollo; P. Nardini; M. Bardaro; N.C. Facciolongo; S. Mezzadri; T. Walsh; O0073  Long-term outcomes in dalbavancin-treated patients; with vascular graft infection. A. Specklin*; France); T. Noël; M. Bonnet; A. Duprey; M. Hentzien; O0074  Aztreonam; ceftazidime/avibactam; and tigecycline; combination for the management of multi-drug; resistant E.coli  on peritonitis in a pediatric liver; transplant recipient R. Morales Junior*; United States); V. Juodinis; C. Donini; J. Sampaio; O0075  Early oral antibiotic treatment in patients with post-; neurosurgical brain abscesses caused by; Cutibacterium acnes  – a case series M. Karolyi*; (Vienna; Austria); D. Stahl; E. Pawelka; S. Omid; A.; Kuran; M. Naegeli; A. Zoufaly; C. Well; S. Fischoeder; M. Ortler; C. Wenisch; O0076  Meropenem-vaborbactam as intrathecal-sparing; therapy for the treatment of carbapenem-resistant K.; pneumoniae  shunt-related ventriculitis: two case; reports. G. Giuliano*; Italy); M. Sambo; P.; Castellani; S. Benedetti; F. Tarantino; M. Tumbarello,S010,11:00,- 12:00,"Hall 10
1-hour Case Session
Antimicrobial drugs in action
Chairs Katy Jeannot (Besançon, France)"
11 April 2025,SY047,11:00 - 12:00,11,,,Cansu Cimen; Germany); Kyriaki Tryfinopoulou; Greece),,,,
11 April 2025,ME048,11:00 - 12:00,12,Meet-the-Expert,Cut a long story short: choosing NGS platforms,,M0143,11:00,,"Etienne Ruppe (Paris, France)"
11 April 2025,ME048,11:00 - 12:00,12,Meet-the-Expert,Cut a long story short: choosing NGS platforms,,M0144,11:12,,"Stefan Green (Chicago, United States)"
11 April 2025,OS011,11:00 - 12:00,13,1-hour Oral Session,Around the lab in 80 ways: a journey through innovative therapeutics,Zuzanna Drulis-Kawa; Poland); Helena Zemlickova; Czech Republic); O0077  In vivo expression of an mRNA encoded multi-; mechanistic mAb combination against; Staphylococcus aureus and protection in a disease; model C. Tkaczyk*; United States); N.; Michael; P. Mun Mun; T. George; S. Martin; G. Adam; M. Andal; D. Julie; S. Oleg; B. Elin; Y. Haitao; E. Mark; L. Ashley; D. Antonio; S. Bret; O0078  Hijacking intrinsic resistance in Mycobacterium; abscessus G. Phelps*; United States); S.; Kurt; A. Jenner; S. Anderson; T. Jayasinghe; E.; Griffith; C. Thompson; L. Yang; B. Wicki; F. Bright; L.; Boeck; V. Loudon; R. Lee; A. Wright; W. Wright; O.; Grant-Chapman; J. Ochoado; D. Conner; B. Troyer; A.; Iverson; J.W. Rosch; B. Schulthess; P. Geeleher; S.; Hobbie; B. Meibohm; A. Obregon-Henao; P. Sander; R. Lee; O0079  Tripartite bacteriophage-based strategy to combat; human clinical pathogens P. Kalatzis*; Denmark); R. Ibarra-Chávez; H. Sampson; S.; Michniewski; A. Shen; M. Ford; B. Petersen; P.; Worning; P. Klement; H.P. Calum; U.M. Singh; A.; Millard; M. Clokie; T. Sicheritz-Pontén; ESCMID Global 2025 - Programme,,,,
11 April 2025,KN044,11:00 - 12:00,1,,,Giulia De Angelis; Italy); Robert Leo Skov; Denmark),K0136,11:00,,"David L. Paterson (Singapore, Singapore)"
11 April 2025,OS010,11:00 - 12:00,10,,,Katy Jeannot; France); Timothy R. Walsh; United Kingdom); O0072  In vivo cefiderocol resistance due to cirA  modification; during treatment E. Carretto*; Italy); P.; Pini; R. Farzana; C. Bedogni; R. Marrollo; P. Nardini; M. Bardaro; N.C. Facciolongo; S. Mezzadri; T. Walsh; O0073  Long-term outcomes in dalbavancin-treated patients; with vascular graft infection. A. Specklin*; France); T. Noël; M. Bonnet; A. Duprey; M. Hentzien; O0074  Aztreonam; ceftazidime/avibactam; and tigecycline; combination for the management of multi-drug; resistant E.coli  on peritonitis in a pediatric liver; transplant recipient R. Morales Junior*; United States); V. Juodinis; C. Donini; J. Sampaio; O0075  Early oral antibiotic treatment in patients with post-; neurosurgical brain abscesses caused by; Cutibacterium acnes  – a case series M. Karolyi*; (Vienna; Austria); D. Stahl; E. Pawelka; S. Omid; A.; Kuran; M. Naegeli; A. Zoufaly; C. Well; S. Fischoeder; M. Ortler; C. Wenisch; O0076  Meropenem-vaborbactam as intrathecal-sparing; therapy for the treatment of carbapenem-resistant K.; pneumoniae  shunt-related ventriculitis: two case; reports. G. Giuliano*; Italy); M. Sambo; P.; Castellani; S. Benedetti; F. Tarantino; M. Tumbarello,S010,11:00,- 12:00,"Hall 10
1-hour Case Session
Antimicrobial drugs in action
Chairs Katy Jeannot (Besançon, France)"
11 April 2025,SY047,11:00 - 12:00,11,,,Cansu Cimen; Germany); Kyriaki Tryfinopoulou; Greece),,,,
11 April 2025,ME048,11:00 - 12:00,12,Meet-the-Expert,Cut a long story short: choosing NGS platforms,,M0143,11:00,,"Etienne Ruppe (Paris, France)"
11 April 2025,ME048,11:00 - 12:00,12,Meet-the-Expert,Cut a long story short: choosing NGS platforms,,M0144,11:12,,"Stefan Green (Chicago, United States)"
11 April 2025,OS011,11:00 - 12:00,13,1-hour Oral Session,Around the lab in 80 ways: a journey through innovative therapeutics,Zuzanna Drulis-Kawa; Poland); Helena Zemlickova; Czech Republic); O0077  In vivo expression of an mRNA encoded multi-; mechanistic mAb combination against; Staphylococcus aureus and protection in a disease; model C. Tkaczyk*; United States); N.; Michael; P. Mun Mun; T. George; S. Martin; G. Adam; M. Andal; D. Julie; S. Oleg; B. Elin; Y. Haitao; E. Mark; L. Ashley; D. Antonio; S. Bret; O0078  Hijacking intrinsic resistance in Mycobacterium; abscessus G. Phelps*; United States); S.; Kurt; A. Jenner; S. Anderson; T. Jayasinghe; E.; Griffith; C. Thompson; L. Yang; B. Wicki; F. Bright; L.; Boeck; V. Loudon; R. Lee; A. Wright; W. Wright; O.; Grant-Chapman; J. Ochoado; D. Conner; B. Troyer; A.; Iverson; J.W. Rosch; B. Schulthess; P. Geeleher; S.; Hobbie; B. Meibohm; A. Obregon-Henao; P. Sander; R. Lee; O0079  Tripartite bacteriophage-based strategy to combat; human clinical pathogens P. Kalatzis*; Denmark); R. Ibarra-Chávez; H. Sampson; S.; Michniewski; A. Shen; M. Ford; B. Petersen; P.; Worning; P. Klement; H.P. Calum; U.M. Singh; A.; Millard; M. Clokie; T. Sicheritz-Pontén; ESCMID Global 2025 - Programme; O0080  Eosin Y and Ceragenin combinations for enhanced; antimicrobial photodynamic therapy Y. Tekintas*; (Cigli; Türkiye); P.B. Savage; M. Ucuncu; O0081  Identification of compounds capable of removing; established bacterial biofilms T. Inzana*; United States); A. Gates; W. Weng; J. Cusumano; Y.J.; Lee; N. Vogelaar,,,,
11 April 2025,ME049,11:00 - 12:00,14,Meet-the-Expert,How to perform clinical trials in mycoses?,,M0145,11:00,,"Monica Slavin (Melbourne, Australia)"
11 April 2025,ME049,11:00 - 12:00,14,Meet-the-Expert,How to perform clinical trials in mycoses?,,M0146,11:12,,"Nkechi Azie (Barrington, United States)"
11 April 2025,OS012,11:00 - 12:00,15,1-hour Oral Session,Climate Impact and One Health Approaches Against Infectious Diseases,,S012,11:00,- 12:00,"Hall 15
1-hour Oral Session
Climate Impact and One Health Approaches Against Infectious Diseases
Chair Chadia Wannous (Paris, France)"
11 April 2025,OS013,11:00 - 12:00,16,1-hour Oral Session,Viral challenges in organ transplantation,Ghady Haidar; United States); Cristiana Oprea; Romania); O0087  Evaluation of an individualized CMV prevention; strategy guided by post-transplant CMV-specific cell-; mediated immunity in intermediate-risk kidney; transplant recipients I. Rodríguez-Goncer*; Spain); J.M. Caso; M. Fernández-Ruiz; E. González; N.; Polanco; N. Redondo; T. Ruiz-Merlo; R. San-Juan; L.M. Allende; E. Paz-Artal; A. Andrés; F. López-; Medrano; J.M. Aguado; I. Rodríguez-Góncer; O0088  Real-world Use of Letermovir Prophylaxis for; Cytomegalovirus; Transplant Recipients A. Mughrabi*; Minnesota; United States); B. Bisono-Garcia; S.; Chesdachai; N. Ranganath; R. Razonable; O0089  Real-world administration of maribavir beyond the; eight weeks established in the clinical trial D. Martínez-Simón*; Spain); C. Ribera-Puig; M. Bodro; D. Campany; J. Esperalba; I. Los Arcos; P.; Clèries-Rovira; A. Padullés; N. Sabé Fernández; M.; Tuset; O. Len; O0090  Prediction of BK Polyomavirus nephropathy in kidney; transplantation by measuring neutralizing responses; in a large cohort of donor and recipients M. Solis*; (Strasbourg; France); W. Fardi; I. Benotmane; F.; Gallais; S. Caillard; S. Fafi-Kremer; O0091  Dengue in solid organ transplant recipients S.I.; Galian*; Argentina); N. Pujato; N.S.; Nolis; R. Del Grosso; P. Lopez; G. Aballay; M. Agustin; G. Werber,S013,11:00,- 12:00,"Hall 16
1-hour Oral Session
Viral challenges in organ transplantation
Chairs Ghady Haidar (Pittsburgh, United States)"
11 April 2025,SY045,11:00 - 12:00,2,,,Catherine Ong; Singapore); Sean Wasserman; United Kingdom),S0137,11:00,Post-TB disease:,"burden and treatment 
strategies Deborah Chong (London, United Kingdom)"
11 April 2025,SY045,11:00 - 12:00,2,,,Catherine Ong; Singapore); Sean Wasserman; United Kingdom),S0138,11:30,,"TB sequelae and fungal infection Helmut Salzer (Linz, 
Austria)"
11 April 2025,SY045,11:00 - 12:00,2,,,Catherine Ong; Singapore); Sean Wasserman; United Kingdom),A002,11:12,Drugs for Vector-borne Infections:,"Facts and 
Fibrillations Xin Hui Chan (Oxford, United Kingdom)"
11 April 2025,SY045,11:00 - 12:00,2,,,Catherine Ong; Singapore); Sean Wasserman; United Kingdom),A004,11:36,,"Finding a place for observational studies in infectious 
diseases research Anthony Bai (Kingston, Canada)"
11 April 2025,SY045,11:00 - 12:00,2,,,Catherine Ong; Singapore); Sean Wasserman; United Kingdom),A005,11:48,Clearing fungal fog in viral storms:,"deciphering 
influenza- and COVID-19-associated pulmonary 
aspergillosis Simon Feys (Leuven, Belgium)"
11 April 2025,SY046,11:00 - 12:00,5,,,Silvio Daniel Brugger; Switzerland); Abdou Hachani; Australia),Y046,11:00,- 12:00,"Hall 5
1-hour Symposium
New frontiers in bacterial pathogenesis
Chairs Silvio Daniel Brugger (Zurich, Switzerland)"
11 April 2025,SY046,11:00 - 12:00,5,,,Silvio Daniel Brugger; Switzerland); Abdou Hachani; Australia),S0139,11:00,,"Bacterial infections and cellular immunity Charlotte 
Odendall (London, United Kingdom)"
11 April 2025,SY046,11:00 - 12:00,5,,,Silvio Daniel Brugger; Switzerland); Abdou Hachani; Australia),S0140,11:20,,"Immuno-metabolism in bacterial diseases Tania Wong 
(New York, United States)"
11 April 2025,OS007,11:00 - 12:00,6,1-hour Oral Session,New developements in prophylaxis and treatment of COVID-19,Gülsen Özkaya Sahin; Sweden); Snjezana Zidovec Lepej; Croatia); ESCMID Global 2025 - Programme; O0080  Eosin Y and Ceragenin combinations for enhanced; antimicrobial photodynamic therapy Y. Tekintas*; (Cigli; Türkiye); P.B. Savage; M. Ucuncu; O0081  Identification of compounds capable of removing; established bacterial biofilms T. Inzana*; United States); A. Gates; W. Weng; J. Cusumano; Y.J.; Lee; N. Vogelaar,S007,11:00,- 12:00,"Hall 6
1-hour Oral Session
New developements in prophylaxis and treatment of COVID-19
Chairs Gülsen Özkaya Sahin (Lund, Sweden)"
11 April 2025,ME049,11:00 - 12:00,14,Meet-the-Expert,How to perform clinical trials in mycoses?,,M0145,11:00,,"Monica Slavin (Melbourne, Australia)"
11 April 2025,ME049,11:00 - 12:00,14,Meet-the-Expert,How to perform clinical trials in mycoses?,,M0146,11:12,,"Nkechi Azie (Barrington, United States)"
11 April 2025,OS012,11:00 - 12:00,15,1-hour Oral Session,Climate Impact and One Health Approaches Against Infectious Diseases,,S012,11:00,- 12:00,"Hall 15
1-hour Oral Session
Climate Impact and One Health Approaches Against Infectious Diseases
Chair Chadia Wannous (Paris, France)"
11 April 2025,OS013,11:00 - 12:00,16,1-hour Oral Session,Viral challenges in organ transplantation,Ghady Haidar; United States); Cristiana Oprea; Romania); O0087  Evaluation of an individualized CMV prevention; strategy guided by post-transplant CMV-specific cell-; mediated immunity in intermediate-risk kidney; transplant recipients I. Rodríguez-Goncer*; Spain); J.M. Caso; M. Fernández-Ruiz; E. González; N.; Polanco; N. Redondo; T. Ruiz-Merlo; R. San-Juan; L.M. Allende; E. Paz-Artal; A. Andrés; F. López-; Medrano; J.M. Aguado; I. Rodríguez-Góncer; O0088  Real-world Use of Letermovir Prophylaxis for; Cytomegalovirus; Transplant Recipients A. Mughrabi*; Minnesota; United States); B. Bisono-Garcia; S.; Chesdachai; N. Ranganath; R. Razonable; O0089  Real-world administration of maribavir beyond the; eight weeks established in the clinical trial D. Martínez-Simón*; Spain); C. Ribera-Puig; M. Bodro; D. Campany; J. Esperalba; I. Los Arcos; P.; Clèries-Rovira; A. Padullés; N. Sabé Fernández; M.; Tuset; O. Len; O0090  Prediction of BK Polyomavirus nephropathy in kidney; transplantation by measuring neutralizing responses; in a large cohort of donor and recipients M. Solis*; (Strasbourg; France); W. Fardi; I. Benotmane; F.; Gallais; S. Caillard; S. Fafi-Kremer; O0091  Dengue in solid organ transplant recipients S.I.; Galian*; Argentina); N. Pujato; N.S.; Nolis; R. Del Grosso; P. Lopez; G. Aballay; M. Agustin; G. Werber,S013,11:00,- 12:00,"Hall 16
1-hour Oral Session
Viral challenges in organ transplantation
Chairs Ghady Haidar (Pittsburgh, United States)"
11 April 2025,SY045,11:00 - 12:00,2,,,Catherine Ong; Singapore); Sean Wasserman; United Kingdom),S0137,11:00,Post-TB disease:,"burden and treatment 
strategies Deborah Chong (London, United Kingdom)"
11 April 2025,SY045,11:00 - 12:00,2,,,Catherine Ong; Singapore); Sean Wasserman; United Kingdom),S0138,11:30,,"TB sequelae and fungal infection Helmut Salzer (Linz, 
Austria)"
11 April 2025,SY045,11:00 - 12:00,2,,,Catherine Ong; Singapore); Sean Wasserman; United Kingdom),A002,11:12,Drugs for Vector-borne Infections:,"Facts and 
Fibrillations Xin Hui Chan (Oxford, United Kingdom)"
11 April 2025,SY045,11:00 - 12:00,2,,,Catherine Ong; Singapore); Sean Wasserman; United Kingdom),A004,11:36,,"Finding a place for observational studies in infectious 
diseases research Anthony Bai (Kingston, Canada)"
11 April 2025,SY045,11:00 - 12:00,2,,,Catherine Ong; Singapore); Sean Wasserman; United Kingdom),A005,11:48,Clearing fungal fog in viral storms:,"deciphering 
influenza- and COVID-19-associated pulmonary 
aspergillosis Simon Feys (Leuven, Belgium)"
11 April 2025,SY046,11:00 - 12:00,5,,,Silvio Daniel Brugger; Switzerland); Abdou Hachani; Australia),Y046,11:00,- 12:00,"Hall 5
1-hour Symposium
New frontiers in bacterial pathogenesis
Chairs Silvio Daniel Brugger (Zurich, Switzerland)"
11 April 2025,SY046,11:00 - 12:00,5,,,Silvio Daniel Brugger; Switzerland); Abdou Hachani; Australia),S0139,11:00,,"Bacterial infections and cellular immunity Charlotte 
Odendall (London, United Kingdom)"
11 April 2025,SY046,11:00 - 12:00,5,,,Silvio Daniel Brugger; Switzerland); Abdou Hachani; Australia),S0140,11:20,,"Immuno-metabolism in bacterial diseases Tania Wong 
(New York, United States)"
11 April 2025,OS007,11:00 - 12:00,6,1-hour Oral Session,New developements in prophylaxis and treatment of COVID-19,Gülsen Özkaya Sahin; Sweden); Snjezana Zidovec Lepej; Croatia); ESCMID Global 2025 - Programme; O0057  Ensitrelvir for the prevention of COVID-19 among; household contacts: key subgroup analyses of a; randomized; double-blinded; placebo controlled; post-exposure prophylaxis study; SCORPIO-PEP F.; Hayden*; United States); N. Ohmagari; T.W. Clark; M. Shinkai; A.F. Luetkemeyer; P. Sax; W.P. Hanage; K.A. Gebo; H. Ikematsu; K. Izumikawa; C.C. Butler; A. Fukushi; S. Kezbor; H. Sakaguchi; S.; Lacey; G. Ichihashi; T. Uehara; O0058  Efficacy of nirmatrelvir/ritonavir on overall COVID-; 19 related symptoms in immunocompromised adult; participants from the EPIC-IC trial R. Mokgokong*; (Tadworth; United Kingdom); P. Cislo; E. Tudone; E.; Weinstein; J.C. Cappelleri; O0059  COVID-19 patients benefitting from remdesivir for; improved survival: a neural network-based; approach. T.F. Aiello*; Spain); C. Teijón-; Lumbreras; C. Garcia-Vidal; M. Chumbita; M.; Rosario; A. Mateu Subirà; O. Peyrony; P. Monzó-; Gallo; A. Gallardo-Pizarro; A. Martinez-Urrea; R.; Méndez; E. Calbo; M. Ballestero-Tellez; G. Cuesta-; Chasco; M. Marcos; A. Soriano; O0060  Efficacy and safety of sotrovimab vs oral antivirals; in omicron waves: a retrospective analysisC.; Cacace*; Italy); A. Russo; M. Pisaturo; P.; Grimaldi; F. Ambrisi; G. Granata; F.G. Numis; N.; Coppola; O0061  Pharmacokinetics and immunogenicity of AZD7442; (Tixagevimab/Cilgavimab) in hospitalised COVID-19; patients: results from the DisCoVeRy trial C.; Massonnaud*; France); M. Hites; N. Peiffer-; Smadja; T.H.L. Han; G. Carcelain; F. Mentré; F. Ader,S007,11:00,- 12:00,"Hall 6
1-hour Oral Session
New developements in prophylaxis and treatment of COVID-19
Chairs Gülsen Özkaya Sahin (Lund, Sweden)"
11 April 2025,OS008,11:00 - 12:00,7,1-hour Oral Session,Advancing Malaria Research: From Molecular Insights to Clinical Challenges,Kamruddin Ahmed; Malaysia); Giri Shan Rajahram; Malaysia); O0062  Influence of second blood meals on Plasmodium; vivax  development and infectivity in mosquitoes S.; Bantuchai*; Thailand); W. Nguitragool; J.; Sattabongkot; C. Kumpitak; O0064  Severe imported Plasmodium falciparum  malaria with; hyperparasitaemia: evaluation of predictors for; critical disease T. Lingscheid*; Germany); J.; Jochum; P. Tober-Lau; J. Schöllgen; T. Zoller; L.E.; Sander; M. Ramharter; F. Kurth; O0065  The current status of Plasmodium falciparum; chloroquine resistance transporter gene; Plasmodium falciparum  multi-drug resistance gene 1; (N86Y) in Cameroon M. Fru*; Cameroon); O0066  SOFA score vs WHO severity criteria to guide; antimalarial treatment - 10 years of imported malaria; cases in a UK tertiary centre reviewed. E. Savory*; (Cambridge; United Kingdom); M. Routledge; B.; Warne; E. Moore; D. Sparkes,,,,
11 April 2025,OS009,11:00 - 12:00,8,,,Tiziana Ascione; Italy); Jaime Esteban; Spain); O0067  Antibiotic-refractory oligoarthritis in an adolescent; caused by Borrelia bavariensis  in Croatia N. Krajcar*; (Zagreb; Croatia); L. Stemberger Marić; M. Vrdoljak; Pažur; S. Roglić; R. Beck; G. Tešović; O0068  Progression of vertebral echinococcosis despite; radiotherapy treatment M. González-Sanz*; Spain); O. Martín; A. Romero-Alegría; M. Belhassen; S. Chamorro Tojeiro; D. Gayoso Cantero; F. Norman; B. Monge Maillo; C. Crespillo-Andújar; M.D. Corbacho-Loarte; S. De La Fuente-Herranz; J. Cobo; Soriano; J. Urbano; M. Martín Martín; J.A. Pérez-; Molina; O0069  Two cases of septic osteoarthritis of Cutibacterium; acnes  detected by 16S rRNA gene sequencing in; immunocompetent adolescents H. Okuno*; Japan); K. Shiota; K. Amo; O0070  A UK case of Melioidosis with osteomyelitis two years; after geographical exposure C. Darlow*; United Kingdom); L. Swithenbank; R. Taggart; V.; Owen; N. Wong; S. Woolley; W.D. Harrison; L.; Ratcliffe; J. Lewis; O0071  When Infection Masquerades as Malignancy: A Case; of Disseminated Mycobacterium fortuitum  complex; infection with Mixed Osteoblastic and Osteolytic; Lesions and Lymphadenopathy in Anti-IFN-￿; Immunodeficiency Syndrome N. Hiranburana*; (Bangkok; Thailand); S. Khahakaew; K.; Meesilpavikkai; M. Satja; G. Suwanpimolkul,S009,11:00,- 12:00,"Hall 8
1-hour Case Session
Osteoarticular uninvited guests
Chairs Tiziana Ascione (Naples, Italy)"
11 April 2025,LB001,11:00 - 12:00,9,1-hour Oral Session,Advances in vaccine effectiveness for viral respiratory infections,,B001,11:00,- 12:00,"Hall 9
1-hour Oral Session
Advances in vaccine effectiveness for viral respiratory infections
Chair Jean Paul Stahl (Corenc, France)"
11 April 2025,SY051,13:30 - 14:30,1,,,Nur Benzonana; Türkiye); Evelina Tacconelli; Italy),Y051,13:30,- 14:30,"Hall 1
1-hour Symposium
Year in infectious diseases
Chairs Nur Benzonana (Istanbul, Türkiye)"
11 April 2025,SY051,13:30 - 14:30,1,,,Nur Benzonana; Türkiye); Evelina Tacconelli; Italy),S0151,13:30,,"Yoav Keynan (Winnipeg, Canada)"
11 April 2025,SY051,13:30 - 14:30,1,,,Nur Benzonana; Türkiye); Evelina Tacconelli; Italy),S0152,14:00,,"Elisa Cordero Matia (Seville, Spain)"
11 April 2025,OS008,11:00 - 12:00,7,1-hour Oral Session,Advancing Malaria Research: From Molecular Insights to Clinical Challenges,Kamruddin Ahmed; Malaysia); Giri Shan Rajahram; Malaysia); O0062  Influence of second blood meals on Plasmodium; vivax  development and infectivity in mosquitoes S.; Bantuchai*; Thailand); W. Nguitragool; J.; Sattabongkot; C. Kumpitak; O0064  Severe imported Plasmodium falciparum  malaria with; hyperparasitaemia: evaluation of predictors for; critical disease T. Lingscheid*; Germany); J.; Jochum; P. Tober-Lau; J. Schöllgen; T. Zoller; L.E.; Sander; M. Ramharter; F. Kurth; O0065  The current status of Plasmodium falciparum; chloroquine resistance transporter gene; Plasmodium falciparum  multi-drug resistance gene 1; (N86Y) in Cameroon M. Fru*; Cameroon); O0066  SOFA score vs WHO severity criteria to guide; antimalarial treatment - 10 years of imported malaria; cases in a UK tertiary centre reviewed. E. Savory*; (Cambridge; United Kingdom); M. Routledge; B.; Warne; E. Moore; D. Sparkes,,,,
11 April 2025,OS009,11:00 - 12:00,8,,,Tiziana Ascione; Italy); Jaime Esteban; Spain); O0067  Antibiotic-refractory oligoarthritis in an adolescent; caused by Borrelia bavariensis  in Croatia N. Krajcar*; (Zagreb; Croatia); L. Stemberger Marić; M. Vrdoljak; Pažur; S. Roglić; R. Beck; G. Tešović; O0068  Progression of vertebral echinococcosis despite; radiotherapy treatment M. González-Sanz*; Spain); O. Martín; A. Romero-Alegría; M. Belhassen; S. Chamorro Tojeiro; D. Gayoso Cantero; F. Norman; B. Monge Maillo; C. Crespillo-Andújar; M.D. Corbacho-Loarte; S. De La Fuente-Herranz; J. Cobo; Soriano; J. Urbano; M. Martín Martín; J.A. Pérez-; Molina; O0069  Two cases of septic osteoarthritis of Cutibacterium; acnes  detected by 16S rRNA gene sequencing in; immunocompetent adolescents H. Okuno*; Japan); K. Shiota; K. Amo; O0070  A UK case of Melioidosis with osteomyelitis two years; after geographical exposure C. Darlow*; United Kingdom); L. Swithenbank; R. Taggart; V.; Owen; N. Wong; S. Woolley; W.D. Harrison; L.; Ratcliffe; J. Lewis; O0071  When Infection Masquerades as Malignancy: A Case; of Disseminated Mycobacterium fortuitum  complex; infection with Mixed Osteoblastic and Osteolytic; Lesions and Lymphadenopathy in Anti-IFN-￿; Immunodeficiency Syndrome N. Hiranburana*; (Bangkok; Thailand); S. Khahakaew; K.; Meesilpavikkai; M. Satja; G. Suwanpimolkul,S009,11:00,- 12:00,"Hall 8
1-hour Case Session
Osteoarticular uninvited guests
Chairs Tiziana Ascione (Naples, Italy)"
11 April 2025,LB001,11:00 - 12:00,9,1-hour Oral Session,Advances in vaccine effectiveness for viral respiratory infections,,B001,11:00,- 12:00,"Hall 9
1-hour Oral Session
Advances in vaccine effectiveness for viral respiratory infections
Chair Jean Paul Stahl (Corenc, France)"
11 April 2025,SY051,13:30 - 14:30,1,,,Nur Benzonana; Türkiye); Evelina Tacconelli; Italy),Y051,13:30,- 14:30,"Hall 1
1-hour Symposium
Year in infectious diseases
Chairs Nur Benzonana (Istanbul, Türkiye)"
11 April 2025,SY051,13:30 - 14:30,1,,,Nur Benzonana; Türkiye); Evelina Tacconelli; Italy),S0151,13:30,,"Yoav Keynan (Winnipeg, Canada)"
11 April 2025,SY051,13:30 - 14:30,1,,,Nur Benzonana; Türkiye); Evelina Tacconelli; Italy),S0152,14:00,,"Elisa Cordero Matia (Seville, Spain)"
11 April 2025,SY053,13:30 - 14:30,16,,,Miranda Langendam; Netherlands); Blin Nagavci; Kosovo),S0155,13:30,,"The PROs and CONs of using AI tools for developing 
guidelines Holger Schuenemann (Milano, Italy)"
11 April 2025,SY053,13:30 - 14:30,16,,,Miranda Langendam; Netherlands); Blin Nagavci; Kosovo),S0156,14:00,AI in action:,"validated tools for speeding up your 
systematic reviews and how to use them Sara 
Fernandez (Oslo, Norway)"
11 April 2025,SY052,13:30 - 14:30,2,ePoster Flash Session,Syndromic testing is still coming of age,Angelika Berger; Sanjay Patel; United Kingdom),Y052,13:30,- 14:30,"Hall 2
1-hour Symposium
Exploring children's role in infection spread
Chairs Angelika Berger 
Sanjay Patel (Winchester, United Kingdom)"
11 April 2025,SY052,13:30 - 14:30,2,ePoster Flash Session,Syndromic testing is still coming of age,Angelika Berger; Sanjay Patel; United Kingdom),F022,13:30,- 14:30,"Arena 2
ePoster Flash Session
Syndromic testing is still coming of age
Chair Tommaso Giani (Florence, Italy)"
11 April 2025,SY053,13:30 - 14:30,16,,,Miranda Langendam; Netherlands); Blin Nagavci; Kosovo),S0155,13:30,,"The PROs and CONs of using AI tools for developing 
guidelines Holger Schuenemann (Milano, Italy)"
11 April 2025,SY053,13:30 - 14:30,16,,,Miranda Langendam; Netherlands); Blin Nagavci; Kosovo),S0156,14:00,AI in action:,"validated tools for speeding up your 
systematic reviews and how to use them Sara 
Fernandez (Oslo, Norway)"
11 April 2025,SY052,13:30 - 14:30,2,ePoster Flash Session,A never-ending evolution of antimicrobial resistance,Angelika Berger; Sanjay Patel; United Kingdom),Y052,13:30,- 14:30,"Hall 2
1-hour Symposium
Exploring children's role in infection spread
Chairs Angelika Berger 
Sanjay Patel (Winchester, United Kingdom)"
11 April 2025,SY052,13:30 - 14:30,2,ePoster Flash Session,A never-ending evolution of antimicrobial resistance,Angelika Berger; Sanjay Patel; United Kingdom),F022,13:30,- 14:30,"Arena 2
ePoster Flash Session
Syndromic testing is still coming of age
Chair Tommaso Giani (Florence, Italy)"
11 April 2025,SY052,13:30 - 14:30,2,ePoster Flash Session,A never-ending evolution of antimicrobial resistance,Angelika Berger; Sanjay Patel; United Kingdom),F023,13:30,- 14:30,"Arena 3
ePoster Flash Session
Effective microbiology for the management of sepsis
Chair Maurizio Sanguinetti (Rome, Italy)"
11 April 2025,SY052,13:30 - 14:30,2,ePoster Flash Session,A never-ending evolution of antimicrobial resistance,Angelika Berger; Sanjay Patel; United Kingdom),F024,13:30,- 14:30,"Arena 4
ePoster Flash Session
A never-ending evolution of antimicrobial resistance 
Chair Antonio Oliver (Palma De Mallorca, Spain)"
11 April 2025,OS018,13:30 - 14:30,11,1-hour Oral Session,Battling the Spore: C. difficile  epidemiology and management,Nicolas Benech; France); Fidelma Fitzpatrick; Ireland); O0124  Molecular epidemiology and antimicrobial resistome; of Clostridioides difficile from private and public; healthcare settings in three provinces in South; Africa H. Shirinda*; South Africa); A.M.; Smith; B. Prinsloo; M. Kock; M. Moodley; M. Said; M.; Ehlers; O0125  Screening for Clostridioides difficile  colonization at; admission and during hospitalization N. Khanafer*; (Lyon; France); S. Bennia; G. Martin-Gaujard; L.; Juillard; T. Rimmelé; L. Argaud; P. Cassier; O. Martin; P. Vanhems; O0126  Revolutionizing CDI treatment: Are shorter antibiotic; regimens the future M. Duricek*; Czech; Republic); J. Benes; K. Halmova; O0127  Extended-pulsed fidaxomicin versus conventional; dosing in patients at high risk of recurrence of; Clostridioides difficile  infection E. Rubio-Martín*; (Seville; Spain); R. Escudero-Sánchez; Á. Gutiérrez; Liarte; A. Ibañez Zurriaga; C. Saez Bejar; B. Díaz; Pollán; C. Marcelo Calvo; G. Ruiz Carrasco; G. Pérez; Caballero; A.M. Rodríguez Benavente; S. De La Villa; J.D. Ruiz-Mesa; L.F. Caballero Martínez; I. Márquez; Gómez; E. Calabuig; M. Tasias; R. Blanes; M.Á. López; Zúñiga; J. Rodríguez Granger; P. Merino Amador; A.; Salinas; D. Rodríguez-Pardo; M. Villamarín Merlo; G.; Maestro De La Calle; J. Mateo Flores; J.B. Pérez; Gilaberte; R.M. Martínez Álvarez; F. Martínez García; N. Cobos-Trigueros; J. Llenas-García; M. Solivella-; Rodríguez; L. Ramos Merino; B. Castelo López; M.M.; ESCMID Global 2025 - Programme; Dubois; L. Muller; J.P. Lavigne; A. Pantel,F023,13:30,- 14:30,"Arena 3
ePoster Flash Session
Effective microbiology for the management of sepsis
Chair Maurizio Sanguinetti (Rome, Italy)"
11 April 2025,OS018,13:30 - 14:30,11,1-hour Oral Session,Battling the Spore: C. difficile  epidemiology and management,Nicolas Benech; France); Fidelma Fitzpatrick; Ireland); O0124  Molecular epidemiology and antimicrobial resistome; of Clostridioides difficile from private and public; healthcare settings in three provinces in South; Africa H. Shirinda*; South Africa); A.M.; Smith; B. Prinsloo; M. Kock; M. Moodley; M. Said; M.; Ehlers; O0125  Screening for Clostridioides difficile  colonization at; admission and during hospitalization N. Khanafer*; (Lyon; France); S. Bennia; G. Martin-Gaujard; L.; Juillard; T. Rimmelé; L. Argaud; P. Cassier; O. Martin; P. Vanhems; O0126  Revolutionizing CDI treatment: Are shorter antibiotic; regimens the future M. Duricek*; Czech; Republic); J. Benes; K. Halmova; O0127  Extended-pulsed fidaxomicin versus conventional; dosing in patients at high risk of recurrence of; Clostridioides difficile  infection E. Rubio-Martín*; (Seville; Spain); R. Escudero-Sánchez; Á. Gutiérrez; Liarte; A. Ibañez Zurriaga; C. Saez Bejar; B. Díaz; Pollán; C. Marcelo Calvo; G. Ruiz Carrasco; G. Pérez; Caballero; A.M. Rodríguez Benavente; S. De La Villa; J.D. Ruiz-Mesa; L.F. Caballero Martínez; I. Márquez; Gómez; E. Calabuig; M. Tasias; R. Blanes; M.Á. López; Zúñiga; J. Rodríguez Granger; P. Merino Amador; A.; Salinas; D. Rodríguez-Pardo; M. Villamarín Merlo; G.; Maestro De La Calle; J. Mateo Flores; J.B. Pérez; Gilaberte; R.M. Martínez Álvarez; F. Martínez García; N. Cobos-Trigueros; J. Llenas-García; M. Solivella-; Rodríguez; L. Ramos Merino; B. Castelo López; M.M.; ESCMID Global 2025 - Programme; Dubois; L. Muller; J.P. Lavigne; A. Pantel,F024,13:30,- 14:30,"Arena 4
ePoster Flash Session
A never-ending evolution of antimicrobial resistance 
Chair Antonio Oliver (Palma De Mallorca, Spain)"
11 April 2025,OS018,13:30 - 14:30,11,1-hour Oral Session,Battling the Spore: C. difficile  epidemiology and management,Nicolas Benech; France); Fidelma Fitzpatrick; Ireland); O0124  Molecular epidemiology and antimicrobial resistome; of Clostridioides difficile from private and public; healthcare settings in three provinces in South; Africa H. Shirinda*; South Africa); A.M.; Smith; B. Prinsloo; M. Kock; M. Moodley; M. Said; M.; Ehlers; O0125  Screening for Clostridioides difficile  colonization at; admission and during hospitalization N. Khanafer*; (Lyon; France); S. Bennia; G. Martin-Gaujard; L.; Juillard; T. Rimmelé; L. Argaud; P. Cassier; O. Martin; P. Vanhems; O0126  Revolutionizing CDI treatment: Are shorter antibiotic; regimens the future M. Duricek*; Czech; Republic); J. Benes; K. Halmova; O0127  Extended-pulsed fidaxomicin versus conventional; dosing in patients at high risk of recurrence of; Clostridioides difficile  infection E. Rubio-Martín*; (Seville; Spain); R. Escudero-Sánchez; Á. Gutiérrez; Liarte; A. Ibañez Zurriaga; C. Saez Bejar; B. Díaz; Pollán; C. Marcelo Calvo; G. Ruiz Carrasco; G. Pérez; Caballero; A.M. Rodríguez Benavente; S. De La Villa; J.D. Ruiz-Mesa; L.F. Caballero Martínez; I. Márquez; Gómez; E. Calabuig; M. Tasias; R. Blanes; M.Á. López; Zúñiga; J. Rodríguez Granger; P. Merino Amador; A.; Salinas; D. Rodríguez-Pardo; M. Villamarín Merlo; G.; Maestro De La Calle; J. Mateo Flores; J.B. Pérez; Gilaberte; R.M. Martínez Álvarez; F. Martínez García; N. Cobos-Trigueros; J. Llenas-García; M. Solivella-; Rodríguez; L. Ramos Merino; B. Castelo López; M.M.; ESCMID Global 2025 - Programme; Montero; D. Echeverría-Esnal; J. López-Contreras; P.; Duch Llorach; M.R. Oltra-Sempere; C. Pinto-Pla; Í.; Pineda; J.L. Del Pozo; J. Rodríguez-Baño; A. Halperin; A. Muriel García; S. Moreno Guillén; J. Cobo; O0128  Gut phageome profiling in Clostridioides difficile; infection and faecal microbiota transplantation C.; Chen*; Switzerland); T. Pillonel; J. Schaer; G. Greub; G. Resch; B. Guery; C. Bertelli; T. Galpérine,,,,
11 April 2025,OS019,13:30 - 14:30,12,1-hour Oral Session,Microbiome Dynamics and Health: From Pathogenesis to Therapeutic,Mauricio Farfan; Chile); Eija Inkeri Könönen; Finland); O0129  Multi-omics integrated analysis revealed the key role; of Fusobacterium periodonticum in colorectal; tumorigenesis by decanoic acid promoting neutrophil; chemotaxis. X. Chu*; China); Q. Yang; O0130  Exploring the respiratory microbiome in COPD; patients: The role of Haemophilus  spp. in disease; pathogenesis P. Camps-Massa*; Spain); L.; Saiz-Escobedo; J. Guerrero; E. Cuevas; D. Guevara-; Nuñez; F. Tubau; J. Burgos; M. Lopez; A. González-; Díaz; C. Ardanuy; M. Dominguez; S. Santos; S. Martí; O0131  Using the in vitro MiGut system to simulate the; ulcerative colitis microbiome and post-antibiotic; recovery supported by a pre-defined consortium of; microbes I. Moura*; United Kingdom); W.; Davis Birch; N. Beauchemin; M. Vulic; K. Bentley; P.; Culmer; M. Mayol; C. Ford; M. Henn; E. Halvorsen; M.; Wilcox; N. Kapur; A. Buckley; O0132  Functional characterization of the Brazilian Yanomami; microbiome along an urbanization gradient: Insights; into the impacts of Westernization on human; health M. Thorp*; Belgium); C. Callewaert; B. De; Pessemier; D. Good; E. Allen-Vercoe; L. Paulino; L.; Vereecke; O0133  Colonization resistance of the intestinal microbiota to; multidrug-resistant bacteria? K. Villageois-Tran*; (Bobigny; France); C. Emavivie; H. Skerdi; E.N. Saad; M. Julie; E. Ruppé,,,,
11 April 2025,ME055,13:30 - 14:30,14,Meet-the-Expert,Long acting injectables to treat and prevent infections: an example from HIV,,M0159,13:30,,"Monica Gandhi (Salt Lake City, United States)"
11 April 2025,ME055,13:30 - 14:30,14,Meet-the-Expert,Long acting injectables to treat and prevent infections: an example from HIV,,M0160,13:42,,"Pedro Cahn (Buenos Aires, Argentina)"
11 April 2025,OS020,13:30 - 14:30,15,1-hour Oral Session,How to evaluate AMS programs,Esther Calbo; Spain); Sabiha Essack; South Africa); O0134  Preference-based instrumental variables for; estimating the causal effects of antibiotic prescribing; decisions in common infections: Assessing potential; validity using CPRD data N. Nguyen*; United; Kingdom); K. Pouwels; J.V. Robotham; S. Yu; S.; Wordsworth; O0135  Novel antibiotic spectrum metrics to quantify the; impact of antimicrobial stewardship: a multicentre; study B. Moshy*; United Kingdom); R.; Llewellyn; R. Lester; G. Pollara; T. Samuels; J. Sarah; B. Gemma; I. BalakrishnanO0136  Utilizing a weighted-incidence syndromic; antibiogram to evaluate antimicrobial therapies and; resistance trends in community-acquired infections; in a community teaching hospital V. Huang*; (Glendale; United States); T. Pham; A. Vogler; H.; Chhen; C. Vandenberg; O0137  Capturing days of therapy per days of service as a; stewardship tool to identify outliers in prescribing; broad-spectrum antimicrobials in the hospital; setting A. Hopkins*; United States); A.; Farkas; S. Tamirisa; G. Severance; A. Yassin; E. Jaime; O0138  Timing of Novel ￿-Lactams vs. Alternatives in; Hospitalized Patients with Gram-Negative Infections:; Line of Therapy; Yucel*; United States); J. Min; Y. Wang; M.; Vendetti; Y. Emre; R.K. Shields,S020,13:30,- 14:30,"Hall 15
1-hour Oral Session
How to evaluate AMS programs
Chairs Esther Calbo (Terrassa, Spain)"
11 April 2025,ME054,13:30 - 14:30,3,Meet-the-Expert,How antimicrobial tolerance impacts polymicrobial biofilm-associated,,M0157,13:30,,"Hans Steenackers (Leuven, Belgium)"
11 April 2025,ME054,13:30 - 14:30,3,Meet-the-Expert,How antimicrobial tolerance impacts polymicrobial biofilm-associated,,M0158,13:42,,"Brian Conlon (Chapel Hill, United States)"
11 April 2025,OS017,13:30 - 14:30,5,,,Maristela P. Freire; Brazil); Siegbert Rieg; Germany); O0119  Vancomycin Dependent Enterococci: An evolutionary; dead end or the ultimate evolution of a superbug R.; Gupta; Canada); R. Gupta; A.; Cabrera; A. Kanyua; F. Almutawa; J. Delport; K.; Kavanoor Sridhar; O0120  Whipple's disease: one of medicine's great; imitators S. Kesavan*; United Kingdom); F. Heard; S. Kesevan; E. Hart; V. Fleming; C. Santos; R. Thomson; O0121  Phage Therapy as a Rescue Treatment for Recurrent; Pseudomonas aeruginosa Bentall Infection V.; Eiferman*; France); P.A. Vion; B. Rached; C.; Granger; N. Hammoudi; A. Bleibtreu; O0122  A clinical case of Legionella longbeachae  pneumonia; featuring unique epidemiological features in a major; italian hospital S. Guerriero*; Italy); M. La; Sorda; F. De Maio; S. Cardinali; M. Di Donato; P. Del; Vecchio; C. Tarli; M. Fantoni; R. Murri; M. Sanguinetti; C. Torti; O0123  Francisella tularensis  – First autochthonous case in; the UK G. Vanstone*; United Kingdom); A.; Belfield; L. Vincent; V. Perks; D. Wadham; B. Marques; Silva; A. Evans; O. Lloyd; N.C. Gordon; C. Arumugam; A. Ainarozidou,S017,13:30,- 14:30,"Hall 5
1-hour Case Session
Bad bacteria
Chairs Maristela P. Freire (Sao Paulo, Brazil)"
11 April 2025,ME061,14:45 - 15:45,3,Meet-the-Expert,How to use large language models and machine learning for improving One,,M0170,14:45,,"Javier Fernández (Oviedo, Spain)"
11 April 2025,ME061,14:45 - 15:45,3,Meet-the-Expert,How to use large language models and machine learning for improving One,,M0171,14:57,,"Nicolas Radomski (Teramo, Italy)"
11 April 2025,OS019,13:30 - 14:30,12,1-hour Oral Session,Microbiome Dynamics and Health: From Pathogenesis to Therapeutic,Mauricio Farfan; Chile); Eija Inkeri Könönen; Finland); O0129  Multi-omics integrated analysis revealed the key role; of Fusobacterium periodonticum in colorectal; tumorigenesis by decanoic acid promoting neutrophil; chemotaxis. X. Chu*; China); Q. Yang; O0130  Exploring the respiratory microbiome in COPD; patients: The role of Haemophilus  spp. in disease; pathogenesis P. Camps-Massa*; Spain); L.; Saiz-Escobedo; J. Guerrero; E. Cuevas; D. Guevara-; Nuñez; F. Tubau; J. Burgos; M. Lopez; A. González-; Díaz; C. Ardanuy; M. Dominguez; S. Santos; S. Martí; O0131  Using the in vitro MiGut system to simulate the; ulcerative colitis microbiome and post-antibiotic; recovery supported by a pre-defined consortium of; microbes I. Moura*; United Kingdom); W.; Davis Birch; N. Beauchemin; M. Vulic; K. Bentley; P.; Culmer; M. Mayol; C. Ford; M. Henn; E. Halvorsen; M.; Wilcox; N. Kapur; A. Buckley; O0132  Functional characterization of the Brazilian Yanomami; microbiome along an urbanization gradient: Insights; into the impacts of Westernization on human; health M. Thorp*; Belgium); C. Callewaert; B. De; Pessemier; D. Good; E. Allen-Vercoe; L. Paulino; L.; Vereecke; O0133  Colonization resistance of the intestinal microbiota to; multidrug-resistant bacteria? K. Villageois-Tran*; (Bobigny; France); C. Emavivie; H. Skerdi; E.N. Saad; M. Julie; E. Ruppé,,,,
11 April 2025,ME055,13:30 - 14:30,14,Meet-the-Expert,Long acting injectables to treat and prevent infections: an example from HIV,,M0159,13:30,,"Monica Gandhi (Salt Lake City, United States)"
11 April 2025,ME055,13:30 - 14:30,14,Meet-the-Expert,Long acting injectables to treat and prevent infections: an example from HIV,,M0160,13:42,,"Pedro Cahn (Buenos Aires, Argentina)"
11 April 2025,OS020,13:30 - 14:30,15,1-hour Oral Session,How to evaluate AMS programs,Esther Calbo; Spain); Sabiha Essack; South Africa); O0134  Preference-based instrumental variables for; estimating the causal effects of antibiotic prescribing; decisions in common infections: Assessing potential; validity using CPRD data N. Nguyen*; United; Kingdom); K. Pouwels; J.V. Robotham; S. Yu; S.; Wordsworth; O0135  Novel antibiotic spectrum metrics to quantify the; impact of antimicrobial stewardship: a multicentre; study B. Moshy*; United Kingdom); R.; Llewellyn; R. Lester; G. Pollara; T. Samuels; J. Sarah; B. Gemma; I. BalakrishnanO0136  Utilizing a weighted-incidence syndromic; antibiogram to evaluate antimicrobial therapies and; resistance trends in community-acquired infections; in a community teaching hospital V. Huang*; (Glendale; United States); T. Pham; A. Vogler; H.; Chhen; C. Vandenberg; O0137  Capturing days of therapy per days of service as a; stewardship tool to identify outliers in prescribing; broad-spectrum antimicrobials in the hospital; setting A. Hopkins*; United States); A.; Farkas; S. Tamirisa; G. Severance; A. Yassin; E. Jaime; O0138  Timing of Novel ￿-Lactams vs. Alternatives in; Hospitalized Patients with Gram-Negative Infections:; Line of Therapy; Yucel*; United States); J. Min; Y. Wang; M.; Vendetti; Y. Emre; R.K. Shields,S020,13:30,- 14:30,"Hall 15
1-hour Oral Session
How to evaluate AMS programs
Chairs Esther Calbo (Terrassa, Spain)"
11 April 2025,ME054,13:30 - 14:30,3,Meet-the-Expert,How antimicrobial tolerance impacts polymicrobial biofilm-associated,,M0157,13:30,,"Hans Steenackers (Leuven, Belgium)"
11 April 2025,ME054,13:30 - 14:30,3,Meet-the-Expert,How antimicrobial tolerance impacts polymicrobial biofilm-associated,,M0158,13:42,,"Brian Conlon (Chapel Hill, United States)"
11 April 2025,OS017,13:30 - 14:30,5,,,Maristela P. Freire; Brazil); Siegbert Rieg; Germany); O0119  Vancomycin Dependent Enterococci: An evolutionary; dead end or the ultimate evolution of a superbug R.; Gupta; Canada); R. Gupta; A.; Cabrera; A. Kanyua; F. Almutawa; J. Delport; K.; Kavanoor Sridhar; O0120  Whipple's disease: one of medicine's great; imitators S. Kesavan*; United Kingdom); F. Heard; S. Kesevan; E. Hart; V. Fleming; C. Santos; R. Thomson; O0121  Phage Therapy as a Rescue Treatment for Recurrent; Pseudomonas aeruginosa Bentall Infection V.; Eiferman*; France); P.A. Vion; B. Rached; C.; Granger; N. Hammoudi; A. Bleibtreu; O0122  A clinical case of Legionella longbeachae  pneumonia; featuring unique epidemiological features in a major; italian hospital S. Guerriero*; Italy); M. La; Sorda; F. De Maio; S. Cardinali; M. Di Donato; P. Del; Vecchio; C. Tarli; M. Fantoni; R. Murri; M. Sanguinetti; C. Torti; O0123  Francisella tularensis  – First autochthonous case in; the UK G. Vanstone*; United Kingdom); A.; Belfield; L. Vincent; V. Perks; D. Wadham; B. Marques; Silva; A. Evans; O. Lloyd; N.C. Gordon; C. Arumugam; A. Ainarozidou,S017,13:30,- 14:30,"Hall 5
1-hour Case Session
Bad bacteria
Chairs Maristela P. Freire (Sao Paulo, Brazil)"
11 April 2025,ME061,14:45 - 15:45,3,Meet-the-Expert,How to use large language models and machine learning for improving One,,M0170,14:45,,"Javier Fernández (Oviedo, Spain)"
11 April 2025,ME061,14:45 - 15:45,3,Meet-the-Expert,How to use large language models and machine learning for improving One,,M0171,14:57,,"Nicolas Radomski (Teramo, Italy)"
11 April 2025,ME061,14:45 - 15:45,3,Meet-the-Expert,How to use large language models and machine learning for improving One,,F0175,14:55,Using social media for CM/,"ID education Scott Jake 
(Oakland, United States)"
11 April 2025,ME061,14:45 - 15:45,3,Meet-the-Expert,How to use large language models and machine learning for improving One,,F0176,15:05,,"Podcasting and social media for antimicrobial 
stewardship and pharmacy Erin Mccreary 
(Pittsburgh, United States)"
11 April 2025,ME061,14:45 - 15:45,3,Meet-the-Expert,How to use large language models and machine learning for improving One,,F029,14:45,- 15:45,"Arena 2
ePoster Flash Session
Vaccination uptake-challenges and opportunities
Chair Joanne M. Langley (Halifax, Canada)"
11 April 2025,ME061,14:45 - 15:45,3,Meet-the-Expert,How to use large language models and machine learning for improving One,,F0175,14:55,Using social media for CM/,"ID education Scott Jake 
(Oakland, United States)"
11 April 2025,ME061,14:45 - 15:45,3,Meet-the-Expert,How to use large language models and machine learning for improving One,,F0176,15:05,,"Podcasting and social media for antimicrobial 
stewardship and pharmacy Erin Mccreary 
(Pittsburgh, United States)"
11 April 2025,ME061,14:45 - 15:45,3,Meet-the-Expert,How to use large language models and machine learning for improving One,,F029,14:45,- 15:45,"Arena 2
ePoster Flash Session
Vaccination uptake-challenges and opportunities
Chair Joanne M. Langley (Halifax, Canada)"
11 April 2025,KN056,14:45 - 15:45,1,,,Anu Kantele; Finland); Carlos Seas; Peru),K0161,14:45,,"Fernanda Boulos (São Paulo, Brazil)"
11 April 2025,OS026,14:45 - 15:45,11,1-hour Oral Session,"Carbapenem resistance Gram-negatives, what's new in treatment?",,,,,
11 April 2025,OS027,14:45 - 15:45,12,1-hour Oral Session,"Staphylococcus aureus : colonisation, virulence, and persistence",,,,,
11 April 2025,SY059,14:45 - 15:45,13,,,Hege Vangstein Aamot; Norway); Eric Claas; Netherlands),S0166,14:45,Pro:,"clinical benefit and potential for improved patient 
outcomes Kirstine K. Søgaard (Aalborg, Denmark)"
11 April 2025,SY059,14:45 - 15:45,13,,,Hege Vangstein Aamot; Norway); Eric Claas; Netherlands),S0167,15:15,"Con: limitations, costs,","and possible overuse of 
syndromic panels Gilbert Greub (Lausanne, 
Switzerland)"
11 April 2025,SY060,14:45 - 15:45,14,,,Stephanie J. Dancer; United Kingdom); Juliette Severin; Netherlands),S0168,14:45,,"Infection risks from sanitation engineering Davey 
Jones (Bangor, United Kingdom)"
11 April 2025,SY060,14:45 - 15:45,14,,,Stephanie J. Dancer; United Kingdom); Juliette Severin; Netherlands),S0169,15:15,Ventilation in toilets: how can we improve it?,"Michael 
Gormley (Edinburgh, United Kingdom)"
11 April 2025,OS028,14:45 - 15:45,15,1-hour Oral Session,ESCMID Global 2025 - Programme,,S028,14:45,- 15:45,"Hall 15
1-hour Oral Session
ESCMID Global 2025 - Programme
(Tokyo, Japan)"
11 April 2025,KN056,14:45 - 15:45,1,,,Anu Kantele; Finland); Carlos Seas; Peru),K0161,14:45,,"Fernanda Boulos (São Paulo, Brazil)"
11 April 2025,OS026,14:45 - 15:45,11,1-hour Oral Session,"Carbapenem resistance Gram-negatives, what's new in treatment?",,,,,
11 April 2025,OS027,14:45 - 15:45,12,1-hour Oral Session,"Staphylococcus aureus : colonisation, virulence, and persistence",,,,,
11 April 2025,SY059,14:45 - 15:45,13,,,Hege Vangstein Aamot; Norway); Eric Claas; Netherlands),S0166,14:45,Pro:,"clinical benefit and potential for improved patient 
outcomes Kirstine K. Søgaard (Aalborg, Denmark)"
11 April 2025,SY059,14:45 - 15:45,13,,,Hege Vangstein Aamot; Norway); Eric Claas; Netherlands),S0167,15:15,"Con: limitations, costs,","and possible overuse of 
syndromic panels Gilbert Greub (Lausanne, 
Switzerland)"
11 April 2025,SY060,14:45 - 15:45,14,,,Stephanie J. Dancer; United Kingdom); Juliette Severin; Netherlands),S0168,14:45,,"Infection risks from sanitation engineering Davey 
Jones (Bangor, United Kingdom)"
11 April 2025,SY060,14:45 - 15:45,14,,,Stephanie J. Dancer; United Kingdom); Juliette Severin; Netherlands),S0169,15:15,Ventilation in toilets: how can we improve it?,"Michael 
Gormley (Edinburgh, United Kingdom)"
11 April 2025,OS028,14:45 - 15:45,15,1-hour Oral Session,ESCMID Global 2025 - Programme,John W. A. Rossen; Netherlands); Maria Vehreschild; Germany); O0190  Deep learning-enhanced wellness scores: Advancing; gut microbiome-based health predictions O.; Nalbantoglu*; Türkiye); A. Gundogdu; B.H.; Ermis; O0191  Comparison of Second-Generation and Third-; Generation Sequencing technologies for 16S rRNA; amplicon-based gut microbiome analysis E. Rubio; García*; Spain); E. Rubio-García; A.; Pulgarin; R. López-Aladid; L. Martínez-Priego; N.; Palau; A. Mendoza; R. Isanta; A. Montalban; J.L.; Villanueva-Cañas; M.M. Montero; M. Sanduzzi; M.; Reig; C. Casals-Pascual; O0192  Donor for fecal microbiota transplantation: a; challenging research. B.S. Orena*; Italy); M.F.; Liporace; A. Maraschini; D. Girelli; D. Pizzotti; E.; Petrillo; C. Alteri; C. Amoroso; F. Caprioli; A.; Callegaro; L. Cariani; O0193  Antibiotic resistance genes diversity and; antimicrobial effects in the vaginal microbiome during; pregnancy N. Boutouchent*; France); S.; Kennedy; O0194  Distinct gut microbiota and metabolic profiles in brain; tumor patients: Bridging microbial insights to CNS; oncology A. Gundogdu*; Türkiye); O.U.; Nalbantoglu; M. Ulgen; M.A. Sav; G. Ekinci; H.F.; Kelestimur; U. Ture,S028,14:45,- 15:45,"Hall 15
1-hour Oral Session
ESCMID Global 2025 - Programme
Unlocking the potential of the human microbiome for clinical diagnostics
Chairs John W. A. Rossen (Groningen, Netherlands)"
11 April 2025,ME062,14:45 - 15:45,16,Meet-the-Expert,Untangling the web: antimicrobial dose adjustments in renal impairment,,M0172,14:45,,"Claire Roger (Nimes, France)"
11 April 2025,ME062,14:45 - 15:45,16,Meet-the-Expert,Untangling the web: antimicrobial dose adjustments in renal impairment,,M0173,14:57,,"Isabel Spriet (Leuven, Belgium)"
11 April 2025,SY057,14:45 - 15:45,2,,,Marc J.M. Bonten; Netherlands); Karin Thursky; Australia),S0162,14:45,Pro:,"maximising outcomes with evidence-based 
useEvangelos Giamarellos-Bourboulis (Athens, 
Greece)"
11 April 2025,SY057,14:45 - 15:45,2,,,Marc J.M. Bonten; Netherlands); Karin Thursky; Australia),S0163,15:15,Con:,the risks of routine (over)
11 April 2025,SY058,14:45 - 15:45,4,,,Nicolas Mueller; Switzerland); Alessandra Mularoni; Italy),Y058,14:45,- 15:45,"Hall 4
1-hour Symposium
Top papers in transplant ID
Chairs Nicolas Mueller (Zurich, Switzerland)"
11 April 2025,SY058,14:45 - 15:45,4,,,Nicolas Mueller; Switzerland); Alessandra Mularoni; Italy),S0164,14:45,,"Top 10 papers in infections in SOT Patricia Munoz 
(Madrid, Spain)"
11 April 2025,SY058,14:45 - 15:45,4,,,Nicolas Mueller; Switzerland); Alessandra Mularoni; Italy),S0165,15:15,,"Top 10 paper in infections in HCT and cellular 
therapy Joshua Hill (Seattle, United States)"
11 April 2025,OS025,14:45 - 15:45,5,1-hour Oral Session,Bacterial battles: a paediatric perspective on infections and interventions,Angelika Berger; Julie Toubiana; France); O0175  Strong Alignment Between National Standard; Treatment Guidelines and WHO AWaRe Book; Recommendations for Primary Care Pediatric; Infections D. Dona*; Italy); D. Donà; G.; Brigadoi; A. Cantarutti; M. Masetti; G. Autore; S.; Mathur; M. Sharland; S.M.R. Esposito; O0176  Correlation between antibiotic consumption and; digestive colonization with multidrug-resistant; Enterobacterales  in a paediatric haematology; department S. Frigui Ep Oueslati*; Tunisia); N.; Fitouri; S. Frigui; Y. Chebbi; I. Fezaa; M. Ouederni; C.; Drira; W. Achour; O0177  Interleukin-6 as a diagnostic biomarker for sepsis in; neonates; children and pregnant women – a real-; world cohort study Sean Olann Whelan; Ireland); O0178  Impact of rapid diagnostic stewardship interventions; to reduce blood culture utilization in a pediatric; medical center E. Vaugon*; United; States); C. Costales; T. Barter; L. Posch; E. Orgel; J.; Dien Bard; O0179  Infective endocarditis: A Decade of Experience at a; Tertiary Pediatric Care Centre M. De Luca*; Italy); R. Iacobelli; S. Samperi; S. Mercadante; L.; Romani; L. Ragni; P. Bruno; G. Brancaccio; F.I. Calò; Carducci; P. Bernaschi; A. Rizza; L. Lancella; L. Galletti,,,,
11 April 2025,EW071,16:15 - 18:15,15,Educational Session,The rare art of writing scientific articles: from conception to submission,Marlieke De Kraker; Switzerland); Mical Paul; Israel),W0205,16:15,Expressing yourself correctly:,"writing tips Angela 
Huttner (Geneva, Switzerland)"
11 April 2025,EW071,16:15 - 18:15,15,Educational Session,The rare art of writing scientific articles: from conception to submission,Marlieke De Kraker; Switzerland); Mical Paul; Israel),W0206,16:35,,"Constructing your manuscript for an original 
article Jesús Rodríguez-Baño (Seville, Spain)"
11 April 2025,EW071,16:15 - 18:15,15,Educational Session,The rare art of writing scientific articles: from conception to submission,Marlieke De Kraker; Switzerland); Mical Paul; Israel),W0208,17:15,,"Selecting the best journal for my manuscript Andre 
Kalil (Omaha, United States)"
11 April 2025,SY069,16:15 - 18:15,16,2-hour Symposium,Controlled human infection models,Frederick Hayden; United States); Nikolai Siemens; Germany),Y069,16:15,- 18:15,"Hall 16
2-hour Symposium
Controlled human infection models
Chairs Frederick Hayden (Charlottesville, United States)"
11 April 2025,SY069,16:15 - 18:15,16,2-hour Symposium,Controlled human infection models,Frederick Hayden; United States); Nikolai Siemens; Germany),S0197,16:15,,"Updates on the dengue human infection 
model Kirsten Lyke (Baltimore, United States)"
11 April 2025,SY069,16:15 - 18:15,16,2-hour Symposium,Controlled human infection models,Frederick Hayden; United States); Nikolai Siemens; Germany),S0198,16:45,,"CHIM in endemic countries Melissa Kapulu (Kilifi, 
Kenya)"
11 April 2025,SY069,16:15 - 18:15,16,2-hour Symposium,Controlled human infection models,Frederick Hayden; United States); Nikolai Siemens; Germany),S0199,17:15,,"Controlled human infection models of parasitic 
infections Meta Roestenberg (Leiden, Netherlands)"
11 April 2025,SY069,16:15 - 18:15,16,2-hour Symposium,Controlled human infection models,Frederick Hayden; United States); Nikolai Siemens; Germany),S0200,17:45,,"Controlled human infection models of non-typhoidal 
SalmonellaMalick Gibani (London, United Kingdom)"
11 April 2025,ME062,14:45 - 15:45,16,Meet-the-Expert,Untangling the web: antimicrobial dose adjustments in renal impairment,,M0172,14:45,,"Claire Roger (Nimes, France)"
11 April 2025,ME062,14:45 - 15:45,16,Meet-the-Expert,Untangling the web: antimicrobial dose adjustments in renal impairment,,M0173,14:57,,"Isabel Spriet (Leuven, Belgium)"
11 April 2025,SY057,14:45 - 15:45,2,,,Marc J.M. Bonten; Netherlands); Karin Thursky; Australia),S0162,14:45,Pro:,"maximising outcomes with evidence-based 
useEvangelos Giamarellos-Bourboulis (Athens, 
Greece)"
11 April 2025,SY057,14:45 - 15:45,2,,,Marc J.M. Bonten; Netherlands); Karin Thursky; Australia),S0163,15:15,Con:,the risks of routine (over)
11 April 2025,SY058,14:45 - 15:45,4,,,Nicolas Mueller; Switzerland); Alessandra Mularoni; Italy),Y058,14:45,- 15:45,"Hall 4
1-hour Symposium
Top papers in transplant ID
Chairs Nicolas Mueller (Zurich, Switzerland)"
11 April 2025,SY058,14:45 - 15:45,4,,,Nicolas Mueller; Switzerland); Alessandra Mularoni; Italy),S0164,14:45,,"Top 10 papers in infections in SOT Patricia Munoz 
(Madrid, Spain)"
11 April 2025,SY058,14:45 - 15:45,4,,,Nicolas Mueller; Switzerland); Alessandra Mularoni; Italy),S0165,15:15,,"Top 10 paper in infections in HCT and cellular 
therapy Joshua Hill (Seattle, United States)"
11 April 2025,OS025,14:45 - 15:45,5,1-hour Oral Session,Bacterial battles: a paediatric perspective on infections and interventions,Angelika Berger; Julie Toubiana; France); O0175  Strong Alignment Between National Standard; Treatment Guidelines and WHO AWaRe Book; Recommendations for Primary Care Pediatric; Infections D. Dona*; Italy); D. Donà; G.; Brigadoi; A. Cantarutti; M. Masetti; G. Autore; S.; Mathur; M. Sharland; S.M.R. Esposito; O0176  Correlation between antibiotic consumption and; digestive colonization with multidrug-resistant; Enterobacterales  in a paediatric haematology; department S. Frigui Ep Oueslati*; Tunisia); N.; Fitouri; S. Frigui; Y. Chebbi; I. Fezaa; M. Ouederni; C.; Drira; W. Achour; O0177  Interleukin-6 as a diagnostic biomarker for sepsis in; neonates; children and pregnant women – a real-; world cohort study Sean Olann Whelan; Ireland); O0178  Impact of rapid diagnostic stewardship interventions; to reduce blood culture utilization in a pediatric; medical center E. Vaugon*; United; States); C. Costales; T. Barter; L. Posch; E. Orgel; J.; Dien Bard; O0179  Infective endocarditis: A Decade of Experience at a; Tertiary Pediatric Care Centre M. De Luca*; Italy); R. Iacobelli; S. Samperi; S. Mercadante; L.; Romani; L. Ragni; P. Bruno; G. Brancaccio; F.I. Calò; Carducci; P. Bernaschi; A. Rizza; L. Lancella; L. Galletti,,,,
11 April 2025,EW071,16:15 - 18:15,15,Educational Session,The rare art of writing scientific articles: from conception to submission,Marlieke De Kraker; Switzerland); Mical Paul; Israel),W0205,16:15,Expressing yourself correctly:,"writing tips Angela 
Huttner (Geneva, Switzerland)"
11 April 2025,EW071,16:15 - 18:15,15,Educational Session,The rare art of writing scientific articles: from conception to submission,Marlieke De Kraker; Switzerland); Mical Paul; Israel),W0206,16:35,,"Constructing your manuscript for an original 
article Jesús Rodríguez-Baño (Seville, Spain)"
11 April 2025,EW071,16:15 - 18:15,15,Educational Session,The rare art of writing scientific articles: from conception to submission,Marlieke De Kraker; Switzerland); Mical Paul; Israel),W0208,17:15,,"Selecting the best journal for my manuscript Andre 
Kalil (Omaha, United States)"
11 April 2025,SY069,16:15 - 18:15,16,2-hour Symposium,Controlled human infection models,Frederick Hayden; United States); Nikolai Siemens; Germany),Y069,16:15,- 18:15,"Hall 16
2-hour Symposium
Controlled human infection models
Chairs Frederick Hayden (Charlottesville, United States)"
11 April 2025,SY069,16:15 - 18:15,16,2-hour Symposium,Controlled human infection models,Frederick Hayden; United States); Nikolai Siemens; Germany),S0197,16:15,,"Updates on the dengue human infection 
model Kirsten Lyke (Baltimore, United States)"
11 April 2025,SY069,16:15 - 18:15,16,2-hour Symposium,Controlled human infection models,Frederick Hayden; United States); Nikolai Siemens; Germany),S0198,16:45,,"CHIM in endemic countries Melissa Kapulu (Kilifi, 
Kenya)"
11 April 2025,SY069,16:15 - 18:15,16,2-hour Symposium,Controlled human infection models,Frederick Hayden; United States); Nikolai Siemens; Germany),S0199,17:15,,"Controlled human infection models of parasitic 
infections Meta Roestenberg (Leiden, Netherlands)"
11 April 2025,SY069,16:15 - 18:15,16,2-hour Symposium,Controlled human infection models,Frederick Hayden; United States); Nikolai Siemens; Germany),S0200,17:45,,"Controlled human infection models of non-typhoidal 
SalmonellaMalick Gibani (London, United Kingdom)"
11 April 2025,SY069,16:15 - 18:15,16,2-hour Symposium,Controlled human infection models,Frederick Hayden; United States); Nikolai Siemens; Germany),F033,16:15,- 17:15,"Arena 2
ePoster Flash Session
Current treatment options for invasive fungal infections
Chair Andreas H. Groll (Münster, Germany)"
11 April 2025,SY067,16:15 - 18:15,11,2-hour Symposium,STIs: an ongoing crisis,Dagmar Heuer; Germany); Tomislav Mestrovic; Croatia),S0189,16:15,,"STI treatment options are running out due to 
AMR Magnus Unemo (Örebro, Sweden)"
11 April 2025,SY067,16:15 - 18:15,11,2-hour Symposium,STIs: an ongoing crisis,Dagmar Heuer; Germany); Tomislav Mestrovic; Croatia),S0190,16:45,,"Genomic surveillance of Neisseria gonorrhoeae  
strains Petra Wolffs (Maastricht, Netherlands)"
11 April 2025,SY067,16:15 - 18:15,11,2-hour Symposium,STIs: an ongoing crisis,Dagmar Heuer; Germany); Tomislav Mestrovic; Croatia),S0191,17:15,,"Evolutionary insights into syphilis and Treponema 
pallidumMathew Beale (Hinxton, United Kingdom)"
11 April 2025,SY067,16:15 - 18:15,11,2-hour Symposium,STIs: an ongoing crisis,Dagmar Heuer; Germany); Tomislav Mestrovic; Croatia),S0192,17:45,,"Challenges in chlamydial STI infections Cecile Bebear 
(Bordeaux, France)"
11 April 2025,SY068,16:15 - 18:15,12,2-hour Symposium,Tick-borne encephalitis: contemporary diagnosis and management,Joanna Maria Zajkowska; Poland); Dace Zavadska; Latvia),S0193,16:15,Tick-borne encephalitis:,"immune response and 
clinical experience Sara Gredmark Russ (Stockholm, 
Sweden)"
11 April 2025,SY068,16:15 - 18:15,12,2-hour Symposium,Tick-borne encephalitis: contemporary diagnosis and management,Joanna Maria Zajkowska; Poland); Dace Zavadska; Latvia),S0194,16:45,,"TBE immune responses and vaccine 
effectiveness Karin Stiasny (Vienna, Austria)"
11 April 2025,SY068,16:15 - 18:15,12,2-hour Symposium,Tick-borne encephalitis: contemporary diagnosis and management,Joanna Maria Zajkowska; Poland); Dace Zavadska; Latvia),S0195,17:15,NS1 antibodies:,"diagnostics and screening of 
seroprevalence of TBE virus infection Gerhard 
Dobler (Munich, Germany)"
11 April 2025,SY068,16:15 - 18:15,12,2-hour Symposium,Tick-borne encephalitis: contemporary diagnosis and management,Joanna Maria Zajkowska; Poland); Dace Zavadska; Latvia),S0196,17:45,Treatment for TBE: where do we stand?,"Daniel 
Ruzek (Brno, Czech Republic)"
11 April 2025,LB006,16:15 - 18:15,13,ePoster Flash Session,"Surgical site infections: epidemiology, risk factors, and prevention strategies",Julia Anna Bielicki; United Kingdom); Vance Fowler; United States),L0031,16:15,"Introduction ,","Julia Anna Bielicki (London, United 
Kingdom)"
11 April 2025,LB006,16:15 - 18:15,13,ePoster Flash Session,"Surgical site infections: epidemiology, risk factors, and prevention strategies",Julia Anna Bielicki; United Kingdom); Vance Fowler; United States),L0033,16:30,,Benzylpenicillin versus (flu)
11 April 2025,LB006,16:15 - 18:15,13,ePoster Flash Session,"Surgical site infections: epidemiology, risk factors, and prevention strategies",Julia Anna Bielicki; United Kingdom); Vance Fowler; United States),L0034,16:45,,Cefazolin versus (flu)
11 April 2025,LB006,16:15 - 18:15,13,ePoster Flash Session,"Surgical site infections: epidemiology, risk factors, and prevention strategies",Julia Anna Bielicki; United Kingdom); Vance Fowler; United States),F033,16:15,- 17:15,"Arena 2
ePoster Flash Session
Current treatment options for invasive fungal infections
Chair Andreas H. Groll (Münster, Germany)"
11 April 2025,SY067,16:15 - 18:15,11,2-hour Symposium,STIs: an ongoing crisis,Dagmar Heuer; Germany); Tomislav Mestrovic; Croatia),S0189,16:15,,"STI treatment options are running out due to 
AMR Magnus Unemo (Örebro, Sweden)"
11 April 2025,SY067,16:15 - 18:15,11,2-hour Symposium,STIs: an ongoing crisis,Dagmar Heuer; Germany); Tomislav Mestrovic; Croatia),S0190,16:45,,"Genomic surveillance of Neisseria gonorrhoeae  
strains Petra Wolffs (Maastricht, Netherlands)"
11 April 2025,SY067,16:15 - 18:15,11,2-hour Symposium,STIs: an ongoing crisis,Dagmar Heuer; Germany); Tomislav Mestrovic; Croatia),S0191,17:15,,"Evolutionary insights into syphilis and Treponema 
pallidumMathew Beale (Hinxton, United Kingdom)"
11 April 2025,SY067,16:15 - 18:15,11,2-hour Symposium,STIs: an ongoing crisis,Dagmar Heuer; Germany); Tomislav Mestrovic; Croatia),S0192,17:45,,"Challenges in chlamydial STI infections Cecile Bebear 
(Bordeaux, France)"
11 April 2025,SY068,16:15 - 18:15,12,2-hour Symposium,Tick-borne encephalitis: contemporary diagnosis and management,Joanna Maria Zajkowska; Poland); Dace Zavadska; Latvia),S0193,16:15,Tick-borne encephalitis:,"immune response and 
clinical experience Sara Gredmark Russ (Stockholm, 
Sweden)"
11 April 2025,SY068,16:15 - 18:15,12,2-hour Symposium,Tick-borne encephalitis: contemporary diagnosis and management,Joanna Maria Zajkowska; Poland); Dace Zavadska; Latvia),S0194,16:45,,"TBE immune responses and vaccine 
effectiveness Karin Stiasny (Vienna, Austria)"
11 April 2025,SY068,16:15 - 18:15,12,2-hour Symposium,Tick-borne encephalitis: contemporary diagnosis and management,Joanna Maria Zajkowska; Poland); Dace Zavadska; Latvia),S0195,17:15,NS1 antibodies:,"diagnostics and screening of 
seroprevalence of TBE virus infection Gerhard 
Dobler (Munich, Germany)"
11 April 2025,SY068,16:15 - 18:15,12,2-hour Symposium,Tick-borne encephalitis: contemporary diagnosis and management,Joanna Maria Zajkowska; Poland); Dace Zavadska; Latvia),S0196,17:45,Treatment for TBE: where do we stand?,"Daniel 
Ruzek (Brno, Czech Republic)"
11 April 2025,LB006,16:15 - 18:15,13,,,Julia Anna Bielicki; United Kingdom); Vance Fowler; United States),L0031,16:15,"Introduction ,","Julia Anna Bielicki (London, United 
Kingdom)"
11 April 2025,LB006,16:15 - 18:15,13,,,Julia Anna Bielicki; United Kingdom); Vance Fowler; United States),L0033,16:30,,Benzylpenicillin versus (flu)
11 April 2025,LB006,16:15 - 18:15,13,,,Julia Anna Bielicki; United Kingdom); Vance Fowler; United States),L0034,16:45,,Cefazolin versus (flu)
11 April 2025,LB006,16:15 - 18:15,13,,,Julia Anna Bielicki; United Kingdom); Vance Fowler; United States),L0035,17:00,,"Cloxacillin versus cefazolin for methicillin-susceptible 
Staphylococcus aureus bacteraemia (CloCeBa)"
11 April 2025,LB006,16:15 - 18:15,13,,,Julia Anna Bielicki; United Kingdom); Vance Fowler; United States),L0036,17:15,,"Trial Discussion Julia Anna Bielicki (London, United 
Kingdom)"
11 April 2025,LB006,16:15 - 18:15,13,,,Julia Anna Bielicki; United Kingdom); Vance Fowler; United States),L0037,17:30,,"Trial Discussion Vance Fowler (Durham, United 
States)"
11 April 2025,OS032,16:15 - 18:15,14,,,Eeva Broberg; Sweden); Florian Krammer; United States); O0222  Human metapneumovirus infections in hospitalized; adults compared to respiratory syncytial virus and; influenza infections over ten years in France P.; Loubet*; France); S. Guitton; R. Simon; L.; Lefrancois; L.B. Luong Nguyen; P. Vanhems; F.; Laine; F. Galtier; X. Duval; B. Lina; M. Valette; G.; Lagathu; V. Foulogne; N. Houhou-Fidhou; A.S.; L'honneur; F. Carrat; L. Meyer; C. Durier; O. Launay; O0223  Unveiling animal susceptibility to influenza viruses; (H1N1(pdm09) and H5N1 HPAIV) using animal-; derived respiratory organoids F. Tarrés-Freixas*; (Bellaterra; Spain); G. Ceada; N. Navarro; M. Pérez-; Simó; N. Carmona-Vicente; L. Bonillo-Lopez; A.; Moreno; C. López; J. Segalés; N. Majó; K.; Kochanowski; J. Vergara-Alert; O0224  Exploring the impact of acute lung hypoxia on CD8; T cell phenotypes following severe influenza; infection. B. Huckestein*; United States); P. Thomas; O0225  Virological characterisation of RSV after Nirsevimab; Breakthrough Infections in a Multicentre; Observational Real-world Study in France S.; Fourati*; France); A. Reslan; J. Bourret; Y.; Rahou; L. Chollet; S. Pillet; P. Tremeaux; N. Candace; Dossou; E. Gault; M. Salmona; B.M. Imbert; A.; Mirand; S. Larrat; A. Moisan; S. Marot; A.; Schnuriger; N. Veyrenche; I. Engelmann; L. Handala; A. Henry; V. Stephan; S. Brichler; V. Avettand-; Fenoel; N. Zemali; C. Lefeuvre; C. Pronier; L.; Deroche; M.C. Jaffar; L. Mouna; C. François; A.; Regueme; C. Hartard; S. Roger; F. Gallais; A. Ly; C.; Rodriguez; G. Dos Santos; J. Buchrieser; O.; Schwartz; J.M. Pawlotsky; F. Lemoine; E. Audureau; M.A. Rameix-Welti; O0226  Baseline immunity to highly pathogenic avian; influenza viruses in a healthcare worker cohort C.; Geurts Van Kessel*; Netherlands); M.; Power; W. Rijnink; L. Gommers; T. Bestebroer; W.; Soochit; W. Tan; B. Verstrepen; S. Bogers; G. Van; Nierop; R. Sikkema; A. Grifoni; A. Sette; M.; Koopmans; R. Fouchier; M. Richard; R. De Vries; C.; Geurtsvankessel; O0227  Impact of reinfection on post-acute sequelae of; COVID-19 over multi-organ systems J. Tan*; (Singapore; Singapore); J.T. Lim; L.E. Wee; C.; Chiew; B. Ong; D. Lye; O0228  Clinical and economic burden of respiratory; syncytial virus in adults with acute respiratory; infections – a Danish nationwide cohort; study Stanislava Bratkovic; Denmark); O0229  The burden of respiratory syncytial virus in children; <3 years old presenting to primary; secondary and; tertiary care in England: report from the STOP RSV; prospective surveillance study E. Carter*; United Kingdom); H. Hill; D. Ferreira; A. Collins; C.; Solórzano; L. Mclellan; L. Kerruish; F. Fyles; S.; Drysdale; P. Gonzalez-Dias; G. Duncan; K. Davies; P.; Crozier; P. Saunderson; R. Kramer; M. Bangert; N.; Vassilouthis; S. Messahel; B. Caroline; S. Brearey; J. Bernatoniene; S. Bhowmik; J. Perry; P. Mottram; P.; Mcnamara; D. Lewis; N. Van Kinnekan; A. Finn; O0230  Targeted metagenomic sequencing of influenza; RSV; and symptomatic respiratory infections from; UK healthcare workers M. Knoll*; United; Kingdom); L. Findlater; B. Katie; J. Wagner; T. Diego; D. Rajan; S. Frances Field; S. Thurston; A. Wong; B.; Hyatt; N. Thesin; J. Robinson; R. Yeadon; A. Galvin; B. Blane; Y.L. Huang; K. Howe; M. Forbes; K.; Figueroa; F. Schwach; S. Stott; A. Marhino; A. Frick-; Kretschmer; B. Dave; T. Maddison; S. Hopkins; S.; Foulkes; J. Islam; A. Atti; V. Hall; E. Harrison,,,,
11 April 2025,SY064,16:15 - 18:15,2,2-hour Symposium,PK/PD to avoid emergence of resistance?,Anne-Grete Märtson; Netherlands); Joseph Meletiadis; Greece),S0177,16:15,PK/,"PD and antibacterial therapy Dolors Soy-Muner 
(Barcelona, Spain)"
11 April 2025,SY064,16:15 - 18:15,2,2-hour Symposium,PK/PD to avoid emergence of resistance?,Anne-Grete Märtson; Netherlands); Joseph Meletiadis; Greece),S0178,16:45,PK/,"PD and antifungal therapy Roger Brüggemann 
(Nijmegen, Netherlands)"
11 April 2025,SY064,16:15 - 18:15,2,2-hour Symposium,PK/PD to avoid emergence of resistance?,Anne-Grete Märtson; Netherlands); Joseph Meletiadis; Greece),S0179,17:15,PK/,"PD and antiviral therapy Joe Standing (London, 
United Kingdom)"
11 April 2025,SY064,16:15 - 18:15,2,2-hour Symposium,PK/PD to avoid emergence of resistance?,Anne-Grete Märtson; Netherlands); Joseph Meletiadis; Greece),S0180,17:45,PK/,"PD considerations in anthelminthic 
treatment Jennifer Keiser (Allschwil, Switzerland)"
11 April 2025,EW070,16:15 - 18:15,3,Educational Session,Malaria: when the drugs don’t work Management of treatment failure in non-,Laura Nabarro; United Kingdom); Caroline Rönnberg; Sweden),W0201,16:15,Malaria in the non-endemic setting:,"who to treat as 
an outpatient and how to detect treatment 
failure Emmanuel Bottieau (Antwerp, Belgium)"
11 April 2025,EW070,16:15 - 18:15,3,Educational Session,Malaria: when the drugs don’t work Management of treatment failure in non-,Laura Nabarro; United Kingdom); Caroline Rönnberg; Sweden),W0203,16:55,,"How to manage Plasmodium Knowlesi  infection Giri 
Shan Rajahram (Kota Kinabalu, Malaysia)"
11 April 2025,EW070,16:15 - 18:15,3,Educational Session,Malaria: when the drugs don’t work Management of treatment failure in non-,Laura Nabarro; United Kingdom); Caroline Rönnberg; Sweden),W0204,17:15,,"Epidemiology and control of Plasmodium 
KnowlesiKimberly Fornace (Singapore, Singapore)"
11 April 2025,SY065,16:15 - 18:15,4,2-hour Symposium,"Gram-positives, are they still going?",Diederik Bathoorn; Netherlands); Stefania Stefani; Italy),S0181,16:15,The vanco chronicles:,"enterococci's global 
journey Guido Werner (Wernigerode, Germany)"
11 April 2025,SY065,16:15 - 18:15,4,2-hour Symposium,"Gram-positives, are they still going?",Diederik Bathoorn; Netherlands); Stefania Stefani; Italy),S0182,16:45,,"Pitfall in susceptibility testing of Gram-
positives Helena Zemlickova (Prague, Czech 
Republic)"
11 April 2025,SY065,16:15 - 18:15,4,2-hour Symposium,"Gram-positives, are they still going?",Diederik Bathoorn; Netherlands); Stefania Stefani; Italy),S0183,17:15,,"Drivers for daptomycin and linezolid resistance in 
Gram-positives Glen Carter (Melbourne, Australia)"
11 April 2025,SY066,16:15 - 18:15,5,2-hour Symposium,ESCMID Global 2025 - Programme,,L0035,17:00,,"Cloxacillin versus cefazolin for methicillin-susceptible 
Staphylococcus aureus bacteraemia (CloCeBa)"
11 April 2025,SY066,16:15 - 18:15,5,2-hour Symposium,ESCMID Global 2025 - Programme,,L0036,17:15,,"Trial Discussion Julia Anna Bielicki (London, United 
Kingdom)"
11 April 2025,SY066,16:15 - 18:15,5,2-hour Symposium,ESCMID Global 2025 - Programme,,L0037,17:30,,"Trial Discussion Vance Fowler (Durham, United 
States)"
11 April 2025,OS032,16:15 - 18:15,14,,,Eeva Broberg; Sweden); Florian Krammer; United States); O0222  Human metapneumovirus infections in hospitalized; adults compared to respiratory syncytial virus and; influenza infections over ten years in France P.; Loubet*; France); S. Guitton; R. Simon; L.; Lefrancois; L.B. Luong Nguyen; P. Vanhems; F.; Laine; F. Galtier; X. Duval; B. Lina; M. Valette; G.; Lagathu; V. Foulogne; N. Houhou-Fidhou; A.S.; L'honneur; F. Carrat; L. Meyer; C. Durier; O. Launay; O0223  Unveiling animal susceptibility to influenza viruses; (H1N1(pdm09) and H5N1 HPAIV) using animal-; derived respiratory organoids F. Tarrés-Freixas*; (Bellaterra; Spain); G. Ceada; N. Navarro; M. Pérez-; Simó; N. Carmona-Vicente; L. Bonillo-Lopez; A.; Moreno; C. López; J. Segalés; N. Majó; K.; Kochanowski; J. Vergara-Alert; O0224  Exploring the impact of acute lung hypoxia on CD8; T cell phenotypes following severe influenza; infection. B. Huckestein*; United States); P. Thomas; O0225  Virological characterisation of RSV after Nirsevimab; Breakthrough Infections in a Multicentre; Observational Real-world Study in France S.; Fourati*; France); A. Reslan; J. Bourret; Y.; Rahou; L. Chollet; S. Pillet; P. Tremeaux; N. Candace; Dossou; E. Gault; M. Salmona; B.M. Imbert; A.; Mirand; S. Larrat; A. Moisan; S. Marot; A.; Schnuriger; N. Veyrenche; I. Engelmann; L. Handala; A. Henry; V. Stephan; S. Brichler; V. Avettand-; Fenoel; N. Zemali; C. Lefeuvre; C. Pronier; L.; Deroche; M.C. Jaffar; L. Mouna; C. François; A.; Regueme; C. Hartard; S. Roger; F. Gallais; A. Ly; C.; Rodriguez; G. Dos Santos; J. Buchrieser; O.; Schwartz; J.M. Pawlotsky; F. Lemoine; E. Audureau; M.A. Rameix-Welti; O0226  Baseline immunity to highly pathogenic avian; influenza viruses in a healthcare worker cohort C.; Geurts Van Kessel*; Netherlands); M.; Power; W. Rijnink; L. Gommers; T. Bestebroer; W.; Soochit; W. Tan; B. Verstrepen; S. Bogers; G. Van; Nierop; R. Sikkema; A. Grifoni; A. Sette; M.; Koopmans; R. Fouchier; M. Richard; R. De Vries; C.; Geurtsvankessel; O0227  Impact of reinfection on post-acute sequelae of; COVID-19 over multi-organ systems J. Tan*; (Singapore; Singapore); J.T. Lim; L.E. Wee; C.; Chiew; B. Ong; D. Lye; O0228  Clinical and economic burden of respiratory; syncytial virus in adults with acute respiratory; infections – a Danish nationwide cohort; study Stanislava Bratkovic; Denmark); O0229  The burden of respiratory syncytial virus in children; <3 years old presenting to primary; secondary and; tertiary care in England: report from the STOP RSV; prospective surveillance study E. Carter*; United Kingdom); H. Hill; D. Ferreira; A. Collins; C.; Solórzano; L. Mclellan; L. Kerruish; F. Fyles; S.; Drysdale; P. Gonzalez-Dias; G. Duncan; K. Davies; P.; Crozier; P. Saunderson; R. Kramer; M. Bangert; N.; Vassilouthis; S. Messahel; B. Caroline; S. Brearey; J. Bernatoniene; S. Bhowmik; J. Perry; P. Mottram; P.; Mcnamara; D. Lewis; N. Van Kinnekan; A. Finn; O0230  Targeted metagenomic sequencing of influenza; RSV; and symptomatic respiratory infections from; UK healthcare workers M. Knoll*; United; Kingdom); L. Findlater; B. Katie; J. Wagner; T. Diego; D. Rajan; S. Frances Field; S. Thurston; A. Wong; B.; Hyatt; N. Thesin; J. Robinson; R. Yeadon; A. Galvin; B. Blane; Y.L. Huang; K. Howe; M. Forbes; K.; Figueroa; F. Schwach; S. Stott; A. Marhino; A. Frick-; Kretschmer; B. Dave; T. Maddison; S. Hopkins; S.; Foulkes; J. Islam; A. Atti; V. Hall; E. Harrison,,,,
11 April 2025,SY064,16:15 - 18:15,2,2-hour Symposium,PK/PD to avoid emergence of resistance?,Anne-Grete Märtson; Netherlands); Joseph Meletiadis; Greece),S0177,16:15,PK/,"PD and antibacterial therapy Dolors Soy-Muner 
(Barcelona, Spain)"
11 April 2025,SY064,16:15 - 18:15,2,2-hour Symposium,PK/PD to avoid emergence of resistance?,Anne-Grete Märtson; Netherlands); Joseph Meletiadis; Greece),S0178,16:45,PK/,"PD and antifungal therapy Roger Brüggemann 
(Nijmegen, Netherlands)"
11 April 2025,SY064,16:15 - 18:15,2,2-hour Symposium,PK/PD to avoid emergence of resistance?,Anne-Grete Märtson; Netherlands); Joseph Meletiadis; Greece),S0179,17:15,PK/,"PD and antiviral therapy Joe Standing (London, 
United Kingdom)"
11 April 2025,SY064,16:15 - 18:15,2,2-hour Symposium,PK/PD to avoid emergence of resistance?,Anne-Grete Märtson; Netherlands); Joseph Meletiadis; Greece),S0180,17:45,PK/,"PD considerations in anthelminthic 
treatment Jennifer Keiser (Allschwil, Switzerland)"
11 April 2025,EW070,16:15 - 18:15,3,Educational Session,Malaria: when the drugs don’t work Management of treatment failure in non-,Laura Nabarro; United Kingdom); Caroline Rönnberg; Sweden),W0201,16:15,Malaria in the non-endemic setting:,"who to treat as 
an outpatient and how to detect treatment 
failure Emmanuel Bottieau (Antwerp, Belgium)"
11 April 2025,EW070,16:15 - 18:15,3,Educational Session,Malaria: when the drugs don’t work Management of treatment failure in non-,Laura Nabarro; United Kingdom); Caroline Rönnberg; Sweden),W0203,16:55,,"How to manage Plasmodium Knowlesi  infection Giri 
Shan Rajahram (Kota Kinabalu, Malaysia)"
11 April 2025,EW070,16:15 - 18:15,3,Educational Session,Malaria: when the drugs don’t work Management of treatment failure in non-,Laura Nabarro; United Kingdom); Caroline Rönnberg; Sweden),W0204,17:15,,"Epidemiology and control of Plasmodium 
KnowlesiKimberly Fornace (Singapore, Singapore)"
11 April 2025,SY065,16:15 - 18:15,4,2-hour Symposium,"Gram-positives, are they still going?",Diederik Bathoorn; Netherlands); Stefania Stefani; Italy),S0181,16:15,The vanco chronicles:,"enterococci's global 
journey Guido Werner (Wernigerode, Germany)"
11 April 2025,SY065,16:15 - 18:15,4,2-hour Symposium,"Gram-positives, are they still going?",Diederik Bathoorn; Netherlands); Stefania Stefani; Italy),S0182,16:45,,"Pitfall in susceptibility testing of Gram-
positives Helena Zemlickova (Prague, Czech 
Republic)"
11 April 2025,SY065,16:15 - 18:15,4,2-hour Symposium,"Gram-positives, are they still going?",Diederik Bathoorn; Netherlands); Stefania Stefani; Italy),S0183,17:15,,"Drivers for daptomycin and linezolid resistance in 
Gram-positives Glen Carter (Melbourne, Australia)"
11 April 2025,SY066,16:15 - 18:15,5,2-hour Symposium,ESCMID Global 2025 - Programme,Sonia Lewycka; Vietnam); Heiman Wertheim; Netherlands),Y066,16:15,- 18:15,"Hall 5
2-hour Symposium
ESCMID Global 2025 - Programme
Biomarker testing to manage respiratory infections in primary care in low 
resource settings
Chairs Sonia Lewycka (Hanoi, Vietnam)"
11 April 2025,SY066,16:15 - 18:15,5,2-hour Symposium,ESCMID Global 2025 - Programme,Sonia Lewycka; Vietnam); Heiman Wertheim; Netherlands),S0185,16:15,,"The Vietnamese experience with CRP testing in the 
community setting Thi Thuy Nga Do (Ha Noi, Vietnam)"
11 April 2025,SY066,16:15 - 18:15,5,2-hour Symposium,ESCMID Global 2025 - Programme,Sonia Lewycka; Vietnam); Heiman Wertheim; Netherlands),S0186,16:45,,"The Nigerian experience with CRP testing in the 
community setting Augustine Onwunduba (Awka, 
Nigeria)"
11 April 2025,SY066,16:15 - 18:15,5,2-hour Symposium,ESCMID Global 2025 - Programme,Sonia Lewycka; Vietnam); Heiman Wertheim; Netherlands),S0187,17:15,,"CRP testing in diagnosing tuberculosis in Zambia and 
South Africa Helen Ayles (Lusaka, Zambia)"
11 April 2025,SY066,16:15 - 18:15,5,2-hour Symposium,ESCMID Global 2025 - Programme,Sonia Lewycka; Vietnam); Heiman Wertheim; Netherlands),S0188,17:45,,"The health economics of CRP testing in LMICs Yoel 
Lubell (Bangkok, Thailand)"
11 April 2025,SY066,16:15 - 18:15,5,2-hour Symposium,ESCMID Global 2025 - Programme,Sonia Lewycka; Vietnam); Heiman Wertheim; Netherlands),F035,17:15,- 18:15,"Arena 1
ePoster Flash Session
Genomics in pathogen surveillance
Chair Vítor Borges (Lisbon, Portugal)"
11 April 2025,SY075,08:30 - 10:30,15,2-hour Symposium,Diphtheria: from re-emergence to vaccine strategies,Helena Seth-Smith; Switzerland); Julie Toubiana; France),S0221,08:30,Diphtheria:,"from clinical picture to medical 
management Regina Oladokun (Oyo, Nigeria)"
11 April 2025,SY075,08:30 - 10:30,15,2-hour Symposium,Diphtheria: from re-emergence to vaccine strategies,Helena Seth-Smith; Switzerland); Julie Toubiana; France),S0224,10:00,Diphtheria vaccination:,"a reappraisal Gayatri 
Amirthalingam (London, United Kingdom)"
11 April 2025,SY075,08:30 - 10:30,15,2-hour Symposium,Diphtheria: from re-emergence to vaccine strategies,Helena Seth-Smith; Switzerland); Julie Toubiana; France),F039,08:30,- 09:30,"Arena 1
ePoster Flash Session
ESCMID Global 2025 - Programme
Biomarker testing to manage respiratory infections in primary care in low 
resource settings
Chairs Sonia Lewycka (Hanoi, Vietnam)"
11 April 2025,SY075,08:30 - 10:30,15,2-hour Symposium,Diphtheria: from re-emergence to vaccine strategies,Helena Seth-Smith; Switzerland); Julie Toubiana; France),S0185,16:15,,"The Vietnamese experience with CRP testing in the 
community setting Thi Thuy Nga Do (Ha Noi, Vietnam)"
11 April 2025,SY075,08:30 - 10:30,15,2-hour Symposium,Diphtheria: from re-emergence to vaccine strategies,Helena Seth-Smith; Switzerland); Julie Toubiana; France),S0186,16:45,,"The Nigerian experience with CRP testing in the 
community setting Augustine Onwunduba (Awka, 
Nigeria)"
11 April 2025,SY075,08:30 - 10:30,15,2-hour Symposium,Diphtheria: from re-emergence to vaccine strategies,Helena Seth-Smith; Switzerland); Julie Toubiana; France),S0187,17:15,,"CRP testing in diagnosing tuberculosis in Zambia and 
South Africa Helen Ayles (Lusaka, Zambia)"
11 April 2025,SY075,08:30 - 10:30,15,2-hour Symposium,Diphtheria: from re-emergence to vaccine strategies,Helena Seth-Smith; Switzerland); Julie Toubiana; France),S0188,17:45,,"The health economics of CRP testing in LMICs Yoel 
Lubell (Bangkok, Thailand)"
11 April 2025,SY075,08:30 - 10:30,15,2-hour Symposium,Diphtheria: from re-emergence to vaccine strategies,Helena Seth-Smith; Switzerland); Julie Toubiana; France),F035,17:15,- 18:15,"Arena 1
ePoster Flash Session
Genomics in pathogen surveillance
Chair Vítor Borges (Lisbon, Portugal)"
11 April 2025,SY075,08:30 - 10:30,15,2-hour Symposium,Diphtheria: from re-emergence to vaccine strategies,Helena Seth-Smith; Switzerland); Julie Toubiana; France),S0221,08:30,Diphtheria:,"from clinical picture to medical 
management Regina Oladokun (Oyo, Nigeria)"
11 April 2025,SY075,08:30 - 10:30,15,2-hour Symposium,Diphtheria: from re-emergence to vaccine strategies,Helena Seth-Smith; Switzerland); Julie Toubiana; France),S0224,10:00,Diphtheria vaccination:,"a reappraisal Gayatri 
Amirthalingam (London, United Kingdom)"
11 April 2025,SY075,08:30 - 10:30,15,2-hour Symposium,Diphtheria: from re-emergence to vaccine strategies,Helena Seth-Smith; Switzerland); Julie Toubiana; France),F039,08:30,- 09:30,"Arena 1
ePoster Flash Session
ESCMID Global 2025 - Programme
Novel approaches to antiviral therapy
Chair Pinyo Rattanaumpawan (Bangkok, Thailand)"
11 April 2025,EW079,08:30 - 10:30,11,Educational Session,New guidelines for management of brain infections,Jacob Bodilsen; Denmark); Kartika Maharani; Indonesia),W079,08:30,- 10:30,"Hall 11
Educational Session
New guidelines for management of brain infections
Chairs Jacob Bodilsen (Aalborg, Denmark)"
11 April 2025,EW079,08:30 - 10:30,11,Educational Session,New guidelines for management of brain infections,Jacob Bodilsen; Denmark); Kartika Maharani; Indonesia),W0240,09:30,WHO guidelines for cryptococcal meningitis:,"success 
stories and barriers to implementation Nelesh 
Govender (Johannesburg, South Africa)"
11 April 2025,SY073,08:30 - 10:30,12,2-hour Symposium,Proxy indicators: bridging the gap between surveillance and antimicrobial,Bhanu Sinha; Netherlands); Annelies Verbon; Netherlands),S0213,08:30,A broad spectrum of possibilities:,"spectrum scores as 
a unifying metric Céline Pulcini (Nancy, France)"
11 April 2025,SY073,08:30 - 10:30,12,2-hour Symposium,Proxy indicators: bridging the gap between surveillance and antimicrobial,Bhanu Sinha; Netherlands); Annelies Verbon; Netherlands),S0214,09:00,,"Proxy indicators to estimate appropriateness of 
antibiotic prescriptions Diane Ashiru-Oredope 
(London, United Kingdom)"
11 April 2025,SY073,08:30 - 10:30,12,2-hour Symposium,Proxy indicators: bridging the gap between surveillance and antimicrobial,Bhanu Sinha; Netherlands); Annelies Verbon; Netherlands),S0215,09:30,,"How to bridge the gap between surveillance and 
antimicrobial stewardship Mark G. J. De Boer (Leiden, 
Netherlands)"
11 April 2025,SY073,08:30 - 10:30,12,2-hour Symposium,Proxy indicators: bridging the gap between surveillance and antimicrobial,Bhanu Sinha; Netherlands); Annelies Verbon; Netherlands),S0216,10:00,"Health economics,","surveillance and antimicrobial 
stewardship Zhu Nina Jiayue (London, United 
Kingdom)"
11 April 2025,SY074,08:30 - 10:30,13,ePoster Flash Session,New frontiers in parasitic disease and migrant health research,,Y074,08:30,- 10:30,"Hall 13
ESCMID Global 2025 - Programme
Novel approaches to antiviral therapy
Chair Pinyo Rattanaumpawan (Bangkok, Thailand)"
11 April 2025,EW079,08:30 - 10:30,11,Educational Session,New guidelines for management of brain infections,Jacob Bodilsen; Denmark); Kartika Maharani; Indonesia),W079,08:30,- 10:30,"Hall 11
Educational Session
New guidelines for management of brain infections
Chairs Jacob Bodilsen (Aalborg, Denmark)"
11 April 2025,EW079,08:30 - 10:30,11,Educational Session,New guidelines for management of brain infections,Jacob Bodilsen; Denmark); Kartika Maharani; Indonesia),W0240,09:30,WHO guidelines for cryptococcal meningitis:,"success 
stories and barriers to implementation Nelesh 
Govender (Johannesburg, South Africa)"
11 April 2025,SY073,08:30 - 10:30,12,2-hour Symposium,Proxy indicators: bridging the gap between surveillance and antimicrobial,Bhanu Sinha; Netherlands); Annelies Verbon; Netherlands),S0213,08:30,A broad spectrum of possibilities:,"spectrum scores as 
a unifying metric Céline Pulcini (Nancy, France)"
11 April 2025,SY073,08:30 - 10:30,12,2-hour Symposium,Proxy indicators: bridging the gap between surveillance and antimicrobial,Bhanu Sinha; Netherlands); Annelies Verbon; Netherlands),S0214,09:00,,"Proxy indicators to estimate appropriateness of 
antibiotic prescriptions Diane Ashiru-Oredope 
(London, United Kingdom)"
11 April 2025,SY073,08:30 - 10:30,12,2-hour Symposium,Proxy indicators: bridging the gap between surveillance and antimicrobial,Bhanu Sinha; Netherlands); Annelies Verbon; Netherlands),S0215,09:30,,"How to bridge the gap between surveillance and 
antimicrobial stewardship Mark G. J. De Boer (Leiden, 
Netherlands)"
11 April 2025,SY073,08:30 - 10:30,12,2-hour Symposium,Proxy indicators: bridging the gap between surveillance and antimicrobial,Bhanu Sinha; Netherlands); Annelies Verbon; Netherlands),S0216,10:00,"Health economics,","surveillance and antimicrobial 
stewardship Zhu Nina Jiayue (London, United 
Kingdom)"
11 April 2025,SY074,08:30 - 10:30,13,2-hour Symposium,Difficile  to treat: advanced management strategies in difficult to treat CDI,Frédéric Barbut; France); Kerrie Davies; United Kingdom),S0217,08:30,Severe CDI:,"when standard protocols fail Hynek 
Bartos (Prague, Czech Republic)"
11 April 2025,SY074,08:30 - 10:30,13,2-hour Symposium,Difficile  to treat: advanced management strategies in difficult to treat CDI,Frédéric Barbut; France); Kerrie Davies; United Kingdom),S0218,09:00,,"Therapies for complicated CDI Emma Bishop (Clayton 
Vic, Australia)"
11 April 2025,SY074,08:30 - 10:30,13,2-hour Symposium,Difficile  to treat: advanced management strategies in difficult to treat CDI,Frédéric Barbut; France); Kerrie Davies; United Kingdom),S0219,09:30,Recurrent CDI:,"Breaking the cycle Andrea Marino 
(Catania, Italy)"
11 April 2025,SY074,08:30 - 10:30,13,2-hour Symposium,Difficile  to treat: advanced management strategies in difficult to treat CDI,Frédéric Barbut; France); Kerrie Davies; United Kingdom),S0220,10:00,,"Live biotherapeutic products for Clostridioides 
difficile  infection Simon Goldenberg (London, United 
Kingdom)"
11 April 2025,OS038,08:30 - 10:30,14,,,Giulia De Angelis; Italy); Onur Karatuna; Sweden); O0278  Point of care rapid lateral flow antibiotic resistance; test to detect carbapenem resistance in lower; respiratory tract infections J. Rogers*; United Kingdom); A. Gregg; Q. Liu; S. Owen; C. Chen; M. Edward; S. Jiang; W. Lu; L. Mynheer; W. Finch; O0279  Evaluation of a new rapid Lateral flow immunoassay; for the detection of DHA-producing Gram-negative; bacteria C. Moguet*; France); S. Oueslati; A.; Vogel; S. Gelhaye; A. Chalin; H. Volland; T. Naas; O0280  The NitroSpeed Taniborbactam NP test; easy; detection of ￿-lactamase sensitivity to; taniborbactam O. Raro*; Switzerland); S.; Herrera-Espejo; M. Bouvier; A. Kerbol; L. Poirel; P.; Nordmann; O0281  Rapid detection of ￿-lactamase-mediated resistance; to aminopenicillins from urines. P. Nordmann*; (Fribourg; Switzerland); N. Helsens; C. Duployez; L.; Poirel; R. Dessein; O0282  Rapid detection of antibiotic resistance in direct urine; samples M. Bot*; Netherlands); J. Flipse; S.; Bongers; J. Hoogerwerf; J. Ten Oever; H. Wertheim; M. Van Meer; O0283  Next-Generation Utilizer Dipsticks for direct-from-; sample phenotypic Antibiotic Susceptibility Testing in; UTIs E. Iseri*; Sweden); W. Van Der; Wijngaart; V. Özenci; R. Santini; A. Nakama; O.; Ekelund; A. Van Belkum; O0284  Screening for ceftriaxone-resistant Neisseria; gonorrhoeae  with the Urogenital and Resistance kit; (AusDiagnostic) A. Braille*; France); M.; Mainardis; F. Meunier; M. Mathar; M. Mérimèche; B.; Condamine; F. Caméléna; B. Berçot; O0285  Comparative evaluation of rapid antimicrobial; susceptibility testing assays for Gram-negative; bacteria from positive blood cultures D. Squitieri*; (Rome; Italy); G. Menchinelli; C. Magrì; T. D'inzeo; M.; Cacaci; B. Posteraro; G. De Angelis; M. Sanguinetti; O0286  Rapid detection of Carbapenemases directly from; positive blood culture bottle: A tool for early shifting; from empirical to targeted therapy K. Chaudhary*; (New Delhi; India); H. Gautam; P. Batra; S. Mohapatra; S. Sood; B. Dhawan; B. Das Kumar,,,,
11 April 2025,SY076,08:30 - 10:30,16,2-hour Symposium,AMR Surveillance in low resource countries: insights into clinical and policy,Kwame Ohene Buabeng; Ghana); H. Rogier Van Doorn; Vietnam)S0225  08:30  New indicators in national monitoring and evaluation; of AMR supported by improved data utilisation Direk; Limmathurotsakul; Thailand),S0225,08:30,,"New indicators in national monitoring and evaluation 
of AMR supported by improved data utilisation Direk 
Limmathurotsakul (Bangkok, Thailand)"
11 April 2025,SY076,08:30 - 10:30,16,2-hour Symposium,AMR Surveillance in low resource countries: insights into clinical and policy,Kwame Ohene Buabeng; Ghana); H. Rogier Van Doorn; Vietnam)S0225  08:30  New indicators in national monitoring and evaluation; of AMR supported by improved data utilisation Direk; Limmathurotsakul; Thailand),S0226,09:00,,"Interdisciplinary investigation of the drivers and 
burden of AMR in urinary tract infections Stephen 
Mshana (Mwanza, Tanzania, United republic of)"
11 April 2025,SY076,08:30 - 10:30,16,2-hour Symposium,AMR Surveillance in low resource countries: insights into clinical and policy,Kwame Ohene Buabeng; Ghana); H. Rogier Van Doorn; Vietnam)S0225  08:30  New indicators in national monitoring and evaluation; of AMR supported by improved data utilisation Direk; Limmathurotsakul; Thailand),S0227,09:30,A clinically-oriented AMR surveillance network:,"case-
based surveillance and implementation Paul Turner 
(Siem Reap, Cambodia)"
11 April 2025,SY076,08:30 - 10:30,16,2-hour Symposium,AMR Surveillance in low resource countries: insights into clinical and policy,Kwame Ohene Buabeng; Ghana); H. Rogier Van Doorn; Vietnam)S0225  08:30  New indicators in national monitoring and evaluation; of AMR supported by improved data utilisation Direk; Limmathurotsakul; Thailand),S0228,10:00,,"National prescribing guidelines based on AMR 
surveillance data Vilada Chansamouth (Vientiane, Lao 
People's democratic republic)"
11 April 2025,EW077,08:30 - 10:30,2,Educational Session,New tools in acute bacterial infections and sepsis: from machine learning to,Benjamin Mcfadden; Australia); Rita Murri; Italy),W0230,08:50,,"Machine learning for early recognition of 
sepsis Karsten Borgwardt (Martinsried, Germany)"
11 April 2025,EW077,08:30 - 10:30,2,Educational Session,New tools in acute bacterial infections and sepsis: from machine learning to,Benjamin Mcfadden; Australia); Rita Murri; Italy),W0231,09:10,,"How to avoid common mistakes in randomised 
clinical study design Yin Mo (Singapore, Singapore)"
11 April 2025,EW077,08:30 - 10:30,2,Educational Session,New tools in acute bacterial infections and sepsis: from machine learning to,Benjamin Mcfadden; Australia); Rita Murri; Italy),W0232,09:30,,"Improved clinical trials in community-acquired 
pneumonia using precision medicine Lennie Derde 
(Utrecht, Netherlands)"
11 April 2025,SY072,08:30 - 10:30,3,2-hour Symposium,Tackling the emergence of dengue and other Aedes -borne diseases in,Fernanda Boulos; Brazil); Martin P. Grobusch; Netherlands),Y072,08:30,- 10:30,"Hall 3
2-hour Symposium
Tackling the emergence of dengue and other Aedes -borne diseases in 
Europe
Chairs Fernanda Boulos (São Paulo, Brazil)"
11 April 2025,SY072,08:30 - 10:30,3,2-hour Symposium,Tackling the emergence of dengue and other Aedes -borne diseases in,Fernanda Boulos; Brazil); Martin P. Grobusch; Netherlands),S0209,08:30,"How dengue,","chikungunya and zika virus disease 
became emerging threats to Europe Celine Gossner 
(Solna, Sweden)"
11 April 2025,SY072,08:30 - 10:30,3,2-hour Symposium,Tackling the emergence of dengue and other Aedes -borne diseases in,Fernanda Boulos; Brazil); Martin P. Grobusch; Netherlands),S0210,09:00,,"Surveillance of dengue in urbanised tropical 
regions Vincent Junxiong Pang (Singapore, 
Singapore)"
11 April 2025,SY072,08:30 - 10:30,3,2-hour Symposium,Tackling the emergence of dengue and other Aedes -borne diseases in,Fernanda Boulos; Brazil); Martin P. Grobusch; Netherlands),S0212,10:00,,"Tracking autochthonous arboviral infection Luisa 
Barzon (Padua, Italy)"
11 April 2025,EW078,08:30 - 10:30,4,Educational Session,Implementing metagenomics in my lab and mistakes to avoid,Hege Vangstein Aamot; Norway); Claudio Neidhöfer; Germany),W078,08:30,- 10:30,"Hall 4
Educational Session
Implementing metagenomics in my lab and mistakes to avoid
Chairs Hege Vangstein Aamot (Lørenskog, Norway)"
11 April 2025,EW078,08:30 - 10:30,4,Educational Session,Implementing metagenomics in my lab and mistakes to avoid,Hege Vangstein Aamot; Norway); Claudio Neidhöfer; Germany),W0233,08:30,Is metagenomics right for my lab?,"Paula Mölling 
(Örebro, Sweden)"
11 April 2025,EW078,08:30 - 10:30,4,Educational Session,Implementing metagenomics in my lab and mistakes to avoid,Hege Vangstein Aamot; Norway); Claudio Neidhöfer; Germany),S0217,08:30,Severe CDI:,"when standard protocols fail Hynek 
Bartos (Prague, Czech Republic)"
11 April 2025,EW078,08:30 - 10:30,4,Educational Session,Implementing metagenomics in my lab and mistakes to avoid,Hege Vangstein Aamot; Norway); Claudio Neidhöfer; Germany),S0218,09:00,,"Therapies for complicated CDI Emma Bishop (Clayton 
Vic, Australia)"
11 April 2025,EW078,08:30 - 10:30,4,Educational Session,Implementing metagenomics in my lab and mistakes to avoid,Hege Vangstein Aamot; Norway); Claudio Neidhöfer; Germany),S0219,09:30,Recurrent CDI:,"Breaking the cycle Andrea Marino 
(Catania, Italy)"
11 April 2025,EW078,08:30 - 10:30,4,Educational Session,Implementing metagenomics in my lab and mistakes to avoid,Hege Vangstein Aamot; Norway); Claudio Neidhöfer; Germany),S0220,10:00,,"Live biotherapeutic products for Clostridioides 
difficile  infection Simon Goldenberg (London, United 
Kingdom)"
11 April 2025,OS038,08:30 - 10:30,14,,,Giulia De Angelis; Italy); Onur Karatuna; Sweden); O0278  Point of care rapid lateral flow antibiotic resistance; test to detect carbapenem resistance in lower; respiratory tract infections J. Rogers*; United Kingdom); A. Gregg; Q. Liu; S. Owen; C. Chen; M. Edward; S. Jiang; W. Lu; L. Mynheer; W. Finch; O0279  Evaluation of a new rapid Lateral flow immunoassay; for the detection of DHA-producing Gram-negative; bacteria C. Moguet*; France); S. Oueslati; A.; Vogel; S. Gelhaye; A. Chalin; H. Volland; T. Naas; O0280  The NitroSpeed Taniborbactam NP test; easy; detection of ￿-lactamase sensitivity to; taniborbactam O. Raro*; Switzerland); S.; Herrera-Espejo; M. Bouvier; A. Kerbol; L. Poirel; P.; Nordmann; O0281  Rapid detection of ￿-lactamase-mediated resistance; to aminopenicillins from urines. P. Nordmann*; (Fribourg; Switzerland); N. Helsens; C. Duployez; L.; Poirel; R. Dessein; O0282  Rapid detection of antibiotic resistance in direct urine; samples M. Bot*; Netherlands); J. Flipse; S.; Bongers; J. Hoogerwerf; J. Ten Oever; H. Wertheim; M. Van Meer; O0283  Next-Generation Utilizer Dipsticks for direct-from-; sample phenotypic Antibiotic Susceptibility Testing in; UTIs E. Iseri*; Sweden); W. Van Der; Wijngaart; V. Özenci; R. Santini; A. Nakama; O.; Ekelund; A. Van Belkum; O0284  Screening for ceftriaxone-resistant Neisseria; gonorrhoeae  with the Urogenital and Resistance kit; (AusDiagnostic) A. Braille*; France); M.; Mainardis; F. Meunier; M. Mathar; M. Mérimèche; B.; Condamine; F. Caméléna; B. Berçot; O0285  Comparative evaluation of rapid antimicrobial; susceptibility testing assays for Gram-negative; bacteria from positive blood cultures D. Squitieri*; (Rome; Italy); G. Menchinelli; C. Magrì; T. D'inzeo; M.; Cacaci; B. Posteraro; G. De Angelis; M. Sanguinetti; O0286  Rapid detection of Carbapenemases directly from; positive blood culture bottle: A tool for early shifting; from empirical to targeted therapy K. Chaudhary*; (New Delhi; India); H. Gautam; P. Batra; S. Mohapatra; S. Sood; B. Dhawan; B. Das Kumar,,,,
11 April 2025,SY076,08:30 - 10:30,16,2-hour Symposium,AMR Surveillance in low resource countries: insights into clinical and policy,Kwame Ohene Buabeng; Ghana); H. Rogier Van Doorn; Vietnam)S0225  08:30  New indicators in national monitoring and evaluation; of AMR supported by improved data utilisation Direk; Limmathurotsakul; Thailand),S0225,08:30,,"New indicators in national monitoring and evaluation 
of AMR supported by improved data utilisation Direk 
Limmathurotsakul (Bangkok, Thailand)"
11 April 2025,SY076,08:30 - 10:30,16,2-hour Symposium,AMR Surveillance in low resource countries: insights into clinical and policy,Kwame Ohene Buabeng; Ghana); H. Rogier Van Doorn; Vietnam)S0225  08:30  New indicators in national monitoring and evaluation; of AMR supported by improved data utilisation Direk; Limmathurotsakul; Thailand),S0226,09:00,,"Interdisciplinary investigation of the drivers and 
burden of AMR in urinary tract infections Stephen 
Mshana (Mwanza, Tanzania, United republic of)"
11 April 2025,SY076,08:30 - 10:30,16,2-hour Symposium,AMR Surveillance in low resource countries: insights into clinical and policy,Kwame Ohene Buabeng; Ghana); H. Rogier Van Doorn; Vietnam)S0225  08:30  New indicators in national monitoring and evaluation; of AMR supported by improved data utilisation Direk; Limmathurotsakul; Thailand),S0227,09:30,A clinically-oriented AMR surveillance network:,"case-
based surveillance and implementation Paul Turner 
(Siem Reap, Cambodia)"
11 April 2025,SY076,08:30 - 10:30,16,2-hour Symposium,AMR Surveillance in low resource countries: insights into clinical and policy,Kwame Ohene Buabeng; Ghana); H. Rogier Van Doorn; Vietnam)S0225  08:30  New indicators in national monitoring and evaluation; of AMR supported by improved data utilisation Direk; Limmathurotsakul; Thailand),S0228,10:00,,"National prescribing guidelines based on AMR 
surveillance data Vilada Chansamouth (Vientiane, Lao 
People's democratic republic)"
11 April 2025,EW077,08:30 - 10:30,2,Educational Session,New tools in acute bacterial infections and sepsis: from machine learning to,Benjamin Mcfadden; Australia); Rita Murri; Italy),W0230,08:50,,"Machine learning for early recognition of 
sepsis Karsten Borgwardt (Martinsried, Germany)"
11 April 2025,EW077,08:30 - 10:30,2,Educational Session,New tools in acute bacterial infections and sepsis: from machine learning to,Benjamin Mcfadden; Australia); Rita Murri; Italy),W0231,09:10,,"How to avoid common mistakes in randomised 
clinical study design Yin Mo (Singapore, Singapore)"
11 April 2025,EW077,08:30 - 10:30,2,Educational Session,New tools in acute bacterial infections and sepsis: from machine learning to,Benjamin Mcfadden; Australia); Rita Murri; Italy),W0232,09:30,,"Improved clinical trials in community-acquired 
pneumonia using precision medicine Lennie Derde 
(Utrecht, Netherlands)"
11 April 2025,SY072,08:30 - 10:30,3,2-hour Symposium,Tackling the emergence of dengue and other Aedes -borne diseases in,Fernanda Boulos; Brazil); Martin P. Grobusch; Netherlands),Y072,08:30,- 10:30,"Hall 3
2-hour Symposium
Tackling the emergence of dengue and other Aedes -borne diseases in 
Europe
Chairs Fernanda Boulos (São Paulo, Brazil)"
11 April 2025,SY072,08:30 - 10:30,3,2-hour Symposium,Tackling the emergence of dengue and other Aedes -borne diseases in,Fernanda Boulos; Brazil); Martin P. Grobusch; Netherlands),S0209,08:30,"How dengue,","chikungunya and zika virus disease 
became emerging threats to Europe Celine Gossner 
(Solna, Sweden)"
11 April 2025,SY072,08:30 - 10:30,3,2-hour Symposium,Tackling the emergence of dengue and other Aedes -borne diseases in,Fernanda Boulos; Brazil); Martin P. Grobusch; Netherlands),S0210,09:00,,"Surveillance of dengue in urbanised tropical 
regions Vincent Junxiong Pang (Singapore, 
Singapore)"
11 April 2025,SY072,08:30 - 10:30,3,2-hour Symposium,Tackling the emergence of dengue and other Aedes -borne diseases in,Fernanda Boulos; Brazil); Martin P. Grobusch; Netherlands),S0212,10:00,,"Tracking autochthonous arboviral infection Luisa 
Barzon (Padua, Italy)"
11 April 2025,EW078,08:30 - 10:30,4,Educational Session,Implementing metagenomics in my lab and mistakes to avoid,Hege Vangstein Aamot; Norway); Claudio Neidhöfer; Germany),W078,08:30,- 10:30,"Hall 4
Educational Session
Implementing metagenomics in my lab and mistakes to avoid
Chairs Hege Vangstein Aamot (Lørenskog, Norway)"
11 April 2025,EW078,08:30 - 10:30,4,Educational Session,Implementing metagenomics in my lab and mistakes to avoid,Hege Vangstein Aamot; Norway); Claudio Neidhöfer; Germany),W0233,08:30,Is metagenomics right for my lab?,"Paula Mölling 
(Örebro, Sweden)"
11 April 2025,EW078,08:30 - 10:30,4,Educational Session,Implementing metagenomics in my lab and mistakes to avoid,Hege Vangstein Aamot; Norway); Claudio Neidhöfer; Germany),W0234,08:50,,"Understanding the experimental and certification 
aspects of metagenomics Mads Albertsen (Aalborg, 
Denmark)"
11 April 2025,EW078,08:30 - 10:30,4,Educational Session,Implementing metagenomics in my lab and mistakes to avoid,Hege Vangstein Aamot; Norway); Claudio Neidhöfer; Germany),W0235,09:10,"Navigating tools, techniques,","and procurement Basil 
Britto Xavier (Groningen, Netherlands)"
11 April 2025,EW078,08:30 - 10:30,4,Educational Session,Implementing metagenomics in my lab and mistakes to avoid,Hege Vangstein Aamot; Norway); Claudio Neidhöfer; Germany),W0236,09:30,,"Setting realistic goals and outcomes for 
metagenomics integration Claire Bertelli (Lausanne, 
Switzerland)"
11 April 2025,OS037,08:30 - 10:30,5,ePoster Flash Session,Prosthetic and device-associated infections,Eric Claas; Netherlands); Paul G. Higgins; Germany); O0268  From outbreaks to outcomes: Harnessing WGS for; IPC in a high-risk paediatric setting N. Storey*; (London; United Kingdom); E. Cloutman-Green; J.; Hartley; H. Dunn; B. Brekle; M. Adil; S. Barua; J.; Hatcher; J. Brown; J. Breuer; O0269  Why do routine genome-oriented surveillance for; Pseudomonas aeruginosa? A. Rath*; Germany); L. Grancicova; B. Kieninger; A. Caplunik-; Pratsch; J. Fritsch; A. Eichner; W. Schneider-Brachert; O0270  TreeTime estimation depicts transmission dynamics; of clinical and environmental Pseudomonas; aeruginosa  from common reservoirs in healthcare; environment through whole genome sequencing; (WGS) Ö. Yetis*; United Kingdom); Ö. Yetiş; F. Dyrkell; S. Ali; P. Wilson; O0271  Understanding Serratia transmission during a; neonatal ICU outbreak: A combined genotyping and; risk factor analysis K. Jaakkola*; France); C.; Dananché; A. Fischer; J.C. Picaud; P. Cassier; M.; Colomb-Cotinat; S. Haÿs; J.P. Rasigade; O0272  Genomic Insights into the Regional Transmission of; KPC-Producing Bacteria: Clonal and Non-Clonal; Plasmid Sharing C. Shankar*; United; States); A.M. Pirani; D.B. Narayanan; B. Brennan; S.; Mcnamara; A. Miles-Jay; A. Bahr; E.S. Snitkin; O0273  Genome-oriented analysis of the first outbreaks; involving the novel Serratia sarumanii at a neonatal; unit A. Rath*; Germany); B. Kieninger; L.J. Klages; A. Eichner; A. Keller-Wackerbauer; S.M.; Wellmann; A. Ambrosch; J. Fritsch; A. Caplunik-; Pratsch; M. Kabesch; J. Kalinowski; W. Schneider-; Brachert; O0274  Evaluating the Utility of Whole-Genome Sequencing; to Optimise Infection Prevention and Control in a; Hospital Setting: Findings from the GENOTIPE; Study J. Price*; United Kingdom); I. Sey; A.; Yeoh; D. Wlazly; A. Davies; O. Makanjuola; J. Leach; S.; Mookerjee; M. Krutikov; O0275  Outbreak of Carbapenem-Resistant Acinetobacter; seifertii  in a Neonatal Intensive Care Unit: Genomic; Characterization and Surveillance. D. Pereira*; Alegre; Brazil); P. Barth; L. Konkewicz; W. Latosinski; G. De Oliveira; L. Lutz; M. Mott; C. Constante; C.; Wilhelm; L. Antochevis; R. Paiva; K. Tragnago; A.; Barth; A. Martins; O0276  Unveiling the Clonal Dynamics and transmission; mechanism of Carbapenem-Resistant Klebsiella; pneumoniae  in the ICU environment X. Han*; (Hangzhou; China); J. Zhou; Y. Jiang; Y. Yu; O0277  Survey of Infection Prevention staff perception of; WGS integration into routine IPC practice D. Ling*; (Melbourne; Australia); B. Baral; V. Madigan,F041,09:30,- 10:30,"Arena 2
ePoster Flash SessionContemporary diagnostic approaches for fungal infections 
Chair Ilse D. Jacobsen (Jena, Germany)"
11 April 2025,OS037,08:30 - 10:30,5,ePoster Flash Session,Prosthetic and device-associated infections,Eric Claas; Netherlands); Paul G. Higgins; Germany); O0268  From outbreaks to outcomes: Harnessing WGS for; IPC in a high-risk paediatric setting N. Storey*; (London; United Kingdom); E. Cloutman-Green; J.; Hartley; H. Dunn; B. Brekle; M. Adil; S. Barua; J.; Hatcher; J. Brown; J. Breuer; O0269  Why do routine genome-oriented surveillance for; Pseudomonas aeruginosa? A. Rath*; Germany); L. Grancicova; B. Kieninger; A. Caplunik-; Pratsch; J. Fritsch; A. Eichner; W. Schneider-Brachert; O0270  TreeTime estimation depicts transmission dynamics; of clinical and environmental Pseudomonas; aeruginosa  from common reservoirs in healthcare; environment through whole genome sequencing; (WGS) Ö. Yetis*; United Kingdom); Ö. Yetiş; F. Dyrkell; S. Ali; P. Wilson; O0271  Understanding Serratia transmission during a; neonatal ICU outbreak: A combined genotyping and; risk factor analysis K. Jaakkola*; France); C.; Dananché; A. Fischer; J.C. Picaud; P. Cassier; M.; Colomb-Cotinat; S. Haÿs; J.P. Rasigade; O0272  Genomic Insights into the Regional Transmission of; KPC-Producing Bacteria: Clonal and Non-Clonal; Plasmid Sharing C. Shankar*; United; States); A.M. Pirani; D.B. Narayanan; B. Brennan; S.; Mcnamara; A. Miles-Jay; A. Bahr; E.S. Snitkin; O0273  Genome-oriented analysis of the first outbreaks; involving the novel Serratia sarumanii at a neonatal; unit A. Rath*; Germany); B. Kieninger; L.J. Klages; A. Eichner; A. Keller-Wackerbauer; S.M.; Wellmann; A. Ambrosch; J. Fritsch; A. Caplunik-; Pratsch; M. Kabesch; J. Kalinowski; W. Schneider-; Brachert; O0274  Evaluating the Utility of Whole-Genome Sequencing; to Optimise Infection Prevention and Control in a; Hospital Setting: Findings from the GENOTIPE; Study J. Price*; United Kingdom); I. Sey; A.; Yeoh; D. Wlazly; A. Davies; O. Makanjuola; J. Leach; S.; Mookerjee; M. Krutikov; O0275  Outbreak of Carbapenem-Resistant Acinetobacter; seifertii  in a Neonatal Intensive Care Unit: Genomic; Characterization and Surveillance. D. Pereira*; Alegre; Brazil); P. Barth; L. Konkewicz; W. Latosinski; G. De Oliveira; L. Lutz; M. Mott; C. Constante; C.; Wilhelm; L. Antochevis; R. Paiva; K. Tragnago; A.; Barth; A. Martins; O0276  Unveiling the Clonal Dynamics and transmission; mechanism of Carbapenem-Resistant Klebsiella; pneumoniae  in the ICU environment X. Han*; (Hangzhou; China); J. Zhou; Y. Jiang; Y. Yu; O0277  Survey of Infection Prevention staff perception of; WGS integration into routine IPC practice D. Ling*; (Melbourne; Australia); B. Baral; V. Madigan,F042,09:30,- 10:30,"Arena 4
ePoster Flash Session
Prosthetic and device-associated infections
Chair Marjan Wouthuyzen-Bakker (Groningen, 
Netherlands)"
11 April 2025,OS037,08:30 - 10:30,5,ePoster Flash Session,Prosthetic and device-associated infections,Eric Claas; Netherlands); Paul G. Higgins; Germany); O0268  From outbreaks to outcomes: Harnessing WGS for; IPC in a high-risk paediatric setting N. Storey*; (London; United Kingdom); E. Cloutman-Green; J.; Hartley; H. Dunn; B. Brekle; M. Adil; S. Barua; J.; Hatcher; J. Brown; J. Breuer; O0269  Why do routine genome-oriented surveillance for; Pseudomonas aeruginosa? A. Rath*; Germany); L. Grancicova; B. Kieninger; A. Caplunik-; Pratsch; J. Fritsch; A. Eichner; W. Schneider-Brachert; O0270  TreeTime estimation depicts transmission dynamics; of clinical and environmental Pseudomonas; aeruginosa  from common reservoirs in healthcare; environment through whole genome sequencing; (WGS) Ö. Yetis*; United Kingdom); Ö. Yetiş; F. Dyrkell; S. Ali; P. Wilson; O0271  Understanding Serratia transmission during a; neonatal ICU outbreak: A combined genotyping and; risk factor analysis K. Jaakkola*; France); C.; Dananché; A. Fischer; J.C. Picaud; P. Cassier; M.; Colomb-Cotinat; S. Haÿs; J.P. Rasigade; O0272  Genomic Insights into the Regional Transmission of; KPC-Producing Bacteria: Clonal and Non-Clonal; Plasmid Sharing C. Shankar*; United; States); A.M. Pirani; D.B. Narayanan; B. Brennan; S.; Mcnamara; A. Miles-Jay; A. Bahr; E.S. Snitkin; O0273  Genome-oriented analysis of the first outbreaks; involving the novel Serratia sarumanii at a neonatal; unit A. Rath*; Germany); B. Kieninger; L.J. Klages; A. Eichner; A. Keller-Wackerbauer; S.M.; Wellmann; A. Ambrosch; J. Fritsch; A. Caplunik-; Pratsch; M. Kabesch; J. Kalinowski; W. Schneider-; Brachert; O0274  Evaluating the Utility of Whole-Genome Sequencing; to Optimise Infection Prevention and Control in a; Hospital Setting: Findings from the GENOTIPE; Study J. Price*; United Kingdom); I. Sey; A.; Yeoh; D. Wlazly; A. Davies; O. Makanjuola; J. Leach; S.; Mookerjee; M. Krutikov; O0275  Outbreak of Carbapenem-Resistant Acinetobacter; seifertii  in a Neonatal Intensive Care Unit: Genomic; Characterization and Surveillance. D. Pereira*; Alegre; Brazil); P. Barth; L. Konkewicz; W. Latosinski; G. De Oliveira; L. Lutz; M. Mott; C. Constante; C.; Wilhelm; L. Antochevis; R. Paiva; K. Tragnago; A.; Barth; A. Martins; O0276  Unveiling the Clonal Dynamics and transmission; mechanism of Carbapenem-Resistant Klebsiella; pneumoniae  in the ICU environment X. Han*; (Hangzhou; China); J. Zhou; Y. Jiang; Y. Yu; O0277  Survey of Infection Prevention staff perception of; WGS integration into routine IPC practice D. Ling*; (Melbourne; Australia); B. Baral; V. Madigan,W0234,08:50,,"Understanding the experimental and certification 
aspects of metagenomics Mads Albertsen (Aalborg, 
Denmark)"
11 April 2025,OS037,08:30 - 10:30,5,ePoster Flash Session,Prosthetic and device-associated infections,Eric Claas; Netherlands); Paul G. Higgins; Germany); O0268  From outbreaks to outcomes: Harnessing WGS for; IPC in a high-risk paediatric setting N. Storey*; (London; United Kingdom); E. Cloutman-Green; J.; Hartley; H. Dunn; B. Brekle; M. Adil; S. Barua; J.; Hatcher; J. Brown; J. Breuer; O0269  Why do routine genome-oriented surveillance for; Pseudomonas aeruginosa? A. Rath*; Germany); L. Grancicova; B. Kieninger; A. Caplunik-; Pratsch; J. Fritsch; A. Eichner; W. Schneider-Brachert; O0270  TreeTime estimation depicts transmission dynamics; of clinical and environmental Pseudomonas; aeruginosa  from common reservoirs in healthcare; environment through whole genome sequencing; (WGS) Ö. Yetis*; United Kingdom); Ö. Yetiş; F. Dyrkell; S. Ali; P. Wilson; O0271  Understanding Serratia transmission during a; neonatal ICU outbreak: A combined genotyping and; risk factor analysis K. Jaakkola*; France); C.; Dananché; A. Fischer; J.C. Picaud; P. Cassier; M.; Colomb-Cotinat; S. Haÿs; J.P. Rasigade; O0272  Genomic Insights into the Regional Transmission of; KPC-Producing Bacteria: Clonal and Non-Clonal; Plasmid Sharing C. Shankar*; United; States); A.M. Pirani; D.B. Narayanan; B. Brennan; S.; Mcnamara; A. Miles-Jay; A. Bahr; E.S. Snitkin; O0273  Genome-oriented analysis of the first outbreaks; involving the novel Serratia sarumanii at a neonatal; unit A. Rath*; Germany); B. Kieninger; L.J. Klages; A. Eichner; A. Keller-Wackerbauer; S.M.; Wellmann; A. Ambrosch; J. Fritsch; A. Caplunik-; Pratsch; M. Kabesch; J. Kalinowski; W. Schneider-; Brachert; O0274  Evaluating the Utility of Whole-Genome Sequencing; to Optimise Infection Prevention and Control in a; Hospital Setting: Findings from the GENOTIPE; Study J. Price*; United Kingdom); I. Sey; A.; Yeoh; D. Wlazly; A. Davies; O. Makanjuola; J. Leach; S.; Mookerjee; M. Krutikov; O0275  Outbreak of Carbapenem-Resistant Acinetobacter; seifertii  in a Neonatal Intensive Care Unit: Genomic; Characterization and Surveillance. D. Pereira*; Alegre; Brazil); P. Barth; L. Konkewicz; W. Latosinski; G. De Oliveira; L. Lutz; M. Mott; C. Constante; C.; Wilhelm; L. Antochevis; R. Paiva; K. Tragnago; A.; Barth; A. Martins; O0276  Unveiling the Clonal Dynamics and transmission; mechanism of Carbapenem-Resistant Klebsiella; pneumoniae  in the ICU environment X. Han*; (Hangzhou; China); J. Zhou; Y. Jiang; Y. Yu; O0277  Survey of Infection Prevention staff perception of; WGS integration into routine IPC practice D. Ling*; (Melbourne; Australia); B. Baral; V. Madigan,W0235,09:10,"Navigating tools, techniques,","and procurement Basil 
Britto Xavier (Groningen, Netherlands)"
11 April 2025,OS037,08:30 - 10:30,5,ePoster Flash Session,Prosthetic and device-associated infections,Eric Claas; Netherlands); Paul G. Higgins; Germany); O0268  From outbreaks to outcomes: Harnessing WGS for; IPC in a high-risk paediatric setting N. Storey*; (London; United Kingdom); E. Cloutman-Green; J.; Hartley; H. Dunn; B. Brekle; M. Adil; S. Barua; J.; Hatcher; J. Brown; J. Breuer; O0269  Why do routine genome-oriented surveillance for; Pseudomonas aeruginosa? A. Rath*; Germany); L. Grancicova; B. Kieninger; A. Caplunik-; Pratsch; J. Fritsch; A. Eichner; W. Schneider-Brachert; O0270  TreeTime estimation depicts transmission dynamics; of clinical and environmental Pseudomonas; aeruginosa  from common reservoirs in healthcare; environment through whole genome sequencing; (WGS) Ö. Yetis*; United Kingdom); Ö. Yetiş; F. Dyrkell; S. Ali; P. Wilson; O0271  Understanding Serratia transmission during a; neonatal ICU outbreak: A combined genotyping and; risk factor analysis K. Jaakkola*; France); C.; Dananché; A. Fischer; J.C. Picaud; P. Cassier; M.; Colomb-Cotinat; S. Haÿs; J.P. Rasigade; O0272  Genomic Insights into the Regional Transmission of; KPC-Producing Bacteria: Clonal and Non-Clonal; Plasmid Sharing C. Shankar*; United; States); A.M. Pirani; D.B. Narayanan; B. Brennan; S.; Mcnamara; A. Miles-Jay; A. Bahr; E.S. Snitkin; O0273  Genome-oriented analysis of the first outbreaks; involving the novel Serratia sarumanii at a neonatal; unit A. Rath*; Germany); B. Kieninger; L.J. Klages; A. Eichner; A. Keller-Wackerbauer; S.M.; Wellmann; A. Ambrosch; J. Fritsch; A. Caplunik-; Pratsch; M. Kabesch; J. Kalinowski; W. Schneider-; Brachert; O0274  Evaluating the Utility of Whole-Genome Sequencing; to Optimise Infection Prevention and Control in a; Hospital Setting: Findings from the GENOTIPE; Study J. Price*; United Kingdom); I. Sey; A.; Yeoh; D. Wlazly; A. Davies; O. Makanjuola; J. Leach; S.; Mookerjee; M. Krutikov; O0275  Outbreak of Carbapenem-Resistant Acinetobacter; seifertii  in a Neonatal Intensive Care Unit: Genomic; Characterization and Surveillance. D. Pereira*; Alegre; Brazil); P. Barth; L. Konkewicz; W. Latosinski; G. De Oliveira; L. Lutz; M. Mott; C. Constante; C.; Wilhelm; L. Antochevis; R. Paiva; K. Tragnago; A.; Barth; A. Martins; O0276  Unveiling the Clonal Dynamics and transmission; mechanism of Carbapenem-Resistant Klebsiella; pneumoniae  in the ICU environment X. Han*; (Hangzhou; China); J. Zhou; Y. Jiang; Y. Yu; O0277  Survey of Infection Prevention staff perception of; WGS integration into routine IPC practice D. Ling*; (Melbourne; Australia); B. Baral; V. Madigan,W0236,09:30,,"Setting realistic goals and outcomes for 
metagenomics integration Claire Bertelli (Lausanne, 
Switzerland)"
11 April 2025,OS037,08:30 - 10:30,5,ePoster Flash Session,Prosthetic and device-associated infections,Eric Claas; Netherlands); Paul G. Higgins; Germany); O0268  From outbreaks to outcomes: Harnessing WGS for; IPC in a high-risk paediatric setting N. Storey*; (London; United Kingdom); E. Cloutman-Green; J.; Hartley; H. Dunn; B. Brekle; M. Adil; S. Barua; J.; Hatcher; J. Brown; J. Breuer; O0269  Why do routine genome-oriented surveillance for; Pseudomonas aeruginosa? A. Rath*; Germany); L. Grancicova; B. Kieninger; A. Caplunik-; Pratsch; J. Fritsch; A. Eichner; W. Schneider-Brachert; O0270  TreeTime estimation depicts transmission dynamics; of clinical and environmental Pseudomonas; aeruginosa  from common reservoirs in healthcare; environment through whole genome sequencing; (WGS) Ö. Yetis*; United Kingdom); Ö. Yetiş; F. Dyrkell; S. Ali; P. Wilson; O0271  Understanding Serratia transmission during a; neonatal ICU outbreak: A combined genotyping and; risk factor analysis K. Jaakkola*; France); C.; Dananché; A. Fischer; J.C. Picaud; P. Cassier; M.; Colomb-Cotinat; S. Haÿs; J.P. Rasigade; O0272  Genomic Insights into the Regional Transmission of; KPC-Producing Bacteria: Clonal and Non-Clonal; Plasmid Sharing C. Shankar*; United; States); A.M. Pirani; D.B. Narayanan; B. Brennan; S.; Mcnamara; A. Miles-Jay; A. Bahr; E.S. Snitkin; O0273  Genome-oriented analysis of the first outbreaks; involving the novel Serratia sarumanii at a neonatal; unit A. Rath*; Germany); B. Kieninger; L.J. Klages; A. Eichner; A. Keller-Wackerbauer; S.M.; Wellmann; A. Ambrosch; J. Fritsch; A. Caplunik-; Pratsch; M. Kabesch; J. Kalinowski; W. Schneider-; Brachert; O0274  Evaluating the Utility of Whole-Genome Sequencing; to Optimise Infection Prevention and Control in a; Hospital Setting: Findings from the GENOTIPE; Study J. Price*; United Kingdom); I. Sey; A.; Yeoh; D. Wlazly; A. Davies; O. Makanjuola; J. Leach; S.; Mookerjee; M. Krutikov; O0275  Outbreak of Carbapenem-Resistant Acinetobacter; seifertii  in a Neonatal Intensive Care Unit: Genomic; Characterization and Surveillance. D. Pereira*; Alegre; Brazil); P. Barth; L. Konkewicz; W. Latosinski; G. De Oliveira; L. Lutz; M. Mott; C. Constante; C.; Wilhelm; L. Antochevis; R. Paiva; K. Tragnago; A.; Barth; A. Martins; O0276  Unveiling the Clonal Dynamics and transmission; mechanism of Carbapenem-Resistant Klebsiella; pneumoniae  in the ICU environment X. Han*; (Hangzhou; China); J. Zhou; Y. Jiang; Y. Yu; O0277  Survey of Infection Prevention staff perception of; WGS integration into routine IPC practice D. Ling*; (Melbourne; Australia); B. Baral; V. Madigan,F041,09:30,- 10:30,"Arena 2
ePoster Flash SessionContemporary diagnostic approaches for fungal infections 
Chair Ilse D. Jacobsen (Jena, Germany)"
11 April 2025,OS037,08:30 - 10:30,5,ePoster Flash Session,Prosthetic and device-associated infections,Eric Claas; Netherlands); Paul G. Higgins; Germany); O0268  From outbreaks to outcomes: Harnessing WGS for; IPC in a high-risk paediatric setting N. Storey*; (London; United Kingdom); E. Cloutman-Green; J.; Hartley; H. Dunn; B. Brekle; M. Adil; S. Barua; J.; Hatcher; J. Brown; J. Breuer; O0269  Why do routine genome-oriented surveillance for; Pseudomonas aeruginosa? A. Rath*; Germany); L. Grancicova; B. Kieninger; A. Caplunik-; Pratsch; J. Fritsch; A. Eichner; W. Schneider-Brachert; O0270  TreeTime estimation depicts transmission dynamics; of clinical and environmental Pseudomonas; aeruginosa  from common reservoirs in healthcare; environment through whole genome sequencing; (WGS) Ö. Yetis*; United Kingdom); Ö. Yetiş; F. Dyrkell; S. Ali; P. Wilson; O0271  Understanding Serratia transmission during a; neonatal ICU outbreak: A combined genotyping and; risk factor analysis K. Jaakkola*; France); C.; Dananché; A. Fischer; J.C. Picaud; P. Cassier; M.; Colomb-Cotinat; S. Haÿs; J.P. Rasigade; O0272  Genomic Insights into the Regional Transmission of; KPC-Producing Bacteria: Clonal and Non-Clonal; Plasmid Sharing C. Shankar*; United; States); A.M. Pirani; D.B. Narayanan; B. Brennan; S.; Mcnamara; A. Miles-Jay; A. Bahr; E.S. Snitkin; O0273  Genome-oriented analysis of the first outbreaks; involving the novel Serratia sarumanii at a neonatal; unit A. Rath*; Germany); B. Kieninger; L.J. Klages; A. Eichner; A. Keller-Wackerbauer; S.M.; Wellmann; A. Ambrosch; J. Fritsch; A. Caplunik-; Pratsch; M. Kabesch; J. Kalinowski; W. Schneider-; Brachert; O0274  Evaluating the Utility of Whole-Genome Sequencing; to Optimise Infection Prevention and Control in a; Hospital Setting: Findings from the GENOTIPE; Study J. Price*; United Kingdom); I. Sey; A.; Yeoh; D. Wlazly; A. Davies; O. Makanjuola; J. Leach; S.; Mookerjee; M. Krutikov; O0275  Outbreak of Carbapenem-Resistant Acinetobacter; seifertii  in a Neonatal Intensive Care Unit: Genomic; Characterization and Surveillance. D. Pereira*; Alegre; Brazil); P. Barth; L. Konkewicz; W. Latosinski; G. De Oliveira; L. Lutz; M. Mott; C. Constante; C.; Wilhelm; L. Antochevis; R. Paiva; K. Tragnago; A.; Barth; A. Martins; O0276  Unveiling the Clonal Dynamics and transmission; mechanism of Carbapenem-Resistant Klebsiella; pneumoniae  in the ICU environment X. Han*; (Hangzhou; China); J. Zhou; Y. Jiang; Y. Yu; O0277  Survey of Infection Prevention staff perception of; WGS integration into routine IPC practice D. Ling*; (Melbourne; Australia); B. Baral; V. Madigan,F042,09:30,- 10:30,"Arena 4
ePoster Flash Session
Prosthetic and device-associated infections
Chair Marjan Wouthuyzen-Bakker (Groningen, 
Netherlands)"
11 April 2025,KN080,09:30 - 10:30,1,,,Nina Khanna; Switzerland); Priscilla Rupali; India),K0241,09:30,,"Jay Fishman (Boston, United States)"
11 April 2025,SY082,11:00 - 12:00,6,ePoster Flash Session,Expanding MALDI-TOF applications,Tuba Dal; Türkiye); Tyra Grove Krause; Denmark),S0243,11:00,The rise of anti-science:,"lessons for the future 
scientist Marion Koopmans (Rotterdam, Netherlands)"
11 April 2025,SY082,11:00 - 12:00,6,ePoster Flash Session,Expanding MALDI-TOF applications,Tuba Dal; Türkiye); Tyra Grove Krause; Denmark),S0244,11:30,,"Open science for public trust Lisa Hansen (Ottawa, 
Canada)"
11 April 2025,SY082,11:00 - 12:00,6,ePoster Flash Session,Expanding MALDI-TOF applications,Tuba Dal; Türkiye); Tyra Grove Krause; Denmark),F0259,11:00,,"View from medical microbiology Maeve Doyle 
(Waterford, Ireland)"
11 April 2025,SY082,11:00 - 12:00,6,ePoster Flash Session,Expanding MALDI-TOF applications,Tuba Dal; Türkiye); Tyra Grove Krause; Denmark),F0260,11:10,,"view from infectious diseases Eoghan De Barra 
(Dublin, Ireland)"
11 April 2025,SY082,11:00 - 12:00,6,ePoster Flash Session,Expanding MALDI-TOF applications,Tuba Dal; Türkiye); Tyra Grove Krause; Denmark),F0261,11:20,,view from trainees (TAE)
11 April 2025,SY082,11:00 - 12:00,6,ePoster Flash Session,Expanding MALDI-TOF applications,Tuba Dal; Türkiye); Tyra Grove Krause; Denmark),F0262,11:30,European exam - how to prepare?,"Annelies Verbon 
(Bosch En Duin, Netherlands)"
11 April 2025,SY082,11:00 - 12:00,6,ePoster Flash Session,Expanding MALDI-TOF applications,Tuba Dal; Türkiye); Tyra Grove Krause; Denmark),F049,11:00,- 12:00,"Arena 2
ePoster Flash Session
Sometimes it's hard to be a woman
Chair Debora Konopnicki (Brussels, Belgium)"
11 April 2025,SY082,11:00 - 12:00,6,ePoster Flash Session,Expanding MALDI-TOF applications,Tuba Dal; Türkiye); Tyra Grove Krause; Denmark),F050,11:00,- 12:00,"Arena 3
ePoster Flash Session
Expanding MALDI-TOF applications
Chair Belen Rodriguez-Sanchez (Madrid, Spain)"
11 April 2025,KN080,09:30 - 10:30,1,,,Nina Khanna; Switzerland); Priscilla Rupali; India),K0241,09:30,,"Jay Fishman (Boston, United States)"
11 April 2025,SY082,11:00 - 12:00,6,ePoster Flash Session,The enemy of my enemy: From jumbo phages to cocktails for difficult to treat,Tuba Dal; Türkiye); Tyra Grove Krause; Denmark),S0243,11:00,The rise of anti-science:,"lessons for the future 
scientist Marion Koopmans (Rotterdam, Netherlands)"
11 April 2025,SY082,11:00 - 12:00,6,ePoster Flash Session,The enemy of my enemy: From jumbo phages to cocktails for difficult to treat,Tuba Dal; Türkiye); Tyra Grove Krause; Denmark),S0244,11:30,,"Open science for public trust Lisa Hansen (Ottawa, 
Canada)"
11 April 2025,SY082,11:00 - 12:00,6,ePoster Flash Session,The enemy of my enemy: From jumbo phages to cocktails for difficult to treat,Tuba Dal; Türkiye); Tyra Grove Krause; Denmark),F0259,11:00,,"View from medical microbiology Maeve Doyle 
(Waterford, Ireland)"
11 April 2025,SY082,11:00 - 12:00,6,ePoster Flash Session,The enemy of my enemy: From jumbo phages to cocktails for difficult to treat,Tuba Dal; Türkiye); Tyra Grove Krause; Denmark),F0260,11:10,,"view from infectious diseases Eoghan De Barra 
(Dublin, Ireland)"
11 April 2025,SY082,11:00 - 12:00,6,ePoster Flash Session,The enemy of my enemy: From jumbo phages to cocktails for difficult to treat,Tuba Dal; Türkiye); Tyra Grove Krause; Denmark),F0261,11:20,,view from trainees (TAE)
11 April 2025,SY082,11:00 - 12:00,6,ePoster Flash Session,The enemy of my enemy: From jumbo phages to cocktails for difficult to treat,Tuba Dal; Türkiye); Tyra Grove Krause; Denmark),F0262,11:30,European exam - how to prepare?,"Annelies Verbon 
(Bosch En Duin, Netherlands)"
11 April 2025,SY082,11:00 - 12:00,6,ePoster Flash Session,The enemy of my enemy: From jumbo phages to cocktails for difficult to treat,Tuba Dal; Türkiye); Tyra Grove Krause; Denmark),F049,11:00,- 12:00,"Arena 2
ePoster Flash Session
Sometimes it's hard to be a woman
Chair Debora Konopnicki (Brussels, Belgium)"
11 April 2025,SY082,11:00 - 12:00,6,ePoster Flash Session,The enemy of my enemy: From jumbo phages to cocktails for difficult to treat,Tuba Dal; Türkiye); Tyra Grove Krause; Denmark),F050,11:00,- 12:00,"Arena 3
ePoster Flash Session
Expanding MALDI-TOF applications
Chair Belen Rodriguez-Sanchez (Madrid, Spain)"
11 April 2025,KN081,11:00 - 12:00,1,,,Jose Ramon Pano-Pardo; Spain); Jeroen Schouten; Netherlands),N081,11:00,- 12:00,"Hall 1
Keynote LectureThe new frontiers in antimicrobial stewardship
Chairs Jose Ramon Pano-Pardo (Zaragoza, Spain)"
11 April 2025,KN081,11:00 - 12:00,1,,,Jose Ramon Pano-Pardo; Spain); Jeroen Schouten; Netherlands),K0242,11:00,,"Karin Thursky (Carlton, Australia)"
11 April 2025,SY084,11:00 - 12:00,10,,,Hanne Brekke; Norway); Irene Losada Galvan; Spain),S0247,11:00,Human African Trypanosomiasis:,"recent diagnostic 
and medical practices Jean-Mathieu Bart (Conakry, 
Guinea)"
11 April 2025,OS047,11:00 - 12:00,11,1-hour Oral Session,Clinical studies in UTI,Iva Butic; Croatia); Paul Christoffer Lindemann; Norway); O0344  Short versus long antibiotic treatment for; pyelonephritis and complicated UTIs: an updated; systematic review and meta-analysis of RCTs I.; Zahavi*; Israel); D. Kunwar; J. Olchowski; H.; Dallasheh; M. Paul; O0345  Antibiotic treatment duration of complicated urinary; tract infection patients in Europe: results from the; Ecraid POS-cUTI study C. Kats*; Netherlands); J.M. Bravo-Ferrer; T.T. Doesschate; P.D. Van Der Linden; P. Martinez; O. Awwad; E. Rubio; P. Clevenbergh; A. Barac; A. Cano; E. Merino; P.; Andrade; L. Jacquin; B. Koprivica; R. Espindola; P.; Muñoz; T. Lafon; M. Mendris; J. Van Laethem; D.; Viglino; A. Ternhag; J. Rupp; A. Hernandez-Torres; D.; Chadwick; B. Carevic; M. Bonten; E. Tacconelli; J.; Rodríguez-Baño; O0346  Prevalence and impact of multidrug resistance in a; cohort of patients admitted to emergency; department for urinary tract infections: the UTILITY; study; a prospective multicentre study L. Onorato*; (Naples; Italy); E. Allegorico; M. Macera; C. Monari; B.; Migliaccio; F.G. Numis; C. Nasta; M.T. Florio; R.; Sciorio; G. Guiotto; M. Giordano; R. Raucci; F. Dello; Vicario; R. Nasti; A. Voza; N. Coppola; O0347  Weekly sequential antibioprophylaxis for UTI in; neurogenic bladder R. Calin*; France); C.; Chesnel; C. Hentzen; M. Teng; F. Le Breton; V. Phe; F.; Adda; C. Palacios; G. Amarenco; G. Pialoux; O0348  Evidence for the duration of antibiotic therapy for; chronic bacterial prostatitis: a systematic review L.; Cordes*; Switzerland); A. Huttner; R. Calin; K. Gupta; M. Lafaurie; M. Lambregts; V. Lavergne; B.; Trautner,S047,11:00,- 12:00,"Hall 11
1-hour Oral Session
Clinical studies in UTI
Chairs Iva Butic (Zagreb, Croatia)"
11 April 2025,OS048,11:00 - 12:00,12,1-hour Oral Session,Complexities of infections in solid organ transplantation,,S048,11:00,- 12:00,"Hall 12
1-hour Oral Session
Complexities of infections in solid organ transplantation
Chair Silvia Corcione (Turin, Italy)"
11 April 2025,KN081,11:00 - 12:00,1,,,Jose Ramon Pano-Pardo; Spain); Jeroen Schouten; Netherlands),N081,11:00,- 12:00,"Hall 1
Keynote LectureThe new frontiers in antimicrobial stewardship
Chairs Jose Ramon Pano-Pardo (Zaragoza, Spain)"
11 April 2025,KN081,11:00 - 12:00,1,,,Jose Ramon Pano-Pardo; Spain); Jeroen Schouten; Netherlands),K0242,11:00,,"Karin Thursky (Carlton, Australia)"
11 April 2025,SY084,11:00 - 12:00,10,,,Hanne Brekke; Norway); Irene Losada Galvan; Spain),S0247,11:00,Human African Trypanosomiasis:,"recent diagnostic 
and medical practices Jean-Mathieu Bart (Conakry, 
Guinea)"
11 April 2025,OS047,11:00 - 12:00,11,1-hour Oral Session,Clinical studies in UTI,Iva Butic; Croatia); Paul Christoffer Lindemann; Norway); O0344  Short versus long antibiotic treatment for; pyelonephritis and complicated UTIs: an updated; systematic review and meta-analysis of RCTs I.; Zahavi*; Israel); D. Kunwar; J. Olchowski; H.; Dallasheh; M. Paul; O0345  Antibiotic treatment duration of complicated urinary; tract infection patients in Europe: results from the; Ecraid POS-cUTI study C. Kats*; Netherlands); J.M. Bravo-Ferrer; T.T. Doesschate; P.D. Van Der Linden; P. Martinez; O. Awwad; E. Rubio; P. Clevenbergh; A. Barac; A. Cano; E. Merino; P.; Andrade; L. Jacquin; B. Koprivica; R. Espindola; P.; Muñoz; T. Lafon; M. Mendris; J. Van Laethem; D.; Viglino; A. Ternhag; J. Rupp; A. Hernandez-Torres; D.; Chadwick; B. Carevic; M. Bonten; E. Tacconelli; J.; Rodríguez-Baño; O0346  Prevalence and impact of multidrug resistance in a; cohort of patients admitted to emergency; department for urinary tract infections: the UTILITY; study; a prospective multicentre study L. Onorato*; (Naples; Italy); E. Allegorico; M. Macera; C. Monari; B.; Migliaccio; F.G. Numis; C. Nasta; M.T. Florio; R.; Sciorio; G. Guiotto; M. Giordano; R. Raucci; F. Dello; Vicario; R. Nasti; A. Voza; N. Coppola; O0347  Weekly sequential antibioprophylaxis for UTI in; neurogenic bladder R. Calin*; France); C.; Chesnel; C. Hentzen; M. Teng; F. Le Breton; V. Phe; F.; Adda; C. Palacios; G. Amarenco; G. Pialoux; O0348  Evidence for the duration of antibiotic therapy for; chronic bacterial prostatitis: a systematic review L.; Cordes*; Switzerland); A. Huttner; R. Calin; K. Gupta; M. Lafaurie; M. Lambregts; V. Lavergne; B.; Trautner,S047,11:00,- 12:00,"Hall 11
1-hour Oral Session
Clinical studies in UTI
Chairs Iva Butic (Zagreb, Croatia)"
11 April 2025,OS048,11:00 - 12:00,12,1-hour Oral Session,Complexities of infections in solid organ transplantation,,S048,11:00,- 12:00,"Hall 12
1-hour Oral Session
Complexities of infections in solid organ transplantation
Chair Silvia Corcione (Turin, Italy)"
11 April 2025,SY085,11:00 - 12:00,13,,,Mojca Maticic; Slovenia); Snjezana Zidovec Lepej; Croatia),S0249,11:00,,"Role of reflex testing strategies in identifying patients 
with chronic viral hepatitis Oana Sandulescu 
(Bucharest, Romania)"
11 April 2025,SY085,11:00 - 12:00,13,,,Mojca Maticic; Slovenia); Snjezana Zidovec Lepej; Croatia),S0250,11:30,,"Management and elimination of hepatitis in hard-to-
reach persons Suda Tekin (Istanbul, Türkiye)"
11 April 2025,SY086,11:00 - 12:00,14,,,Fusun Can; Türkiye); Denise O'sullivan; United Kingdom),Y086,11:00,- 12:00,"Hall 14
1-hour Symposium
Impact on including a measure of viability in molecular diagnostic tests
Chairs Fusun Can (Istanbul, Türkiye)"
11 April 2025,SY086,11:00 - 12:00,14,,,Fusun Can; Türkiye); Denise O'sullivan; United Kingdom),S0251,11:00,,"Viability markers in support of development of 
Chlamydia  screening recommendations Petra Wolffs 
(Maastricht, Netherlands)"
11 April 2025,SY086,11:00 - 12:00,14,,,Fusun Can; Türkiye); Denise O'sullivan; United Kingdom),S0252,11:30,,"Measuring viability to improve the correlation of AMR 
markers and clinical outcomes in Neisseria 
gonorrhoeaeTatum Mortimer (Athens, United States)"
11 April 2025,ME089,11:00 - 12:00,15,Meet-the-Expert,How to teach Medical Mycology,,M0257,11:00,,"Katrien Lagrou (Leuven, Belgium)"
11 April 2025,ME089,11:00 - 12:00,15,Meet-the-Expert,How to teach Medical Mycology,,M0258,11:12,,"Mihai Mares (Iasi, Romania)"
11 April 2025,SY087,11:00 - 12:00,16,,,,Y087,11:00,- 12:00,"Hall 16
1-hour Symposium
Innovating antimicrobial drug discovery and host-pathogen interaction 
studies using chemical biology
Chair Laurent Poirel (Fribourg, Switzerland)"
11 April 2025,ME088,11:00 - 12:00,2,Meet-the-Expert,Global AMR Policy after UNGA: what do we do now!,,M0255,11:00,,"Gisela Robles Aguilar (Oxford, United Kingdom)"
11 April 2025,ME088,11:00 - 12:00,2,Meet-the-Expert,Global AMR Policy after UNGA: what do we do now!,,M0256,11:12,,"Mike Sharland (London, United Kingdom)"
11 April 2025,OS043,11:00 - 12:00,3,1-hour Oral Session,"Navigating disinfection challenges: resistance, outbreaks, and efficacy",Hillary A. Craddock; Ireland); Stephanie J. Dancer; United Kingdom); O0324  Prolonged disinfectant exposure impacts the; antimicrobial resistance of healthcare-associated; microorganisms: a systematic review Â.R. Fernandes*; (Porto; Portugal); A. Gonçalves Rodrigues; L.; Cobrado; O0325  Sink-associated outbreak of verona integron-; encoded metallo-??-lactamase-producing; carbapenem-resistant Pseudomonas aeruginosa  in a; Dutch intensive care unit M. Van Den Bos Kromhout*; (Zwolle; Netherlands); S. Debast; M. Van Den Bos-; Kromhout; S. De Vries-Van Rossum; S. Abma-Blatter; B. Immeker; K. Zuur; M. Hijmering; J.W.A. Rossen; O0326  Carbapenemase-producing Enterobacterales; outbreak control by replacement of toilets or long-; term disinfection? A real-life experience. A.L.; Engsbro*; Denmark); K.H. Hansen; M.F.J.; Larsen; N. Kling; H.T. Larsen; R. Kjølsen; B. Hansen; L.K. Vejrum; A.L. Laugesen; M. Kemp; O0327  Tolerance of Klebsiella pneumoniae  biofilms to; disinfection with peracetic acid M. Arvand*; Germany); A.M. Richter; D. Csertö; K. Konrat; O0328  Bringing balance to the formulation: disinfection; efficacy and material compatibility J. Jennings*; (Halifax; United Kingdom); T. Langford; H.; Mansbridge; E. Fraser; I. Poles; J. Clarke,,,,
11 April 2025,LB002,11:00 - 12:00,4,1-hour Oral Session,Investigation of intriguing outbreaks,,,,,
11 April 2025,SY085,11:00 - 12:00,13,,,Mojca Maticic; Slovenia); Snjezana Zidovec Lepej; Croatia),S0249,11:00,,"Role of reflex testing strategies in identifying patients 
with chronic viral hepatitis Oana Sandulescu 
(Bucharest, Romania)"
11 April 2025,SY085,11:00 - 12:00,13,,,Mojca Maticic; Slovenia); Snjezana Zidovec Lepej; Croatia),S0250,11:30,,"Management and elimination of hepatitis in hard-to-
reach persons Suda Tekin (Istanbul, Türkiye)"
11 April 2025,SY086,11:00 - 12:00,14,,,Fusun Can; Türkiye); Denise O'sullivan; United Kingdom),Y086,11:00,- 12:00,"Hall 14
1-hour Symposium
Impact on including a measure of viability in molecular diagnostic tests
Chairs Fusun Can (Istanbul, Türkiye)"
11 April 2025,SY086,11:00 - 12:00,14,,,Fusun Can; Türkiye); Denise O'sullivan; United Kingdom),S0251,11:00,,"Viability markers in support of development of 
Chlamydia  screening recommendations Petra Wolffs 
(Maastricht, Netherlands)"
11 April 2025,SY086,11:00 - 12:00,14,,,Fusun Can; Türkiye); Denise O'sullivan; United Kingdom),S0252,11:30,,"Measuring viability to improve the correlation of AMR 
markers and clinical outcomes in Neisseria 
gonorrhoeaeTatum Mortimer (Athens, United States)"
11 April 2025,ME089,11:00 - 12:00,15,Meet-the-Expert,How to teach Medical Mycology,,M0257,11:00,,"Katrien Lagrou (Leuven, Belgium)"
11 April 2025,ME089,11:00 - 12:00,15,Meet-the-Expert,How to teach Medical Mycology,,M0258,11:12,,"Mihai Mares (Iasi, Romania)"
11 April 2025,SY087,11:00 - 12:00,16,,,,Y087,11:00,- 12:00,"Hall 16
1-hour Symposium
Innovating antimicrobial drug discovery and host-pathogen interaction 
studies using chemical biology
Chair Laurent Poirel (Fribourg, Switzerland)"
11 April 2025,ME088,11:00 - 12:00,2,Meet-the-Expert,Global AMR Policy after UNGA: what do we do now!,,M0255,11:00,,"Gisela Robles Aguilar (Oxford, United Kingdom)"
11 April 2025,ME088,11:00 - 12:00,2,Meet-the-Expert,Global AMR Policy after UNGA: what do we do now!,,M0256,11:12,,"Mike Sharland (London, United Kingdom)"
11 April 2025,OS043,11:00 - 12:00,3,1-hour Oral Session,"Navigating disinfection challenges: resistance, outbreaks, and efficacy",Hillary A. Craddock; Ireland); Stephanie J. Dancer; United Kingdom); O0324  Prolonged disinfectant exposure impacts the; antimicrobial resistance of healthcare-associated; microorganisms: a systematic review Â.R. Fernandes*; (Porto; Portugal); A. Gonçalves Rodrigues; L.; Cobrado; O0325  Sink-associated outbreak of verona integron-; encoded metallo-??-lactamase-producing; carbapenem-resistant Pseudomonas aeruginosa  in a; Dutch intensive care unit M. Van Den Bos Kromhout*; (Zwolle; Netherlands); S. Debast; M. Van Den Bos-; Kromhout; S. De Vries-Van Rossum; S. Abma-Blatter; B. Immeker; K. Zuur; M. Hijmering; J.W.A. Rossen; O0326  Carbapenemase-producing Enterobacterales; outbreak control by replacement of toilets or long-; term disinfection? A real-life experience. A.L.; Engsbro*; Denmark); K.H. Hansen; M.F.J.; Larsen; N. Kling; H.T. Larsen; R. Kjølsen; B. Hansen; L.K. Vejrum; A.L. Laugesen; M. Kemp; O0327  Tolerance of Klebsiella pneumoniae  biofilms to; disinfection with peracetic acid M. Arvand*; Germany); A.M. Richter; D. Csertö; K. Konrat; O0328  Bringing balance to the formulation: disinfection; efficacy and material compatibility J. Jennings*; (Halifax; United Kingdom); T. Langford; H.; Mansbridge; E. Fraser; I. Poles; J. Clarke,,,,
11 April 2025,LB002,11:00 - 12:00,4,1-hour Oral Session,Investigation of intriguing outbreaks,,,,,
11 April 2025,OS044,11:00 - 12:00,5,,,Emmanuel Bottieau; Belgium); Marcelo Victor Radisic; Argentina); O0329  Atypical neonatal cutaneous myiasis: a diagnostic; challenge mimicking pustular rash in a resource-; limited setting D. Ekwem Amarachi*; Uganda); E. Namara; E. Ssenuni; A. Amuge; V. Omona; R. Okidi; R. Olum; O0330  An itchy awakening due to Dermanyssus infestation J.; Sevestre*; France); A.Z. Diarra; J.P. Dales; J.M. Bérenegr; S. Ranque; O0331  Uterine Myiasis: A Rare Case of External; Genitourinary Myiasis R.L. Johnson*; United States); J.C.F. Nakazaki; P. Legua; O0332  Neurognathostomiasis Presenting with Cerebral; Venous Sinus Thrombosis: A case report of rare; clinical manifestation. C. Norsungnern*; Thailand); J. Vinichanan; L. Paitoonpong; O0333  If at first; you don't succeed… Treatment-resistant; Fascioliasis: case report W. Garr*; United; Kingdom); K. Woods; L. Nabarro,S044,11:00,- 12:00,"Hall 5
1-hour Case Session
Unusual presentations of unusual parasites
Chairs Emmanuel Bottieau (Antwerp, Belgium)"
11 April 2025,SY083,11:00 - 12:00,7,,,Alexandra Mailles; France); Joanna Maria Zajkowska; Poland),S0245,11:00,,"Challenges in diagnosis of Lyme neuroborreliosis Rick 
Dersch (Freiburg, Germany)"
11 April 2025,SY083,11:00 - 12:00,7,,,Alexandra Mailles; France); Joanna Maria Zajkowska; Poland),S0246,11:30,,"Challenges in treatment of Lyme 
neuroborreliosis Anne Marit Solheim (Kristiansand, 
Norway)"
11 April 2025,OS045,11:00 - 12:00,8,1-hour Oral Session,Social behavioural dynamics of antibiotic use and AMR,Sonia Lewycka; Vietnam); Filippo Medioli; Italy); O0334  Investigating the Knowledge; Attitudes; and Practices; around Antimicrobial Resistance and Stewardship; Among Syrian Healthcare Professionals: A Cross-; Sectional Survey A. Abbara*; United Kingdom); H. Alhosni; F. Alahdab; O0335  Gamified Intervention to Enhance Antimicrobial; Stewardship: Improving Knowledge and Practices on; the Rational Use of Antimicrobials Among Medicines; and Therapeutics Committee Members ??? S.; Mahadevaiah*; India); C. Es; K. Anil; Y.; Maheshwarappa; S.S. Sc; S. Srinivas; V. Swamy Gs; K. Gautam; O0336  Healthcare providers' perspectives on antibiotic use; and resistance in pregnancy; childbirth; and children; under five years of age across four levels of hospitals; in Lao PDR; 2024 S. Vantava*; Lao; People's democratic republic); K. Thilakoun; D.; Sypaseuth; C. Khamla; I. Bounxou; P. Vanpheng; B.; Phetsamone; S. Bangthong; K. Sengchanh; S.; Latsamy; S. Vanphanom; L. Annick; S. Somphou; O0337  High gender gap in female labour force participation; and reduced gender inequality linked to high; antibiotic consumption: Evidence from a global; analysis D. Samria*; India); D. Batheja; A.; Nandi; O0338  Gender gaps in knowledge of antibiotics and; antimicrobial resistance: Evidence from India D.; Batheja*; India); S.R. Umenthala; S. Goel; D.; Samria; R. Bhagawati; B. Deepshikha,S045,11:00,- 12:00,"Hall 8
1-hour Oral Session
Social behavioural dynamics of antibiotic use and AMR
Chairs Sonia Lewycka (Hanoi, Vietnam)"
11 April 2025,OS046,11:00 - 12:00,9,1-hour Oral Session,Vaccines and prophylaxis against respiratory viral infections,Ana Atti; United Kingdom); Sophie Schneitler; Germany); O0339  Public health impact of universal prophylaxis with; nirsevimab for prevention of infant hospitalizations; due to respiratory syncytial virus. Full 2023-24; season analysis of the NIRSE-GAL study; (www.nirsegal.es/en) F. Martinón-Torres*; De Compsotela; Spain); N. Mallah; J. Pardo-Seco; O.; Pérez-Martínez; M.I. Santiago-Pérez; M.T. Otero-; Barrós; N. Suárez-Gaiche; R. Kramer; J. Jing; L.; Platero-Alonso; R.M. Alvárez-Gil; O.M. Ces-Ozores; V.; Nartallo-Penas; S. Mirás-Carballal; M. Piñeiro-Sotelo; J.M. González-Pérez; C. Rodríguez-Tenreiro-Sánchez; I. Rivero-Calle; Á. Manzanares-Casteleiro; O0340  Relative effectiveness of high-dose versus standard-; dose quadrivalent influenza vaccine against; hospitalizations and mortality according to Charlson; Comorbidity Index: A post-hoc analysis of the; DANFLU-1 randomized trial K. Feldballe Bernholm*; (Copenhagen; Denmark); N. Dyrby Johansen; C.; Espersen; D. Modin; K. Hyldekær Janstrup; J. Nealon; S. Samson; M.M. Loiacono; R. Harris; C. Schade; Larsen; A.M. Reimer Jensen; N.E. Landler; S. Tellerup; Nielsen; L. Russell; T. Skovsgaard Itenov; B.L.; Claggett; S.D. Solomon; M.J. Landray; G.H. Gislason; L. Køber; P. Sivapalan; J.U. Stæhr Jensen; T. Biering-; Sørensen; O0341  Relative vaccine efficacy of a SARS-CoV-2 spike; receptor-binding and N-terminal domain COVID-19; vaccine versus mRNA-1273: subgroup analyses C.; Grassi*; United States); S. Chalkias; P.; Dennis; D. Petersen; K. Radhakrishnan; L. Vaughan; R.; Handforth; N. Vicic; A. Rossi; R. Wahid; D. Edwards; J.; Feng; W. Deng; H. Zhou; E. De Windt; V. Urdaneta; B.; Girard; S. Faust; S. Walsh; C. Cosgrove; R. Das; O0342  Effectiveness of RSV vaccine in lung transplant; recipients: neutralizing antibody response against; reference and seasonal strainsN. Shirin*; Israel); L. Levy; D. Yahav; M. Benzimra; Y. Bezalel; T.; Hoffman; T. Sinai; M. Jurkowicz; O. Deri; N. Matalon; M. Saute; Y. Lustig; E. Nachum; M. Peled; I. Nemet; M.; Mandelboim; O0343  Novavax investigational COVID-19 Influenza; Combination nanoparticle vaccine phase 2 study; safety evaluation C. Bennett*; United; States); V. Shinde; S. Neal; J.S. Plested; T. Vincent; M.; Zhu; S. Cloney-Clark; Z. Cai; B. Riviers; A. Ahmed; F.; Mahkhou; A.M. Marchese; I. Cho; L. Fries; W. Woo; ESCMID Global 2025 - Programme; Putoto; F. Di Gennaro; C. Severini; A. Saracino; L0007  Investigation of an international pseudo-outbreak; involving Paraburkholderia fungorum  blood culture; contamination J. Moran-Gilad*; Israel); J.L. Dale; A. Michael-Gayego; A. Gross; V. Temper; S.; Lim; C. Lees; K. Knowles; J. Strahilevitz; Y. Oster; D.; Grupel; D. Reshef; B.A. Smith; B. Warren; E.L.; Palavecino; P. Snippes Vagnone; L0008  Evolving cluster of severe infective endocarditis with; non-toxigenic C. diphtheriae amongst people; experiencing homelessness and substance misuse in; the UK R. Cordery*; United Kingdom); T.; Patel; T. Anwar; N. Utjesanovic; A. Aryee; E.; Mavrogiorgou; N. Karogiannis; D.J. Litt; J. D'aeth; C.; Primus; S. Das; K. Paranthaman; G. Amirthalingham; L0009  AI-driven live cough rate tracking for public health; surveillance M. Kågebäck*; Sweden); E.; Carlsson,S046,11:00,- 12:00,"Hall 9
1-hour Oral Session
Vaccines and prophylaxis against respiratory viral infections
Chairs Ana Atti (London, United Kingdom)"
11 April 2025,OS044,11:00 - 12:00,5,,,Emmanuel Bottieau; Belgium); Marcelo Victor Radisic; Argentina); O0329  Atypical neonatal cutaneous myiasis: a diagnostic; challenge mimicking pustular rash in a resource-; limited setting D. Ekwem Amarachi*; Uganda); E. Namara; E. Ssenuni; A. Amuge; V. Omona; R. Okidi; R. Olum; O0330  An itchy awakening due to Dermanyssus infestation J.; Sevestre*; France); A.Z. Diarra; J.P. Dales; J.M. Bérenegr; S. Ranque; O0331  Uterine Myiasis: A Rare Case of External; Genitourinary Myiasis R.L. Johnson*; United States); J.C.F. Nakazaki; P. Legua; O0332  Neurognathostomiasis Presenting with Cerebral; Venous Sinus Thrombosis: A case report of rare; clinical manifestation. C. Norsungnern*; Thailand); J. Vinichanan; L. Paitoonpong; O0333  If at first; you don't succeed… Treatment-resistant; Fascioliasis: case report W. Garr*; United; Kingdom); K. Woods; L. Nabarro,S044,11:00,- 12:00,"Hall 5
1-hour Case Session
Unusual presentations of unusual parasites
Chairs Emmanuel Bottieau (Antwerp, Belgium)"
11 April 2025,SY083,11:00 - 12:00,7,,,Alexandra Mailles; France); Joanna Maria Zajkowska; Poland),S0245,11:00,,"Challenges in diagnosis of Lyme neuroborreliosis Rick 
Dersch (Freiburg, Germany)"
11 April 2025,SY083,11:00 - 12:00,7,,,Alexandra Mailles; France); Joanna Maria Zajkowska; Poland),S0246,11:30,,"Challenges in treatment of Lyme 
neuroborreliosis Anne Marit Solheim (Kristiansand, 
Norway)"
11 April 2025,OS045,11:00 - 12:00,8,1-hour Oral Session,Social behavioural dynamics of antibiotic use and AMR,Sonia Lewycka; Vietnam); Filippo Medioli; Italy); O0334  Investigating the Knowledge; Attitudes; and Practices; around Antimicrobial Resistance and Stewardship; Among Syrian Healthcare Professionals: A Cross-; Sectional Survey A. Abbara*; United Kingdom); H. Alhosni; F. Alahdab; O0335  Gamified Intervention to Enhance Antimicrobial; Stewardship: Improving Knowledge and Practices on; the Rational Use of Antimicrobials Among Medicines; and Therapeutics Committee Members ??? S.; Mahadevaiah*; India); C. Es; K. Anil; Y.; Maheshwarappa; S.S. Sc; S. Srinivas; V. Swamy Gs; K. Gautam; O0336  Healthcare providers' perspectives on antibiotic use; and resistance in pregnancy; childbirth; and children; under five years of age across four levels of hospitals; in Lao PDR; 2024 S. Vantava*; Lao; People's democratic republic); K. Thilakoun; D.; Sypaseuth; C. Khamla; I. Bounxou; P. Vanpheng; B.; Phetsamone; S. Bangthong; K. Sengchanh; S.; Latsamy; S. Vanphanom; L. Annick; S. Somphou; O0337  High gender gap in female labour force participation; and reduced gender inequality linked to high; antibiotic consumption: Evidence from a global; analysis D. Samria*; India); D. Batheja; A.; Nandi; O0338  Gender gaps in knowledge of antibiotics and; antimicrobial resistance: Evidence from India D.; Batheja*; India); S.R. Umenthala; S. Goel; D.; Samria; R. Bhagawati; B. Deepshikha,S045,11:00,- 12:00,"Hall 8
1-hour Oral Session
Social behavioural dynamics of antibiotic use and AMR
Chairs Sonia Lewycka (Hanoi, Vietnam)"
11 April 2025,OS046,11:00 - 12:00,9,1-hour Oral Session,Vaccines and prophylaxis against respiratory viral infections,Ana Atti; United Kingdom); Sophie Schneitler; Germany); O0339  Public health impact of universal prophylaxis with; nirsevimab for prevention of infant hospitalizations; due to respiratory syncytial virus. Full 2023-24; season analysis of the NIRSE-GAL study; (www.nirsegal.es/en) F. Martinón-Torres*; De Compsotela; Spain); N. Mallah; J. Pardo-Seco; O.; Pérez-Martínez; M.I. Santiago-Pérez; M.T. Otero-; Barrós; N. Suárez-Gaiche; R. Kramer; J. Jing; L.; Platero-Alonso; R.M. Alvárez-Gil; O.M. Ces-Ozores; V.; Nartallo-Penas; S. Mirás-Carballal; M. Piñeiro-Sotelo; J.M. González-Pérez; C. Rodríguez-Tenreiro-Sánchez; I. Rivero-Calle; Á. Manzanares-Casteleiro; O0340  Relative effectiveness of high-dose versus standard-; dose quadrivalent influenza vaccine against; hospitalizations and mortality according to Charlson; Comorbidity Index: A post-hoc analysis of the; DANFLU-1 randomized trial K. Feldballe Bernholm*; (Copenhagen; Denmark); N. Dyrby Johansen; C.; Espersen; D. Modin; K. Hyldekær Janstrup; J. Nealon; S. Samson; M.M. Loiacono; R. Harris; C. Schade; Larsen; A.M. Reimer Jensen; N.E. Landler; S. Tellerup; Nielsen; L. Russell; T. Skovsgaard Itenov; B.L.; Claggett; S.D. Solomon; M.J. Landray; G.H. Gislason; L. Køber; P. Sivapalan; J.U. Stæhr Jensen; T. Biering-; Sørensen; O0341  Relative vaccine efficacy of a SARS-CoV-2 spike; receptor-binding and N-terminal domain COVID-19; vaccine versus mRNA-1273: subgroup analyses C.; Grassi*; United States); S. Chalkias; P.; Dennis; D. Petersen; K. Radhakrishnan; L. Vaughan; R.; Handforth; N. Vicic; A. Rossi; R. Wahid; D. Edwards; J.; Feng; W. Deng; H. Zhou; E. De Windt; V. Urdaneta; B.; Girard; S. Faust; S. Walsh; C. Cosgrove; R. Das; O0342  Effectiveness of RSV vaccine in lung transplant; recipients: neutralizing antibody response against; reference and seasonal strainsN. Shirin*; Israel); L. Levy; D. Yahav; M. Benzimra; Y. Bezalel; T.; Hoffman; T. Sinai; M. Jurkowicz; O. Deri; N. Matalon; M. Saute; Y. Lustig; E. Nachum; M. Peled; I. Nemet; M.; Mandelboim; O0343  Novavax investigational COVID-19 Influenza; Combination nanoparticle vaccine phase 2 study; safety evaluation C. Bennett*; United; States); V. Shinde; S. Neal; J.S. Plested; T. Vincent; M.; Zhu; S. Cloney-Clark; Z. Cai; B. Riviers; A. Ahmed; F.; Mahkhou; A.M. Marchese; I. Cho; L. Fries; W. Woo; ESCMID Global 2025 - Programme,S046,11:00,- 12:00,"Hall 9
1-hour Oral Session
Vaccines and prophylaxis against respiratory viral infections
Chairs Ana Atti (London, United Kingdom)"
11 April 2025,SY093,13:30 - 14:30,11,,,Petar Velikov; Bulgaria); Dafna Yahav; Israel),Y093,13:30,- 14:30,"Hall 11
1-hour Symposium
Immunosenescence and immune response to vaccination
Chairs Petar Velikov (Sofia, Bulgaria)"
11 April 2025,SY093,13:30 - 14:30,11,,,Petar Velikov; Bulgaria); Dafna Yahav; Israel),S0267,13:30,,"How immunosenescence impacts vaccine 
response Andrea Cossarizza (Modena, Italy)"
11 April 2025,SY093,13:30 - 14:30,11,,,Petar Velikov; Bulgaria); Dafna Yahav; Israel),S0268,14:00,,"Strategies to tackle immunosenescence and improve 
immune response to vaccination in the elderly Inna 
Ovsyannikova (Rochester, United States)"
11 April 2025,EW096,13:30 - 15:30,15,Educational Session,Tools for successful development as a medical educator,Giorgia Caruana; Switzerland); Yoav Keynan; Canada),W096,13:30,- 15:30,"Hall 15
Educational Session
Tools for successful development as a medical educator
Chairs Giorgia Caruana (Sion, Switzerland)"
11 April 2025,EW096,13:30 - 15:30,15,Educational Session,Tools for successful development as a medical educator,Giorgia Caruana; Switzerland); Yoav Keynan; Canada),W0273,13:30,,"Developing your educator professional identity Todd 
Cassese (Bronx, United States)"
11 April 2025,EW096,13:30 - 15:30,15,Educational Session,Tools for successful development as a medical educator,Giorgia Caruana; Switzerland); Yoav Keynan; Canada),W0274,13:50,,"What do IPC doctors need to learn to be 
prepared Simone Scheithauer (Göttingen, Germany)"
11 April 2025,EW096,13:30 - 15:30,15,Educational Session,Tools for successful development as a medical educator,Giorgia Caruana; Switzerland); Yoav Keynan; Canada),W0275,14:10,Communities of practice:,"successful experience of a 
transformative collaboration and roadmap Erin 
Bonura (Portland, United States)"
11 April 2025,EW096,13:30 - 15:30,15,Educational Session,Tools for successful development as a medical educator,Giorgia Caruana; Switzerland); Yoav Keynan; Canada),W0276,14:30,,"The critical need for ongoing innovations in medical 
education Clémentine Schilte (Paris, France)"
11 April 2025,EW096,13:30 - 15:30,15,Educational Session,Tools for successful development as a medical educator,Giorgia Caruana; Switzerland); Yoav Keynan; Canada),F0278,13:40,,"Leveraging surveillance networks to strengthen basic 
bacteriology Dissou Affolabi (Cotonou, Benin)"
11 April 2025,EW096,13:30 - 15:30,15,Educational Session,Tools for successful development as a medical educator,Giorgia Caruana; Switzerland); Yoav Keynan; Canada),O098,13:30,- 14:30,"Arena 2
Open Forum
Best of ID Week
Chair Tina Tan (Chicago, United States)"
11 April 2025,EW096,13:30 - 15:30,15,Educational Session,Tools for successful development as a medical educator,Giorgia Caruana; Switzerland); Yoav Keynan; Canada),F055,13:30,- 14:30,"Arena 4
ePoster Flash Session
The cutting edge in tuberculosis
Chair Graeme Ayton Meintjes (Observatory, South Africa)"
11 April 2025,SY093,13:30 - 14:30,11,,,Petar Velikov; Bulgaria); Dafna Yahav; Israel),Y093,13:30,- 14:30,"Hall 11
1-hour Symposium
Immunosenescence and immune response to vaccination
Chairs Petar Velikov (Sofia, Bulgaria)"
11 April 2025,SY093,13:30 - 14:30,11,,,Petar Velikov; Bulgaria); Dafna Yahav; Israel),S0267,13:30,,"How immunosenescence impacts vaccine 
response Andrea Cossarizza (Modena, Italy)"
11 April 2025,SY093,13:30 - 14:30,11,,,Petar Velikov; Bulgaria); Dafna Yahav; Israel),S0268,14:00,,"Strategies to tackle immunosenescence and improve 
immune response to vaccination in the elderly Inna 
Ovsyannikova (Rochester, United States)"
11 April 2025,EW096,13:30 - 15:30,15,Educational Session,Tools for successful development as a medical educator,Giorgia Caruana; Switzerland); Yoav Keynan; Canada),W096,13:30,- 15:30,"Hall 15
Educational Session
Tools for successful development as a medical educator
Chairs Giorgia Caruana (Sion, Switzerland)"
11 April 2025,EW096,13:30 - 15:30,15,Educational Session,Tools for successful development as a medical educator,Giorgia Caruana; Switzerland); Yoav Keynan; Canada),W0273,13:30,,"Developing your educator professional identity Todd 
Cassese (Bronx, United States)"
11 April 2025,EW096,13:30 - 15:30,15,Educational Session,Tools for successful development as a medical educator,Giorgia Caruana; Switzerland); Yoav Keynan; Canada),W0274,13:50,,"What do IPC doctors need to learn to be 
prepared Simone Scheithauer (Göttingen, Germany)"
11 April 2025,EW096,13:30 - 15:30,15,Educational Session,Tools for successful development as a medical educator,Giorgia Caruana; Switzerland); Yoav Keynan; Canada),W0275,14:10,Communities of practice:,"successful experience of a 
transformative collaboration and roadmap Erin 
Bonura (Portland, United States)"
11 April 2025,EW096,13:30 - 15:30,15,Educational Session,Tools for successful development as a medical educator,Giorgia Caruana; Switzerland); Yoav Keynan; Canada),W0276,14:30,,"The critical need for ongoing innovations in medical 
education Clémentine Schilte (Paris, France)"
11 April 2025,EW096,13:30 - 15:30,15,Educational Session,Tools for successful development as a medical educator,Giorgia Caruana; Switzerland); Yoav Keynan; Canada),F0278,13:40,,"Leveraging surveillance networks to strengthen basic 
bacteriology Dissou Affolabi (Cotonou, Benin)"
11 April 2025,EW096,13:30 - 15:30,15,Educational Session,Tools for successful development as a medical educator,Giorgia Caruana; Switzerland); Yoav Keynan; Canada),O098,13:30,- 14:30,"Arena 2
Open Forum
Best of ID Week
Chair Tina Tan (Chicago, United States)"
11 April 2025,EW096,13:30 - 15:30,15,Educational Session,Tools for successful development as a medical educator,Giorgia Caruana; Switzerland); Yoav Keynan; Canada),F055,13:30,- 14:30,"Arena 4
ePoster Flash Session
The cutting edge in tuberculosis
Chair Graeme Ayton Meintjes (Observatory, South Africa)"
11 April 2025,JS1,13:30 - 14:30,12,Journal Session,Late-breaker research from CMI and CMI Communications,,,,,
11 April 2025,LB003,13:30 - 14:30,13,1-hour Oral Session,New solutions for difficult-to-treat infection,,B003,13:30,- 14:30,"Hall 13
1-hour Oral Session
New solutions for difficult-to-treat infection
L0011  Antimicrobial CRISPR-Cas9-based treatment against 
antibiotic resistant extraintestinal pathogenic E. coli  
(ExPEC)"
11 April 2025,SY094,13:30 - 14:30,14,,,Beatriz Guerra Román; Spain); Joel Mossong; Luxembourg),S0269,13:30,,"Foodborne risk in meat and fishery products and 
impact on AMR Anders Dalsgaard (Frederiksberg C, 
Denmark)"
11 April 2025,SY094,13:30 - 14:30,14,,,Beatriz Guerra Román; Spain); Joel Mossong; Luxembourg),S0270,14:00,,"Control challenges associated with food-borne 
multidrug resistance Luisa Maria Vieira Peixe (Porto, 
Portugal)"
11 April 2025,ME095,13:30 - 14:30,16,Meet-the-Expert,Local antimicrobials for deep infections,,M0271,13:30,,"Karolina Akinosoglou (Patra, Greece)"
11 April 2025,ME095,13:30 - 14:30,16,Meet-the-Expert,Local antimicrobials for deep infections,,M0272,13:42,,"Pierre Tattevin (Rennes, France)"
11 April 2025,OS052,13:30 - 14:30,2,1-hour Oral Session,AI in infectious diseases: the lab and beyond,Jacob Moran-Gilad; Israel); Joshua Nosanchuk; United States); Jose Ramon Pano-Pardo; Spain); Jesús Rodríguez-Baño; Spain); Anja Šterbenc; Slovenia); Suzanne Van Asten; Netherlands); David Van Duin; Nc; United States),,,,
11 April 2025,JS1,13:30 - 14:30,12,Journal Session,Late-breaker research from CMI and CMI Communications,,,,,
11 April 2025,LB003,13:30 - 14:30,13,1-hour Oral Session,New solutions for difficult-to-treat infection,,B003,13:30,- 14:30,"Hall 13
1-hour Oral Session
New solutions for difficult-to-treat infection
L0011  Antimicrobial CRISPR-Cas9-based treatment against 
antibiotic resistant extraintestinal pathogenic E. coli  
(ExPEC)"
11 April 2025,SY094,13:30 - 14:30,14,,,Beatriz Guerra Román; Spain); Joel Mossong; Luxembourg),S0269,13:30,,"Foodborne risk in meat and fishery products and 
impact on AMR Anders Dalsgaard (Frederiksberg C, 
Denmark)"
11 April 2025,SY094,13:30 - 14:30,14,,,Beatriz Guerra Román; Spain); Joel Mossong; Luxembourg),S0270,14:00,,"Control challenges associated with food-borne 
multidrug resistance Luisa Maria Vieira Peixe (Porto, 
Portugal)"
11 April 2025,ME095,13:30 - 14:30,16,Meet-the-Expert,Local antimicrobials for deep infections,,M0271,13:30,,"Karolina Akinosoglou (Patra, Greece)"
11 April 2025,ME095,13:30 - 14:30,16,Meet-the-Expert,Local antimicrobials for deep infections,,M0272,13:42,,"Pierre Tattevin (Rennes, France)"
11 April 2025,OS052,13:30 - 14:30,2,1-hour Oral Session,AI in infectious diseases: the lab and beyond,,,,,
11 April 2025,OS053,13:30 - 14:30,3,1-hour Oral Session,Immune evasion and intracellular survival strategies,Juliane Bubeck Wardenburg; United States); Giovanni Delogu; Italy); O0386  Capsule-Dependent Modulation of Cell Death; Pathways and Immune Evasion in Acinetobacter; baumanniiH. Wang*; China); C. Jiang; O0387  Intracellular lifestyle of Acinetobacter baumannii :; Role of phospholipase A2 and transcriptional factor; EB; Spain); C. Atalaya Rey; I.; Molina Panadero; A. Lora González; A. Hmadcha; O0388  The role of peg344 of hypervirulent Klebsiella; pneumoniae  on suppressing autophagy responses of; macrophages Z.E. Kuloğlu*; Türkiye); Ö.; Albayrak; D. Güllü; G. Ekinci; F. Can; O0389  c-Myc Inhibits Macrophage Antimycobacterial; Response in Mycobacterium tuberculosis Infection C.; Dollé*; Switzerland); E. Sarti; R.; Wolfensberger; K. Kusjeko; S. Bredl; R.A. Speck; M.; Greter; J.H. Rueschoff; D. Mai; A. Diercks; P. Sander; G.S. Olson; J. Nemeth; O0390  Targeting neutrophil extracellular traps; prevents tuberculosis immunopathology J.; Kutschenreuter*; United Kingdom); D.; Kirwan; R. Cusman; K.H. Skolimowska; R.H. Gilman; J.S. Friedland; D.L.W. Chong,S053,13:30,- 14:30,"Hall 3
1-hour Oral Session
Immune evasion and intracellular survival strategies
Chairs Juliane Bubeck Wardenburg (St. Louis, United States)"
11 April 2025,SY091,13:30 - 14:30,4,,,Nitin Gupta; India); Pikka Jokelainen; Denmark),S0264,14:00,Disease X:,"preparedness for the next pandemic Yee 
Sin Leo (Singapore, Singapore)"
11 April 2025,SY092,13:30 - 14:30,5,,,Michele Bartoletti; Italy); Merel Lambregts; Netherlands)S0265  13:30  Sex impacts incidence; management; and outcome in; bacteraemia Annette Westgeest; Netherlands),Y092,13:30,- 14:30,"Hall 5
1-hour Symposium
Sex differences in management and outcome of patients with serious 
bacterial infections
Chairs Michele Bartoletti (Milan, Italy)"
11 April 2025,SY092,13:30 - 14:30,5,,,Michele Bartoletti; Italy); Merel Lambregts; Netherlands)S0265  13:30  Sex impacts incidence; management; and outcome in; bacteraemia Annette Westgeest; Netherlands),S0265,13:30,"Sex impacts incidence, management,","and outcome in 
bacteraemia Annette Westgeest (Leiden, 
Netherlands)"
11 April 2025,SY092,13:30 - 14:30,5,,,Michele Bartoletti; Italy); Merel Lambregts; Netherlands)S0265  13:30  Sex impacts incidence; management; and outcome in; bacteraemia Annette Westgeest; Netherlands),S0266,14:00,,"The complex interplay between gender and 
sepsis Ines Lakbar (Montpellier, France)"
11 April 2025,ME101,14:45 - 15:45,14,Meet-the-Expert,How to master conflict management and negotiation in healthcare,,M0285,14:45,,"Esther Calbo (Terrassa, Spain)"
11 April 2025,ME101,14:45 - 15:45,14,Meet-the-Expert,How to master conflict management and negotiation in healthcare,,M0286,14:57,,"Jan A.J.W. Kluytmans (Utrecht, Netherlands)"
11 April 2025,ME101,14:45 - 15:45,14,Meet-the-Expert,How to master conflict management and negotiation in healthcare,,O102,14:45,- 15:45,"Arena 1
Open Forum
Navigating the future of pandemics across One Health
Chair Xavier Lescure (Paris, France)"
11 April 2025,ME101,14:45 - 15:45,14,Meet-the-Expert,How to master conflict management and negotiation in healthcare,,F0287,14:45,,"Status of the One Health Joint Plan of Action by the 
Quadripartite Chadia Wannous (Paris, France)"
11 April 2025,ME101,14:45 - 15:45,14,Meet-the-Expert,How to master conflict management and negotiation in healthcare,,F0289,15:05,,"Long-term consequences of emerging viral 
diseases Alfonso J. Rodriguez-Morales (Pereira, 
Colombia)"
11 April 2025,ME101,14:45 - 15:45,14,Meet-the-Expert,How to master conflict management and negotiation in healthcare,,F059,14:45,- 15:45,"Arena 2
ePoster Flash Session
Bacterial infections in the post pandemic era
Chair Özlem Kurt Azap (Ankara, Türkiye)"
11 April 2025,OS053,13:30 - 14:30,3,1-hour Oral Session,Immune evasion and intracellular survival strategies,Juliane Bubeck Wardenburg; United States); Giovanni Delogu; Italy); O0386  Capsule-Dependent Modulation of Cell Death; Pathways and Immune Evasion in Acinetobacter; baumanniiH. Wang*; China); C. Jiang; O0387  Intracellular lifestyle of Acinetobacter baumannii :; Role of phospholipase A2 and transcriptional factor; EB; Spain); C. Atalaya Rey; I.; Molina Panadero; A. Lora González; A. Hmadcha; O0388  The role of peg344 of hypervirulent Klebsiella; pneumoniae  on suppressing autophagy responses of; macrophages Z.E. Kuloğlu*; Türkiye); Ö.; Albayrak; D. Güllü; G. Ekinci; F. Can; O0389  c-Myc Inhibits Macrophage Antimycobacterial; Response in Mycobacterium tuberculosis Infection C.; Dollé*; Switzerland); E. Sarti; R.; Wolfensberger; K. Kusjeko; S. Bredl; R.A. Speck; M.; Greter; J.H. Rueschoff; D. Mai; A. Diercks; P. Sander; G.S. Olson; J. Nemeth; O0390  Targeting neutrophil extracellular traps; prevents tuberculosis immunopathology J.; Kutschenreuter*; United Kingdom); D.; Kirwan; R. Cusman; K.H. Skolimowska; R.H. Gilman; J.S. Friedland; D.L.W. Chong,S053,13:30,- 14:30,"Hall 3
1-hour Oral Session
Immune evasion and intracellular survival strategies
Chairs Juliane Bubeck Wardenburg (St. Louis, United States)"
11 April 2025,SY091,13:30 - 14:30,4,,,Nitin Gupta; India); Pikka Jokelainen; Denmark),S0264,14:00,Disease X:,"preparedness for the next pandemic Yee 
Sin Leo (Singapore, Singapore)"
11 April 2025,SY092,13:30 - 14:30,5,,,Michele Bartoletti; Italy); Merel Lambregts; Netherlands)S0265  13:30  Sex impacts incidence; management; and outcome in; bacteraemia Annette Westgeest; Netherlands),Y092,13:30,- 14:30,"Hall 5
1-hour Symposium
Sex differences in management and outcome of patients with serious 
bacterial infections
Chairs Michele Bartoletti (Milan, Italy)"
11 April 2025,SY092,13:30 - 14:30,5,,,Michele Bartoletti; Italy); Merel Lambregts; Netherlands)S0265  13:30  Sex impacts incidence; management; and outcome in; bacteraemia Annette Westgeest; Netherlands),S0265,13:30,"Sex impacts incidence, management,","and outcome in 
bacteraemia Annette Westgeest (Leiden, 
Netherlands)"
11 April 2025,SY092,13:30 - 14:30,5,,,Michele Bartoletti; Italy); Merel Lambregts; Netherlands)S0265  13:30  Sex impacts incidence; management; and outcome in; bacteraemia Annette Westgeest; Netherlands),S0266,14:00,,"The complex interplay between gender and 
sepsis Ines Lakbar (Montpellier, France)"
11 April 2025,ME101,14:45 - 15:45,14,Meet-the-Expert,How to master conflict management and negotiation in healthcare,,M0285,14:45,,"Esther Calbo (Terrassa, Spain)"
11 April 2025,ME101,14:45 - 15:45,14,Meet-the-Expert,How to master conflict management and negotiation in healthcare,,M0286,14:57,,"Jan A.J.W. Kluytmans (Utrecht, Netherlands)"
11 April 2025,ME101,14:45 - 15:45,14,Meet-the-Expert,How to master conflict management and negotiation in healthcare,,O102,14:45,- 15:45,"Arena 1
Open Forum
Navigating the future of pandemics across One Health
Chair Xavier Lescure (Paris, France)"
11 April 2025,ME101,14:45 - 15:45,14,Meet-the-Expert,How to master conflict management and negotiation in healthcare,,F0287,14:45,,"Status of the One Health Joint Plan of Action by the 
Quadripartite Chadia Wannous (Paris, France)"
11 April 2025,ME101,14:45 - 15:45,14,Meet-the-Expert,How to master conflict management and negotiation in healthcare,,F0289,15:05,,"Long-term consequences of emerging viral 
diseases Alfonso J. Rodriguez-Morales (Pereira, 
Colombia)"
11 April 2025,ME101,14:45 - 15:45,14,Meet-the-Expert,How to master conflict management and negotiation in healthcare,,F059,14:45,- 15:45,"Arena 2
ePoster Flash Session
Bacterial infections in the post pandemic era
Chair Özlem Kurt Azap (Ankara, Türkiye)"
11 April 2025,ME101,14:45 - 15:45,14,Meet-the-Expert,How to master conflict management and negotiation in healthcare,,F060,14:45,- 15:45,"Arena 3
ePoster Flash Session
AMR in the community
Chair Camilla Wiuff Coia (Copenhagen, Denmark)"
11 April 2025,ME101,14:45 - 15:45,14,Meet-the-Expert,How to master conflict management and negotiation in healthcare,,F060,14:45,- 15:45,"Arena 3
ePoster Flash Session
AMR in the community
Chair Camilla Wiuff Coia (Copenhagen, Denmark)"
11 April 2025,SY100,14:45 - 15:45,12,,,Maria Vehreschild; Germany); Walter Zingg; Switzerland),Y100,14:45,- 15:45,"Hall 12
1-hour Symposium
The challenge of a healthy microbiota in neonates
Chairs Maria Vehreschild (Frankfurt Am Main, Germany)"
11 April 2025,SY100,14:45 - 15:45,12,,,Maria Vehreschild; Germany); Walter Zingg; Switzerland),S0283,14:45,,"Infant gut microbiome development Debby Bogaert 
(Edinburgh, United Kingdom)"
11 April 2025,SY100,14:45 - 15:45,12,,,Maria Vehreschild; Germany); Walter Zingg; Switzerland),S0284,15:15,,"Metagenomic signatures and antibiotic disruption of 
the gut microbiome in neonates Gautam Dantas (Saint 
Louis, United States)"
11 April 2025,OS058,14:45 - 15:45,16,,,Beatriz L. Gomez; Colombia); Leonardo Nimrichter; Brazil); O0419  Fosmanogepix expanded access in patients with; Fusarium  infections S. Dadwal*; United; States); A. Baluch; J. Dickter; J.R. Newman; M.H.; Nguyen; R. Weihe; H. Schlamm; L. Ostrosky-Zeichner; O0420  Voriconazole's hidden toll: unveiling periostitis in a; heart transplant recipient and a hematologic; patient. G. Motoa*; United States); A.; Woolley; N. Issa; O0421  Unveiling the Uncommon: Managing Geotrichum; candidum in Pancreatic Necrosis L. Kriegl*; Austria); C. Geiger; I. Zollner-Schwetz; T. Valentin; H.; Schlager; G. Zollner; K. Dichtl; R. Krause; O0422  Detection of siderophores as a superior non-invasive; diagnostic tool in unravelling mixed fungal; infections V. Havlicek*; Czech Republic); R.; Dobias; M. Navrátil; R. Patil; D. Luptakova; D.A.; Stevens; O0423  Efficacy of novel antifungal therapies in refractory; Candida  and Aspergillus  infections: insights from; compassionate use and clinical trials S. Sedik*; Austria); R. Krause; C. Zurl; I. Zollner-Schwetz; M.; Linhofer; C. Hoegenauer; G. Gorkiewicz; M. Hoenigl; J. Prattes,S058,14:45,- 15:45,"Hall 16
1-hour Case Session
In the field with fungi
Chairs Beatriz L. Gomez (Bogota, Colombia)"
11 April 2025,OS056,14:45 - 15:45,2,1-hour Oral Session,Emerging trends in viral hepatitis across Europe,Federico Garcia; Spain); Neven Papic; Croatia); O0409  One of the largest outbreak of hepatitis A in the 21st; century in Europe I. Hockickova*; Slovakia); I.; Hockicková; J. Hockicko; D. Javorská; Š. Zamba; A.; Vasiľová; M. Ševčík; A. Cehelská; D. Hudáčková; P.; Kristian; O0410  Higher prevalence of Cytomegalovirus and Epstein–Barr virus in acute-on-chronic liver failure – cause or; consequence? J. Sonnenberg*; Germany); K. Thiyagarajah; E. Görgülü; P. Lembeck; M. Glitscher; F. Uschner; M. Brol; W. Gu; R. Schierwagen; S. Klein; M. Schulz; T. Wiedemann; J. Reißing; J. Söhne; N.; Kraus; M. Praktinjo; J. Fischer; H.P. Erasmus; J.; Vasseur; S. Zeuzem; H. Storf; C. Welsch; J. Trebicka; S. Ciesek; J. Chang; T. Bruns; E. Hildt; K.H. Peiffer; O0411  Delta in Denmark: current prevalence of hepatitis; delta virus infection H. Watson*; France); P.; Jepsen; H. Vilstrup; H. Krarup; O0412  RatHEV as an aetiological agent of acute hepatitis in; Europe: results from the ESGHV-RHEV Study A.; Rivero-Juarez*; Spain); M. Casares; B.; Becerril; Á. Dencs; G. Gherlan; J. Caballero; L. Rios-; Muñoz; A.B. Pérez; A. Fuentes; C. Freyre; F. Franco-; Álvarez De Luna; I. Viciana; M.D.C. Domínguez; M.; Altindis; G. Özkaya; A. Rivero; A. Rivero-Juárez; O0413  Understanding the incidence and risk factors of low-; level viremia in chronic hepatitis B: A propensity-; matched comparison of tenofovir and entecavir I.; Hasanoglu*; Türkiye); R. Guner; E. Zerdali; A.; Batirel; Y. Onlen; E. Parlak; B. Kurtaran; S. Tosun; I.; Yilmaz Nakir; O. Gunal; N. Eser; H. Yaqoobi; O. Tabki; T. Turunc; U. Balci; S. Komur; E.E. Tutuncu; L.N.; Altunal; N.D. Sari; D.S. Yildiz; H.D. Ozkaya; I.E. Yildiz; S. Kaya; O. Karabay; S. Alkan; F. Tabak,S056,14:45,- 15:45,"Hall 2
1-hour Oral Session
Emerging trends in viral hepatitis across Europe
Chairs Federico Garcia (Granada, Spain)"
11 April 2025,OS057,14:45 - 15:45,3,1-hour Oral Session,Precision Medecine: from models to patient care,Anouk Edwina Muller; Netherlands); Sebastian Wicha; Germany); O0414  Pharmacokinetics and pharmacodynamics of BPaLM; BPaLC and BPaL regimens for treatment of RR-TB F.; Kloprogge*; United Kingdom); B.T.; Nyang'wa; I. Motta; R. Moodliar; V. Solodovnikova; S.; Rajaram; M. Rasool; Z. Huang; C. Berry; G. Davies; D.; Moore; O0415  Physiologically Based Pharmacokinetic Modeling for; Nemonoxacin in Predicting the Respiratory System; Pharmacokinetic Profile: Based on Comprehensive; Preclinical and Clinical Data Y. Chen*; China); J. Zhao; J. Zhang; O0416  Context-specific genome-scale metabolic modelling; reveals metabolic alterations in multidrug-resistant; Klebsiella pneumoniae  in response to polymyxin; B/zidovudine combination J. Zhao*; Australia); Y.W. Lin; J. Tao; Y. Zhu; T. Velkov; J. Li; O0417  Agent-based model predictions of polymyxin B; activity on Acinetobacter baumannii H. Soeorg*; (London; United Kingdom); Y. Yuan; J. Readman; J.F.; Standing; O0418  Monthly dalbavancin dosing for suppressive therapy:; a case series and pharmacokinetic estimation; analysis C. Volk*; United States); W. Kufel; P. Hutson; R. Mahapatra; W. Rose,,,,
11 April 2025,SY099,14:45 - 15:45,4,,,Pascal Astagneau; France); Mandy Wootton; United Kingdom),Y099,14:45,- 15:45,"Hall 4
1-hour Symposium
How innovations of AMR and HAI surveillance systems help the clinical 
practice
Chairs Pascal Astagneau (Paris, France)"
11 April 2025,SY099,14:45 - 15:45,4,,,Pascal Astagneau; France); Mandy Wootton; United Kingdom),S0281,14:45,,"The EUCAST system in surveillance of AMR Sören G. 
Gatermann (Bochum, Germany)"
11 April 2025,SY099,14:45 - 15:45,4,,,Pascal Astagneau; France); Mandy Wootton; United Kingdom),S0282,15:15,,"Insights into developments in the surveillance of 
HAIs Diamantis Plachouras (Solna, Sweden)"
11 April 2025,SY100,14:45 - 15:45,12,,,Maria Vehreschild; Germany); Walter Zingg; Switzerland),Y100,14:45,- 15:45,"Hall 12
1-hour Symposium
The challenge of a healthy microbiota in neonates
Chairs Maria Vehreschild (Frankfurt Am Main, Germany)"
11 April 2025,SY100,14:45 - 15:45,12,,,Maria Vehreschild; Germany); Walter Zingg; Switzerland),S0283,14:45,,"Infant gut microbiome development Debby Bogaert 
(Edinburgh, United Kingdom)"
11 April 2025,SY100,14:45 - 15:45,12,,,Maria Vehreschild; Germany); Walter Zingg; Switzerland),S0284,15:15,,"Metagenomic signatures and antibiotic disruption of 
the gut microbiome in neonates Gautam Dantas (Saint 
Louis, United States)"
11 April 2025,OS058,14:45 - 15:45,16,,,Beatriz L. Gomez; Colombia); Leonardo Nimrichter; Brazil); O0419  Fosmanogepix expanded access in patients with; Fusarium  infections S. Dadwal*; United; States); A. Baluch; J. Dickter; J.R. Newman; M.H.; Nguyen; R. Weihe; H. Schlamm; L. Ostrosky-Zeichner; O0420  Voriconazole's hidden toll: unveiling periostitis in a; heart transplant recipient and a hematologic; patient. G. Motoa*; United States); A.; Woolley; N. Issa; O0421  Unveiling the Uncommon: Managing Geotrichum; candidum in Pancreatic Necrosis L. Kriegl*; Austria); C. Geiger; I. Zollner-Schwetz; T. Valentin; H.; Schlager; G. Zollner; K. Dichtl; R. Krause; O0422  Detection of siderophores as a superior non-invasive; diagnostic tool in unravelling mixed fungal; infections V. Havlicek*; Czech Republic); R.; Dobias; M. Navrátil; R. Patil; D. Luptakova; D.A.; Stevens; O0423  Efficacy of novel antifungal therapies in refractory; Candida  and Aspergillus  infections: insights from; compassionate use and clinical trials S. Sedik*; Austria); R. Krause; C. Zurl; I. Zollner-Schwetz; M.; Linhofer; C. Hoegenauer; G. Gorkiewicz; M. Hoenigl; J. Prattes,S058,14:45,- 15:45,"Hall 16
1-hour Case Session
In the field with fungi
Chairs Beatriz L. Gomez (Bogota, Colombia)"
11 April 2025,OS056,14:45 - 15:45,2,1-hour Oral Session,Emerging trends in viral hepatitis across Europe,Federico Garcia; Spain); Neven Papic; Croatia); O0409  One of the largest outbreak of hepatitis A in the 21st; century in Europe I. Hockickova*; Slovakia); I.; Hockicková; J. Hockicko; D. Javorská; Š. Zamba; A.; Vasiľová; M. Ševčík; A. Cehelská; D. Hudáčková; P.; Kristian; O0410  Higher prevalence of Cytomegalovirus and Epstein–Barr virus in acute-on-chronic liver failure – cause or; consequence? J. Sonnenberg*; Germany); K. Thiyagarajah; E. Görgülü; P. Lembeck; M. Glitscher; F. Uschner; M. Brol; W. Gu; R. Schierwagen; S. Klein; M. Schulz; T. Wiedemann; J. Reißing; J. Söhne; N.; Kraus; M. Praktinjo; J. Fischer; H.P. Erasmus; J.; Vasseur; S. Zeuzem; H. Storf; C. Welsch; J. Trebicka; S. Ciesek; J. Chang; T. Bruns; E. Hildt; K.H. Peiffer; O0411  Delta in Denmark: current prevalence of hepatitis; delta virus infection H. Watson*; France); P.; Jepsen; H. Vilstrup; H. Krarup; O0412  RatHEV as an aetiological agent of acute hepatitis in; Europe: results from the ESGHV-RHEV Study A.; Rivero-Juarez*; Spain); M. Casares; B.; Becerril; Á. Dencs; G. Gherlan; J. Caballero; L. Rios-; Muñoz; A.B. Pérez; A. Fuentes; C. Freyre; F. Franco-; Álvarez De Luna; I. Viciana; M.D.C. Domínguez; M.; Altindis; G. Özkaya; A. Rivero; A. Rivero-Juárez; O0413  Understanding the incidence and risk factors of low-; level viremia in chronic hepatitis B: A propensity-; matched comparison of tenofovir and entecavir I.; Hasanoglu*; Türkiye); R. Guner; E. Zerdali; A.; Batirel; Y. Onlen; E. Parlak; B. Kurtaran; S. Tosun; I.; Yilmaz Nakir; O. Gunal; N. Eser; H. Yaqoobi; O. Tabki; T. Turunc; U. Balci; S. Komur; E.E. Tutuncu; L.N.; Altunal; N.D. Sari; D.S. Yildiz; H.D. Ozkaya; I.E. Yildiz; S. Kaya; O. Karabay; S. Alkan; F. Tabak,S056,14:45,- 15:45,"Hall 2
1-hour Oral Session
Emerging trends in viral hepatitis across Europe
Chairs Federico Garcia (Granada, Spain)"
11 April 2025,OS057,14:45 - 15:45,3,1-hour Oral Session,Precision Medecine: from models to patient care,Anouk Edwina Muller; Netherlands); Sebastian Wicha; Germany); O0414  Pharmacokinetics and pharmacodynamics of BPaLM; BPaLC and BPaL regimens for treatment of RR-TB F.; Kloprogge*; United Kingdom); B.T.; Nyang'wa; I. Motta; R. Moodliar; V. Solodovnikova; S.; Rajaram; M. Rasool; Z. Huang; C. Berry; G. Davies; D.; Moore; O0415  Physiologically Based Pharmacokinetic Modeling for; Nemonoxacin in Predicting the Respiratory System; Pharmacokinetic Profile: Based on Comprehensive; Preclinical and Clinical Data Y. Chen*; China); J. Zhao; J. Zhang; O0416  Context-specific genome-scale metabolic modelling; reveals metabolic alterations in multidrug-resistant; Klebsiella pneumoniae  in response to polymyxin; B/zidovudine combination J. Zhao*; Australia); Y.W. Lin; J. Tao; Y. Zhu; T. Velkov; J. Li; O0417  Agent-based model predictions of polymyxin B; activity on Acinetobacter baumannii H. Soeorg*; (London; United Kingdom); Y. Yuan; J. Readman; J.F.; Standing; O0418  Monthly dalbavancin dosing for suppressive therapy:; a case series and pharmacokinetic estimation; analysis C. Volk*; United States); W. Kufel; P. Hutson; R. Mahapatra; W. Rose,,,,
11 April 2025,SY099,14:45 - 15:45,4,Special Session,Behind the scenes: Contagion,Pascal Astagneau; France); Mandy Wootton; United Kingdom),Y099,14:45,- 15:45,"Hall 4
1-hour Symposium
How innovations of AMR and HAI surveillance systems help the clinical 
practice
Chairs Pascal Astagneau (Paris, France)"
11 April 2025,SY099,14:45 - 15:45,4,Special Session,Behind the scenes: Contagion,Pascal Astagneau; France); Mandy Wootton; United Kingdom),S0281,14:45,,"The EUCAST system in surveillance of AMR Sören G. 
Gatermann (Bochum, Germany)"
11 April 2025,SY099,14:45 - 15:45,4,Special Session,Behind the scenes: Contagion,Pascal Astagneau; France); Mandy Wootton; United Kingdom),S0282,15:15,,"Insights into developments in the surveillance of 
HAIs Diamantis Plachouras (Solna, Sweden)"
11 April 2025,SY107,16:15 - 17:15,15,,,Leonard Leibovici; Israel); Ines Steffens; Sweden),Y107,16:15,- 17:15,"Hall 15
1-hour Symposium
Communicating (your)"
11 April 2025,SY107,16:15 - 17:15,15,,,Leonard Leibovici; Israel); Ines Steffens; Sweden),S0297,16:15,,"Communicating to policy makers and for societal 
impact Balázs Babarczy (Budapest, Hungary)"
11 April 2025,SY107,16:15 - 17:15,15,,,Leonard Leibovici; Israel); Ines Steffens; Sweden),S0298,16:45,,"Influencing behaviour through the media and a 
multichannel communications strategy Charlotte 
Hutchinson (London, United Kingdom)"
11 April 2025,EW109,16:15 - 18:15,2,Educational Session,Infections in cancer patients: tips for daily practice,José Molina Gil-Bermejo; Spain); Stefan Schwartz; Germany),W0303,16:55,,"The diagnostic dilemmas and treatment challenges of 
mycobacteria in cancer patients Şiran Keske 
(Istanbul, Türkiye)"
11 April 2025,EW109,16:15 - 18:15,2,Educational Session,Infections in cancer patients: tips for daily practice,José Molina Gil-Bermejo; Spain); Stefan Schwartz; Germany),W0304,17:15,HTLV-1 and T-cell lymphoma - predict &,"prevent Lucy 
Cook (London, United Kingdom)"
11 April 2025,EW109,16:15 - 18:15,2,Educational Session,Infections in cancer patients: tips for daily practice,José Molina Gil-Bermejo; Spain); Stefan Schwartz; Germany),F066,16:15,- 17:15,"Arena 2
ePoster Flash Session
Modelling infectious disease burden and impact of vaccination
Chair David Fisman (Toronto, Canada)"
11 April 2025,SY107,16:15 - 17:15,15,,,Leonard Leibovici; Israel); Ines Steffens; Sweden),Y107,16:15,- 17:15,"Hall 15
1-hour Symposium
Communicating (your)"
11 April 2025,SY107,16:15 - 17:15,15,,,Leonard Leibovici; Israel); Ines Steffens; Sweden),S0297,16:15,,"Communicating to policy makers and for societal 
impact Balázs Babarczy (Budapest, Hungary)"
11 April 2025,SY107,16:15 - 17:15,15,,,Leonard Leibovici; Israel); Ines Steffens; Sweden),S0298,16:45,,"Influencing behaviour through the media and a 
multichannel communications strategy Charlotte 
Hutchinson (London, United Kingdom)"
11 April 2025,EW109,16:15 - 18:15,2,Educational Session,Infections in cancer patients: tips for daily practice,José Molina Gil-Bermejo; Spain); Stefan Schwartz; Germany),W0303,16:55,,"The diagnostic dilemmas and treatment challenges of 
mycobacteria in cancer patients Şiran Keske 
(Istanbul, Türkiye)"
11 April 2025,EW109,16:15 - 18:15,2,Educational Session,Infections in cancer patients: tips for daily practice,José Molina Gil-Bermejo; Spain); Stefan Schwartz; Germany),W0304,17:15,HTLV-1 and T-cell lymphoma - predict &,"prevent Lucy 
Cook (London, United Kingdom)"
11 April 2025,EW109,16:15 - 18:15,2,Educational Session,Infections in cancer patients: tips for daily practice,José Molina Gil-Bermejo; Spain); Stefan Schwartz; Germany),F066,16:15,- 17:15,"Arena 2
ePoster Flash Session
Modelling infectious disease burden and impact of vaccination
Chair David Fisman (Toronto, Canada)"
11 April 2025,EW109,16:15 - 18:15,2,Educational Session,Infections in cancer patients: tips for daily practice,José Molina Gil-Bermejo; Spain); Stefan Schwartz; Germany),F067,16:15,- 17:15,"Arena 3
ESCMID Global 2025 - Programme
ePoster Flash Session
Blood parasitology at its best
Chair Miriam José Álvarez-Martínez (Barcelona, Spain)"
11 April 2025,EW109,16:15 - 18:15,2,Educational Session,Infections in cancer patients: tips for daily practice,José Molina Gil-Bermejo; Spain); Stefan Schwartz; Germany),F068,16:15,- 17:15,"Arena 4
ePoster Flash Session
A global perspective on antimicrobial resistance surveillance
Chair Mirfin Mpundu (Lusaka, Zambia)"
11 April 2025,KN103,16:15 - 17:15,1,,,Jon S. Friedland; United Kingdom); Delia Goletti; Italy),K0290,16:15,,"Guy Thwaites (Ho Chi Minh City, Vietnam)"
11 April 2025,OS063,16:15 - 17:15,11,1-hour Oral Session,Improving blood culture diagnostics: rethinking the basics,"Direk Limmathurotsakul; Thailand); Pilar Retamar Gentil; Spain); O0461  Blood culture volume; guideline adherence and; pathogen yield of 35; 433 paediatric blood cultures in; Germany J. Forster*; Germany); A.L. Sieg; V. Rücker; H. Haefner; T. Bähr; S. Rössler; J. Held; V.; Le Saout – Chapot; M. Hogardt; B. Spielberger; E.A.; Idelevich; M. Christner; S. Zimmermann; S.; Schneitler; M. Mauritz; C.S. Stingu; M. Gerlach; U.; Von Both; S. Schoeler; L. Marr; J. Zens; E. Komini; M.; Krone; O0462  Changing the paradigm: are two sets of blood; cultures always needed? R. Rosa*; United; States); J. Somani; K. Manzanillo; H. Dinh; G. Rosello; L. Abbo; O0463  Evaluating clinical and economic empact of reducing; blood culture incubation timings: Time to shift the; paradigm? R. Gupta; Canada); R.; Gupta; J. Delport; T. Mazzulli; O0464  Revolutionizing hospital workflows with blood; culture-free ultra-rapid antimicrobial susceptibility; testing: A clinical pilot study S. Kwon*; Korea; Republic of); K. Sunghoon; K. Dong Young; J. Jisung; K. Tae Hyun; K. Junwon; J. Hyelyn; L. Gi Yoon; P. Wan; Beom; O0465  Human in vivo  footprints from blood plasma for; improved diagnostics in sepsis M. Sonntag*; (Stuttgart; Germany); J. Mueller; A. Von Haeseler; Y.; Vainshtein; S.O. Decker; T. Brenner; K. Sohn; ESCMID Global 2025 - Programme; ePoster Flash Session; Blood parasitology at its best; Chair Miriam José Álvarez-Martínez; Spain); E0489  Unexepected P.malariae diagnosis in Italian woman; with no history of travel to endemic areas A. Busni*; (Milan; Italy); L. Tartaglione; S. Torri; A. Longhi; E.M.; Zavaroni; F. Crippa; C.S. Vismara; E0490  A blue-hued mystery: Primaquine-induced; methemoglobinemia in mixed infection with; Plasmodium vivax  and Plasmodium falciparumU.A.; Zainulabid*; Malaysia); X.K. Cheong; P.; Periyasamy; A.F. Mohd Salleh; N. Ghazali; N.W.; Hassan; K. Sangaran; A. Mohd Yasin; Z.M. Idris; E0491  Trick or Treat? An unrelenting malaria case C.; Uhomoibhi*; Ireland); E. De Barra; C. Leddy; A. Brown; E0492  ""64% Parasitaemia in Falciparum Malaria:; Challenges in Managing Severe Infection and; Delayed Haemolysis"" F. Murphy*; Ireland); A.; Albadi; P. Coakley; C. Mcnally; E0493  Benznidazole treatment in Chagas Disease: a case; series in Luigi Sacco Hospital; Milan; (Milan; Italy); A. Giacomelli; M. Beltrami; L.R.; Galimberti; S. Antinori; E0494  The Challenge of Managing Visceral Leishmaniasis in; Immunocompromised Patients S. Vita*; Italy); A. D'abramo; A. Corpolongo; M.V. Tomassi; F.; Faraglia; T. Ascoli Bartoli; A. Mariano; A. Vulcano; G.; Maffongelli; E. Nicastri; E0495  Diagnosis and management of visceral leishmaniasis; in children in France : a national retrospective study J.; De Larminat*; France); N. Dahane; N. Argy; M.; Rifai; O. Haas Ferrua; C. Pomares; N. Rasandisona; Ravonjena; D. Dupont; J.P. Lemoine; T. Cesar; O.; Pineau; P. Picherit Steinbrucker; S. Azohana; S.; Guilmon-Crepon; I. Allouche; C. Ravel; A. Faye; E0496  Chronic cutaneous leishmaniasis following visceral; leishmaniasis in a pediatric patient: a rare report of; extensive facial involvement A. Mohta*; India); E0497  Therapeutic challenges in the management of; Disseminated leishmaniasis in a patient with HIV co-; infection N. T R*; India); T. Kanagiri; S.; Angirekula; N. Kaur; Y. Khatod; D. Kumar; A. Purohit; G.K. Bohra",F068,16:15,- 17:15,"Arena 4
ePoster Flash Session
A global perspective on antimicrobial resistance surveillance
Chair Mirfin Mpundu (Lusaka, Zambia)"
11 April 2025,KN103,16:15 - 17:15,1,,,Jon S. Friedland; United Kingdom); Delia Goletti; Italy),K0290,16:15,,"Guy Thwaites (Ho Chi Minh City, Vietnam)"
11 April 2025,OS063,16:15 - 17:15,11,1-hour Oral Session,Improving blood culture diagnostics: rethinking the basics,Direk Limmathurotsakul; Thailand); Pilar Retamar Gentil; Spain); O0461  Blood culture volume; guideline adherence and; pathogen yield of 35; 433 paediatric blood cultures in; Germany J. Forster*; Germany); A.L. Sieg; V. Rücker; H. Haefner; T. Bähr; S. Rössler; J. Held; V.; Le Saout – Chapot; M. Hogardt; B. Spielberger; E.A.; Idelevich; M. Christner; S. Zimmermann; S.; Schneitler; M. Mauritz; C.S. Stingu; M. Gerlach; U.; Von Both; S. Schoeler; L. Marr; J. Zens; E. Komini; M.; Krone; O0462  Changing the paradigm: are two sets of blood; cultures always needed? R. Rosa*; United; States); J. Somani; K. Manzanillo; H. Dinh; G. Rosello; L. Abbo; O0463  Evaluating clinical and economic empact of reducing; blood culture incubation timings: Time to shift the; paradigm? R. Gupta; Canada); R.; Gupta; J. Delport; T. Mazzulli; O0464  Revolutionizing hospital workflows with blood; culture-free ultra-rapid antimicrobial susceptibility; testing: A clinical pilot study S. Kwon*; Korea; Republic of); K. Sunghoon; K. Dong Young; J. Jisung; K. Tae Hyun; K. Junwon; J. Hyelyn; L. Gi Yoon; P. Wan; Beom; O0465  Human in vivo  footprints from blood plasma for; improved diagnostics in sepsis M. Sonntag*; (Stuttgart; Germany); J. Mueller; A. Von Haeseler; Y.; Vainshtein; S.O. Decker; T. Brenner; K. Sohn; ESCMID Global 2025 - Programme,,,,
11 April 2025,ME108,16:15 - 17:15,12,Meet-the-Expert,Navigating travel medicine: expert tips for safe international travel,,M0299,16:15,,"Sophie Schneitler (Homburg, Germany)"
11 April 2025,ME108,16:15 - 17:15,12,Meet-the-Expert,Navigating travel medicine: expert tips for safe international travel,,M0300,16:27,,"Andreas Neumayr (Basel, Switzerland)"
11 April 2025,OS062,16:15 - 18:15,13,,,Despoina Koulenti; United Kingdom); Sylvain Meylan; Switzerland); O0451  A consensus immune dysregulation framework for; sepsis: results of the SUBSPACE consortium A.; Moore*; United States); T. Sweeney; A. Rogers; P. Khatri; H. Zheng; A. Ganesan; Y. Hasin-; Brumshtein; M. Maddali; J. Levitt; T. Van Der Poll; B.; Scicluna; E.J. Giamarellos-Bourboulis; A. Kotsaki; I.; Martin-Loeches; A. Garduno; J. Sevransky; D.; Wright; R. Rothman; M. Atreya; L. Moldawer; P.; Efron; M. Kralovcova; T. Karvunidis; H. Giannini; N.; Meyer; O0452  BLOODICU: Bloodstream infections and their; outcomes in ICU patients - Insights from the; PROSAFE Study C. Genovese*; Italy); M.; Offer; G. Tricella; G. Scaglione; E. Palomba; G.; Montrucchio; F. Agostini; F. Dore; G. Monti; B.; Viaggi; A. Gori; S. Finazzi; M. Colaneri; O0453  Deciphering the Dynamics of Klebsiella pneumoniae; Colonization and Infection: Genomic Insights and; Microbiome Interactions in ICU Patients W. Yu*; (Beijing; China); O0454  Antibiotics with anti-anaerobe activity promote; enteric pathobionts in ICU patients S. Taylor*; (Adelaide; Australia); S. Miller; E. Vasil; B. Reddi; L.A. Chapple; S. Bihari; M. Chapman; G. Rogers; L.; Papanicolas; O0455  Association between blood culture time to positivity; and 30-day bacteremia mortality differs for; bacterial groups M.H. Øvre*; Denmark); J.B. Boel; J.G. Holler; S. Skovgaard; D.S.; Hansen; T.S. Itenov; B.J. Holzknecht; O0456  Treatment patterns of patients with; sepsis/SIRS/septic shock treated with; ceftolozane/tazobactam – results from SPECTRA E.; Yucel*; United States); A. Soriano; F.; Thalhammer; S. Kluge; P. Viale; M. Allen; B. Akrich; J. Levy; H. Yang; S. Kaul; O0457  Risk of myocardial infarction and stroke following; bloodstream infection: a population-based self-; controlled case series J. Underwood*; United Kingdom); N. Reeve; V. Best; A. Akbari; H.; Ahmed; O0458  Is transthoracic echocardiography required in all; patients with Staphylococcus aureus  bacteremia?; Validating the VIRSTA and VIRSTA+ scores to; define the population at low risk of endocarditis M.; Verdejo Gómez*; Spain); D. Malano-; Barletta; M.Á. Verdejo; G. Cuervo; C. Pitart; M.; Hernández-Meneses; M. Bodro; S. Herrera; C.; Garcia-Vidal; P. Puerta; A. Del Rio; M. Espasa; J.A.; Martínez; L. Morata; A. Soriano; O0459  DNA methylation changes in Sepsis: Potential use; as biomarkers I. López-Cruz*; Spain); J.L.; García-Giménez; L. Piles; M. Madrazo; G. Judit; M.; López-Torres; A. Artero; O0460  Host response plasma biomarkers and; transcriptomic alterations in critically ill patients; with suspected aspiration pneumonia S. Doeleman*; (Amsterdam; Netherlands); D. Susanne; E. Michels; J. Butler; F. Uhel; O. Cremer; T. Van Der Poll,S062,16:15,- 18:15,"Hall 13
2-hour Oral Session
Heterogeneity and complexity of sepsis
Chairs Despoina Koulenti (London, United Kingdom)"
11 April 2025,SY106,16:15 - 17:15,14,,,Silvio Daniel Brugger; Switzerland); Li Yang Hsu; Singapore),Y106,16:15,- 17:15,"Hall 14
1-hour Symposium
Strain dynamics in determining gut microbial colonisation resistance
Chairs Silvio Daniel Brugger (Zurich, Switzerland)"
11 April 2025,SY106,16:15 - 17:15,14,,,Silvio Daniel Brugger; Switzerland); Li Yang Hsu; Singapore),S0295,16:15,,"Strain dynamics in serious bacterial infections in 
infants Drew Schwartz (Saint Louis, United States)"
11 April 2025,SY106,16:15 - 17:15,14,,,Silvio Daniel Brugger; Switzerland); Li Yang Hsu; Singapore),S0296,16:45,,"Long-term colonisation dynamics of carbapenemase-
producing Enterobacterales Niranjan Nagarajan 
(Singapore, Singapore)"
11 April 2025,OS064,16:15 - 17:15,16,1-hour Oral Session,Viral immune response - nature or nurture? Exploring the limits of immune,Malin Flodström-Tullberg; Sweden); Florian Krammer; United States); O0466  Orthopoxvirus-specific antibody dynamics up to; two years after monkeypoxvirus infection or; vaccination C. Van Dijck*; Belgium); N.; Berens-Riha; L. Zaeck; I. Brosius; R. De Vries; J.; Marien; L. Liesenborghs; O0467  DENG-VAC study: preliminary data on; immunogenity and reactogenity of Qdenga vaccine; versus natural infection A. D'abramo*; Italy); S. Vita; F. Colavita; E. Cimini; P. De Marco; E. Lalle; G. Maffongelli; L. Rosa; S. Cammisa; G. Delia; M.; Fabrizio; N. Emanuele; O0468  Long-Lasting Immunity Followed by Natural CCHFV; Infection H. Karakoc*; Türkiye); H.N.; Karakoç Parlayan; A. Aslanabadi; D. Yapar; Q.; Murphy; G. Kaplan; O. Akdoğan; A. Çelikbaş; A.; Koroglu; F. Aksoy; E. Karaaslan; A. Abbasi; M.; Karimi; M. Hojabri; G. Yilmaz; S.M. Ciupe; S.D.; Pegan; É. Bergeron; G. Lewis; N. Baykam; M.M.; Sajadi; O0469  Why does rabies virus not induce an anti-viral; immune response : insights from experimental; models and a human cohort C. Geurts Van Kessel*; (Rotterdam; Netherlands); C. Embregts; A. Gohar; B. Verstrepen; J. Aijaz; N. Salahuddin; C.; Geurtsvankessel; O0470  Establishing a human challenge model for human; metapneumovirus: disease characteristics and; immune responses N. Noulin*; United; Kingdom); A. Mann; N. Veselinski; J. Mori; B. Löndt; K. Bradley; M. Kalinova; S. Ascough; G. Boivin; C.; Chiu; A. Catchpole,,,,
11 April 2025,SY104,16:15 - 17:15,3,,,Elda Righi; United Kingdom); David Van Duin; Nc; United States),Y104,16:15,- 17:15,"Hall 3
1-hour Symposium
Targeted vs. standard perioperative prophylaxis in Solid Organ Transplant 
with MDR Gram-negative colonisation
Chairs Elda Righi (London, United Kingdom)"
11 April 2025,SY104,16:15 - 17:15,3,,,Elda Righi; United Kingdom); David Van Duin; Nc; United States),S0291,16:15,,"Standard prophylaxis Maddalena Giannella (Bologna, 
Italy)"
11 April 2025,SY104,16:15 - 17:15,3,,,Elda Righi; United Kingdom); David Van Duin; Nc; United States),S0292,16:45,,"Targeted approaches Maristela P. Freire (Sao Paulo, 
Brazil)"
11 April 2025,SY105,16:15 - 17:15,4,,,,,,,
11 April 2025,ME108,16:15 - 17:15,12,Meet-the-Expert,Navigating travel medicine: expert tips for safe international travel,,M0299,16:15,,"Sophie Schneitler (Homburg, Germany)"
11 April 2025,ME108,16:15 - 17:15,12,Meet-the-Expert,Navigating travel medicine: expert tips for safe international travel,,M0300,16:27,,"Andreas Neumayr (Basel, Switzerland)"
11 April 2025,OS062,16:15 - 18:15,13,,,Despoina Koulenti; United Kingdom); Sylvain Meylan; Switzerland); O0451  A consensus immune dysregulation framework for; sepsis: results of the SUBSPACE consortium A.; Moore*; United States); T. Sweeney; A. Rogers; P. Khatri; H. Zheng; A. Ganesan; Y. Hasin-; Brumshtein; M. Maddali; J. Levitt; T. Van Der Poll; B.; Scicluna; E.J. Giamarellos-Bourboulis; A. Kotsaki; I.; Martin-Loeches; A. Garduno; J. Sevransky; D.; Wright; R. Rothman; M. Atreya; L. Moldawer; P.; Efron; M. Kralovcova; T. Karvunidis; H. Giannini; N.; Meyer; O0452  BLOODICU: Bloodstream infections and their; outcomes in ICU patients - Insights from the; PROSAFE Study C. Genovese*; Italy); M.; Offer; G. Tricella; G. Scaglione; E. Palomba; G.; Montrucchio; F. Agostini; F. Dore; G. Monti; B.; Viaggi; A. Gori; S. Finazzi; M. Colaneri; O0453  Deciphering the Dynamics of Klebsiella pneumoniae; Colonization and Infection: Genomic Insights and; Microbiome Interactions in ICU Patients W. Yu*; (Beijing; China); O0454  Antibiotics with anti-anaerobe activity promote; enteric pathobionts in ICU patients S. Taylor*; (Adelaide; Australia); S. Miller; E. Vasil; B. Reddi; L.A. Chapple; S. Bihari; M. Chapman; G. Rogers; L.; Papanicolas; O0455  Association between blood culture time to positivity; and 30-day bacteremia mortality differs for; bacterial groups M.H. Øvre*; Denmark); J.B. Boel; J.G. Holler; S. Skovgaard; D.S.; Hansen; T.S. Itenov; B.J. Holzknecht; O0456  Treatment patterns of patients with; sepsis/SIRS/septic shock treated with; ceftolozane/tazobactam – results from SPECTRA E.; Yucel*; United States); A. Soriano; F.; Thalhammer; S. Kluge; P. Viale; M. Allen; B. Akrich; J. Levy; H. Yang; S. Kaul; O0457  Risk of myocardial infarction and stroke following; bloodstream infection: a population-based self-; controlled case series J. Underwood*; United Kingdom); N. Reeve; V. Best; A. Akbari; H.; Ahmed; O0458  Is transthoracic echocardiography required in all; patients with Staphylococcus aureus  bacteremia?; Validating the VIRSTA and VIRSTA+ scores to; define the population at low risk of endocarditis M.; Verdejo Gómez*; Spain); D. Malano-; Barletta; M.Á. Verdejo; G. Cuervo; C. Pitart; M.; Hernández-Meneses; M. Bodro; S. Herrera; C.; Garcia-Vidal; P. Puerta; A. Del Rio; M. Espasa; J.A.; Martínez; L. Morata; A. Soriano; O0459  DNA methylation changes in Sepsis: Potential use; as biomarkers I. López-Cruz*; Spain); J.L.; García-Giménez; L. Piles; M. Madrazo; G. Judit; M.; López-Torres; A. Artero; O0460  Host response plasma biomarkers and; transcriptomic alterations in critically ill patients; with suspected aspiration pneumonia S. Doeleman*; (Amsterdam; Netherlands); D. Susanne; E. Michels; J. Butler; F. Uhel; O. Cremer; T. Van Der Poll,S062,16:15,- 18:15,"Hall 13
2-hour Oral Session
Heterogeneity and complexity of sepsis
Chairs Despoina Koulenti (London, United Kingdom)"
11 April 2025,SY106,16:15 - 17:15,14,,,Silvio Daniel Brugger; Switzerland); Li Yang Hsu; Singapore),Y106,16:15,- 17:15,"Hall 14
1-hour Symposium
Strain dynamics in determining gut microbial colonisation resistance
Chairs Silvio Daniel Brugger (Zurich, Switzerland)"
11 April 2025,SY106,16:15 - 17:15,14,,,Silvio Daniel Brugger; Switzerland); Li Yang Hsu; Singapore),S0295,16:15,,"Strain dynamics in serious bacterial infections in 
infants Drew Schwartz (Saint Louis, United States)"
11 April 2025,SY106,16:15 - 17:15,14,,,Silvio Daniel Brugger; Switzerland); Li Yang Hsu; Singapore),S0296,16:45,,"Long-term colonisation dynamics of carbapenemase-
producing Enterobacterales Niranjan Nagarajan 
(Singapore, Singapore)"
11 April 2025,OS064,16:15 - 17:15,16,1-hour Oral Session,Viral immune response - nature or nurture? Exploring the limits of immune,Malin Flodström-Tullberg; Sweden); Florian Krammer; United States); O0466  Orthopoxvirus-specific antibody dynamics up to; two years after monkeypoxvirus infection or; vaccination C. Van Dijck*; Belgium); N.; Berens-Riha; L. Zaeck; I. Brosius; R. De Vries; J.; Marien; L. Liesenborghs; O0467  DENG-VAC study: preliminary data on; immunogenity and reactogenity of Qdenga vaccine; versus natural infection A. D'abramo*; Italy); S. Vita; F. Colavita; E. Cimini; P. De Marco; E. Lalle; G. Maffongelli; L. Rosa; S. Cammisa; G. Delia; M.; Fabrizio; N. Emanuele; O0468  Long-Lasting Immunity Followed by Natural CCHFV; Infection H. Karakoc*; Türkiye); H.N.; Karakoç Parlayan; A. Aslanabadi; D. Yapar; Q.; Murphy; G. Kaplan; O. Akdoğan; A. Çelikbaş; A.; Koroglu; F. Aksoy; E. Karaaslan; A. Abbasi; M.; Karimi; M. Hojabri; G. Yilmaz; S.M. Ciupe; S.D.; Pegan; É. Bergeron; G. Lewis; N. Baykam; M.M.; Sajadi; O0469  Why does rabies virus not induce an anti-viral; immune response : insights from experimental; models and a human cohort C. Geurts Van Kessel*; (Rotterdam; Netherlands); C. Embregts; A. Gohar; B. Verstrepen; J. Aijaz; N. Salahuddin; C.; Geurtsvankessel; O0470  Establishing a human challenge model for human; metapneumovirus: disease characteristics and; immune responses N. Noulin*; United; Kingdom); A. Mann; N. Veselinski; J. Mori; B. Löndt; K. Bradley; M. Kalinova; S. Ascough; G. Boivin; C.; Chiu; A. Catchpole,,,,
11 April 2025,SY104,16:15 - 17:15,3,,,Elda Righi; United Kingdom); David Van Duin; Nc; United States),Y104,16:15,- 17:15,"Hall 3
1-hour Symposium
Targeted vs. standard perioperative prophylaxis in Solid Organ Transplant 
with MDR Gram-negative colonisation
Chairs Elda Righi (London, United Kingdom)"
11 April 2025,SY104,16:15 - 17:15,3,,,Elda Righi; United Kingdom); David Van Duin; Nc; United States),S0291,16:15,,"Standard prophylaxis Maddalena Giannella (Bologna, 
Italy)"
11 April 2025,SY104,16:15 - 17:15,3,,,Elda Righi; United Kingdom); David Van Duin; Nc; United States),S0292,16:45,,"Targeted approaches Maristela P. Freire (Sao Paulo, 
Brazil)"
11 April 2025,SY105,16:15 - 17:15,4,,,Robert A. Bonomo; United States); Arjana Tambic Andrasevic; Croatia),S0294,16:45,,"Clinical perspectives of novel beta-lactams and beta-
lactamase inhibitors Parikshit Prayag (Pune, India)"
11 April 2025,LB004,16:15 - 18:15,9,ePoster Flash Session,New methods for rapid pathogen detection and typing,Robert A. Bonomo; United States); Arjana Tambic Andrasevic; Croatia),B004,16:15,- 18:15,"Hall 9
2-hour Oral Session
Trials in severe infections
Chair Steven Tong (Melbourne, Australia)"
11 April 2025,LB004,16:15 - 18:15,9,ePoster Flash Session,New methods for rapid pathogen detection and typing,Robert A. Bonomo; United States); Arjana Tambic Andrasevic; Croatia),L0016,16:15,,"Temocillin versus meropenem for the targeted 
treatment of bacteraemia due to third-generation 
cephalosporin-resistant Enterobacterales (ASTARTÉ)"
11 April 2025,LB004,16:15 - 18:15,9,ePoster Flash Session,New methods for rapid pathogen detection and typing,Robert A. Bonomo; United States); Arjana Tambic Andrasevic; Croatia),L0024,17:51,,"Shortened antibiotic treatment for 5 days in patients 
hospitalised with community-acquired pneumonia 
(CAP5)"
11 April 2025,LB004,16:15 - 18:15,9,ePoster Flash Session,New methods for rapid pathogen detection and typing,Robert A. Bonomo; United States); Arjana Tambic Andrasevic; Croatia),F074,17:30,- 18:30,"Arena 1
ePoster Flash Session
New methods for rapid pathogen detection and typing 
Chair Sylvain Brisse (Paris, France)"
11 April 2025,LB004,16:15 - 18:15,9,ePoster Flash Session,New methods for rapid pathogen detection and typing,Robert A. Bonomo; United States); Arjana Tambic Andrasevic; Croatia),S0294,16:45,,"Clinical perspectives of novel beta-lactams and beta-
lactamase inhibitors Parikshit Prayag (Pune, India)"
11 April 2025,LB004,16:15 - 18:15,9,ePoster Flash Session,Viral aphrodites,,B004,16:15,- 18:15,"Hall 9
2-hour Oral Session
Trials in severe infections
Chair Steven Tong (Melbourne, Australia)"
11 April 2025,LB004,16:15 - 18:15,9,ePoster Flash Session,Viral aphrodites,,L0016,16:15,,"Temocillin versus meropenem for the targeted 
treatment of bacteraemia due to third-generation 
cephalosporin-resistant Enterobacterales (ASTARTÉ)"
11 April 2025,LB004,16:15 - 18:15,9,ePoster Flash Session,Viral aphrodites,,L0024,17:51,,"Shortened antibiotic treatment for 5 days in patients 
hospitalised with community-acquired pneumonia 
(CAP5)"
11 April 2025,LB004,16:15 - 18:15,9,ePoster Flash Session,Viral aphrodites,,F074,17:30,- 18:30,"Arena 1
ePoster Flash Session
New methods for rapid pathogen detection and typing 
Chair Sylvain Brisse (Paris, France)"
11 April 2025,LB004,16:15 - 18:15,9,ePoster Flash Session,Viral aphrodites,,F075,17:30,- 18:30,"Arena 2
ePoster Flash Session
Healthcare (workers')"
11 April 2025,LB004,16:15 - 18:15,9,ePoster Flash Session,Viral aphrodites,,F077,17:30,- 18:30,"Arena 4
ePoster Flash Session
Viral aphrodites
Chair Rémi Charrel (Marseille, France)"
11 April 2025,LB004,16:15 - 18:15,9,ePoster Flash Session,Viral aphrodites,,F075,17:30,- 18:30,"Arena 2
ePoster Flash Session
Healthcare (workers')"
11 April 2025,LB004,16:15 - 18:15,9,ePoster Flash Session,Viral aphrodites,,F077,17:30,- 18:30,"Arena 4
ePoster Flash Session
Viral aphrodites
Chair Rémi Charrel (Marseille, France)"
11 April 2025,SY112,17:30 - 18:30,1,,,Ziad A. Memish; Saudi Arabia); Catherine Moore; United Kingdom),Y112,17:30,- 18:30,"Hall 1
1-hour Symposium
Year in public health
Chairs Ziad A. Memish (Riyadh, Saudi Arabia)"
11 April 2025,SY112,17:30 - 18:30,1,,,Ziad A. Memish; Saudi Arabia); Catherine Moore; United Kingdom),S0309,17:30,,"Li Yang Hsu (Singapore, Singapore)"
11 April 2025,SY112,17:30 - 18:30,1,,,Ziad A. Memish; Saudi Arabia); Catherine Moore; United Kingdom),S0310,18:00,,"Rita Oladele (Lagos, Nigeria)"
11 April 2025,SY111,17:30 - 18:30,11,,,Sandrine Marchand; France); Sebastian Wicha; Germany),S0308,18:00,PK/,"PD for new anti-TB drugs Elin Svensson (Uppsala, 
Sweden)"
11 April 2025,OS070,17:30 - 18:30,12,1-hour Oral Session,What’s new in antifungal guidelines and management,Sharon Chen; Australia); Helmut Salzer; Austria); O0512  Global guideline for the diagnosis and management; of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM R. Sprute*; (Cologne; Germany); O.A. Cornely; M. Bassetti; C.; Sharon; A. Groll; O. Kurzai; C. Lass-Flörl; L. Ostrosky-; Zeichner; R. Rautemaa-Richardson; G. Revathi; M.E.; Santolaya; L. White; L.P. Zhu; O0513  Impact of achieving early mycological eradication; with rezafungin on all-cause mortality and ICU length; of stay M. Bassetti*; Italy); G.R. Thompson; A.; Soriano; S. Dickerson; I. Bielicka; O.A. Cornely; O0514  An open-label study of ibrexafungerp in patients with; refractory fungal infections; (Cologne; Germany); B.D. Alexander; P.G. Pappas; T.F. Patterson; M. Hoenigl; M.H. Miceli; P. Vergidis; A.; Spec; G.R. Thompson; L. Ostrosky-Zeichner; R.S.; Siebert; M. Middle; E. McKie; F. Lewis; D. Angulo; O0515  Novel immunotherapy approach using pan- Candida; monoclonal antibodies to treat life-threatening; invasive candidiasis and tackle global AMR Y. Zhao*; (Aberdeen; United Kingdom); C.A. Munro; S. Palliyil; O0516  Relative contribution of pharmacokinetics and; immune signatures to clinical outcomes in patients; with HIV-associated cryptococcal meningitis. K. Stott*; (Liverpool; United Kingdom); D. Tembo; C. Kajanga; A. Ahmadu; K.D. Ruwanthi; M. Moyo; D. Lawrence; T.; Harrison; J. Jarvis; D. Namakhwa; D. Lalloo; W. Hope; H. Mwandumba,,,,
11 April 2025,OS071,17:30 - 18:30,14,1-hour Oral Session,Intestinal parasitic uncovered: epidemiology and treatment success,Kurt Hanevik; Norway); Pavla Tůmová; Czech Republic); O0517  Giardia- Does the treatment work? The experience; from a national tertiary referral centre A. Boté; Casamitjana*; United Kingdom); A. Boté-; Casamitjana; S. Eisen; L. Nabarro; N. Longley; G.; Godbole; O0518  Giardiasis: Who gets it? Experience from a Central; London Teaching Hospital. A. Boté Casamitjana*; (London; United Kingdom); A. Boté-Casamitjana; S.; Eisen; L. Nabarro; N. Longley; G. Godbole; O0519  Assessing the Effect of Antimicrobial Treatment on; the Accuracy of Serial Serum and Urine Testing for; Detecting E. histolytica cfDNA P. Datta*; India); D. Rattan; A. Duseja; N. Sharma; N. Kalra; S.; Khurana; O0520  Longitudinal observation of Blastocystis  sp. and; Dientamoeba  fragilis  in children: a very rare; occurrence in chronic diseases with gut dysbiosis J.; Hurych*; Czech Republic); J. Havlova; V.; Neuman; K. Litosova; K. Hubackova; L. Hlinakova; M.; Kubat; O. Hradsky; J. Bronsky; K.L. Kolho; P.; Saavalainen; H. Malcova; D. Cebecauerova; P.; Dřevínek; Z. Sumnik; O. Cinek; O0521  High prevalence of the zoonotic Angiostrongylus; cantonensis in rats in Spain J. Caballero Gómez*; (Córdoba; Spain); T. Fajardo-Alonso; I. García-; Bocanegra; M. Gonzálvez; A. Beato-Benítez; R.; Cuadrado-Matías; M.Á. Quevedo; R. Guerra; R.; Martínez; A. Rivero-Juárez; J. Martínez; E. Martínez-; Nevado; P. Soriano; D. Crailsheim; J. Lazpita; A.; González; P. Foronda; J. Caballero-Gómez,,,,
11 April 2025,OS072,17:30 - 18:30,15,1-hour Oral Session,Training models - a new model for training,Erin Bonura; United States); Casandra Bulescu; Romania); O0522  Can ChatGPT4o help build Objective Structured; Clinical Examination; diseases ? S. Villard*; France); Y. Guedj; L.; ESCMID Global 2025 - Programme; from a multicenter questionnaire study in Western; Japan R.M. Sada*; Japan); S. Yamamoto; T.; Toyokawa; T. Takahashi; A. Yamanaka; M.; Kawamura; K. Yokota; Y. Fukumori; T. Taniguchi; R.; Tanizaki; K. Iwata; S. Kutsuna; E0563  Post-Acute Sequelae and Excess Healthcare; Utilization Following Dengue Infection: A; Population-Based Cohort Study J.T. Lim*; (Singapore; Singapore); I. Wee; W.Z. Tan; E0564  Challenges of dengue in haematological malignancy; patients: Analysis from the DANGO registry during; the 2023-2024 outbreak in Argentina G.A. Méndez*; (Posadas; Argentina); J. Salmanton-García; C.; Niveyro; P.A. Villalba Apestegui; V.I. Martín; L.M.; Compañy Kec; M.C. Tomasino; M.D.C. Marull; H.I.; Bernard; C.P.L. Fernández; M.F. Tosin; M.F.; Hobecker; K.B. Duranona; A.D. Jara; O.A. Cornely; E0565  Key predictors of critical illness and mortality in; Crimean-Congo haemorrhagic fever D. Yigci*; (Istanbul; Türkiye); D. Güllü; N. Baykam; A. Kocagül; Çelikbaş; D. Yapar; Ö. Akdoğan; K. Özden; R. İnan; Sarıkaya; İ. Hasanoğlu; H.R. Güner; E. Doğan; F.; Karakeçili; H. Alay; Z. Türe Yüce; E. Eryılmaz Eren; A.; Erbay; Ş.E. Gök; Ç. Kader; G. Ünüvar Kalın; A.; Yetişgen; M. Özgüler; A. Şenol; Ö. Gündağ; M.; Çağlar Özer; F. Soyak; B. Tanır; I.D. Alıravcı; G.; Çınar; B. Öztürk; E. Gürbüz; F. Pınarlık; M. Kuşkucu; Ö. Ergönül; E0566  Kyasanur Forest Disease in 2024: A Retrospective; Cohort Study from a tertiary care centre in South; India P. Venkata Swathi Kiran*; India); P.K.; Tirlangi; N. Gupta; R. Bhat; P. Ravindra; S.K.; Pothumarthy; E0567  Unravelling the aetiology of summer flu-like illness; in Czechia M.F. Kříha*; Czech; Republic); V. Hönig; J. Kamiš; M. Dvořáková; L.; Tardy; D. Teislerová; A. Chrdle; M. Palus; D. Růžek,S072,17:30,- 18:30,"Hall 15
1-hour Oral Session
Training models - a new model for training
Chairs Erin Bonura (Portland, United States)"
11 April 2025,SY112,17:30 - 18:30,1,,,Ziad A. Memish; Saudi Arabia); Catherine Moore; United Kingdom),Y112,17:30,- 18:30,"Hall 1
1-hour Symposium
Year in public health
Chairs Ziad A. Memish (Riyadh, Saudi Arabia)"
11 April 2025,SY112,17:30 - 18:30,1,,,Ziad A. Memish; Saudi Arabia); Catherine Moore; United Kingdom),S0309,17:30,,"Li Yang Hsu (Singapore, Singapore)"
11 April 2025,SY112,17:30 - 18:30,1,,,Ziad A. Memish; Saudi Arabia); Catherine Moore; United Kingdom),S0310,18:00,,"Rita Oladele (Lagos, Nigeria)"
11 April 2025,SY111,17:30 - 18:30,11,,,Sandrine Marchand; France); Sebastian Wicha; Germany),S0308,18:00,PK/,"PD for new anti-TB drugs Elin Svensson (Uppsala, 
Sweden)"
11 April 2025,OS070,17:30 - 18:30,12,1-hour Oral Session,What’s new in antifungal guidelines and management,Sharon Chen; Australia); Helmut Salzer; Austria); O0512  Global guideline for the diagnosis and management; of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM R. Sprute*; (Cologne; Germany); O.A. Cornely; M. Bassetti; C.; Sharon; A. Groll; O. Kurzai; C. Lass-Flörl; L. Ostrosky-; Zeichner; R. Rautemaa-Richardson; G. Revathi; M.E.; Santolaya; L. White; L.P. Zhu; O0513  Impact of achieving early mycological eradication; with rezafungin on all-cause mortality and ICU length; of stay M. Bassetti*; Italy); G.R. Thompson; A.; Soriano; S. Dickerson; I. Bielicka; O.A. Cornely; O0514  An open-label study of ibrexafungerp in patients with; refractory fungal infections; (Cologne; Germany); B.D. Alexander; P.G. Pappas; T.F. Patterson; M. Hoenigl; M.H. Miceli; P. Vergidis; A.; Spec; G.R. Thompson; L. Ostrosky-Zeichner; R.S.; Siebert; M. Middle; E. McKie; F. Lewis; D. Angulo; O0515  Novel immunotherapy approach using pan- Candida; monoclonal antibodies to treat life-threatening; invasive candidiasis and tackle global AMR Y. Zhao*; (Aberdeen; United Kingdom); C.A. Munro; S. Palliyil; O0516  Relative contribution of pharmacokinetics and; immune signatures to clinical outcomes in patients; with HIV-associated cryptococcal meningitis. K. Stott*; (Liverpool; United Kingdom); D. Tembo; C. Kajanga; A. Ahmadu; K.D. Ruwanthi; M. Moyo; D. Lawrence; T.; Harrison; J. Jarvis; D. Namakhwa; D. Lalloo; W. Hope; H. Mwandumba,,,,
11 April 2025,OS071,17:30 - 18:30,14,1-hour Oral Session,Intestinal parasitic uncovered: epidemiology and treatment success,Kurt Hanevik; Norway); Pavla Tůmová; Czech Republic); O0517  Giardia- Does the treatment work? The experience; from a national tertiary referral centre A. Boté; Casamitjana*; United Kingdom); A. Boté-; Casamitjana; S. Eisen; L. Nabarro; N. Longley; G.; Godbole; O0518  Giardiasis: Who gets it? Experience from a Central; London Teaching Hospital. A. Boté Casamitjana*; (London; United Kingdom); A. Boté-Casamitjana; S.; Eisen; L. Nabarro; N. Longley; G. Godbole; O0519  Assessing the Effect of Antimicrobial Treatment on; the Accuracy of Serial Serum and Urine Testing for; Detecting E. histolytica cfDNA P. Datta*; India); D. Rattan; A. Duseja; N. Sharma; N. Kalra; S.; Khurana; O0520  Longitudinal observation of Blastocystis  sp. and; Dientamoeba  fragilis  in children: a very rare; occurrence in chronic diseases with gut dysbiosis J.; Hurych*; Czech Republic); J. Havlova; V.; Neuman; K. Litosova; K. Hubackova; L. Hlinakova; M.; Kubat; O. Hradsky; J. Bronsky; K.L. Kolho; P.; Saavalainen; H. Malcova; D. Cebecauerova; P.; Dřevínek; Z. Sumnik; O. Cinek; O0521  High prevalence of the zoonotic Angiostrongylus; cantonensis in rats in Spain J. Caballero Gómez*; (Córdoba; Spain); T. Fajardo-Alonso; I. García-; Bocanegra; M. Gonzálvez; A. Beato-Benítez; R.; Cuadrado-Matías; M.Á. Quevedo; R. Guerra; R.; Martínez; A. Rivero-Juárez; J. Martínez; E. Martínez-; Nevado; P. Soriano; D. Crailsheim; J. Lazpita; A.; González; P. Foronda; J. Caballero-Gómez,,,,
11 April 2025,OS072,17:30 - 18:30,15,1-hour Oral Session,Training models - a new model for training,Erin Bonura; United States); Casandra Bulescu; Romania); O0522  Can ChatGPT4o help build Objective Structured; Clinical Examination; diseases ? S. Villard*; France); Y. Guedj; L.; ESCMID Global 2025 - Programme; Khider; L. Maisonobe; J. Mesnier; Y. Nguyen; B.; Oules; M. Sanchez; S. Voicu; N. Burnichon; A. Faye; A.; Mageau; T. Mirault; A. Pellat; C.A. Hobson; D. Bouzid; M. Thy; N. Peiffer-Smadja; O0523  Large language model in real-world clinical infectious; diseases: are we there yet? G. Carra*; Switzerland); M. Van Singer; A. Cancela Costa; P.A.; Crisinel; L. Cobuccio; F. Desgranges; A. Filali; Y.; Fougère; T. Galpérine; E. Gauthiez; B. Guery; M.; Jaboyedoff; S. Meylan; A. Munting; E. Kampouri; M.; Papadimitriou-Olivgeris; M. Plebani; V. Suttels; P.; Valladares; M.A. Hartley; J.L. Raisaro; D. Kaufmann; N. Boillat-Blanco; O0524  Artificial Intelligence-Powered Transformation:; Enhancing Public Health Education at Tampere; University Towards Sustainable Development Goal; 3S. Ahmad*; Finland); O0525  A Survey on Perceived Priorities for the; Implementation of Artificial Intelligence in Developing; ESCMID Guidelines J. Molina Gil-Bermejo*; Spain); J. Molina; J.R. Paño-Pardo; B. Nagavci; M.; Paul; T. Kostyanev; M.W. Langendam; J.P. Stahl; E.; Tacconelli; S. Tschudin-Sutter; M. Zervos; L.; Scudeller; O0526  Expect the unexpected: Longitudinally extensive; transverse myelitis in a healthy young adult - a rare; manifestation of tuberculosis S. Angirekula*; (Jodhpur; India); R. Modi; R. Bora; R. Lohiya; S.K.; Shivtarkar; S. Jagennath; D. Kumar; S. Tiwari; G.K.; Bohra,S072,17:30,- 18:30,"Hall 15
1-hour Oral Session
Training models - a new model for training
Chairs Erin Bonura (Portland, United States)"
11 April 2025,OS073,17:30 - 18:30,16,,,Ursula Hofer; United Kingdom); Yee Sin Leo; Singapore); O0527  Clinical outcomes of adoptive cell therapy for EBV; reactivation and EBV-PTLD in primary; immunodeficiencies: prophylactic and therapeutic; applications of post-allo-HSCT memory T cell; infusions. A. Tessitore*; Italy); N. Maximova; S. Braidotti; M. Granzotto; R. Simeone; O0528  Histopathological proof of herpes simplex; pneumonitis in a patient with severe COVID-19; pneumonia J. Heylen*; Belgium); B. Lopuhaa; L. Maessen; S. Feys; L. Vanderbeke; G. De Vlieger; K.; Lagrou; G. Hermans; M. Peetermans; E. Van; Wijngaerden; P. Meersseman; A. Wilmer; G. De; Hertogh; G. Verjans; J. Von Der Thüsen; J. Van; Kampen; J. Wauters; O0529  Transmission of dengue virus from donors to; recipient after solid organ transplantation. Case; series in Argentina. L. Barcan*; Argentina); S. Villamandos; R. Gago; M. Aguirre; A.; Martinoia; A. Patterer; M. Uranga; C. Sarkis; E.; Temporiti; N. Pujato; S. Claudia; D. Calfunao; C.; Nyveyro; M. Martinez; A. Smud; P. Giorgio; L. Barcán; O0530  Rash without borders: waning immunity in a travelling; physician R. Ville Benavides*; Mexico); R. Ville-Benavides; I. Avendaño-Gutiérrez; O0531  A handful of Orf: a case of successful management; with cidofovir in a renal transplant recipient A. Kaya*; (Izmir; Türkiye); G.S. İzgi; B. Yaman; Y. Tiftikçioğlu; I.; Karaaslan; M. Taşbakan,S073,17:30,- 18:30,"Hall 16
1-hour Case Session
Still going viral
Chairs Ursula Hofer (London, United Kingdom)"
11 April 2025,SY110,17:30 - 18:30,3,,,Elisa Borghi; Italy); Justyna Kowalska; Poland),S0305,17:30,IRIS in HIV immunocompromised hosts:,"a failure of success Paola Maria Cinque (Milan, Italy)"
11 April 2025,SY110,17:30 - 18:30,3,,,Elisa Borghi; Italy); Justyna Kowalska; Poland),S0306,18:00,,"Dysregulated host responses to infection Michal 
Holub (Praha, Czech Republic)"
11 April 2025,OS069,17:30 - 18:30,4,1-hour Oral Session,Determining new and revising old breakpoints,Jaroslav Hrabak; Czech Republic); Erika Matuschek; Sweden); O0507  EUCAST disk diffusion testing of ten additional; species of anaerobic bacteria J. Ahman*; Sweden); J. Åhman; E. Matuschek; B.J. Holzknecht; P.C. Lindemann; H. Marchandin; S. Copsey-Mawer; T.; Morris; G. Kahlmeter; O0508  Standardised antimicrobial susceptibility testing; protocol for Legionella pneumophila  validated across; ten European reference laboratories. M. Sewell*; (Cardiff; United Kingdom); C. Farley; A.V. Krøvel; M.; Golob; D. Kese; U. Roisin; D. Lindsay; S. Nadarajah; B.; Afshar; V. Gaia; S. Paukner; C. Michel; E. Fedoua; J.M.; González-Rubio; F. González-Camacho; M. Petzold; M. Scaturro; C. Ginevra; G. Descours; S. Jarraud; L.; Jones; O.B. Spiller; O0509  Antimicrobial susceptibility testing of the; combination of aztreonam and avibactam in; carbapenem-resistant Enterobacterales: a practical; evaluation using the CLSI and EUCAST methods L.; Chan*; Hong-Kong SAR; China); D.Y.L. Lok; R.C.W. Wong; A.L.H. Lee; I.Y.Y. Cheung; V.C.Y. Chow; O0510  Determination of optimal disk diffusion mass for; zosurabalpin M. Castanheira*; United; States); J. Maher; Y. Edah; A. Trauner; O0511  The clinical significance of aminoglycoside; susceptibility breakpoints modification O. Henig*; Aviv; Israel); M. Elbaz; N. Bishouty; Y. Yaakobi; R. Ben-; Ami; Monday; 14 April 2025,S069,17:30,- 18:30,"Hall 4
1-hour Oral Session
Determining new and revising old breakpoints
Chairs Jaroslav Hrabak (Plzen, Czech Republic)"
11 April 2025,SY116,08:30 - 10:30,15,2-hour Symposium,Climate Change: changing risks and adaptation strategies for a world on the,Rachel Lowe; Spain); Giacomo Stroffolini; Switzerland),S0323,08:30,,"Vector-borne diseases in Europe and clinical 
consequences Tuba Dal (Ankara, Türkiye)"
11 April 2025,SY116,08:30 - 10:30,15,2-hour Symposium,Climate Change: changing risks and adaptation strategies for a world on the,Rachel Lowe; Spain); Giacomo Stroffolini; Switzerland),S0324,09:00,,"Rising temperatures and risks of fungal 
disease Anuradha Chowdhary (New Delhi, India)"
11 April 2025,SY116,08:30 - 10:30,15,2-hour Symposium,Climate Change: changing risks and adaptation strategies for a world on the,Rachel Lowe; Spain); Giacomo Stroffolini; Switzerland),S0325,09:30,,"Strategies for climate prevention and adaptation in a 
moving world Kristie Ebi (Seattle, United States)"
11 April 2025,SY116,08:30 - 10:30,15,2-hour Symposium,Climate Change: changing risks and adaptation strategies for a world on the,Rachel Lowe; Spain); Giacomo Stroffolini; Switzerland),S0326,10:00,,"AMR in climate change-affected countries Esmita 
Charani (London, South Africa)"
11 April 2025,OS073,17:30 - 18:30,16,,,Ursula Hofer; United Kingdom); Yee Sin Leo; Singapore); O0527  Clinical outcomes of adoptive cell therapy for EBV; reactivation and EBV-PTLD in primary; immunodeficiencies: prophylactic and therapeutic; applications of post-allo-HSCT memory T cell; infusions. A. Tessitore*; Italy); N. Maximova; S. Braidotti; M. Granzotto; R. Simeone; O0528  Histopathological proof of herpes simplex; pneumonitis in a patient with severe COVID-19; pneumonia J. Heylen*; Belgium); B. Lopuhaa; L. Maessen; S. Feys; L. Vanderbeke; G. De Vlieger; K.; Lagrou; G. Hermans; M. Peetermans; E. Van; Wijngaerden; P. Meersseman; A. Wilmer; G. De; Hertogh; G. Verjans; J. Von Der Thüsen; J. Van; Kampen; J. Wauters; O0529  Transmission of dengue virus from donors to; recipient after solid organ transplantation. Case; series in Argentina. L. Barcan*; Argentina); S. Villamandos; R. Gago; M. Aguirre; A.; Martinoia; A. Patterer; M. Uranga; C. Sarkis; E.; Temporiti; N. Pujato; S. Claudia; D. Calfunao; C.; Nyveyro; M. Martinez; A. Smud; P. Giorgio; L. Barcán; O0530  Rash without borders: waning immunity in a travelling; physician R. Ville Benavides*; Mexico); R. Ville-Benavides; I. Avendaño-Gutiérrez; O0531  A handful of Orf: a case of successful management; with cidofovir in a renal transplant recipient A. Kaya*; (Izmir; Türkiye); G.S. İzgi; B. Yaman; Y. Tiftikçioğlu; I.; Karaaslan; M. Taşbakan,S073,17:30,- 18:30,"Hall 16
1-hour Case Session
Still going viral
Chairs Ursula Hofer (London, United Kingdom)"
11 April 2025,SY110,17:30 - 18:30,3,,,Elisa Borghi; Italy); Justyna Kowalska; Poland),S0305,17:30,IRIS in HIV immunocompromised hosts:,"a failure of success Paola Maria Cinque (Milan, Italy)"
11 April 2025,SY110,17:30 - 18:30,3,,,Elisa Borghi; Italy); Justyna Kowalska; Poland),S0306,18:00,,"Dysregulated host responses to infection Michal 
Holub (Praha, Czech Republic)"
11 April 2025,OS069,17:30 - 18:30,4,1-hour Oral Session,Determining new and revising old breakpoints,Jaroslav Hrabak; Czech Republic); Erika Matuschek; Sweden); O0507  EUCAST disk diffusion testing of ten additional; species of anaerobic bacteria J. Ahman*; Sweden); J. Åhman; E. Matuschek; B.J. Holzknecht; P.C. Lindemann; H. Marchandin; S. Copsey-Mawer; T.; Morris; G. Kahlmeter; O0508  Standardised antimicrobial susceptibility testing; protocol for Legionella pneumophila  validated across; ten European reference laboratories. M. Sewell*; (Cardiff; United Kingdom); C. Farley; A.V. Krøvel; M.; Golob; D. Kese; U. Roisin; D. Lindsay; S. Nadarajah; B.; Afshar; V. Gaia; S. Paukner; C. Michel; E. Fedoua; J.M.; González-Rubio; F. González-Camacho; M. Petzold; M. Scaturro; C. Ginevra; G. Descours; S. Jarraud; L.; Jones; O.B. Spiller; O0509  Antimicrobial susceptibility testing of the; combination of aztreonam and avibactam in; carbapenem-resistant Enterobacterales: a practical; evaluation using the CLSI and EUCAST methods L.; Chan*; Hong-Kong SAR; China); D.Y.L. Lok; R.C.W. Wong; A.L.H. Lee; I.Y.Y. Cheung; V.C.Y. Chow; O0510  Determination of optimal disk diffusion mass for; zosurabalpin M. Castanheira*; United; States); J. Maher; Y. Edah; A. Trauner; O0511  The clinical significance of aminoglycoside; susceptibility breakpoints modification O. Henig*; Aviv; Israel); M. Elbaz; N. Bishouty; Y. Yaakobi; R. Ben-; Ami; Monday; 14 April 2025,S069,17:30,- 18:30,"Hall 4
1-hour Oral Session
Determining new and revising old breakpoints
Chairs Jaroslav Hrabak (Plzen, Czech Republic)"
11 April 2025,SY116,08:30 - 10:30,15,2-hour Symposium,Climate Change: changing risks and adaptation strategies for a world on the,Rachel Lowe; Spain); Giacomo Stroffolini; Switzerland),S0323,08:30,,"Vector-borne diseases in Europe and clinical 
consequences Tuba Dal (Ankara, Türkiye)"
11 April 2025,SY116,08:30 - 10:30,15,2-hour Symposium,Climate Change: changing risks and adaptation strategies for a world on the,Rachel Lowe; Spain); Giacomo Stroffolini; Switzerland),S0324,09:00,,"Rising temperatures and risks of fungal 
disease Anuradha Chowdhary (New Delhi, India)"
11 April 2025,SY116,08:30 - 10:30,15,2-hour Symposium,Climate Change: changing risks and adaptation strategies for a world on the,Rachel Lowe; Spain); Giacomo Stroffolini; Switzerland),S0325,09:30,,"Strategies for climate prevention and adaptation in a 
moving world Kristie Ebi (Seattle, United States)"
11 April 2025,SY116,08:30 - 10:30,15,2-hour Symposium,Climate Change: changing risks and adaptation strategies for a world on the,Rachel Lowe; Spain); Giacomo Stroffolini; Switzerland),S0326,10:00,,"AMR in climate change-affected countries Esmita 
Charani (London, South Africa)"
11 April 2025,EW119,08:30 - 10:30,11,Educational Session,"This bacterium might harbour AmpC, what should I do?!",Sören G. Gatermann; Germany); Pranita Tamma; United States),W0336,08:50,,"Divergent levels of AmpC expression in Gram-
negative pathogens Antonio Oliver (Palma De 
Mallorca, Spain)"
11 April 2025,EW119,08:30 - 10:30,11,Educational Session,"This bacterium might harbour AmpC, what should I do?!",Sören G. Gatermann; Germany); Pranita Tamma; United States),W0337,09:10,,"Rational choice of antimicrobial therapy against 
AmpC-producing pathogens Patrick Harris (Herston, 
Australia)"
11 April 2025,SY114,08:30 - 10:30,13,2-hour Symposium,Sepsis Global 2025,Brigitte Lamy; France); Willem Joost Wiersinga; Netherlands),Y114,08:30,- 10:30,"Hall 13
2-hour Symposium
Sepsis Global 2025
Chairs Brigitte Lamy (Bobigny, France)"
11 April 2025,SY114,08:30 - 10:30,13,2-hour Symposium,Sepsis Global 2025,Brigitte Lamy; France); Willem Joost Wiersinga; Netherlands),S0315,08:30,,"The ESCMID-ISF Sepsis Award Lecture Andrew 
Moore (Emerald Hills, United States)"
11 April 2025,SY114,08:30 - 10:30,13,2-hour Symposium,Sepsis Global 2025,Brigitte Lamy; France); Willem Joost Wiersinga; Netherlands),S0316,08:45,,"The WHO Global Maternal Sepsis Study Carolina 
Carvalho Ribeiro Do Valle (Sao Paulo, Brazil)"
11 April 2025,SY114,08:30 - 10:30,13,2-hour Symposium,Sepsis Global 2025,Brigitte Lamy; France); Willem Joost Wiersinga; Netherlands),S0317,09:15,Sepsis:,"year in review Sylvain Meylan (Lausanne, 
Switzerland)"
11 April 2025,SY114,08:30 - 10:30,13,2-hour Symposium,Sepsis Global 2025,Brigitte Lamy; France); Willem Joost Wiersinga; Netherlands),S0318,09:45,,"How to design and implement a Sepsis National 
Action Plan (SNAP)"
11 April 2025,SY115,08:30 - 10:30,14,2-hour Symposium,"Challenges in infection management, prevention and antimicrobial",,,,,
11 April 2025,EW119,08:30 - 10:30,11,Educational Session,"This bacterium might harbour AmpC, what should I do?!",Sören G. Gatermann; Germany); Pranita Tamma; United States),W0336,08:50,,"Divergent levels of AmpC expression in Gram-
negative pathogens Antonio Oliver (Palma De 
Mallorca, Spain)"
11 April 2025,EW119,08:30 - 10:30,11,Educational Session,"This bacterium might harbour AmpC, what should I do?!",Sören G. Gatermann; Germany); Pranita Tamma; United States),W0337,09:10,,"Rational choice of antimicrobial therapy against 
AmpC-producing pathogens Patrick Harris (Herston, 
Australia)"
11 April 2025,SY114,08:30 - 10:30,13,2-hour Symposium,Sepsis Global 2025,Brigitte Lamy; France); Willem Joost Wiersinga; Netherlands),Y114,08:30,- 10:30,"Hall 13
2-hour Symposium
Sepsis Global 2025
Chairs Brigitte Lamy (Bobigny, France)"
11 April 2025,SY114,08:30 - 10:30,13,2-hour Symposium,Sepsis Global 2025,Brigitte Lamy; France); Willem Joost Wiersinga; Netherlands),S0315,08:30,,"The ESCMID-ISF Sepsis Award Lecture Andrew 
Moore (Emerald Hills, United States)"
11 April 2025,SY114,08:30 - 10:30,13,2-hour Symposium,Sepsis Global 2025,Brigitte Lamy; France); Willem Joost Wiersinga; Netherlands),S0316,08:45,,"The WHO Global Maternal Sepsis Study Carolina 
Carvalho Ribeiro Do Valle (Sao Paulo, Brazil)"
11 April 2025,SY114,08:30 - 10:30,13,2-hour Symposium,Sepsis Global 2025,Brigitte Lamy; France); Willem Joost Wiersinga; Netherlands),S0317,09:15,Sepsis:,"year in review Sylvain Meylan (Lausanne, 
Switzerland)"
11 April 2025,SY114,08:30 - 10:30,13,2-hour Symposium,Sepsis Global 2025,Brigitte Lamy; France); Willem Joost Wiersinga; Netherlands),S0318,09:45,,"How to design and implement a Sepsis National 
Action Plan (SNAP)"
11 April 2025,SY115,08:30 - 10:30,14,2-hour Symposium,"Challenges in infection management, prevention and antimicrobial",Gaetan Gavazzi; France); Giusy Tiseo; Italy),S0319,08:30,,"The burden of nosocomial infections in long-term 
facilities Virginie Prendki (Genève-Thônex, 
Switzerland)"
11 April 2025,SY115,08:30 - 10:30,14,2-hour Symposium,"Challenges in infection management, prevention and antimicrobial",Gaetan Gavazzi; France); Giusy Tiseo; Italy),S0320,09:00,Pneumonia in the elderly:,"management and 
prevention Marcos Restrepo (San Antonio, United 
States)"
11 April 2025,SY115,08:30 - 10:30,14,2-hour Symposium,"Challenges in infection management, prevention and antimicrobial",Gaetan Gavazzi; France); Giusy Tiseo; Italy),S0321,09:30,,"Challenges in the clinical diagnosis of infection in the 
elderly Maheen Abidi (Denver, United States)"
11 April 2025,SY115,08:30 - 10:30,14,2-hour Symposium,"Challenges in infection management, prevention and antimicrobial",Gaetan Gavazzi; France); Giusy Tiseo; Italy),S0322,10:00,,"Challenges in implementing antimicrobial 
stewardship in long-term care facilities Elena Carrara 
(Verona, Italy)"
11 April 2025,SY117,08:30 - 10:30,16,2-hour Symposium,Survival of the parasites: is treatment failure due to antimicrobial resistance?,Hanne Brekke; Norway); Jaco J. Verweij; Netherlands),S0327,08:30,,"Nitroimidazole refractory Giardia intestinalis  
infection Pavla Tůmová (Praha, Czech Republic)"
11 April 2025,SY117,08:30 - 10:30,16,2-hour Symposium,Survival of the parasites: is treatment failure due to antimicrobial resistance?,Hanne Brekke; Norway); Jaco J. Verweij; Netherlands),S0328,09:00,,"Treatment failure in scabies Francisco Bravo (Lima, 
Peru)"
11 April 2025,SY117,08:30 - 10:30,16,2-hour Symposium,Survival of the parasites: is treatment failure due to antimicrobial resistance?,Hanne Brekke; Norway); Jaco J. Verweij; Netherlands),S0329,09:30,,"Recurrent Enterobius  infections Sarah Eisen (London, 
United Kingdom)"
11 April 2025,SY117,08:30 - 10:30,16,2-hour Symposium,Survival of the parasites: is treatment failure due to antimicrobial resistance?,Hanne Brekke; Norway); Jaco J. Verweij; Netherlands),S0330,10:00,,"Recent advances in the treatment of Visceral 
Leishmaniasis and PKDL Shyam Sundar (Varanasi, 
India)"
11 April 2025,EW118,08:30 - 10:30,2,Educational Session,How can we infer and track plasmid outbreaks?,Alessandra Carattoli; Italy); Jacob Moran-Gilad; Israel),W0331,08:30,,"Evolutionary modelling of plasmids Manuel Ares 
Arroyo (Paris, France)"
11 April 2025,EW118,08:30 - 10:30,2,Educational Session,How can we infer and track plasmid outbreaks?,Alessandra Carattoli; Italy); Jacob Moran-Gilad; Israel),W0332,08:50,,"How plasmids shape the emergence of nosocomial 
pathogens Jukka Corander (Oslo, Norway)"
11 April 2025,EW118,08:30 - 10:30,2,Educational Session,How can we infer and track plasmid outbreaks?,Alessandra Carattoli; Italy); Jacob Moran-Gilad; Israel),W0333,09:10,,"Understanding the complexity of plasmid outbreaks 
using bioinformatics Torsten Seemann (Melbourne 
(VIC)"
11 April 2025,EW118,08:30 - 10:30,2,Educational Session,How can we infer and track plasmid outbreaks?,Alessandra Carattoli; Italy); Jacob Moran-Gilad; Israel),W0334,09:30,,"Plasmid transmission at the One Health 
interface Nicole Stoesser (Oxford, United Kingdom)"
11 April 2025,SY113,08:30 - 10:30,3,2-hour Symposium,Haemorrhagic viral infections,Önder Ergönül; Türkiye); Catherine Houlihan; United Kingdom),Y113,08:30,- 10:30,"Hall 3
2-hour Symposium
Haemorrhagic viral infections
Chairs Önder Ergönül (Istanbul, Türkiye)"
11 April 2025,SY113,08:30 - 10:30,3,2-hour Symposium,Haemorrhagic viral infections,Önder Ergönül; Türkiye); Catherine Houlihan; United Kingdom),S0311,08:30,Filovirus disease:,"evolving therapeutic strategies Ian 
Crozier (Frederick, United States)"
11 April 2025,SY113,08:30 - 10:30,3,2-hour Symposium,Haemorrhagic viral infections,Önder Ergönül; Türkiye); Catherine Houlihan; United Kingdom),S0312,09:00,Jack in the box:,"Re-emergence of Kyasanur Forest 
Disease in India Kavitha Saravu (Manipal, India)"
11 April 2025,SY113,08:30 - 10:30,3,2-hour Symposium,Haemorrhagic viral infections,Önder Ergönül; Türkiye); Catherine Houlihan; United Kingdom),S0313,09:30,Crimean Congo Haemorrhagic Fever:,"Newer insights 
into pathogenesis leading to new vaccines and 
therapeutics Ali Mirazimi (Stockholm, Sweden)"
11 April 2025,SY113,08:30 - 10:30,3,2-hour Symposium,Haemorrhagic viral infections,Önder Ergönül; Türkiye); Catherine Houlihan; United Kingdom),S0314,10:00,Venezuelan Equine Encephalitis:,"Impact of newer 
strategies for vector control Carlos Seas (Lima, Peru)"
11 April 2025,OS078,08:30 - 10:30,5,,,Delia Goletti; Italy); Sean Wasserman; United Kingdom); O0568  Lineage-specific immune responses to; Mycobacterium tuberculosis : insights into L4 and; L6 pathogenesis M. Silva*; Portugal); J.; Couto; M. Cardoso; B. Cá; M. Saraiva; O0569  Deciphering the functional role of distinctive; Mycobacterium tuberculosis  peptidoglycan; modifications in modulating antibiotic resistance; and the immune response C. Silveiro*; Portugal); F. Olivença; M. Mandal; D. Pires; E. Anes; M.J. Catalão; O0570  Increased innate immune and neutrophil blood; transcriptomic signatures associate with poor; outcome in HIV-1 tuberculous meningitis J.; Barnacle*; United Kingdom); A. Davis; R.J.; Wilkinson; K. Wilkinson; C. Stek; M. Maxebengula; N. Bangani; G. Kelly; M. Rodriguez-Lopez; R. Lai; S.; Wasserman; G. Meintjes; A. O' Garra; O0571  Subpopulations in clinical samples of; Mycobacterium tuberculosis  can give rise to; rifampicin resistance and shed light on how; resistance is acquired V. Brunner*; United; Kingdom); P. Fowler; O0572  A systematic comparison of automated; Mycobacterium tuberculosis  complex whole; genome sequencing analysis pipelines R. Spies*; Chi Minh City; Vietnam); D. Crook; T. Peto; P.; Fowler; R. Turner; H. Thai; J. Watson; T. Walker; O0573  Lung ultrasound for the detection of pulmonary; tuberculosis using expert and AI-guided; interpretation Veronique Suttels; Switzerland); O0574  Nanomotion Technology for Rapid Antimicrobial; Susceptibility Testing of Mycobacterium; tuberculosis : Evaluating Novel Benzothiazinone; Derivatives. A. Vocat*; Switzerland); A.; Luraschi-Eggemann; C. Antoni; G. Cathomen; D.; Cichocka; G. Greub; O. Riabova; V. Makarov; O.; Opota; A. Mendoza; S. Cole; A. Sturm; O0575  Rapid drug susceptibility testing of Mycobacterium; tuberculosis  directly from clinical samples using; targeted next-generation sequencing E. Rosendal*; (Lisbon; Portugal); J. Isidro; S. Carneiro; R. Macedo; O0576  Enhancing cerebral tuberculosis therapy with an; innovative particulate nose-to-Brain drug delivery; system: Insights from pharmacokinetic and; pharmacodynamic studies K. Jadhav*; India); K. Sudhakar Jadhav; A.K. Singh; R.K. Verma; O0577  Multi-drug resistant tuberculosis among migrants; in Europe S. Hayward*; United Kingdom); K. Rustage; L.B. Nellums; J.S. Friedland; S.; Hargreaves,S078,08:30,- 10:30,"Hall 5
2-hour Oral Session
Trending topics in tuberculosis
Chairs Delia Goletti (Rome, Italy)"
11 April 2025,SY120,09:30 - 10:30,1,,,Fidelma Fitzpatrick; Ireland); Maurizio Sanguinetti; Italy),Y120,09:30,- 10:30,"Hall 1
1-hour Symposium
Year in clinical microbiology
Chairs Fidelma Fitzpatrick (Dublin, Ireland)"
11 April 2025,SY120,09:30 - 10:30,1,,,Fidelma Fitzpatrick; Ireland); Maurizio Sanguinetti; Italy),S0339,09:30,,"Mario Ramirez (Lisbon, Portugal)"
11 April 2025,SY120,09:30 - 10:30,1,,,Fidelma Fitzpatrick; Ireland); Maurizio Sanguinetti; Italy),S0340,10:00,,"Anna Papa-Konidari (Thessaloniki, Greece)"
11 April 2025,SY120,09:30 - 10:30,1,,,Fidelma Fitzpatrick; Ireland); Maurizio Sanguinetti; Italy),S0319,08:30,,"The burden of nosocomial infections in long-term 
facilities Virginie Prendki (Genève-Thônex, 
Switzerland)"
11 April 2025,SY120,09:30 - 10:30,1,,,Fidelma Fitzpatrick; Ireland); Maurizio Sanguinetti; Italy),S0320,09:00,Pneumonia in the elderly:,"management and 
prevention Marcos Restrepo (San Antonio, United 
States)"
11 April 2025,SY120,09:30 - 10:30,1,,,Fidelma Fitzpatrick; Ireland); Maurizio Sanguinetti; Italy),S0321,09:30,,"Challenges in the clinical diagnosis of infection in the 
elderly Maheen Abidi (Denver, United States)"
11 April 2025,SY120,09:30 - 10:30,1,,,Fidelma Fitzpatrick; Ireland); Maurizio Sanguinetti; Italy),S0322,10:00,,"Challenges in implementing antimicrobial 
stewardship in long-term care facilities Elena Carrara 
(Verona, Italy)"
11 April 2025,SY117,08:30 - 10:30,16,2-hour Symposium,Survival of the parasites: is treatment failure due to antimicrobial resistance?,Hanne Brekke; Norway); Jaco J. Verweij; Netherlands),S0327,08:30,,"Nitroimidazole refractory Giardia intestinalis  
infection Pavla Tůmová (Praha, Czech Republic)"
11 April 2025,SY117,08:30 - 10:30,16,2-hour Symposium,Survival of the parasites: is treatment failure due to antimicrobial resistance?,Hanne Brekke; Norway); Jaco J. Verweij; Netherlands),S0328,09:00,,"Treatment failure in scabies Francisco Bravo (Lima, 
Peru)"
11 April 2025,SY117,08:30 - 10:30,16,2-hour Symposium,Survival of the parasites: is treatment failure due to antimicrobial resistance?,Hanne Brekke; Norway); Jaco J. Verweij; Netherlands),S0329,09:30,,"Recurrent Enterobius  infections Sarah Eisen (London, 
United Kingdom)"
11 April 2025,SY117,08:30 - 10:30,16,2-hour Symposium,Survival of the parasites: is treatment failure due to antimicrobial resistance?,Hanne Brekke; Norway); Jaco J. Verweij; Netherlands),S0330,10:00,,"Recent advances in the treatment of Visceral 
Leishmaniasis and PKDL Shyam Sundar (Varanasi, 
India)"
11 April 2025,EW118,08:30 - 10:30,2,Educational Session,How can we infer and track plasmid outbreaks?,Alessandra Carattoli; Italy); Jacob Moran-Gilad; Israel),W0331,08:30,,"Evolutionary modelling of plasmids Manuel Ares 
Arroyo (Paris, France)"
11 April 2025,EW118,08:30 - 10:30,2,Educational Session,How can we infer and track plasmid outbreaks?,Alessandra Carattoli; Italy); Jacob Moran-Gilad; Israel),W0332,08:50,,"How plasmids shape the emergence of nosocomial 
pathogens Jukka Corander (Oslo, Norway)"
11 April 2025,EW118,08:30 - 10:30,2,Educational Session,How can we infer and track plasmid outbreaks?,Alessandra Carattoli; Italy); Jacob Moran-Gilad; Israel),W0333,09:10,,"Understanding the complexity of plasmid outbreaks 
using bioinformatics Torsten Seemann (Melbourne 
(VIC)"
11 April 2025,EW118,08:30 - 10:30,2,Educational Session,How can we infer and track plasmid outbreaks?,Alessandra Carattoli; Italy); Jacob Moran-Gilad; Israel),W0334,09:30,,"Plasmid transmission at the One Health 
interface Nicole Stoesser (Oxford, United Kingdom)"
11 April 2025,SY113,08:30 - 10:30,3,2-hour Symposium,Haemorrhagic viral infections,Önder Ergönül; Türkiye); Catherine Houlihan; United Kingdom),Y113,08:30,- 10:30,"Hall 3
2-hour Symposium
Haemorrhagic viral infections
Chairs Önder Ergönül (Istanbul, Türkiye)"
11 April 2025,SY113,08:30 - 10:30,3,2-hour Symposium,Haemorrhagic viral infections,Önder Ergönül; Türkiye); Catherine Houlihan; United Kingdom),S0311,08:30,Filovirus disease:,"evolving therapeutic strategies Ian 
Crozier (Frederick, United States)"
11 April 2025,SY113,08:30 - 10:30,3,2-hour Symposium,Haemorrhagic viral infections,Önder Ergönül; Türkiye); Catherine Houlihan; United Kingdom),S0312,09:00,Jack in the box:,"Re-emergence of Kyasanur Forest 
Disease in India Kavitha Saravu (Manipal, India)"
11 April 2025,SY113,08:30 - 10:30,3,2-hour Symposium,Haemorrhagic viral infections,Önder Ergönül; Türkiye); Catherine Houlihan; United Kingdom),S0313,09:30,Crimean Congo Haemorrhagic Fever:,"Newer insights 
into pathogenesis leading to new vaccines and 
therapeutics Ali Mirazimi (Stockholm, Sweden)"
11 April 2025,SY113,08:30 - 10:30,3,2-hour Symposium,Haemorrhagic viral infections,Önder Ergönül; Türkiye); Catherine Houlihan; United Kingdom),S0314,10:00,Venezuelan Equine Encephalitis:,"Impact of newer 
strategies for vector control Carlos Seas (Lima, Peru)"
11 April 2025,OS078,08:30 - 10:30,5,,,Delia Goletti; Italy); Sean Wasserman; United Kingdom); O0568  Lineage-specific immune responses to; Mycobacterium tuberculosis : insights into L4 and; L6 pathogenesis M. Silva*; Portugal); J.; Couto; M. Cardoso; B. Cá; M. Saraiva; O0569  Deciphering the functional role of distinctive; Mycobacterium tuberculosis  peptidoglycan; modifications in modulating antibiotic resistance; and the immune response C. Silveiro*; Portugal); F. Olivença; M. Mandal; D. Pires; E. Anes; M.J. Catalão; O0570  Increased innate immune and neutrophil blood; transcriptomic signatures associate with poor; outcome in HIV-1 tuberculous meningitis J.; Barnacle*; United Kingdom); A. Davis; R.J.; Wilkinson; K. Wilkinson; C. Stek; M. Maxebengula; N. Bangani; G. Kelly; M. Rodriguez-Lopez; R. Lai; S.; Wasserman; G. Meintjes; A. O' Garra; O0571  Subpopulations in clinical samples of; Mycobacterium tuberculosis  can give rise to; rifampicin resistance and shed light on how; resistance is acquired V. Brunner*; United; Kingdom); P. Fowler; O0572  A systematic comparison of automated; Mycobacterium tuberculosis  complex whole; genome sequencing analysis pipelines R. Spies*; Chi Minh City; Vietnam); D. Crook; T. Peto; P.; Fowler; R. Turner; H. Thai; J. Watson; T. Walker; O0573  Lung ultrasound for the detection of pulmonary; tuberculosis using expert and AI-guided; interpretation Veronique Suttels; Switzerland); O0574  Nanomotion Technology for Rapid Antimicrobial; Susceptibility Testing of Mycobacterium; tuberculosis : Evaluating Novel Benzothiazinone; Derivatives. A. Vocat*; Switzerland); A.; Luraschi-Eggemann; C. Antoni; G. Cathomen; D.; Cichocka; G. Greub; O. Riabova; V. Makarov; O.; Opota; A. Mendoza; S. Cole; A. Sturm; O0575  Rapid drug susceptibility testing of Mycobacterium; tuberculosis  directly from clinical samples using; targeted next-generation sequencing E. Rosendal*; (Lisbon; Portugal); J. Isidro; S. Carneiro; R. Macedo; O0576  Enhancing cerebral tuberculosis therapy with an; innovative particulate nose-to-Brain drug delivery; system: Insights from pharmacokinetic and; pharmacodynamic studies K. Jadhav*; India); K. Sudhakar Jadhav; A.K. Singh; R.K. Verma; O0577  Multi-drug resistant tuberculosis among migrants; in Europe S. Hayward*; United Kingdom); K. Rustage; L.B. Nellums; J.S. Friedland; S.; Hargreaves,S078,08:30,- 10:30,"Hall 5
2-hour Oral Session
Trending topics in tuberculosis
Chairs Delia Goletti (Rome, Italy)"
11 April 2025,SY120,09:30 - 10:30,1,ePoster Flash Session,Addressing the need for speed: advances in point-of-care testing,Fidelma Fitzpatrick; Ireland); Maurizio Sanguinetti; Italy),Y120,09:30,- 10:30,"Hall 1
1-hour Symposium
Year in clinical microbiology
Chairs Fidelma Fitzpatrick (Dublin, Ireland)"
11 April 2025,SY120,09:30 - 10:30,1,ePoster Flash Session,Addressing the need for speed: advances in point-of-care testing,Fidelma Fitzpatrick; Ireland); Maurizio Sanguinetti; Italy),S0339,09:30,,"Mario Ramirez (Lisbon, Portugal)"
11 April 2025,SY120,09:30 - 10:30,1,ePoster Flash Session,Addressing the need for speed: advances in point-of-care testing,Fidelma Fitzpatrick; Ireland); Maurizio Sanguinetti; Italy),S0340,10:00,,"Anna Papa-Konidari (Thessaloniki, Greece)"
11 April 2025,SY120,09:30 - 10:30,1,ePoster Flash Session,Addressing the need for speed: advances in point-of-care testing,Fidelma Fitzpatrick; Ireland); Maurizio Sanguinetti; Italy),F081,09:30,- 10:30,"Arena 2
ePoster Flash Session
Clinical features and outcome of invasive fungal infections
Chair Marcus De Melo Teixeira (Brasília, Brazil)"
11 April 2025,SY120,09:30 - 10:30,1,ePoster Flash Session,Addressing the need for speed: advances in point-of-care testing,Fidelma Fitzpatrick; Ireland); Maurizio Sanguinetti; Italy),F0356,11:00,The genesis of predatory journals:,"symptoms and 
root problems Leonard Leibovici (Petah-Tiqva, Israel)"
11 April 2025,SY120,09:30 - 10:30,1,ePoster Flash Session,Addressing the need for speed: advances in point-of-care testing,Fidelma Fitzpatrick; Ireland); Maurizio Sanguinetti; Italy),F0359,11:30,,"Bibliometric literacy in scientific publication Lauren 
Maggio (Chicago, United States)"
11 April 2025,SY120,09:30 - 10:30,1,ePoster Flash Session,Addressing the need for speed: advances in point-of-care testing,Fidelma Fitzpatrick; Ireland); Maurizio Sanguinetti; Italy),F081,09:30,- 10:30,"Arena 2
ePoster Flash Session
Clinical features and outcome of invasive fungal infections
Chair Marcus De Melo Teixeira (Brasília, Brazil)"
11 April 2025,SY120,09:30 - 10:30,1,ePoster Flash Session,Addressing the need for speed: advances in point-of-care testing,Fidelma Fitzpatrick; Ireland); Maurizio Sanguinetti; Italy),F0356,11:00,The genesis of predatory journals:,"symptoms and 
root problems Leonard Leibovici (Petah-Tiqva, Israel)"
11 April 2025,SY120,09:30 - 10:30,1,ePoster Flash Session,Addressing the need for speed: advances in point-of-care testing,Fidelma Fitzpatrick; Ireland); Maurizio Sanguinetti; Italy),F0359,11:30,,"Bibliometric literacy in scientific publication Lauren 
Maggio (Chicago, United States)"
11 April 2025,KN121,11:00 - 12:00,1,,,Mary Horgan; Ireland); Gülsen Özkaya Sahin; Sweden),K0341,11:00,,"Huldrych Günthard (Zürich, Switzerland)"
11 April 2025,OS085,11:00 - 12:00,10,1-hour Oral Session,"Planes, Pains, and Pathogens: The Perils of Travel Medicine",Anu Kantele; Finland); Carlos Seas; Peru); O0620  Fever in returning travelers from tropical regions:; what not to miss in an evolving epidemiology S.; Caronni*; Italy); M. Pieruzzi; A. Rizzo; A.H.; Behring; A. Poloni; A. Giacomelli; F. Salari; S. Grosso; A. Mancon; D. Mileto; S. Antinori; O0621  Tracing the itch: A spatiotemporal analysis of scabies; rates and its risk factors using the Global Burden of; Disease data S. Gupta*; New Zealand); S.; Thornley; G. Sundborn; C. GrantO0622  Molecular epidemiological characterization of; enterotoxigenic and enteroaggregative Escherichia; coli causing traveller's diarrhoea and their; relationship with clinical features P. Oliveras Julia*; (Barcelona; Spain); P. Oliveras; E. Riera; L. Horvath; R.M. Albarracín; M.E. Valls; M.J. Álvarez-Martínez; M.; Alguacil; E. Guiral; M. Espasa; D. Camprubi-Ferrer; J.; Vila; O0623  Bites and bytes – can digital surveillance of travellers'; illness predict outbreaks? N. Hedrich*; Switzerland); T. Lovey; P. Schlagenhauf; O0624  Travel-associated infections and diseases: a; retrospective cross-sectional study M. Trojanek*; (Prague; Czech Republic); M. Trojánek; V. Grebenyuk; V. Jegorova; P. Hubacek; A. Briksi; J. Havlova; K.; Dundrova; L. Kolarik; I. Zicklerova; L. Richterova; O.; Beranek; T. Ernestova; L. Kohout; G. Meseznikov; A.; Nycova; B. Pisova; R. Šindlerová; M. Tulach; Z.; Uhříková; M. Vidlička; M. Štefan; F. Stejskal,,,,
11 April 2025,OS086,11:00 - 12:00,11,1-hour Oral Session,Marker based diagnostics: forget the pathogen,Virginie Prendki; Switzerland); Suzanne Van Asten; Netherlands); O0625  A 29-mRNA molecular host response test; demonstrates enhanced accuracy compared to a; protein-based host response test for the diagnosis of; bacterial and viral infections N. Whitfield*; United States); C. Lu; O. Liesenfeld; O0626  Diagnostic accuracy of a bacterial versus viral host-; protein test for pediatric inpatients with acute; infection T. Gottlieb*; Israel); L. Bont; A.; Klein; M. Stein; M. Mor; I. Srugo; R. Navon; E. Eden; B.P. Muller; O0627  Diagnostic accuracy of combined urine lipocalin 2; and copper test in acute pyelonephritis or cystitis V.; Havlicek*; Czech Republic); J. Hrbacek; T.; Pluhacek; J. Houst; A. Palyzova; D. Luptakova; D.A.; Stevens; J. Novak; R. Dobias; R. Zachoval; O0628  Diagnostic Performance of Whole-Blood RNA; Signatures for Tuberculosis Diagnosis in a Cohort of; Patients with Non-Tuberculous Mycobacterial Lung; Disease P. Escalante*; Mn; United States); B. Piatkowski; B. Pathakumari; V. Van Keulen; N.; Fadra; P. Arias-Sanchez; L. Gutierrez; S. Karnakoti; T.; Peikert; O0629  Diagnostic utility of MxA and MxA/CRP ratio in; differentiating viral and bacterial infections: a; prospective cohort study O. Beránek*; Czech; Republic); R. Prusa; M. Trojánek; O. Beranek; Z.; Uhříková; J. Illner; P. Lehnert; P. Bukovska; M. Štefan; V. Jegorova; T. Ernestova; L. Kohout; G. Meseznikov; A. Nycova; R. Šindlerová; M. Tulach; M. Vidlička; V.; Grebenyuk,,,,
11 April 2025,PM2,11:00 - 12:00,12,ePoster Flash Session,Addressing the need for speed: advances in point-of-care testing,Charlotte Vernhes; Belgium); Ghada Zoubiane; United Kingdom),M2,11:00,- 12:00,"Hall 12
Panel Discussion
AMR and vaccines
Chairs Charlotte Vernhes (Brussels, Belgium)"
11 April 2025,PM2,11:00 - 12:00,12,ePoster Flash Session,Addressing the need for speed: advances in point-of-care testing,Charlotte Vernhes; Belgium); Ghada Zoubiane; United Kingdom),L005,11:00,,"Overview of the current evidence of the impact of 
vaccines on AMR Adam Cunningham (Birmingham, 
United Kingdom)"
11 April 2025,KN121,11:00 - 12:00,1,,,Mary Horgan; Ireland); Gülsen Özkaya Sahin; Sweden),K0341,11:00,,"Huldrych Günthard (Zürich, Switzerland)"
11 April 2025,OS085,11:00 - 12:00,10,1-hour Oral Session,"Planes, Pains, and Pathogens: The Perils of Travel Medicine",Anu Kantele; Finland); Carlos Seas; Peru); O0620  Fever in returning travelers from tropical regions:; what not to miss in an evolving epidemiology S.; Caronni*; Italy); M. Pieruzzi; A. Rizzo; A.H.; Behring; A. Poloni; A. Giacomelli; F. Salari; S. Grosso; A. Mancon; D. Mileto; S. Antinori; O0621  Tracing the itch: A spatiotemporal analysis of scabies; rates and its risk factors using the Global Burden of; Disease data S. Gupta*; New Zealand); S.; Thornley; G. Sundborn; C. GrantO0622  Molecular epidemiological characterization of; enterotoxigenic and enteroaggregative Escherichia; coli causing traveller's diarrhoea and their; relationship with clinical features P. Oliveras Julia*; (Barcelona; Spain); P. Oliveras; E. Riera; L. Horvath; R.M. Albarracín; M.E. Valls; M.J. Álvarez-Martínez; M.; Alguacil; E. Guiral; M. Espasa; D. Camprubi-Ferrer; J.; Vila; O0623  Bites and bytes – can digital surveillance of travellers'; illness predict outbreaks? N. Hedrich*; Switzerland); T. Lovey; P. Schlagenhauf; O0624  Travel-associated infections and diseases: a; retrospective cross-sectional study M. Trojanek*; (Prague; Czech Republic); M. Trojánek; V. Grebenyuk; V. Jegorova; P. Hubacek; A. Briksi; J. Havlova; K.; Dundrova; L. Kolarik; I. Zicklerova; L. Richterova; O.; Beranek; T. Ernestova; L. Kohout; G. Meseznikov; A.; Nycova; B. Pisova; R. Šindlerová; M. Tulach; Z.; Uhříková; M. Vidlička; M. Štefan; F. Stejskal,,,,
11 April 2025,OS086,11:00 - 12:00,11,1-hour Oral Session,Marker based diagnostics: forget the pathogen,Virginie Prendki; Switzerland); Suzanne Van Asten; Netherlands); O0625  A 29-mRNA molecular host response test; demonstrates enhanced accuracy compared to a; protein-based host response test for the diagnosis of; bacterial and viral infections N. Whitfield*; United States); C. Lu; O. Liesenfeld; O0626  Diagnostic accuracy of a bacterial versus viral host-; protein test for pediatric inpatients with acute; infection T. Gottlieb*; Israel); L. Bont; A.; Klein; M. Stein; M. Mor; I. Srugo; R. Navon; E. Eden; B.P. Muller; O0627  Diagnostic accuracy of combined urine lipocalin 2; and copper test in acute pyelonephritis or cystitis V.; Havlicek*; Czech Republic); J. Hrbacek; T.; Pluhacek; J. Houst; A. Palyzova; D. Luptakova; D.A.; Stevens; J. Novak; R. Dobias; R. Zachoval; O0628  Diagnostic Performance of Whole-Blood RNA; Signatures for Tuberculosis Diagnosis in a Cohort of; Patients with Non-Tuberculous Mycobacterial Lung; Disease P. Escalante*; Mn; United States); B. Piatkowski; B. Pathakumari; V. Van Keulen; N.; Fadra; P. Arias-Sanchez; L. Gutierrez; S. Karnakoti; T.; Peikert; O0629  Diagnostic utility of MxA and MxA/CRP ratio in; differentiating viral and bacterial infections: a; prospective cohort study O. Beránek*; Czech; Republic); R. Prusa; M. Trojánek; O. Beranek; Z.; Uhříková; J. Illner; P. Lehnert; P. Bukovska; M. Štefan; V. Jegorova; T. Ernestova; L. Kohout; G. Meseznikov; A. Nycova; R. Šindlerová; M. Tulach; M. Vidlička; V.; Grebenyuk,,,,
11 April 2025,PM2,11:00 - 12:00,12,,,Charlotte Vernhes; Belgium); Ghada Zoubiane; United Kingdom),M2,11:00,- 12:00,"Hall 12
Panel Discussion
AMR and vaccines
Chairs Charlotte Vernhes (Brussels, Belgium)"
11 April 2025,PM2,11:00 - 12:00,12,,,Charlotte Vernhes; Belgium); Ghada Zoubiane; United Kingdom),L005,11:00,,"Overview of the current evidence of the impact of 
vaccines on AMR Adam Cunningham (Birmingham, 
United Kingdom)"
11 April 2025,SY126,11:00 - 12:00,13,,,Gernot Bonkat; Switzerland); Maeve Doyle; Ireland),S0350,11:00,The concept of complicated UTI:,"underlying 
conditions matter Suzanne Geerlings (Amsterdam, 
Netherlands)"
11 April 2025,SY126,11:00 - 12:00,13,,,Gernot Bonkat; Switzerland); Maeve Doyle; Ireland),S0351,11:30,The concept of complicated UTI:,"the site of infection 
matters most Jesús Rodríguez-Baño (Seville, Spain)"
11 April 2025,ME128,11:00 - 12:00,14,Meet-the-Expert,How to apply organoid models to study infectious disease,,M0354,11:00,,"Jennifer Rohn (London, United Kingdom)"
11 April 2025,ME128,11:00 - 12:00,14,Meet-the-Expert,How to apply organoid models to study infectious disease,,M0355,11:12,,"Nathalie Sauvonnet (Paris, France)"
11 April 2025,OS087,11:00 - 12:00,15,1-hour Oral Session,Antimicrobial resistance around birth,Julia Anna Bielicki; United Kingdom); Surbhi Malhotra-Kumar; Belgium); O0630  Prevalence and risk factors of antibiotic resistance; genes in breastmilk and neonatal oral cavity of; preterm mother-infant pairs A. Sharma*; India); S. Dutta; M. Biswal; A. Chakraborty; V. Suri; P.; Ray; O0631  Effect of maternal peripartum antibiotic exposure on; the microbial diversity; relative abundance of taxa; and resistome in breastmilk A. Chakraborty*; (Chandigarh; India); S. Dutta; P. Sikka; D. Puri; A.; Kumar; P. Kumar; A. Pal; A. Arora; O0632  Dynamics of gastrointestinal colonisation by; antibiotic-resistant bacteria in high-risk infants in; Swiss and Greek neonatal intensive care units A.; Braspenning*; Belgium); L. Timbermont; L.; Van Heirstraeten; M. Berkell; A. Cook; E. Sieswerda; C.H. Van Werkhoven; J. Bielicki; S. Malhotra-Kumar; O0633  Harnessing functional omics to decipher how; probiotics reduce antibiotic resistance gene carriage; in infants' gut V. Pettersen*; Norway); A.; Bargheet; G.H. Bø; C. Klingenberg; O0634  Dynamics of gut resistome and mobilome in early life:; A meta-analysis V. Pettersen*; Norway); A.; Bargheet; H.T. Noordzij; A.J. Ponsero; C. Jian; K.; Korpela; M. Valles-Colomer; J. Debelius; A.; Kurilshikov,S087,11:00,- 12:00,"Hall 15
1-hour Oral Session
Antimicrobial resistance around birth
Chairs Julia Anna Bielicki (London, United Kingdom)"
11 April 2025,OS088,11:00 - 12:00,16,1-hour Oral Session,Advancing diagnostics and preventive measures in hemato-oncological,Dina Averbuch; Israel); Malgorzata Mikulska; Italy); O0635  Prediction of bacterial and fungal bloodstream; infections using machine learning in patients; undergoing chemotherapy M. Freire*; Brazil); A. Villani. Jr; M. P. Freire; F. Lazzar Neto; L.A.; De Padua Covas Lages; M. Salaroli De Oliveira; E.; Abdala; F. L.S. Nunes; A.S. S. LevinO0636  Viral metagenomics in patients with persistent; unexplained neutropenic fever- some clues to the; cause of fever? A. Douglas*; Australia); L. Caly; M.A. Slavin; I. Savic; J. Moselen; A. Aziz; G.; Papadakis; G. Ng; J. Druce; K. Thursky; O0637  Results of Optifil study: 18F-FDG-PET/CT guided; antifungal stewardship in invasive pulmonary; aspergillosis F. Lanternier*; France); C.; Maunoury; F. Montravers; F. Marquant; S. Poiree; C.; Elie; C. Robin; A. Thiebaut; F. Ader; F. Suarez; E.; Blanchard; O. Lortholary; O0638  Long-term immunogenicity and boostability of the; 5-dose pneumococcal vaccination schedule; following allogeneic hematopoietic stem cell; transplantation: a prospective cohort study S.; Haggenburg*; Netherlands); J.; Schnyder; H. Garcia Garrido; M. Schoordijk; A.; Reiners; B. Meek; M. Hazenberg; A. Goorhuis; O0639  Humoral and cellular immune response to; adjuvanted respiratory syncytial virus vaccine; RSVPreF3 in adults after allogeneic hematopoietic; cell transplantation J. Lötscher*; Switzerland); C.S. Walti; J. Halter; N. Khanna; S.; Heller; S. Schmid; K. Leuzinger,S088,11:00,- 12:00,"Hall 16
1-hour Oral Session
Advancing diagnostics and preventive measures in hemato-oncological 
patients
Chairs Dina Averbuch (Jerusalem, Israel)"
11 April 2025,OS082,11:00 - 12:00,2,1-hour Oral Session,New insights in bloodstream infections and endocarditis,Barbara Hasse; Switzerland); José M. Miro; Spain); O0605  Different from the start – Sex differences in; Staphylococcus aureus bacteremia mortality A.; Westgeest*; Netherlands); M. Lambregts; F.; Ruffin; V.G. Fowler; J.T. Thaden; O0606  Tracking evolution in action during invasive; Staphylococcus aureus  infections: the BARISTA; study S. Giulieri*; Australia); D. Daniel; M.; Duarte Aguilera; D. Velasquez-Reyes; R. Guérillot; A.; Gador-Whyte; F. James; E. Goodall; P. Fuge-Larsen; M. Henri; J. Trubiano; M. Leroi; K. Bond; T. Stinear; S.; Tong; J. Kwong; B. Howden; O0607  Identifying heterogeneity of treatment effect for; antibiotic duration in bloodstream infection – an; exploratory post-hoc analysis of the BALANCE; randomized clinical trial S. Ong*; Australia); R. Pinto; A. Rishu; S. Tong; R. Commons; J.M. Conly; G. Evans; M. Fralick; C. Kandel; P. Lagacé-; Wiens; T. Lee; S. Lother; D. Macfadden; J. Marshall; V.; Martel-Laferrière; M. Mayette; E. Mcdonald; J. Neary; J. Prazak; E. Raby; A. Regli; B.A. Rogers; S. Smith; L.; Taggart; H.T. Wang; T. Wuerz; D. Yahav; P. Young; R.A. Fowler; N. Daneman; O0608  Bloodstream infection pathogen diversity and clinical; impact revealed through unbiased whole genome; sequencing: a prospective genomic epidemiology; study N. Macesic*; Australia); J. Hawkey; J.A. Wisniewski; A. Peleg; O0609  Risk of infection of intracardiac devices in patients; with valvular infective endocarditis who carry; cardiovascular implanted electronic devices. Analysis; on a national cohort A. Blanco Arévalo*; Spain); A. Blanco-Arevalo; E. Calbo; P. Muñoz; D.; Monzón; M. Valerio; M. Hernandez Meneses; J.M.; Miró; M. Cobo Belastegui; A. De Alarcón; R.; Rodríguez; I. Villanueva Benito; J.C. Lopez-Azor; L.; Garcia-Alvarez; L. Boix,S082,11:00,- 12:00,"Hall 2
1-hour Oral Session
New insights in bloodstream infections and endocarditis
Chairs Barbara Hasse (Zurich, Switzerland)"
11 April 2025,SY122,11:00 - 12:00,3,,,Pavel Drevinek; Czech Republic); Helle Krogh Johansen; Denmark); ESCMID Global 2025 - Programme,,,,
11 April 2025,SY126,11:00 - 12:00,13,,,Gernot Bonkat; Switzerland); Maeve Doyle; Ireland),S0350,11:00,The concept of complicated UTI:,"underlying 
conditions matter Suzanne Geerlings (Amsterdam, 
Netherlands)"
11 April 2025,SY126,11:00 - 12:00,13,,,Gernot Bonkat; Switzerland); Maeve Doyle; Ireland),S0351,11:30,The concept of complicated UTI:,"the site of infection 
matters most Jesús Rodríguez-Baño (Seville, Spain)"
11 April 2025,ME128,11:00 - 12:00,14,Meet-the-Expert,How to apply organoid models to study infectious disease,,M0354,11:00,,"Jennifer Rohn (London, United Kingdom)"
11 April 2025,ME128,11:00 - 12:00,14,Meet-the-Expert,How to apply organoid models to study infectious disease,,M0355,11:12,,"Nathalie Sauvonnet (Paris, France)"
11 April 2025,OS087,11:00 - 12:00,15,1-hour Oral Session,Antimicrobial resistance around birth,Julia Anna Bielicki; United Kingdom); Surbhi Malhotra-Kumar; Belgium); O0630  Prevalence and risk factors of antibiotic resistance; genes in breastmilk and neonatal oral cavity of; preterm mother-infant pairs A. Sharma*; India); S. Dutta; M. Biswal; A. Chakraborty; V. Suri; P.; Ray; O0631  Effect of maternal peripartum antibiotic exposure on; the microbial diversity; relative abundance of taxa; and resistome in breastmilk A. Chakraborty*; (Chandigarh; India); S. Dutta; P. Sikka; D. Puri; A.; Kumar; P. Kumar; A. Pal; A. Arora; O0632  Dynamics of gastrointestinal colonisation by; antibiotic-resistant bacteria in high-risk infants in; Swiss and Greek neonatal intensive care units A.; Braspenning*; Belgium); L. Timbermont; L.; Van Heirstraeten; M. Berkell; A. Cook; E. Sieswerda; C.H. Van Werkhoven; J. Bielicki; S. Malhotra-Kumar; O0633  Harnessing functional omics to decipher how; probiotics reduce antibiotic resistance gene carriage; in infants' gut V. Pettersen*; Norway); A.; Bargheet; G.H. Bø; C. Klingenberg; O0634  Dynamics of gut resistome and mobilome in early life:; A meta-analysis V. Pettersen*; Norway); A.; Bargheet; H.T. Noordzij; A.J. Ponsero; C. Jian; K.; Korpela; M. Valles-Colomer; J. Debelius; A.; Kurilshikov,S087,11:00,- 12:00,"Hall 15
1-hour Oral Session
Antimicrobial resistance around birth
Chairs Julia Anna Bielicki (London, United Kingdom)"
11 April 2025,OS088,11:00 - 12:00,16,1-hour Oral Session,Advancing diagnostics and preventive measures in hemato-oncological,Dina Averbuch; Israel); Malgorzata Mikulska; Italy); O0635  Prediction of bacterial and fungal bloodstream; infections using machine learning in patients; undergoing chemotherapy M. Freire*; Brazil); A. Villani. Jr; M. P. Freire; F. Lazzar Neto; L.A.; De Padua Covas Lages; M. Salaroli De Oliveira; E.; Abdala; F. L.S. Nunes; A.S. S. LevinO0636  Viral metagenomics in patients with persistent; unexplained neutropenic fever- some clues to the; cause of fever? A. Douglas*; Australia); L. Caly; M.A. Slavin; I. Savic; J. Moselen; A. Aziz; G.; Papadakis; G. Ng; J. Druce; K. Thursky; O0637  Results of Optifil study: 18F-FDG-PET/CT guided; antifungal stewardship in invasive pulmonary; aspergillosis F. Lanternier*; France); C.; Maunoury; F. Montravers; F. Marquant; S. Poiree; C.; Elie; C. Robin; A. Thiebaut; F. Ader; F. Suarez; E.; Blanchard; O. Lortholary; O0638  Long-term immunogenicity and boostability of the; 5-dose pneumococcal vaccination schedule; following allogeneic hematopoietic stem cell; transplantation: a prospective cohort study S.; Haggenburg*; Netherlands); J.; Schnyder; H. Garcia Garrido; M. Schoordijk; A.; Reiners; B. Meek; M. Hazenberg; A. Goorhuis; O0639  Humoral and cellular immune response to; adjuvanted respiratory syncytial virus vaccine; RSVPreF3 in adults after allogeneic hematopoietic; cell transplantation J. Lötscher*; Switzerland); C.S. Walti; J. Halter; N. Khanna; S.; Heller; S. Schmid; K. Leuzinger,S088,11:00,- 12:00,"Hall 16
1-hour Oral Session
Advancing diagnostics and preventive measures in hemato-oncological 
patients
Chairs Dina Averbuch (Jerusalem, Israel)"
11 April 2025,OS082,11:00 - 12:00,2,1-hour Oral Session,New insights in bloodstream infections and endocarditis,Barbara Hasse; Switzerland); José M. Miro; Spain); O0605  Different from the start – Sex differences in; Staphylococcus aureus bacteremia mortality A.; Westgeest*; Netherlands); M. Lambregts; F.; Ruffin; V.G. Fowler; J.T. Thaden; O0606  Tracking evolution in action during invasive; Staphylococcus aureus  infections: the BARISTA; study S. Giulieri*; Australia); D. Daniel; M.; Duarte Aguilera; D. Velasquez-Reyes; R. Guérillot; A.; Gador-Whyte; F. James; E. Goodall; P. Fuge-Larsen; M. Henri; J. Trubiano; M. Leroi; K. Bond; T. Stinear; S.; Tong; J. Kwong; B. Howden; O0607  Identifying heterogeneity of treatment effect for; antibiotic duration in bloodstream infection – an; exploratory post-hoc analysis of the BALANCE; randomized clinical trial S. Ong*; Australia); R. Pinto; A. Rishu; S. Tong; R. Commons; J.M. Conly; G. Evans; M. Fralick; C. Kandel; P. Lagacé-; Wiens; T. Lee; S. Lother; D. Macfadden; J. Marshall; V.; Martel-Laferrière; M. Mayette; E. Mcdonald; J. Neary; J. Prazak; E. Raby; A. Regli; B.A. Rogers; S. Smith; L.; Taggart; H.T. Wang; T. Wuerz; D. Yahav; P. Young; R.A. Fowler; N. Daneman; O0608  Bloodstream infection pathogen diversity and clinical; impact revealed through unbiased whole genome; sequencing: a prospective genomic epidemiology; study N. Macesic*; Australia); J. Hawkey; J.A. Wisniewski; A. Peleg; O0609  Risk of infection of intracardiac devices in patients; with valvular infective endocarditis who carry; cardiovascular implanted electronic devices. Analysis; on a national cohort A. Blanco Arévalo*; Spain); A. Blanco-Arevalo; E. Calbo; P. Muñoz; D.; Monzón; M. Valerio; M. Hernandez Meneses; J.M.; Miró; M. Cobo Belastegui; A. De Alarcón; R.; Rodríguez; I. Villanueva Benito; J.C. Lopez-Azor; L.; Garcia-Alvarez; L. Boix,S082,11:00,- 12:00,"Hall 2
1-hour Oral Session
New insights in bloodstream infections and endocarditis
Chairs Barbara Hasse (Zurich, Switzerland)"
11 April 2025,SY122,11:00 - 12:00,3,,,Pavel Drevinek; Czech Republic); Helle Krogh Johansen; Denmark); ESCMID Global 2025 - Programme,S0342,11:00,,"The lung microbiome of people with cystic fibrosis 
receiving modulator therapy Sebastien Boutin 
(Lübeck, Germany)"
11 April 2025,SY123,11:00 - 12:00,4,,,Antonios Katsounas; Germany); Claire Roger; France),S0344,11:00,,Intensive care unit (ICU)
11 April 2025,SY123,11:00 - 12:00,4,,,Antonios Katsounas; Germany); Claire Roger; France),S0345,11:20,,Ventilator- associated pneumonia (VAP)
11 April 2025,OS083,11:00 - 12:00,5,1-hour Oral Session,Don't 'rash' it,Heli Harvala; Finland); Catherine Moore; United Kingdom); O0610  Current Prevalence of Parvovirus B 19 Infections:; Ankara Bilkent City Hospital Experience 2019-; 2024 B. Dinc*; Türkiye); F.G. Aslan; F. Kırca; A. Toyran; S. Aydoğan; B. Dinç; O0611  Managing an outbreak of parvovirus B19 infection in; pregnancy: clinical outcomes from a single-centre; study M. Melchio*; Italy); E. Ricci; E. Cristina; E. Di Marco; P. Caligiuri; F. Prefumo; S. Mangini; A.; Mesini; M. Mariani; C. Russo Artimagnella; C.; Saffioti; O0612  The dark side of the „fifth disease” endemic: human; parvovirus B19 infections transmitted through blood; transfusions in adults with malignant hematological; diseases B.G. Szabo*; Hungary); D.; Korozs; P. Remenyi; J. Sinko; O0613  Key learnings from a measles outbreak with; multiple hospital exposures in Ireland; May-July; 2024 A.M. Murray*; Ireland); G. Larkin; D.; Hickey; O0614  Measles virus in the context of subacute sclerosing; panencephalitis; France); S.; Medragh; J. Adnet; T. Belveyre; C. Vauloup-Fellous,S083,11:00,- 12:00,"Hall 5
1-hour Oral Session
Don't 'rash' it
Chairs Heli Harvala (Turku, Finland)"
11 April 2025,SY124,11:00 - 12:00,6,,,Massimo Fantoni; Italy); Spyros Pournaras; Greece),S0346,11:00,Why treat IV when PO is possible?,"Bradley Spellberg 
(Los Angeles, United States)"
11 April 2025,SY124,11:00 - 12:00,6,,,Massimo Fantoni; Italy); Spyros Pournaras; Greece),S0347,11:30,,"De-escalation of antibiotic therapy to narrow-
spectrum IV drugs Flaminia Olearo (Hamburg, 
Germany)"
11 April 2025,SY125,11:00 - 12:00,7,,,Katrien Lagrou; Belgium); Antonio Vena; Italy),Y125,11:00,- 12:00,"Hall 7
1-hour Symposium
Cutting edge methods in mycology
Chairs Katrien Lagrou (Leuven, Belgium)"
11 April 2025,SY125,11:00 - 12:00,7,,,Katrien Lagrou; Belgium); Antonio Vena; Italy),S0349,11:30,,"Exploring the intersection of fungal metagenomics 
and medical mycology Marcus De Melo Teixeira 
(Brasília, Brazil)"
11 April 2025,OS084,11:00 - 12:00,8,,,Murat Akova; Türkiye); Muge Cevik; United Kingdom); O0615  Vertical Transmission of Clade Ib monkeypoxvirus; during Pregnancy: Clinical and Histopathological; description of 3 cases E. Hasivirwe Vakaniaki*; (Kinshasa; Congo; the Democratic Republic of the); N.R. Swar Kuispond; H. Yuichiro; S. Tadaki; R. Bulakali; Chirimwami; L. Liesenborghs; P. Mbala-Kingebeni; E.; Bangwen; I. Brosius; T. Wawina-Bokalanga; S. Sabiti; Nundu; O0616  First case of Oropouche fever in the South of Spain I.; Pérez Hernández*; Spain); I.A. Pérez-; Hernández; E. Basallote Leal; M.A. Sempere Alcocer; B. O´donell Cortés; O0617  Wild hippopotamus bite and Aeromonas spp.; infection: a treatment challenge. First case report. J.; Alza Arcila*; Colombia); N.M. Daza Alarcon; M.V. Montoya Garcia; A. Múnera-Echeverri; F.F.; Jiménez Quiroz; J. Alza-Arcila; O0618  From the sea to the land: an emerging species K.; Rodríguez Martínez*; Dominican; Republic); K. Rodríguez; A. Fernández; K. Espaillat; J.; Cruz; X. Rodríguez; T. Flores; O0619  The first findings of Wohlfahrtiimonas chitiniclastica; and Ignatzschineria species bacteremia in two cases; with maggot infested wounds in Scandinavia A.L.; Engsbro*; Denmark); C. Mortensen; R. Jul; W. Cebula; A.L. Laugesen; J.T. Møller; M. Kemp,S084,11:00,- 12:00,"Hall 8
1-hour Case Session
Weird and unusual infections
Chairs Murat Akova (Ankara, Türkiye)"
11 April 2025,ME127,11:00 - 12:00,9,Meet-the-Expert,EUCAST: What's new in susceptibility testing,,M0352,11:00,,"Erika Matuschek (Växjö, Sweden)"
11 April 2025,ME127,11:00 - 12:00,9,Meet-the-Expert,EUCAST: What's new in susceptibility testing,,M0353,11:12,,"Rafael Canton (Madrid, Spain)"
11 April 2025,ME134,13:30 - 14:30,16,Meet-the-Expert,"The older solid organ transplant recipient: between frailty,",,S0342,11:00,,"The lung microbiome of people with cystic fibrosis 
receiving modulator therapy Sebastien Boutin 
(Lübeck, Germany)"
11 April 2025,SY123,11:00 - 12:00,4,,,Antonios Katsounas; Germany); Claire Roger; France),S0344,11:00,,Intensive care unit (ICU)
11 April 2025,SY123,11:00 - 12:00,4,,,Antonios Katsounas; Germany); Claire Roger; France),S0345,11:20,,Ventilator- associated pneumonia (VAP)
11 April 2025,OS083,11:00 - 12:00,5,1-hour Oral Session,Don't 'rash' it,Heli Harvala; Finland); Catherine Moore; United Kingdom); O0610  Current Prevalence of Parvovirus B 19 Infections:; Ankara Bilkent City Hospital Experience 2019-; 2024 B. Dinc*; Türkiye); F.G. Aslan; F. Kırca; A. Toyran; S. Aydoğan; B. Dinç; O0611  Managing an outbreak of parvovirus B19 infection in; pregnancy: clinical outcomes from a single-centre; study M. Melchio*; Italy); E. Ricci; E. Cristina; E. Di Marco; P. Caligiuri; F. Prefumo; S. Mangini; A.; Mesini; M. Mariani; C. Russo Artimagnella; C.; Saffioti; O0612  The dark side of the „fifth disease” endemic: human; parvovirus B19 infections transmitted through blood; transfusions in adults with malignant hematological; diseases B.G. Szabo*; Hungary); D.; Korozs; P. Remenyi; J. Sinko; O0613  Key learnings from a measles outbreak with; multiple hospital exposures in Ireland; May-July; 2024 A.M. Murray*; Ireland); G. Larkin; D.; Hickey; O0614  Measles virus in the context of subacute sclerosing; panencephalitis; France); S.; Medragh; J. Adnet; T. Belveyre; C. Vauloup-Fellous,S083,11:00,- 12:00,"Hall 5
1-hour Oral Session
Don't 'rash' it
Chairs Heli Harvala (Turku, Finland)"
11 April 2025,SY124,11:00 - 12:00,6,,,Massimo Fantoni; Italy); Spyros Pournaras; Greece),S0346,11:00,Why treat IV when PO is possible?,"Bradley Spellberg 
(Los Angeles, United States)"
11 April 2025,SY124,11:00 - 12:00,6,,,Massimo Fantoni; Italy); Spyros Pournaras; Greece),S0347,11:30,,"De-escalation of antibiotic therapy to narrow-
spectrum IV drugs Flaminia Olearo (Hamburg, 
Germany)"
11 April 2025,SY125,11:00 - 12:00,7,,,Katrien Lagrou; Belgium); Antonio Vena; Italy),Y125,11:00,- 12:00,"Hall 7
1-hour Symposium
Cutting edge methods in mycology
Chairs Katrien Lagrou (Leuven, Belgium)"
11 April 2025,SY125,11:00 - 12:00,7,,,Katrien Lagrou; Belgium); Antonio Vena; Italy),S0349,11:30,,"Exploring the intersection of fungal metagenomics 
and medical mycology Marcus De Melo Teixeira 
(Brasília, Brazil)"
11 April 2025,OS084,11:00 - 12:00,8,,,Murat Akova; Türkiye); Muge Cevik; United Kingdom); O0615  Vertical Transmission of Clade Ib monkeypoxvirus; during Pregnancy: Clinical and Histopathological; description of 3 cases E. Hasivirwe Vakaniaki*; (Kinshasa; Congo; the Democratic Republic of the); N.R. Swar Kuispond; H. Yuichiro; S. Tadaki; R. Bulakali; Chirimwami; L. Liesenborghs; P. Mbala-Kingebeni; E.; Bangwen; I. Brosius; T. Wawina-Bokalanga; S. Sabiti; Nundu; O0616  First case of Oropouche fever in the South of Spain I.; Pérez Hernández*; Spain); I.A. Pérez-; Hernández; E. Basallote Leal; M.A. Sempere Alcocer; B. O´donell Cortés; O0617  Wild hippopotamus bite and Aeromonas spp.; infection: a treatment challenge. First case report. J.; Alza Arcila*; Colombia); N.M. Daza Alarcon; M.V. Montoya Garcia; A. Múnera-Echeverri; F.F.; Jiménez Quiroz; J. Alza-Arcila; O0618  From the sea to the land: an emerging species K.; Rodríguez Martínez*; Dominican; Republic); K. Rodríguez; A. Fernández; K. Espaillat; J.; Cruz; X. Rodríguez; T. Flores; O0619  The first findings of Wohlfahrtiimonas chitiniclastica; and Ignatzschineria species bacteremia in two cases; with maggot infested wounds in Scandinavia A.L.; Engsbro*; Denmark); C. Mortensen; R. Jul; W. Cebula; A.L. Laugesen; J.T. Møller; M. Kemp,S084,11:00,- 12:00,"Hall 8
1-hour Case Session
Weird and unusual infections
Chairs Murat Akova (Ankara, Türkiye)"
11 April 2025,ME127,11:00 - 12:00,9,Meet-the-Expert,EUCAST: What's new in susceptibility testing,,M0352,11:00,,"Erika Matuschek (Växjö, Sweden)"
11 April 2025,ME127,11:00 - 12:00,9,Meet-the-Expert,EUCAST: What's new in susceptibility testing,,M0353,11:12,,"Rafael Canton (Madrid, Spain)"
11 April 2025,ME134,13:30 - 14:30,16,Meet-the-Expert,"The older solid organ transplant recipient: between frailty,",,M0367,13:30,,"Maheen Abidi (Denver, United States)"
11 April 2025,ME134,13:30 - 14:30,16,Meet-the-Expert,"The older solid organ transplant recipient: between frailty,",,M0368,13:42,,"Alaa Atamna (Petah-Tikva, Israel)"
11 April 2025,SY131,13:30 - 14:30,2,,,Iva Butic; Croatia); Zitta Barrella Harboe; Denmark),Y131,13:30,- 14:30,"Hall 2
1-hour Symposium
Vaccines and antimicrobial resistance
Chairs Iva Butic (Zagreb, Croatia)"
11 April 2025,EW135,13:30 - 15:30,3,Educational Session,Transforming your research idea into an appropriate study design,Casandra Bulescu; Romania); Mary Horgan; Ireland),W135,13:30,- 15:30,"Hall 3
Educational Session
Transforming your research idea into an appropriate study design
Chairs Casandra Bulescu (Bucharest, Romania)"
11 April 2025,EW135,13:30 - 15:30,3,Educational Session,Transforming your research idea into an appropriate study design,Casandra Bulescu; Romania); Mary Horgan; Ireland),W0370,13:50,,"How to design and run scientific studies using AI 
agents as research assistants Alyssa Bilinski 
(Cambridge, United States)"
11 April 2025,EW135,13:30 - 15:30,3,Educational Session,Transforming your research idea into an appropriate study design,Casandra Bulescu; Romania); Mary Horgan; Ireland),W0371,14:10,Designing your first study:,"how to construct a 
workable project when your work environment may 
not help Thomas Tängdén (Uppsala, Sweden)"
11 April 2025,EW135,13:30 - 15:30,3,Educational Session,Transforming your research idea into an appropriate study design,Casandra Bulescu; Romania); Mary Horgan; Ireland),W0372,14:30,,"Bridging early-career professionals with partners and 
seniors Giorgia Caruana (Sion, Switzerland)"
11 April 2025,EW135,13:30 - 15:30,3,Educational Session,Transforming your research idea into an appropriate study design,Casandra Bulescu; Romania); Mary Horgan; Ireland),F0373,13:30,How to avoid parity traps in ID/CM research?,"Muge 
Cevik (St Andrews, United Kingdom)"
11 April 2025,EW135,13:30 - 15:30,3,Educational Session,Transforming your research idea into an appropriate study design,Casandra Bulescu; Romania); Mary Horgan; Ireland),F0374,13:40,,"Gender gaps in visibility at scientific 
conferences Sarah Delliere (Paris, France)"
11 April 2025,EW135,13:30 - 15:30,3,Educational Session,Transforming your research idea into an appropriate study design,Casandra Bulescu; Romania); Mary Horgan; Ireland),M0367,13:30,,"Maheen Abidi (Denver, United States)"
11 April 2025,EW135,13:30 - 15:30,3,Educational Session,Transforming your research idea into an appropriate study design,Casandra Bulescu; Romania); Mary Horgan; Ireland),M0368,13:42,,"Alaa Atamna (Petah-Tikva, Israel)"
11 April 2025,SY131,13:30 - 14:30,2,,,Iva Butic; Croatia); Zitta Barrella Harboe; Denmark),Y131,13:30,- 14:30,"Hall 2
1-hour Symposium
Vaccines and antimicrobial resistance
Chairs Iva Butic (Zagreb, Croatia)"
11 April 2025,EW135,13:30 - 15:30,3,Educational Session,Transforming your research idea into an appropriate study design,Casandra Bulescu; Romania); Mary Horgan; Ireland),W135,13:30,- 15:30,"Hall 3
Educational Session
Transforming your research idea into an appropriate study design
Chairs Casandra Bulescu (Bucharest, Romania)"
11 April 2025,EW135,13:30 - 15:30,3,Educational Session,Transforming your research idea into an appropriate study design,Casandra Bulescu; Romania); Mary Horgan; Ireland),W0370,13:50,,"How to design and run scientific studies using AI 
agents as research assistants Alyssa Bilinski 
(Cambridge, United States)"
11 April 2025,EW135,13:30 - 15:30,3,Educational Session,Transforming your research idea into an appropriate study design,Casandra Bulescu; Romania); Mary Horgan; Ireland),W0371,14:10,Designing your first study:,"how to construct a 
workable project when your work environment may 
not help Thomas Tängdén (Uppsala, Sweden)"
11 April 2025,EW135,13:30 - 15:30,3,Educational Session,Transforming your research idea into an appropriate study design,Casandra Bulescu; Romania); Mary Horgan; Ireland),W0372,14:30,,"Bridging early-career professionals with partners and 
seniors Giorgia Caruana (Sion, Switzerland)"
11 April 2025,EW135,13:30 - 15:30,3,Educational Session,Transforming your research idea into an appropriate study design,Casandra Bulescu; Romania); Mary Horgan; Ireland),F0373,13:30,How to avoid parity traps in ID/CM research?,"Muge 
Cevik (St Andrews, United Kingdom)"
11 April 2025,EW135,13:30 - 15:30,3,Educational Session,Transforming your research idea into an appropriate study design,Casandra Bulescu; Romania); Mary Horgan; Ireland),F0374,13:40,,"Gender gaps in visibility at scientific 
conferences Sarah Delliere (Paris, France)"
11 April 2025,KN130,13:30 - 14:30,1,,,Jacob Moran-Gilad; Israel); Annelies Zinkernagel; Switzerland),N130,13:30,- 14:30,"Hall 1
Keynote Lecture
Infectious disease challenges in an ever-changing environment
Chairs Jacob Moran-Gilad (Beer Sheva, Israel)"
11 April 2025,KN130,13:30 - 14:30,1,,,Jacob Moran-Gilad; Israel); Annelies Zinkernagel; Switzerland),K0360,13:30,,"Pamela Rendi Wagner (Stockholm, Sweden)"
11 April 2025,PM3,13:30 - 14:30,12,,,,L007,13:30,,"Opportunities for clinical decision support systems in 
infectious disease management Nathan Peiffer-
Smadja (Paris, France)"
11 April 2025,PM3,13:30 - 14:30,12,,,,L008,14:00,CDSS and AMS programs:,"the Lumed 
example Valiquette Louis (Sherbrooke, Canada)"
11 April 2025,SY132,13:30 - 14:30,13,,,Werner Ruppitsch; Austria); Balaji Veeraraghavan; India),S0363,13:30,Impact of the WHO’,"s developed catalogue of 
mutations on rapid TB diagnosis and 
treatment Thomas Schön (Kalmar, Sweden)"
11 April 2025,SY132,13:30 - 14:30,13,,,Werner Ruppitsch; Austria); Balaji Veeraraghavan; India),S0364,14:00,,"Antimicrobial resistance prediction using whole 
genome sequencing Patricia Simner (Rochester, 
United States)"
11 April 2025,OS092,13:30 - 14:30,14,,,Seif Al-Abri; Oman); Linda Aulin; Netherlands); O0663  Limitations of the Xpert® MTB/RIF assay: A series of; four clinical cases A. Haas*; United; States); A. Ma; J. Pham; P. Verma; U. Malhotra; E.C.; Church; M. Narita; V. Escuyer; S. Shakir; O0664  Pharmacokinetic analysis of blood and cerebrospinal; fluid contezolid concentrations in a patient with; tuberculous meningoencephalitis W. Nie*; China); N. Chu; O0665  Is this the first case of Mycobacterium; stephanolepidis infection in humans? S. Pérez-Recio*; (Barcelona; Spain); M.D. Grijota-Camino; A. Lérida; A.; Bauer; L. Fernández-Delgado; M.J. Luque; N. Sabé; Fernández; F. Alcaide; M. Santin; O0666  Diagnostic Aspects of a Bacillus Calmette-Guërin; Infection Following Intravesical Treatment for Bladder; Cancer K.J. Kim*; Korea; Republic of); J.H. Cha; S.G. Yoon; M.H. Nam; G.I. Lee; Y. Cho; O0667  Mycobacterium abscessus : Is Shorter Antibiotic; Therapy Combined with Surgery Sufficient? M.J.; Lopes*; Portugal); C. Paulo; D. Trigo; M.; Caixeiro; M. Alves; R. Macedo; P. Pacheco,S092,13:30,- 14:30,"Hall 14
1-hour Case Session
Mycobacterial mayhem
Chairs Seif Al-Abri (Muscat, Oman)"
11 April 2025,SY133,13:30 - 14:30,15,,,Nicolas Benech; France); Silvia Corcione; Italy),S0366,14:00,,"The horizon of next generation probiotics for 
infectious diseases Cormac Gahan (Cork, Ireland)"
11 April 2025,OS091,13:30 - 14:30,5,1-hour Oral Session,Genomic and molecular drivers of bacterial virulence and resistance,Ecaterina Noroc; Moldova; Republic of); Guido Werner; Germany); O0658  Characterization of the virulence shaping and; adaptability in the methicillin-resistant; Staphylococcus aureus  ST9 lineage. Y. Chen*; (Hangzhou; China); L. Sun; O0659  Elucidating molecular mechanisms of bacterial; conjugation: towards an improved understanding of; plasmid evolution and epidemiology S. David*; (Oxford; United Kingdom); C. Seddon; J. Wong; N.; Ishimoto; S. He; J. Bradshaw; W.W. Low; D.; Aanensen; G. Frankel; K. Beis; O0660  Clinical carbapenem-resistant Klebsiella pneumoniae; (CRKP) strains carrying a mutH mutation are; hypermutators that have heightened virulence and; readily develop ￿-lactam/￿-lactamase resistance S.; Cheng*; United States); C. Clancy; M.H.; Nguyen; B. Hao; G. Liu; O0661  Genomic insights into the new prophages of MDR; Pseudomonas aeruginosa : an example of phage-; host-phage interaction A. Uskudar Guclu*; ESCMID Global 2025 - Programme; E0681  Pathobiome characterization and role in disease; severity in children under 5-years with respiratory; infection symptoms L. Terranova*; Italy); L.; Corneo; G. Di Pietro; R. Pinzani; M. Bolis; L. Alagna; M. Caruso; F. Giorgetti; N. Hejazifar; E. Furchì; M.; Carnevale Schianca; P. Bono; C. Tagliabue; F.B.A.; Blasi; A. Callegaro; A. Bandera; S. Bosis; C. Alteri; E0682  Viral viability markers of SARS-CoV-2: A; Comparison of cell culture genomic RNA RT-PCR; and subgenomic RNA RT-PCR C. Cuesta Chasco*; (Barcelona; Spain); S. Alex; M. Mª Ángeles; C.C.; Genoveva; A. Francesco; R. Cristina; V. Anna; H.; Juan Carlos; F.A. Francesc; R.L. Luis Gerardo; N.; Mireia; G. Ignacio; B. Marta; G.V. Carolina; E0683  Diagnostic performance of Hepatitis B virus surface; antigens in the Netherlands using type-specific; external quality assessment E. Vanhulle*; Netherlands); M. Simões; H. Ten Bruin; G. Boland; A.; Brandenburg; K. Benschop; E0684  Low utility of parallel testing by multiplex and; individual real-time PCR assays for the diagnosis of; viral meningitis and encephalitis at a large public; hospital in the United States. A. Cuber*; Angeles; United States); S. Butler-Wu; E0685  Plasma Separation Card as an alternative sampling; method for quantitative HCV RNA testing with high; comparability to EDTA plasma F. Garcia*; Spain); A. Fuentes López; A. Rando Segura; R.; Carracedo; A. Kessler; A. De Salazar González; S.Z.; Gebreab; E. Molina; N. Parajó; S. Pereira; J. Romero; Vico; E. Ruiz Escolano; M. Vila; L. Viñuela González; A. Carrasco Durán; A. Aguilera; F. García; M. Buti; Ferret,S091,13:30,- 14:30,"Hall 5
1-hour Oral Session
Genomic and molecular drivers of bacterial virulence and resistance
Chairs Ecaterina Noroc (Chisinau, Moldova, Republic of)"
11 April 2025,KN130,13:30 - 14:30,1,,,Jacob Moran-Gilad; Israel); Annelies Zinkernagel; Switzerland),N130,13:30,- 14:30,"Hall 1
Keynote Lecture
Infectious disease challenges in an ever-changing environment
Chairs Jacob Moran-Gilad (Beer Sheva, Israel)"
11 April 2025,KN130,13:30 - 14:30,1,,,Jacob Moran-Gilad; Israel); Annelies Zinkernagel; Switzerland),K0360,13:30,,"Pamela Rendi Wagner (Stockholm, Sweden)"
11 April 2025,PM3,13:30 - 14:30,12,,,,L007,13:30,,"Opportunities for clinical decision support systems in 
infectious disease management Nathan Peiffer-
Smadja (Paris, France)"
11 April 2025,PM3,13:30 - 14:30,12,,,,L008,14:00,CDSS and AMS programs:,"the Lumed 
example Valiquette Louis (Sherbrooke, Canada)"
11 April 2025,SY132,13:30 - 14:30,13,,,Werner Ruppitsch; Austria); Balaji Veeraraghavan; India),S0363,13:30,Impact of the WHO’,"s developed catalogue of 
mutations on rapid TB diagnosis and 
treatment Thomas Schön (Kalmar, Sweden)"
11 April 2025,SY132,13:30 - 14:30,13,,,Werner Ruppitsch; Austria); Balaji Veeraraghavan; India),S0364,14:00,,"Antimicrobial resistance prediction using whole 
genome sequencing Patricia Simner (Rochester, 
United States)"
11 April 2025,OS092,13:30 - 14:30,14,,,Seif Al-Abri; Oman); Linda Aulin; Netherlands); O0663  Limitations of the Xpert® MTB/RIF assay: A series of; four clinical cases A. Haas*; United; States); A. Ma; J. Pham; P. Verma; U. Malhotra; E.C.; Church; M. Narita; V. Escuyer; S. Shakir; O0664  Pharmacokinetic analysis of blood and cerebrospinal; fluid contezolid concentrations in a patient with; tuberculous meningoencephalitis W. Nie*; China); N. Chu; O0665  Is this the first case of Mycobacterium; stephanolepidis infection in humans? S. Pérez-Recio*; (Barcelona; Spain); M.D. Grijota-Camino; A. Lérida; A.; Bauer; L. Fernández-Delgado; M.J. Luque; N. Sabé; Fernández; F. Alcaide; M. Santin; O0666  Diagnostic Aspects of a Bacillus Calmette-Guërin; Infection Following Intravesical Treatment for Bladder; Cancer K.J. Kim*; Korea; Republic of); J.H. Cha; S.G. Yoon; M.H. Nam; G.I. Lee; Y. Cho; O0667  Mycobacterium abscessus : Is Shorter Antibiotic; Therapy Combined with Surgery Sufficient? M.J.; Lopes*; Portugal); C. Paulo; D. Trigo; M.; Caixeiro; M. Alves; R. Macedo; P. Pacheco,S092,13:30,- 14:30,"Hall 14
1-hour Case Session
Mycobacterial mayhem
Chairs Seif Al-Abri (Muscat, Oman)"
11 April 2025,SY133,13:30 - 14:30,15,,,Nicolas Benech; France); Silvia Corcione; Italy),S0366,14:00,,"The horizon of next generation probiotics for 
infectious diseases Cormac Gahan (Cork, Ireland)"
11 April 2025,OS091,13:30 - 14:30,5,1-hour Oral Session,Genomic and molecular drivers of bacterial virulence and resistance,Ecaterina Noroc; Moldova; Republic of); Guido Werner; Germany); O0658  Characterization of the virulence shaping and; adaptability in the methicillin-resistant; Staphylococcus aureus  ST9 lineage. Y. Chen*; (Hangzhou; China); L. Sun; O0659  Elucidating molecular mechanisms of bacterial; conjugation: towards an improved understanding of; plasmid evolution and epidemiology S. David*; (Oxford; United Kingdom); C. Seddon; J. Wong; N.; Ishimoto; S. He; J. Bradshaw; W.W. Low; D.; Aanensen; G. Frankel; K. Beis; O0660  Clinical carbapenem-resistant Klebsiella pneumoniae; (CRKP) strains carrying a mutH mutation are; hypermutators that have heightened virulence and; readily develop ￿-lactam/￿-lactamase resistance S.; Cheng*; United States); C. Clancy; M.H.; Nguyen; B. Hao; G. Liu; O0661  Genomic insights into the new prophages of MDR; Pseudomonas aeruginosa : an example of phage-; host-phage interaction A. Uskudar Guclu*; ESCMID Global 2025 - Programme; Türkiye); S. Unlu; O0662  Genome-wide association study; importance of vaginal epithelium associated genes in; case of recurrent vaginitis R. Mändar*; Estonia); E. Mutli; K. Koort; A. Salumets; T. Laisk,S091,13:30,- 14:30,"Hall 5
1-hour Oral Session
Genomic and molecular drivers of bacterial virulence and resistance
Chairs Ecaterina Noroc (Chisinau, Moldova, Republic of)"
11 April 2025,KN137,14:45 - 15:45,1,,,Werner Ruppitsch; Austria); Annelies Zinkernagel; Switzerland),K0376,14:45,,"Juliane Bubeck Wardenburg (St. Louis, United States)"
11 April 2025,ME140,14:45 - 15:45,11,Meet-the-Expert,Bioinformatic tools from start to finish,,M0381,14:45,,"Vítor Borges (Lisbon, Portugal)"
11 April 2025,ME140,14:45 - 15:45,11,Meet-the-Expert,Bioinformatic tools from start to finish,,M0382,14:57,,"Clare Sloggett (Melbourne, Australia)"
11 April 2025,ME141,14:45 - 15:45,13,Meet-the-Expert,AI use in antimicrobial stewardship,,M0383,14:45,,"Shruti Gohil (Irvine, United States)"
11 April 2025,ME141,14:45 - 15:45,13,Meet-the-Expert,AI use in antimicrobial stewardship,,M0384,14:57,,"Jose Ramon Pano-Pardo (Zaragoza, Spain)"
11 April 2025,OS097,14:45 - 15:45,14,1-hour Oral Session,Update on zoonotic and enteric infections,Steen Ethelberg; Kavitha Saravu; India); O0696  A large-scale epidemiological study of; Campylobacter employing whole genome analysis; reveals the evolution of highly virulent and multidrug-; resistant clones in the UK. B. Lopes*; United Kingdom); A.S. Boaitey-Biko; O0697  Population dynamics and evolution of multidrug; resistant clones of Shigella sonnei  in Metropolitan; France C. Silva Nodari*; France); I. Carle; M.; Lejay-Collin; L. Philippot; C. Ruckly; L. Fabre; M.; Pardos De La Gandara; F.X. WeillO0698  Shiga toxin-producing Escherichia coli  O26 as an; increasingly common cause of haemolytic uraemic; syndrome in England: A fifteen-year analysis of; national enhanced surveillance data L. Mcgeoch*; (London; United Kingdom); O. Quinn; C. Sawyer; A.; Douglas; C. Jenkins; S. Balasegaram; O0699  Incidence; clinical presentation; and outcomes of; Pasteurella infections: a population-based Danish; study L. Øbo Larsen*; Denmark); L.Ø. Larsen; H.L. Nielsen; K.K. Søgaard; O0700  Natural history of latent brucellosis and efficacy; evaluation of B-spot in active and latent cases: A 12-; month prospective cohort study H. Wang*; China); G. Yuan; D. Li; H. Liu; J. Ai; W. Zhang,S097,14:45,- 15:45,"Hall 14
1-hour Oral Session
Update on zoonotic and enteric infections 
Chairs Steen Ethelberg 
Kavitha Saravu (Manipal, India)"
11 April 2025,OS098,14:45 - 15:45,15,,,Aleksandra Barac; Serbia); Olivier Lortholary; France); O0701  Dog scratch disease? A case of Vibrio vulnificus  in a; liver transplant patient E. Kim*; United; States); A. Covington; O0702  Mpox infection among solid organ transplant; recipients: a single center experience at a U.S.; Tertiary Care Facility. J. Bini Viotti*; United; States); J. Bini; O0703  Histoplasmosis in Hansen's Disease: Thalidomide for; TNF-alpha Inhibition in ENL with a Risk of; Opportunistic Infections K.K. Vaitheeswaran*; India); M. Soneja; N. Bhari; R. M.; G. K. V.; S. Agarwal; R. Kumar; Y. Dharmashaktu; O0704  Nocardiosis in a kidney transplant recipient: pros &; cons of tedizolid M. Pellegrino*; Italy); V.; Todisco; S. Generoso; L. Benassi; E. Franceschini; F.; Damiano; G. Donati; C. Mussini; A. Cervo; O0705  Mycobacterium genavense-Associated IRIS with; Macrophage Activation Syndrome: A Case Report; Highlighting Diagnostic Challenges M. Meroi*; (Verona; Italy); M. Morra; M.E. De Rui; E. Tacconelli; F.; Soldani,S098,14:45,- 15:45,"Hall 15
1-hour Case Session
Opportunistic infections in the Immunocompromised
Chairs Aleksandra Barac (Belgrade, Serbia)"
11 April 2025,SY139,14:45 - 15:45,16,,,Joseph Donovan; Vietnam); Christina Obiero; Kenya),Y139,14:45,- 15:45,"Hall 16
1-hour Symposium
How to manage bacterial meningitis in low resource settings
Chairs Joseph Donovan (Ho Chi Minh City, Vietnam)"
11 April 2025,SY139,14:45 - 15:45,16,,,Joseph Donovan; Vietnam); Christina Obiero; Kenya),S0379,14:45,,"Bacterial meningitis diagnosis and surveillance Divya 
Deodhar (Muscat, Oman)"
11 April 2025,SY139,14:45 - 15:45,16,,,Joseph Donovan; Vietnam); Christina Obiero; Kenya),S0380,15:05,,"Clinical presentation and management of CNS 
infections Kartika Maharani (Jakarta, Indonesia)"
11 April 2025,OS095,14:45 - 15:45,2,1-hour Oral Session,Community respiratory tract infections: latest trends and approaches,Catia Cilloniz; Spain); Aurélien Dinh; France); O0686  Mycoplasma pneumoniae  increase in 2023/24; causes disease in adults in Europe B.M.M. Streng*; (Utrecht; Netherlands); C. Prat Aymerich; L. Bont; P.; Meyer Sauteur; M. Bonten; A. Van Rossum; O0687  Serotype distribution of pneumococcal community-; ESCMID Global 2025 - Programme; E0729  Impact of BCG vaccination on adaptive immune; responses to mycobacterial and non-mycobacterial; antigens in HIV-exposed; uninfected infants. R.; Namakula*; Norway); V. Nankabirwa; S.; Cose; O. Namugga; M.G. Netea; H. Steinsland; H.; Sommerfelt; K. Hanevik; E0730  Immune signature against Klebsiella pneumoniae; proteins in a mother-baby cohort from Blantyre; Malawi E. Heinz*; United Kingdom); J.; Campo; O. Pearse; A. Zuza; A. Teng; J. Pablo; A.; Oberai; J. Edgar; A. Shandling; K. Kawaza; N. Feasey; E0731  A comprehensive computational mapping of B-cell; epitopes in the Klebsiella pneumoniae  porinome S.; Prieto Martin Gil*; Spain); S. Prieto Martín; Gil; E. Gato; A. Pérez; M.J. Mcconnell; A.J. Martín; Galiano; E0732  Chronic infection induces a broadly neutralizing; antibody response to Elastase B of Pseudomonas; aeruginosaA. Albus*; Germany); D. Kolling; K. Rox; D. Holzmann; K. Mundry; M. Sánchez Agut; C.; Meyer; R. Brock; J. Kutschera; K. Schmitt; J.A. Wilms; L. Ullrich; C. Kreer; M. Meyer-Willerscheidt; M. Hallek; E. Rietschel; S. Van Koningsbruggen-Rietschel; F.; Klein; J. Koehnke; J. Rybniker; A. Simonis,,,,
11 April 2025,KN137,14:45 - 15:45,1,,,Werner Ruppitsch; Austria); Annelies Zinkernagel; Switzerland),K0376,14:45,,"Juliane Bubeck Wardenburg (St. Louis, United States)"
11 April 2025,ME140,14:45 - 15:45,11,Meet-the-Expert,Bioinformatic tools from start to finish,,M0381,14:45,,"Vítor Borges (Lisbon, Portugal)"
11 April 2025,ME140,14:45 - 15:45,11,Meet-the-Expert,Bioinformatic tools from start to finish,,M0382,14:57,,"Clare Sloggett (Melbourne, Australia)"
11 April 2025,ME141,14:45 - 15:45,13,Meet-the-Expert,AI use in antimicrobial stewardship,,M0383,14:45,,"Shruti Gohil (Irvine, United States)"
11 April 2025,ME141,14:45 - 15:45,13,Meet-the-Expert,AI use in antimicrobial stewardship,,M0384,14:57,,"Jose Ramon Pano-Pardo (Zaragoza, Spain)"
11 April 2025,OS097,14:45 - 15:45,14,1-hour Oral Session,Update on zoonotic and enteric infections,Steen Ethelberg; Kavitha Saravu; India); O0696  A large-scale epidemiological study of; Campylobacter employing whole genome analysis; reveals the evolution of highly virulent and multidrug-; resistant clones in the UK. B. Lopes*; United Kingdom); A.S. Boaitey-Biko; O0697  Population dynamics and evolution of multidrug; resistant clones of Shigella sonnei  in Metropolitan; France C. Silva Nodari*; France); I. Carle; M.; Lejay-Collin; L. Philippot; C. Ruckly; L. Fabre; M.; Pardos De La Gandara; F.X. WeillO0698  Shiga toxin-producing Escherichia coli  O26 as an; increasingly common cause of haemolytic uraemic; syndrome in England: A fifteen-year analysis of; national enhanced surveillance data L. Mcgeoch*; (London; United Kingdom); O. Quinn; C. Sawyer; A.; Douglas; C. Jenkins; S. Balasegaram; O0699  Incidence; clinical presentation; and outcomes of; Pasteurella infections: a population-based Danish; study L. Øbo Larsen*; Denmark); L.Ø. Larsen; H.L. Nielsen; K.K. Søgaard; O0700  Natural history of latent brucellosis and efficacy; evaluation of B-spot in active and latent cases: A 12-; month prospective cohort study H. Wang*; China); G. Yuan; D. Li; H. Liu; J. Ai; W. Zhang,S097,14:45,- 15:45,"Hall 14
1-hour Oral Session
Update on zoonotic and enteric infections 
Chairs Steen Ethelberg 
Kavitha Saravu (Manipal, India)"
11 April 2025,OS098,14:45 - 15:45,15,,,Aleksandra Barac; Serbia); Olivier Lortholary; France); O0701  Dog scratch disease? A case of Vibrio vulnificus  in a; liver transplant patient E. Kim*; United; States); A. Covington; O0702  Mpox infection among solid organ transplant; recipients: a single center experience at a U.S.; Tertiary Care Facility. J. Bini Viotti*; United; States); J. Bini; O0703  Histoplasmosis in Hansen's Disease: Thalidomide for; TNF-alpha Inhibition in ENL with a Risk of; Opportunistic Infections K.K. Vaitheeswaran*; India); M. Soneja; N. Bhari; R. M.; G. K. V.; S. Agarwal; R. Kumar; Y. Dharmashaktu; O0704  Nocardiosis in a kidney transplant recipient: pros &; cons of tedizolid M. Pellegrino*; Italy); V.; Todisco; S. Generoso; L. Benassi; E. Franceschini; F.; Damiano; G. Donati; C. Mussini; A. Cervo; O0705  Mycobacterium genavense-Associated IRIS with; Macrophage Activation Syndrome: A Case Report; Highlighting Diagnostic Challenges M. Meroi*; (Verona; Italy); M. Morra; M.E. De Rui; E. Tacconelli; F.; Soldani,S098,14:45,- 15:45,"Hall 15
1-hour Case Session
Opportunistic infections in the Immunocompromised
Chairs Aleksandra Barac (Belgrade, Serbia)"
11 April 2025,SY139,14:45 - 15:45,16,,,Joseph Donovan; Vietnam); Christina Obiero; Kenya),Y139,14:45,- 15:45,"Hall 16
1-hour Symposium
How to manage bacterial meningitis in low resource settings
Chairs Joseph Donovan (Ho Chi Minh City, Vietnam)"
11 April 2025,SY139,14:45 - 15:45,16,,,Joseph Donovan; Vietnam); Christina Obiero; Kenya),S0379,14:45,,"Bacterial meningitis diagnosis and surveillance Divya 
Deodhar (Muscat, Oman)"
11 April 2025,SY139,14:45 - 15:45,16,,,Joseph Donovan; Vietnam); Christina Obiero; Kenya),S0380,15:05,,"Clinical presentation and management of CNS 
infections Kartika Maharani (Jakarta, Indonesia)"
11 April 2025,OS095,14:45 - 15:45,2,1-hour Oral Session,Community respiratory tract infections: latest trends and approaches,Catia Cilloniz; Spain); Aurélien Dinh; France); O0686  Mycoplasma pneumoniae  increase in 2023/24; causes disease in adults in Europe B.M.M. Streng*; (Utrecht; Netherlands); C. Prat Aymerich; L. Bont; P.; Meyer Sauteur; M. Bonten; A. Van Rossum; O0687  Serotype distribution of pneumococcal community-; ESCMID Global 2025 - Programme; acquired pneumonia in hospitalized adults in; Germany D. Karssen*; Netherlands); L.; Hessels; G. Barten-Neiner; W. Bauer; S. Franch; T.; Fühner; C. Hassiepen; D.F. Heigener; B. Hullegie; R.; Jahja; K.D. Johnson; J. Kremling; C. Roberts; G.G.U.; Rohde; M. Ruggieri; J. Scheider; D. Stolz; T.D.; Swarthout; T. Weiss; H. Van Werkhoven; M. Bonten; C. Prat-Aymerich; O0688  Community-acquired pneumonia identification from; electronic health records in the absence of a gold; standard: a Bayesian latent class analysis J. Wei*; (Oxford; United Kingdom); K. Yuan; A. Luk; S. Walker; D. Eyre; O0689  Causes of death and risk factors for 90-day mortality; and readmission in community-acquired; pneumonia. F. Al-Zergani*; Denmark); C.; Lundetoft Clausen; P. Ravn; M. Sebastian Roldgaard; L. Kolte; H. Sarac; M. Fally; S. Bastrup Israelsen; T.; Benfield; O0690  Oropharyngeal carriage of gut-derived; Enterobacterales increases RTI risk in long-term aged; care residents S. Miller*; Australia); F.; Zhang; S. Taylor; A. Shoubridge; E. Vasil; R.; Woodman; L. Papanicolas; G. Rogers,,,,
11 April 2025,SY138,14:45 - 15:45,4,,,Yesim Besli; Türkiye); Spyros Pournaras; Greece),,,,
11 April 2025,OS096,14:45 - 15:45,5,1-hour Oral Session,Trends in antifungal resistance,Alexandre Alanio; France); Ana Alastruey-Izquierdo; Spain); O0691  Turning resistance into vulnerability: leveraging; genetic insights to predict collateral sensitivity and; synergism for effective multidrug therapies K.; Schmidlin*; United States); K. Geiler-; Samerotte; O0692  Role of the C2585G substitution in the MRR1  gene in; the development of azole resistance in Candida; parapsilosis sensu strictu .I. Franconi*; Italy); P.; Noemi; A. Tavanti; A. Lupetti; R. Cosmeri; L. Maltinti; M. Falcone; O0693  Fungaemia in a tertiary Madrid hospital from 2007 to; 2024: changes in species epidemiology; increase in; echinocandin resistance and low patient-to-patient; transmission in recent years J. Guinea*; Spain); P. Escribano; G. Jesús; M. Machado; A.; Burillo; P. Muñoz; O0694  A multicentre study for determination of; epidemiological cutoff values for rezafungin and four; comparators against Candida auris with EUCAST; broth microdilution reference methodology J.; Meletiadis*; Greece); J. Guinea; S. Arikan-; Akdagli; E.F.J. Meijer; J. Meis; M.C. Arendrup; O0695  Decoding Candida auris Resistance in Latin America:; Candida.app vs. Pathogenwatch J. Acosta España*; (Quiro; Ecuador); P. Eduarda; J.D. Acosta-España; A. Herrera-Yela,S096,14:45,- 15:45,"Hall 5
1-hour Oral Session
Trends in antifungal resistance
Chairs Alexandre Alanio (Paris, France)"
11 April 2025,SY144,16:15 - 17:15,14,ePoster Flash Session,New data in non-tuberculous mycobacterial disease,Joanne M. Langley; Canada); Peter Openshaw; United Kingdom),S0391,16:15,,"Pros and cons of passive infant immunisation with 
mAb before their first RSV season Federico Martinón-
Torres (Santiago De Compostela, Spain)"
11 April 2025,SY144,16:15 - 17:15,14,ePoster Flash Session,New data in non-tuberculous mycobacterial disease,Joanne M. Langley; Canada); Peter Openshaw; United Kingdom),S0392,16:45,,"Pros and cons of maternal vaccination in preventing 
severe RSV infections in infants. Anne Vergison 
(Luxembourg, Luxembourg)"
11 April 2025,SY144,16:15 - 17:15,14,ePoster Flash Session,New data in non-tuberculous mycobacterial disease,Joanne M. Langley; Canada); Peter Openshaw; United Kingdom),F104,16:15,- 17:15,"Arena 1
ePoster Flash Session
Cutting-edge technologies to improve viral diagnostics
Chair Patricia Alvarez (Rio De Janeiro, Brazil)"
11 April 2025,SY144,16:15 - 17:15,14,ePoster Flash Session,New data in non-tuberculous mycobacterial disease,Joanne M. Langley; Canada); Peter Openshaw; United Kingdom),F105,16:15,- 17:15,"Arena 2
ePoster Flash Session
New data in non-tuberculous mycobacterial disease
Chair Lorenzo Guglielmetti (Paris, France)"
11 April 2025,SY138,14:45 - 15:45,4,,,Yesim Besli; Türkiye); Spyros Pournaras; Greece),,,,
11 April 2025,OS096,14:45 - 15:45,5,1-hour Oral Session,Trends in antifungal resistance,Alexandre Alanio; France); Ana Alastruey-Izquierdo; Spain); O0691  Turning resistance into vulnerability: leveraging; genetic insights to predict collateral sensitivity and; synergism for effective multidrug therapies K.; Schmidlin*; United States); K. Geiler-; Samerotte; O0692  Role of the C2585G substitution in the MRR1  gene in; the development of azole resistance in Candida; parapsilosis sensu strictu .I. Franconi*; Italy); P.; Noemi; A. Tavanti; A. Lupetti; R. Cosmeri; L. Maltinti; M. Falcone; O0693  Fungaemia in a tertiary Madrid hospital from 2007 to; 2024: changes in species epidemiology; increase in; echinocandin resistance and low patient-to-patient; transmission in recent years J. Guinea*; Spain); P. Escribano; G. Jesús; M. Machado; A.; Burillo; P. Muñoz; O0694  A multicentre study for determination of; epidemiological cutoff values for rezafungin and four; comparators against Candida auris with EUCAST; broth microdilution reference methodology J.; Meletiadis*; Greece); J. Guinea; S. Arikan-; Akdagli; E.F.J. Meijer; J. Meis; M.C. Arendrup; O0695  Decoding Candida auris Resistance in Latin America:; Candida.app vs. Pathogenwatch J. Acosta España*; (Quiro; Ecuador); P. Eduarda; J.D. Acosta-España; A. Herrera-Yela,S096,14:45,- 15:45,"Hall 5
1-hour Oral Session
Trends in antifungal resistance
Chairs Alexandre Alanio (Paris, France)"
11 April 2025,SY144,16:15 - 17:15,14,ePoster Flash Session,"The ABC (allergy, bloodstream infections and clinical decision support) in",Joanne M. Langley; Canada); Peter Openshaw; United Kingdom),S0391,16:15,,"Pros and cons of passive infant immunisation with 
mAb before their first RSV season Federico Martinón-
Torres (Santiago De Compostela, Spain)"
11 April 2025,SY144,16:15 - 17:15,14,ePoster Flash Session,"The ABC (allergy, bloodstream infections and clinical decision support) in",Joanne M. Langley; Canada); Peter Openshaw; United Kingdom),S0392,16:45,,"Pros and cons of maternal vaccination in preventing 
severe RSV infections in infants. Anne Vergison 
(Luxembourg, Luxembourg)"
11 April 2025,SY144,16:15 - 17:15,14,ePoster Flash Session,"The ABC (allergy, bloodstream infections and clinical decision support) in",Joanne M. Langley; Canada); Peter Openshaw; United Kingdom),F104,16:15,- 17:15,"Arena 1
ePoster Flash Session
Cutting-edge technologies to improve viral diagnostics
Chair Patricia Alvarez (Rio De Janeiro, Brazil)"
11 April 2025,SY144,16:15 - 17:15,14,ePoster Flash Session,"The ABC (allergy, bloodstream infections and clinical decision support) in",Joanne M. Langley; Canada); Peter Openshaw; United Kingdom),F105,16:15,- 17:15,"Arena 2
ePoster Flash Session
New data in non-tuberculous mycobacterial disease
Chair Lorenzo Guglielmetti (Paris, France)"
11 April 2025,SY144,16:15 - 17:15,14,ePoster Flash Session,"The ABC (allergy, bloodstream infections and clinical decision support) in",Joanne M. Langley; Canada); Peter Openshaw; United Kingdom),F106,16:15,- 17:15,"Arena 3
ePoster Flash Session
The ABC (allergy, bloodstream infections and clinical decision support)"
11 April 2025,SY143,16:15 - 17:15,11,,,Elisa Cordero Matia; Spain); Zitta Barrella Harboe; Denmark),S0389,16:15,,"Vaccination against respiratory pathogens Albert 
Vollaard (Bilthoven, Netherlands)"
11 April 2025,SY143,16:15 - 17:15,11,,,Elisa Cordero Matia; Spain); Zitta Barrella Harboe; Denmark),S0390,16:45,,"Other vaccines Olivier Epaulard (Grenoble, France)"
11 April 2025,EW146,16:15 - 18:15,13,Educational Session,"How to detect, manage and communicate hospital outbreaks",Margaret Ip; Hong-Kong SAR; China); Rossitza Vatcheva-Dobrevska; Bulgaria),W0395,16:15,,"How to detect hospital outbreaks David Fisman 
(Toronto, Canada)"
11 April 2025,EW146,16:15 - 18:15,13,Educational Session,"How to detect, manage and communicate hospital outbreaks",Margaret Ip; Hong-Kong SAR; China); Rossitza Vatcheva-Dobrevska; Bulgaria),W0396,16:35,,"How to confirm hospital outbreaks using 
genomics John W. A. Rossen (Groningen, 
Netherlands)"
11 April 2025,EW146,16:15 - 18:15,13,Educational Session,"How to detect, manage and communicate hospital outbreaks",Margaret Ip; Hong-Kong SAR; China); Rossitza Vatcheva-Dobrevska; Bulgaria),W0397,16:55,,"How to rapidly respond to an ongoing hospital 
outbreak Ermira Tartari (Msida, Malta)"
11 April 2025,EW146,16:15 - 18:15,13,Educational Session,"How to detect, manage and communicate hospital outbreaks",Margaret Ip; Hong-Kong SAR; China); Rossitza Vatcheva-Dobrevska; Bulgaria),W0398,17:15,,"How to communicate hospital outbreaks via scientific 
publication Ines Steffens (Solna, Sweden)"
11 April 2025,EW146,16:15 - 18:15,13,Educational Session,"How to detect, manage and communicate hospital outbreaks",Margaret Ip; Hong-Kong SAR; China); Rossitza Vatcheva-Dobrevska; Bulgaria),F106,16:15,- 17:15,"Arena 3
ePoster Flash Session
The ABC (allergy, bloodstream infections and clinical decision support)"
11 April 2025,SY143,16:15 - 17:15,11,,,Elisa Cordero Matia; Spain); Zitta Barrella Harboe; Denmark),S0389,16:15,,"Vaccination against respiratory pathogens Albert 
Vollaard (Bilthoven, Netherlands)"
11 April 2025,SY143,16:15 - 17:15,11,,,Elisa Cordero Matia; Spain); Zitta Barrella Harboe; Denmark),S0390,16:45,,"Other vaccines Olivier Epaulard (Grenoble, France)"
11 April 2025,EW146,16:15 - 18:15,13,Educational Session,"How to detect, manage and communicate hospital outbreaks",Margaret Ip; Hong-Kong SAR; China); Rossitza Vatcheva-Dobrevska; Bulgaria),W0395,16:15,,"How to detect hospital outbreaks David Fisman 
(Toronto, Canada)"
11 April 2025,EW146,16:15 - 18:15,13,Educational Session,"How to detect, manage and communicate hospital outbreaks",Margaret Ip; Hong-Kong SAR; China); Rossitza Vatcheva-Dobrevska; Bulgaria),W0396,16:35,,"How to confirm hospital outbreaks using 
genomics John W. A. Rossen (Groningen, 
Netherlands)"
11 April 2025,EW146,16:15 - 18:15,13,Educational Session,"How to detect, manage and communicate hospital outbreaks",Margaret Ip; Hong-Kong SAR; China); Rossitza Vatcheva-Dobrevska; Bulgaria),W0397,16:55,,"How to rapidly respond to an ongoing hospital 
outbreak Ermira Tartari (Msida, Malta)"
11 April 2025,EW146,16:15 - 18:15,13,Educational Session,"How to detect, manage and communicate hospital outbreaks",Margaret Ip; Hong-Kong SAR; China); Rossitza Vatcheva-Dobrevska; Bulgaria),W0398,17:15,,"How to communicate hospital outbreaks via scientific 
publication Ines Steffens (Solna, Sweden)"
11 April 2025,ME145,16:15 - 17:15,15,Meet-the-Expert,Fungal meningitis: recognition and current status of management,,M0393,16:15,,"Olivier Lortholary (Paris, France)"
11 April 2025,ME145,16:15 - 17:15,15,Meet-the-Expert,Fungal meningitis: recognition and current status of management,,M0394,16:27,,"Janis Blair (Phoenix, United States)"
11 April 2025,JS2,16:15 - 17:15,16,Journal Session,Late-breaker research from the Lancet group: new interventions for familiar,Syeda Saleha Hassan; United Kingdom); Ursula Hofer; United Kingdom),J012,16:30,The spatio-temporal ecology of Oropouche virus:,"a 
laboratory-based modelling study across Latin 
America Jan Felix Drexler (Berlin, Germany)"
11 April 2025,JS2,16:15 - 17:15,16,Journal Session,Late-breaker research from the Lancet group: new interventions for familiar,Syeda Saleha Hassan; United Kingdom); Ursula Hofer; United Kingdom),J014,17:00,"Efficacy, safety,","and immunogenicity of the AS01E-
adjuvanted respiratory syncytial virus prefusion F 
protein vaccine (RSVPreF3 OA)"
11 April 2025,OS102,16:15 - 17:15,2,1-hour Oral Session,AI tools empowering AMR prediction in WGS and MALDI-TOF,Oliver Nolte; Switzerland); Patricia Simner; United States); O0733  A scalable machine learning approach to predict; antimicrobial susceptibility from whole genome; sequencing data Y. Zhong*; United; Kingdom); A. Gerada; A. Howard; P. Green; W. Hope; O0734  Machine Learning-Based Antimicrobial Resistance; Prediction of 11 antibiotics for Klebsiella pneumoniae; from Clinical NGS Data J. Xinmiao*; China); X.; Jia; J. Zhang; J. Chen; Q. Yang; O0735  AI-Powered Real-Time Plasmid Prediction Using; Nanopore Sequencing E. Sauerborn*; Germany); S. Atum; H. Urel; M. Peisker; N. Wantia; E.; Foster-Nyarko; L. Urban; O0736  MALDI-TOF Prediction model based on machine; learning algorithm for the detection of ST23 high-; virulence K. pneumoniaeL. Dortet*; Bicêtre; France); L. Mancera Pascual; M.J. Arroyo; O0737  Predicting rifampicin resistance in Mycobacterium; tuberculosis complex  with a machine learning based; MALDI-TOF MS approche Y.W. Sun*; Taiwan; China); P. Huang; B. Tsou; S.C. Chang; C.W.; Lu; C.C. Chen; J. Yu,S102,16:15,- 17:15,"Hall 2
1-hour Oral Session
AI tools empowering AMR prediction in WGS and MALDI-TOF
Chairs Oliver Nolte (Zürich, Switzerland)"
11 April 2025,LB005,16:15 - 17:15,3,1-hour Oral Session,"Emerging pathogens in humans, animals and vectors",,,,,
11 April 2025,SY142,16:15 - 18:15,4,2-hour Symposium,Precision genomics to improve infectious diseases management,,Y142,16:15,- 18:15,"Hall 4
2-hour Symposium
Precision genomics to improve infectious diseases management
Chair Jacob Moran-Gilad (Beer Sheva, Israel)"
11 April 2025,SY142,16:15 - 18:15,4,2-hour Symposium,Precision genomics to improve infectious diseases management,,S0385,16:15,,"Human genomics approaches to infection 
immunity Fergus Hamilton (Bristol, United Kingdom)"
11 April 2025,SY142,16:15 - 18:15,4,2-hour Symposium,Precision genomics to improve infectious diseases management,,S0386,16:45,,"Applying bacterial GWAS to uncover new 
mechanisms of antibiotic resistance Marco Galardini 
(Hannover, Germany)"
11 April 2025,SY142,16:15 - 18:15,4,2-hour Symposium,Precision genomics to improve infectious diseases management,,S0387,17:15,Evolution in action:,"large-scale within-host evolution 
analyses of persistent bacterial infections Stefano 
Giulieri (Melbourne, Australia)"
11 April 2025,SY142,16:15 - 18:15,4,2-hour Symposium,Precision genomics to improve infectious diseases management,,S0388,17:45,,"Machine learning in bacterial genomics and 
metagenomics Francesco Asnicar (Trento, Italy)"
11 April 2025,OS103,16:15 - 17:15,5,1-hour Oral Session,Polymicrobial interactions and competition,Alessandra Bragonzi; Italy); Kimberly Kline; Switzerland); O0738  The Klebsiella pneumoniae  type VI secretion system; effector Tle4 facilitates adaptation survival by; damaging the cell membrane of competing; bacteria W. Li*; China); J. Zhang; O0739  Candida albicans  promotes TSST-1 production in; Staphylococcus aureus  by depleting glucose and; lifting carbon catabolite repression M. Carriou*; France); C. Badiou; A. Soulard; K. Chikh; O. Vitalis; A.; Frugier; K. Dufresne; G. Lina; O0740  Understanding polymicrobial biofilm dynamics: focus; ESCMID Global 2025 - Programme,S103,16:15,- 17:15,"Hall 5
1-hour Oral Session
Polymicrobial interactions and competition
Chairs Alessandra Bragonzi (Milano, Italy)"
11 April 2025,ME145,16:15 - 17:15,15,Meet-the-Expert,Fungal meningitis: recognition and current status of management,,M0393,16:15,,"Olivier Lortholary (Paris, France)"
11 April 2025,ME145,16:15 - 17:15,15,Meet-the-Expert,Fungal meningitis: recognition and current status of management,,M0394,16:27,,"Janis Blair (Phoenix, United States)"
11 April 2025,JS2,16:15 - 17:15,16,Journal Session,Late-breaker research from the Lancet group: new interventions for familiar,Syeda Saleha Hassan; United Kingdom); Ursula Hofer; United Kingdom),J012,16:30,The spatio-temporal ecology of Oropouche virus:,"a 
laboratory-based modelling study across Latin 
America Jan Felix Drexler (Berlin, Germany)"
11 April 2025,JS2,16:15 - 17:15,16,Journal Session,Late-breaker research from the Lancet group: new interventions for familiar,Syeda Saleha Hassan; United Kingdom); Ursula Hofer; United Kingdom),J014,17:00,"Efficacy, safety,","and immunogenicity of the AS01E-
adjuvanted respiratory syncytial virus prefusion F 
protein vaccine (RSVPreF3 OA)"
11 April 2025,OS102,16:15 - 17:15,2,1-hour Oral Session,AI tools empowering AMR prediction in WGS and MALDI-TOF,Oliver Nolte; Switzerland); Patricia Simner; United States); O0733  A scalable machine learning approach to predict; antimicrobial susceptibility from whole genome; sequencing data Y. Zhong*; United; Kingdom); A. Gerada; A. Howard; P. Green; W. Hope; O0734  Machine Learning-Based Antimicrobial Resistance; Prediction of 11 antibiotics for Klebsiella pneumoniae; from Clinical NGS Data J. Xinmiao*; China); X.; Jia; J. Zhang; J. Chen; Q. Yang; O0735  AI-Powered Real-Time Plasmid Prediction Using; Nanopore Sequencing E. Sauerborn*; Germany); S. Atum; H. Urel; M. Peisker; N. Wantia; E.; Foster-Nyarko; L. Urban; O0736  MALDI-TOF Prediction model based on machine; learning algorithm for the detection of ST23 high-; virulence K. pneumoniaeL. Dortet*; Bicêtre; France); L. Mancera Pascual; M.J. Arroyo; O0737  Predicting rifampicin resistance in Mycobacterium; tuberculosis complex  with a machine learning based; MALDI-TOF MS approche Y.W. Sun*; Taiwan; China); P. Huang; B. Tsou; S.C. Chang; C.W.; Lu; C.C. Chen; J. Yu,S102,16:15,- 17:15,"Hall 2
1-hour Oral Session
AI tools empowering AMR prediction in WGS and MALDI-TOF
Chairs Oliver Nolte (Zürich, Switzerland)"
11 April 2025,LB005,16:15 - 17:15,3,1-hour Oral Session,"Emerging pathogens in humans, animals and vectors",,,,,
11 April 2025,SY142,16:15 - 18:15,4,2-hour Symposium,Precision genomics to improve infectious diseases management,,Y142,16:15,- 18:15,"Hall 4
2-hour Symposium
Precision genomics to improve infectious diseases management
Chair Jacob Moran-Gilad (Beer Sheva, Israel)"
11 April 2025,SY142,16:15 - 18:15,4,2-hour Symposium,Precision genomics to improve infectious diseases management,,S0385,16:15,,"Human genomics approaches to infection 
immunity Fergus Hamilton (Bristol, United Kingdom)"
11 April 2025,SY142,16:15 - 18:15,4,2-hour Symposium,Precision genomics to improve infectious diseases management,,S0386,16:45,,"Applying bacterial GWAS to uncover new 
mechanisms of antibiotic resistance Marco Galardini 
(Hannover, Germany)"
11 April 2025,SY142,16:15 - 18:15,4,2-hour Symposium,Precision genomics to improve infectious diseases management,,S0387,17:15,Evolution in action:,"large-scale within-host evolution 
analyses of persistent bacterial infections Stefano 
Giulieri (Melbourne, Australia)"
11 April 2025,SY142,16:15 - 18:15,4,2-hour Symposium,Precision genomics to improve infectious diseases management,,S0388,17:45,,"Machine learning in bacterial genomics and 
metagenomics Francesco Asnicar (Trento, Italy)"
11 April 2025,OS103,16:15 - 17:15,5,1-hour Oral Session,Polymicrobial interactions and competition,Alessandra Bragonzi; Italy); Kimberly Kline; Switzerland); O0738  The Klebsiella pneumoniae  type VI secretion system; effector Tle4 facilitates adaptation survival by; damaging the cell membrane of competing; bacteria W. Li*; China); J. Zhang; O0739  Candida albicans  promotes TSST-1 production in; Staphylococcus aureus  by depleting glucose and; lifting carbon catabolite repression M. Carriou*; France); C. Badiou; A. Soulard; K. Chikh; O. Vitalis; A.; Frugier; K. Dufresne; G. Lina; O0740  Understanding polymicrobial biofilm dynamics: focus; ESCMID Global 2025 - Programme; on Pseudomonas aeruginosa  and its molecular; interactions S. Kansal*; India); U. Dutta; A. Angrup; P. Ray; O0741  Intra- and interspecific antagonism inhibits growth of; Staphyloccous aureus  in human nasal microbial; communities L. Brülisauer*; Switzerland); M.; Boumasmoud; S. Brugger; A.R. Hall; O0742  Combination therapy against drug resistance; biomimetic dual-species biofilm model of; Pseudomonas aeruginosa  and Staphylococcus; aureusP. Mojarrad*; Finland); P. Tammela; T. Laaksonen; Z. Gounani,S103,16:15,- 17:15,"Hall 5
1-hour Oral Session
Polymicrobial interactions and competition
Chairs Alessandra Bragonzi (Milano, Italy)"
11 April 2025,OS103,16:15 - 17:15,5,1-hour Oral Session,Polymicrobial interactions and competition,Alessandra Bragonzi; Italy); Kimberly Kline; Switzerland); O0738  The Klebsiella pneumoniae  type VI secretion system; effector Tle4 facilitates adaptation survival by; damaging the cell membrane of competing; bacteria W. Li*; China); J. Zhang; O0739  Candida albicans  promotes TSST-1 production in; Staphylococcus aureus  by depleting glucose and; lifting carbon catabolite repression M. Carriou*; France); C. Badiou; A. Soulard; K. Chikh; O. Vitalis; A.; Frugier; K. Dufresne; G. Lina; O0740  Understanding polymicrobial biofilm dynamics: focus; ESCMID Global 2025 - Programme; on Pseudomonas aeruginosa  and its molecular; interactions S. Kansal*; India); U. Dutta; A. Angrup; P. Ray; O0741  Intra- and interspecific antagonism inhibits growth of; Staphyloccous aureus  in human nasal microbial; communities L. Brülisauer*; Switzerland); M.; Boumasmoud; S. Brugger; A.R. Hall; O0742  Combination therapy against drug resistance; biomimetic dual-species biofilm model of; Pseudomonas aeruginosa  and Staphylococcus; aureusP. Mojarrad*; Finland); P. Tammela; T. Laaksonen; Z. Gounani,F110,17:30,- 18:30,"Arena 1
ePoster Flash Session
Advancing diagnostics and treatment of endocarditis
Chair Benoît Guery (Lausanne, Switzerland)"
11 April 2025,OS103,16:15 - 17:15,5,1-hour Oral Session,Polymicrobial interactions and competition,Alessandra Bragonzi; Italy); Kimberly Kline; Switzerland); O0738  The Klebsiella pneumoniae  type VI secretion system; effector Tle4 facilitates adaptation survival by; damaging the cell membrane of competing; bacteria W. Li*; China); J. Zhang; O0739  Candida albicans  promotes TSST-1 production in; Staphylococcus aureus  by depleting glucose and; lifting carbon catabolite repression M. Carriou*; France); C. Badiou; A. Soulard; K. Chikh; O. Vitalis; A.; Frugier; K. Dufresne; G. Lina; O0740  Understanding polymicrobial biofilm dynamics: focus; ESCMID Global 2025 - Programme; on Pseudomonas aeruginosa  and its molecular; interactions S. Kansal*; India); U. Dutta; A. Angrup; P. Ray; O0741  Intra- and interspecific antagonism inhibits growth of; Staphyloccous aureus  in human nasal microbial; communities L. Brülisauer*; Switzerland); M.; Boumasmoud; S. Brugger; A.R. Hall; O0742  Combination therapy against drug resistance; biomimetic dual-species biofilm model of; Pseudomonas aeruginosa  and Staphylococcus; aureusP. Mojarrad*; Finland); P. Tammela; T. Laaksonen; Z. Gounani,F112,17:30,- 18:30,"Arena 3
ePoster Flash Session
Clinical considerations in resistant organisms
Chair Divya Deodhar (Muscat, Oman)"
11 April 2025,OS103,16:15 - 17:15,5,1-hour Oral Session,Polymicrobial interactions and competition,Alessandra Bragonzi; Italy); Kimberly Kline; Switzerland); O0738  The Klebsiella pneumoniae  type VI secretion system; effector Tle4 facilitates adaptation survival by; damaging the cell membrane of competing; bacteria W. Li*; China); J. Zhang; O0739  Candida albicans  promotes TSST-1 production in; Staphylococcus aureus  by depleting glucose and; lifting carbon catabolite repression M. Carriou*; France); C. Badiou; A. Soulard; K. Chikh; O. Vitalis; A.; Frugier; K. Dufresne; G. Lina; O0740  Understanding polymicrobial biofilm dynamics: focus; ESCMID Global 2025 - Programme; on Pseudomonas aeruginosa  and its molecular; interactions S. Kansal*; India); U. Dutta; A. Angrup; P. Ray; O0741  Intra- and interspecific antagonism inhibits growth of; Staphyloccous aureus  in human nasal microbial; communities L. Brülisauer*; Switzerland); M.; Boumasmoud; S. Brugger; A.R. Hall; O0742  Combination therapy against drug resistance; biomimetic dual-species biofilm model of; Pseudomonas aeruginosa  and Staphylococcus; aureusP. Mojarrad*; Finland); P. Tammela; T. Laaksonen; Z. Gounani,F110,17:30,- 18:30,"Arena 1
ePoster Flash Session
Advancing diagnostics and treatment of endocarditis
Chair Benoît Guery (Lausanne, Switzerland)"
11 April 2025,OS103,16:15 - 17:15,5,1-hour Oral Session,Polymicrobial interactions and competition,Alessandra Bragonzi; Italy); Kimberly Kline; Switzerland); O0738  The Klebsiella pneumoniae  type VI secretion system; effector Tle4 facilitates adaptation survival by; damaging the cell membrane of competing; bacteria W. Li*; China); J. Zhang; O0739  Candida albicans  promotes TSST-1 production in; Staphylococcus aureus  by depleting glucose and; lifting carbon catabolite repression M. Carriou*; France); C. Badiou; A. Soulard; K. Chikh; O. Vitalis; A.; Frugier; K. Dufresne; G. Lina; O0740  Understanding polymicrobial biofilm dynamics: focus; ESCMID Global 2025 - Programme; on Pseudomonas aeruginosa  and its molecular; interactions S. Kansal*; India); U. Dutta; A. Angrup; P. Ray; O0741  Intra- and interspecific antagonism inhibits growth of; Staphyloccous aureus  in human nasal microbial; communities L. Brülisauer*; Switzerland); M.; Boumasmoud; S. Brugger; A.R. Hall; O0742  Combination therapy against drug resistance; biomimetic dual-species biofilm model of; Pseudomonas aeruginosa  and Staphylococcus; aureusP. Mojarrad*; Finland); P. Tammela; T. Laaksonen; Z. Gounani,F112,17:30,- 18:30,"Arena 3
ePoster Flash Session
Clinical considerations in resistant organisms
Chair Divya Deodhar (Muscat, Oman)"
11 April 2025,SY147,17:30 - 18:30,11,,,Patricia Antunes; Portugal); Ana Vale; Ireland),S0400,18:00,,"Recent changes in the epidemiology of avian 
influenza in relation to human health risks Ron 
Fouchier (Rotterdam, Netherlands)"
11 April 2025,SY148,17:30 - 18:30,15,,,Daniel Grupel; Israel); Francesca Tamarozzi; Italy),S0401,17:30,,"Expansion and diversity of cystic 
echinococcosis Pedro Legua (Lima, Peru)"
11 April 2025,SY148,17:30 - 18:30,15,,,Daniel Grupel; Israel); Francesca Tamarozzi; Italy),S0402,18:00,"Management of echinococcosis: evidence,","eminence 
and new developments Beate Grüner (Ulm, Germany)"
11 April 2025,OS109,17:30 - 18:30,16,1-hour Oral Session,Training CM/ID - a global view,Mihai Mares; Romania); Priya Nori; United States); O0780  Specialist training in infectious diseases in Europe J.; Salmanton-Garcia*; Germany); J.; Salmanton-García; A. Guerra Maio; J.P. Stahl; E. De; Barra; S. Jensen-Fangel; C. Torti; C. Kraef; J.M. Miró; A. Verbon; O.A. Cornely; N. Beeching; O0781  Infectious Diseases Residency Training over the; World P. Irkören*; Türkiye); P.; Irkoren; C. Cimen; S. Keske; Ö. Ergönül; O0782  Five years of experience with the virtual International; Postgraduate Diploma in Infection Prevention and; Control from the Infection Control Africa Network. A.; Tostmann*; Netherlands); E. Schoeman; B.; Du Toit Ludick; E. Ruizendaal; Y. Gouws; J. Hopman; C. Azzouz; S. Mehtar; O0783  Combatting challenges in laboratory capacity; through an innovative; longitudinal Gram stain; training programme for blood culture specimens in; Zimbabwe. T. Mwaturura*; Zimbabwe); D.; Hettle; F. Makoga; A. Mudungwe; B. Sado; K. Kranzer; O0784  Benefit of the implementation of Entrustable; Professional Activities; the Laboratory of clinical bacteriology: a study; focused on the improvement of residents' skills and; feelings. H. Pailhoriès*; France); H. Pailhories; C. Zins; R. Chenouard; M. Kempf; M. Eveillard,,,,
11 April 2025,ME149,17:30 - 18:30,2,Meet-the-Expert,How to perform molecular surveillance of multidrug resistant bacteria,,M0403,17:30,,"Martina Lengerova (Brno, Czech Republic)"
11 April 2025,ME149,17:30 - 18:30,2,Meet-the-Expert,How to perform molecular surveillance of multidrug resistant bacteria,,M0404,17:42,,"Henrik Hasman (Copenhagen, Denmark)"
11 April 2025,OS107,17:30 - 18:30,3,1-hour Oral Session,Novel vaccines in clinical development,Mateusz Hasso-Agopsowicz; Switzerland); Hanna M. Nohynek; Finland); O0770  Safety and immunogenicity of a seasonal booster; dose of the 6-valent; OspA-based Lyme borreliosis; vaccine candidate VLA15 in a healthy population aged; 5-65 years M. Messier*; France); L. Wagner; R. Hochreiter; J. Larcher-Senn; E. Lamberth; R.; Simon; C. Clarkin; J. Stark; S. Eder-Lingelbach; O0771  Safety and immunogenicity of mRNA mpox vaccine; candidate mRNA-1769: Interim analysis results from a; Phase 1/2 Trial H. Hiruy*; United States); R. Lazarus; K. Mccafferty; K. Cohen; R. Dhar; T. Rizk; A. Adeniji; X. Chang; L. Siquel; H. Bennett; B. Leav; O0772  Development of a Rapid-Acting Oral Cholera Vaccine:; Phase I Clinical Trial A. Hannaford*; United; States); D. Leitner; M. Waldor; L. Baden; M.; Desjardins; M. Suzuki; L. Carr; D. Slater; H. Levine; H.; Kaul; J.B. Park Chang; A. Piermatti; N. Puri; B.; Piantadosi; J. Harris; S. Piantadosi; A. Sherman; S.; Walsh; O0773  Safety and immunogenicity of a Group B; Streptococcus vaccine in participants aged 55-75; years L. Oostvogels*; Denmark); A.; Alhatemi; S. De Gussem; E. Englev; B. Jacobs; B.; Johansson-Lindbom; G. Kitson; G. Waerlop; I. Leroux-; Roels; ESCMID Global 2025 - Programme; Infection: A randomized controlled trial K.; Angkanavisan*; Thailand); B.; Sakboonyarat; C. Ungthammakhun; E0808  Oral switch vs. intravenous antibiotics treatment for; serious carbapenem-resistant Enterobacterales and; Pseudomonas aeruginosa  infections on hospital; discharge: the next frontier for oral switch? C.; Arena*; United States); A. Abed; R. Kenney; G. Suleyman; A. Shallal; S. Davis; M. Veve; E0809  Metallo-￿-lactamase  colonization and subsequent; risk of infection: a retrospective study. C. Lee Luna; Fernandes*; Brazil); C. Vaiana; C. Amato; S. Castelbuono; G. Di Martino; F. Cardinale; F.; Monaco; A. Cona; A. Mularoni; E0810  Polymyxin including therapy versus colistin; including therapy in the therapy of carbapenem-; resistant Gram-negative infections: A retrospective; matched cohort study M. Mert Vahabi*; Türkiye); D. Akyol Seyhan; B. Kenanoğlu; Ş. Yeniyol; G. Şanlıdağ İşbilen; Ş. Dirik; D. Dağ; B. Özkara; M.; Ceylan; C. Bulut Avşar; U. Önal; S. Ketentzi; A. Uyan; Önal; A. Kaya; O. Acet; D. Kaya; N. Yalcin; G.; Vatansever; C. Tol; Ş. Aydemir; D. Akdağ; H.A.; Erdem; T. Yamazhan; H. Sipahi; B. Arda; O.R. Sipahi; E0811  Prognostic factors and role of clinical management; in carbapenem-resistant Acinetobacter baumannii; bacteraemia: results from a prospective; international; multicentre cohort; Cogliati Dezza*; Spain); J.M. Bravo-Ferrer; Acosta; B. Gutiérrez-Gutiérrez; B. Carevic; G.; Dragovac; G.L. Daikos; M. Akova; L. Raka; A.; Hristea; P. Viale; E. Shaw; E. Roilides; M. Antonelli; H. Akalin; A. Komnos; J.M. Reguera; A. Vince; M.; Mašanovic; L. Radulović; C. Kirakli; C. Gogos; A.; Bartoloni; C. Dan; P. Kapisyzi; M.E. Falagas; A. Vata; S. Benea; D. Tomescu; A. Meda Vasiesiu; L.; Bukarica; N. Lukic; A. Cano; V. Pintado; A. Azap; H.; Goosens; M.J.M. Bonten; J. Rodríguez-Baño,S107,17:30,- 18:30,"Hall 3
1-hour Oral Session
Novel vaccines in clinical development
Chairs Mateusz Hasso-Agopsowicz (Geneva, Switzerland)"
11 April 2025,SY147,17:30 - 18:30,11,,,Patricia Antunes; Portugal); Ana Vale; Ireland),S0400,18:00,,"Recent changes in the epidemiology of avian 
influenza in relation to human health risks Ron 
Fouchier (Rotterdam, Netherlands)"
11 April 2025,SY148,17:30 - 18:30,15,,,Daniel Grupel; Israel); Francesca Tamarozzi; Italy),S0401,17:30,,"Expansion and diversity of cystic 
echinococcosis Pedro Legua (Lima, Peru)"
11 April 2025,SY148,17:30 - 18:30,15,,,Daniel Grupel; Israel); Francesca Tamarozzi; Italy),S0402,18:00,"Management of echinococcosis: evidence,","eminence 
and new developments Beate Grüner (Ulm, Germany)"
11 April 2025,OS109,17:30 - 18:30,16,1-hour Oral Session,Training CM/ID - a global view,Mihai Mares; Romania); Priya Nori; United States); O0780  Specialist training in infectious diseases in Europe J.; Salmanton-Garcia*; Germany); J.; Salmanton-García; A. Guerra Maio; J.P. Stahl; E. De; Barra; S. Jensen-Fangel; C. Torti; C. Kraef; J.M. Miró; A. Verbon; O.A. Cornely; N. Beeching; O0781  Infectious Diseases Residency Training over the; World P. Irkören*; Türkiye); P.; Irkoren; C. Cimen; S. Keske; Ö. Ergönül; O0782  Five years of experience with the virtual International; Postgraduate Diploma in Infection Prevention and; Control from the Infection Control Africa Network. A.; Tostmann*; Netherlands); E. Schoeman; B.; Du Toit Ludick; E. Ruizendaal; Y. Gouws; J. Hopman; C. Azzouz; S. Mehtar; O0783  Combatting challenges in laboratory capacity; through an innovative; longitudinal Gram stain; training programme for blood culture specimens in; Zimbabwe. T. Mwaturura*; Zimbabwe); D.; Hettle; F. Makoga; A. Mudungwe; B. Sado; K. Kranzer; O0784  Benefit of the implementation of Entrustable; Professional Activities; the Laboratory of clinical bacteriology: a study; focused on the improvement of residents' skills and; feelings. H. Pailhoriès*; France); H. Pailhories; C. Zins; R. Chenouard; M. Kempf; M. Eveillard,,,,
11 April 2025,ME149,17:30 - 18:30,2,Meet-the-Expert,How to perform molecular surveillance of multidrug resistant bacteria,,M0403,17:30,,"Martina Lengerova (Brno, Czech Republic)"
11 April 2025,ME149,17:30 - 18:30,2,Meet-the-Expert,How to perform molecular surveillance of multidrug resistant bacteria,,M0404,17:42,,"Henrik Hasman (Copenhagen, Denmark)"
11 April 2025,OS107,17:30 - 18:30,3,1-hour Oral Session,Novel vaccines in clinical development,Mateusz Hasso-Agopsowicz; Switzerland); Hanna M. Nohynek; Finland); O0770  Safety and immunogenicity of a seasonal booster; dose of the 6-valent; OspA-based Lyme borreliosis; vaccine candidate VLA15 in a healthy population aged; 5-65 years M. Messier*; France); L. Wagner; R. Hochreiter; J. Larcher-Senn; E. Lamberth; R.; Simon; C. Clarkin; J. Stark; S. Eder-Lingelbach; O0771  Safety and immunogenicity of mRNA mpox vaccine; candidate mRNA-1769: Interim analysis results from a; Phase 1/2 Trial H. Hiruy*; United States); R. Lazarus; K. Mccafferty; K. Cohen; R. Dhar; T. Rizk; A. Adeniji; X. Chang; L. Siquel; H. Bennett; B. Leav; O0772  Development of a Rapid-Acting Oral Cholera Vaccine:; Phase I Clinical Trial A. Hannaford*; United; States); D. Leitner; M. Waldor; L. Baden; M.; Desjardins; M. Suzuki; L. Carr; D. Slater; H. Levine; H.; Kaul; J.B. Park Chang; A. Piermatti; N. Puri; B.; Piantadosi; J. Harris; S. Piantadosi; A. Sherman; S.; Walsh; O0773  Safety and immunogenicity of a Group B; Streptococcus vaccine in participants aged 55-75; years L. Oostvogels*; Denmark); A.; Alhatemi; S. De Gussem; E. Englev; B. Jacobs; B.; Johansson-Lindbom; G. Kitson; G. Waerlop; I. Leroux-; Roels; ESCMID Global 2025 - Programme; O0774  Aggregated summary of immunogenicity and safety; for the chikungunya virus virus-like particle; vaccine development programme L. Tindale*; (Toronto; Canada); J. Richardson; D. Anderson; J.; Mendy; S. Muhammad; T. Loreth; V. Jenkins; P.; Ajiboye; L. Bedell,S107,17:30,- 18:30,"Hall 3
1-hour Oral Session
Novel vaccines in clinical development
Chairs Mateusz Hasso-Agopsowicz (Geneva, Switzerland)"
11 April 2025,OS108,17:30 - 18:30,5,1-hour Oral Session,Novel approaches to preventing device-related infections,Natividad Benito; Spain); Preeti Malani; United States); O0775  Clinical and microbiological impact of antibiotic-; impregnated catheters in ventriculoperitoneal shunt; infections in adults. M. Sanz De Mena*; Spain); I. Pelegrín Senent; J. Gómez Junyent; J.; Poblet Florentin; C. Iglesias; A. Siverio Parés; S.; Gómez Zorrilla; L. Sorlí Redó; M. Montero; J.P.; Horcajada; O0776  Reducing drainage-associated meningitis by using an; antiseptic dressing: A randomized controlled trial; AntiRedMen S. Scheithauer*; Germany); O. Moerer; V. Rohde; N. Srivastava; T. Asendorf; K.; Antweiler; D. Mielke; G. Uwe; N. Lennart; S. Friedrich; A. Beste; N. Kucheryava; M. Baehr; O0777  Efficacy of antimicrobial envelopes in preventing; cardiac implantable electronic device infections –; systematic review and meta-analysis A. Mahajan*; (Melbourne; Australia); C. Robson; O0778  A bundled approach to reducing central line; associated blood stream infections; hemodialysis; (Scarborough; Canada); A. Garga; S. Paramalingam; R. Lovinsky; F. Go; O0779  Increased long-term mortality in patients with; prosthetic joint infection after primary total hip; arthroplasty – a cohort study with 89'709 patients N.; Imhasly*; Switzerland); A. Widmer; C.; Brand; V. Zdravkovic; A. Spoerri; K. Schmidlin; M.; Wicki; M. Beck; R. Sommerstein; Tuesday; 15 April 2025,S108,17:30,- 18:30,"Hall 5
1-hour Oral Session
Novel approaches to preventing device-related infections
Chairs Natividad Benito (Barcelona, Spain)"
11 April 2025,SY152,08:30 - 10:30,12,2-hour Symposium,Out of the spotlight or out of reach? Vaccination of hard-to-reach groups,Olivier Epaulard; France); Justyna Kowalska; Poland),S0416,10:00,,"HPV and other essential vaccinations for sex 
workers Debora Konopnicki (Brussels, Belgium)"
11 April 2025,SY153,08:30 - 10:30,13,2-hour Symposium,Breaking new ground in febrile neutropaenia management,Murat Akova; Türkiye); Stefan Schwartz; Germany)S0417  08:30  Do we need to redefine the concept of febrile; neutropaenia in the era of immunotherapy? Manuela; Aguilar-Guisado; Spain),Y153,08:30,- 10:30,"Hall 13
2-hour Symposium
Breaking new ground in febrile neutropaenia management
Chairs Murat Akova (Ankara, Türkiye)"
11 April 2025,SY153,08:30 - 10:30,13,2-hour Symposium,Breaking new ground in febrile neutropaenia management,Murat Akova; Türkiye); Stefan Schwartz; Germany)S0417  08:30  Do we need to redefine the concept of febrile; neutropaenia in the era of immunotherapy? Manuela; Aguilar-Guisado; Spain),S0419,09:30,,"Role of new antibiotics in febrile 
neutropaenia Malgorzata Mikulska (Genoa, Italy)"
11 April 2025,EW156,08:30 - 10:30,5,Educational Session,The rules of the game: how to tackle the peer-review and publication process,Christian Kraef; Denmark); Oana Sandulescu; Romania),W0429,08:30,"Communicating with journals,","editors and 
reviewers Angela Huttner (Geneva, Switzerland)"
11 April 2025,EW156,08:30 - 10:30,5,Educational Session,The rules of the game: how to tackle the peer-review and publication process,Christian Kraef; Denmark); Oana Sandulescu; Romania),W0430,08:50,,"The Wild West of predatory journals Ursula Hofer 
(London, United Kingdom)"
11 April 2025,EW156,08:30 - 10:30,5,Educational Session,The rules of the game: how to tackle the peer-review and publication process,Christian Kraef; Denmark); Oana Sandulescu; Romania),W0431,09:10,,"Communicating your publications on social media Neil 
Stone (London, United Kingdom)"
11 April 2025,EW156,08:30 - 10:30,5,Educational Session,The rules of the game: how to tackle the peer-review and publication process,Christian Kraef; Denmark); Oana Sandulescu; Romania),W0432,09:30,,"Re-imagining peer review Amelia Joseph 
(Nottingham, United Kingdom)"
11 April 2025,EW156,08:30 - 10:30,5,Educational Session,The rules of the game: how to tackle the peer-review and publication process,Christian Kraef; Denmark); Oana Sandulescu; Romania),F114,08:30,- 09:30,"Arena 1
ePoster Flash Session
Innovations and insights in diagnosing parasitic infections
Chair Pikka Jokelainen (Copenhagen, Denmark)"
11 April 2025,OS108,17:30 - 18:30,5,1-hour Oral Session,Novel approaches to preventing device-related infections,Natividad Benito; Spain); Preeti Malani; United States); O0775  Clinical and microbiological impact of antibiotic-; impregnated catheters in ventriculoperitoneal shunt; infections in adults. M. Sanz De Mena*; Spain); I. Pelegrín Senent; J. Gómez Junyent; J.; Poblet Florentin; C. Iglesias; A. Siverio Parés; S.; Gómez Zorrilla; L. Sorlí Redó; M. Montero; J.P.; Horcajada; O0776  Reducing drainage-associated meningitis by using an; antiseptic dressing: A randomized controlled trial; AntiRedMen S. Scheithauer*; Germany); O. Moerer; V. Rohde; N. Srivastava; T. Asendorf; K.; Antweiler; D. Mielke; G. Uwe; N. Lennart; S. Friedrich; A. Beste; N. Kucheryava; M. Baehr; O0777  Efficacy of antimicrobial envelopes in preventing; cardiac implantable electronic device infections –; systematic review and meta-analysis A. Mahajan*; (Melbourne; Australia); C. Robson; O0778  A bundled approach to reducing central line; associated blood stream infections; hemodialysis; (Scarborough; Canada); A. Garga; S. Paramalingam; R. Lovinsky; F. Go; O0779  Increased long-term mortality in patients with; prosthetic joint infection after primary total hip; arthroplasty – a cohort study with 89'709 patients N.; Imhasly*; Switzerland); A. Widmer; C.; Brand; V. Zdravkovic; A. Spoerri; K. Schmidlin; M.; Wicki; M. Beck; R. Sommerstein; Tuesday; 15 April 2025,S108,17:30,- 18:30,"Hall 5
1-hour Oral Session
Novel approaches to preventing device-related infections
Chairs Natividad Benito (Barcelona, Spain)"
11 April 2025,SY152,08:30 - 10:30,12,2-hour Symposium,Out of the spotlight or out of reach? Vaccination of hard-to-reach groups,Olivier Epaulard; France); Justyna Kowalska; Poland),S0416,10:00,,"HPV and other essential vaccinations for sex 
workers Debora Konopnicki (Brussels, Belgium)"
11 April 2025,SY153,08:30 - 10:30,13,2-hour Symposium,Breaking new ground in febrile neutropaenia management,Murat Akova; Türkiye); Stefan Schwartz; Germany)S0417  08:30  Do we need to redefine the concept of febrile; neutropaenia in the era of immunotherapy? Manuela; Aguilar-Guisado; Spain),Y153,08:30,- 10:30,"Hall 13
2-hour Symposium
Breaking new ground in febrile neutropaenia management
Chairs Murat Akova (Ankara, Türkiye)"
11 April 2025,SY153,08:30 - 10:30,13,2-hour Symposium,Breaking new ground in febrile neutropaenia management,Murat Akova; Türkiye); Stefan Schwartz; Germany)S0417  08:30  Do we need to redefine the concept of febrile; neutropaenia in the era of immunotherapy? Manuela; Aguilar-Guisado; Spain),S0419,09:30,,"Role of new antibiotics in febrile 
neutropaenia Malgorzata Mikulska (Genoa, Italy)"
11 April 2025,EW156,08:30 - 10:30,5,Educational Session,The rules of the game: how to tackle the peer-review and publication process,Christian Kraef; Denmark); Oana Sandulescu; Romania),W0429,08:30,"Communicating with journals,","editors and 
reviewers Angela Huttner (Geneva, Switzerland)"
11 April 2025,EW156,08:30 - 10:30,5,Educational Session,The rules of the game: how to tackle the peer-review and publication process,Christian Kraef; Denmark); Oana Sandulescu; Romania),W0430,08:50,,"The Wild West of predatory journals Ursula Hofer 
(London, United Kingdom)"
11 April 2025,EW156,08:30 - 10:30,5,Educational Session,The rules of the game: how to tackle the peer-review and publication process,Christian Kraef; Denmark); Oana Sandulescu; Romania),W0431,09:10,,"Communicating your publications on social media Neil 
Stone (London, United Kingdom)"
11 April 2025,EW156,08:30 - 10:30,5,Educational Session,The rules of the game: how to tackle the peer-review and publication process,Christian Kraef; Denmark); Oana Sandulescu; Romania),W0432,09:30,,"Re-imagining peer review Amelia Joseph 
(Nottingham, United Kingdom)"
11 April 2025,EW156,08:30 - 10:30,5,Educational Session,The rules of the game: how to tackle the peer-review and publication process,Christian Kraef; Denmark); Oana Sandulescu; Romania),F114,08:30,- 09:30,"Arena 1
ePoster Flash Session
Innovations and insights in diagnosing parasitic infections
Chair Pikka Jokelainen (Copenhagen, Denmark)"
11 April 2025,EW156,08:30 - 10:30,5,Educational Session,The rules of the game: how to tackle the peer-review and publication process,Christian Kraef; Denmark); Oana Sandulescu; Romania),F115,08:30,- 09:30,"Arena 3
ePoster Flash Session
New genomic methods in clinical microbiology
Chair Natacha Couto (Oxford, United Kingdom)"
11 April 2025,OS113,08:30 - 10:30,11,,,Sandrine Marchand; France); Ursula Theuretzbacher; Austria); O0812  Chimerbactin: a hybrid antibiotic for persistent; Gram-positive infections that overcomes resistance; development R. Lee*; United States); Y.; Zhao; A. Arya; M. Lafleur; R. Conlin; G. Phelps; C.; Dunn; E. Griffith; J. Portelinha; N. Chumbler; V.; Loudon; I. Lister; S. Zia; K. Urish; K. Lewis; O0813  A Novel Klebicin Cocktail to Treat Lung Infection; Caused by Klebsiella pneumoniaeV.D. Paul*; (Bangalore; India); A. Ambady; U. Chopra; O0814  Thiophene derivatives: A promising solution against; MDR Gram-negative bacilli Y. Smani*; Spain); I. Molina Panadero; Á. Rey Hidalgo; M.; Morales-Tenorio; A. García-Rubia; T. Samernate; P.; Nonejuie; A. Martínez; A. Hmadcha; A. De Alarcón; C. Gil; O0815  Molecular insight into non-lytic polyproline peptide; disruption of Klebsiella pneumoniae  biofilms R.; Fleeman*; United States); R. Beckman Iv; B. Victoria; L. Suits; P. Eswara; O0816  Reverting cefotaxime resistance in CTX-M-15-; producing Escherichia coli  using Targeted-; Antibacterial-Plasmids; approach. N. Roson Calero*; Spain); N.; Roson-Calero; E. Derollez; P. Rouze; A. Dedieu-; Berne; S. Bigot; C. Ballesté-Delpierre; J. Vila; P.; Bogaerts; C. Lesterlin; O0817  Structural and functional characterization of; LysSM5: An innovative endolysin from Salmonella; Phage vB_SenA_SM5 K. Sharma*; India); H. Kaur; N. Chaudhary; S. Prajapati; B.; Mohan; N. Taneja; O0818  Rational step-by-step design of a two-phage; cocktail against a contemporary A. baumannii  strain; recovered from a burned patient at CHUV. G.; Resch*; Switzerland); H. De Villiers De La; Noue; G. Golliard; X. Vuattoux; O0819  A novel antibiotic class targeting the enolase of; Acinetobacter baumanniiI. Molina Panadero*; (Seville; Spain); A. Moreno Rodríguez; Á. Rey; Hidalgo; L. Tomás Gallardo; M. De La Cruz; P.; Sánchez; T. Samernate; A.J. Pérez Pulido; S. Glisic; O. Genilloud; P. Nonejuie; A. Hmadcha; Y. Smani; O0820  Reviving antibiotic potency: Pharmacological; Assessment of JS238 a newly designed potentiator; against P. aeruginosaP. Rasouli*; Belgium); J.M. Brunel; J.H. Lorent; F. Van Bambeke; O0821  Advancements in combating tularemia: Novel; therapeutic strategies targeting Francisella; tularensisS. Guillier*; France); M. Gâchon; C. Lemoigne; C. Rougeaux; V. Lourde; C. Demeure; J. Pizarro Cerda; G. Guichard; G.; Compain; D. Burnouf; O. Gorgé; J. Wagner,,,,
11 April 2025,SY154,08:30 - 10:30,14,ePoster Flash Session,New genomic methods in clinical microbiology,,F115,08:30,- 09:30,"Arena 3
ePoster Flash Session
New genomic methods in clinical microbiology
Chair Natacha Couto (Oxford, United Kingdom)"
11 April 2025,OS113,08:30 - 10:30,11,,,Sandrine Marchand; France); Ursula Theuretzbacher; Austria); O0812  Chimerbactin: a hybrid antibiotic for persistent; Gram-positive infections that overcomes resistance; development R. Lee*; United States); Y.; Zhao; A. Arya; M. Lafleur; R. Conlin; G. Phelps; C.; Dunn; E. Griffith; J. Portelinha; N. Chumbler; V.; Loudon; I. Lister; S. Zia; K. Urish; K. Lewis; O0813  A Novel Klebicin Cocktail to Treat Lung Infection; Caused by Klebsiella pneumoniaeV.D. Paul*; (Bangalore; India); A. Ambady; U. Chopra; O0814  Thiophene derivatives: A promising solution against; MDR Gram-negative bacilli Y. Smani*; Spain); I. Molina Panadero; Á. Rey Hidalgo; M.; Morales-Tenorio; A. García-Rubia; T. Samernate; P.; Nonejuie; A. Martínez; A. Hmadcha; A. De Alarcón; C. Gil; O0815  Molecular insight into non-lytic polyproline peptide; disruption of Klebsiella pneumoniae  biofilms R.; Fleeman*; United States); R. Beckman Iv; B. Victoria; L. Suits; P. Eswara; O0816  Reverting cefotaxime resistance in CTX-M-15-; producing Escherichia coli  using Targeted-; Antibacterial-Plasmids; approach. N. Roson Calero*; Spain); N.; Roson-Calero; E. Derollez; P. Rouze; A. Dedieu-; Berne; S. Bigot; C. Ballesté-Delpierre; J. Vila; P.; Bogaerts; C. Lesterlin; O0817  Structural and functional characterization of; LysSM5: An innovative endolysin from Salmonella; Phage vB_SenA_SM5 K. Sharma*; India); H. Kaur; N. Chaudhary; S. Prajapati; B.; Mohan; N. Taneja; O0818  Rational step-by-step design of a two-phage; cocktail against a contemporary A. baumannii  strain; recovered from a burned patient at CHUV. G.; Resch*; Switzerland); H. De Villiers De La; Noue; G. Golliard; X. Vuattoux; O0819  A novel antibiotic class targeting the enolase of; Acinetobacter baumanniiI. Molina Panadero*; (Seville; Spain); A. Moreno Rodríguez; Á. Rey; Hidalgo; L. Tomás Gallardo; M. De La Cruz; P.; Sánchez; T. Samernate; A.J. Pérez Pulido; S. Glisic; O. Genilloud; P. Nonejuie; A. Hmadcha; Y. Smani; O0820  Reviving antibiotic potency: Pharmacological; Assessment of JS238 a newly designed potentiator; against P. aeruginosaP. Rasouli*; Belgium); J.M. Brunel; J.H. Lorent; F. Van Bambeke; O0821  Advancements in combating tularemia: Novel; therapeutic strategies targeting Francisella; tularensisS. Guillier*; France); M. Gâchon; C. Lemoigne; C. Rougeaux; V. Lourde; C. Demeure; J. Pizarro Cerda; G. Guichard; G.; Compain; D. Burnouf; O. Gorgé; J. Wagner,,,,
11 April 2025,SY154,08:30 - 10:30,14,2-hour Symposium,Using mathematical and epidemiological models to identify the drivers of,Marc J.M. Bonten; Netherlands); Sarah Tschudin Sutter; Switzerland),Y154,08:30,- 10:30,"Hall 14
ESCMID Global 2025 - Programme
2-hour Symposium
Using mathematical and epidemiological models to identify the drivers of 
AMR 
Chairs Marc J.M. Bonten (Utrecht, Netherlands)"
11 April 2025,SY154,08:30 - 10:30,14,2-hour Symposium,Using mathematical and epidemiological models to identify the drivers of,Marc J.M. Bonten; Netherlands); Sarah Tschudin Sutter; Switzerland),S0422,09:00,,"Inferring the determinants of AMR dynamics across 
bacterial pathogens Lulla Opatowski (Paris, France)"
11 April 2025,SY154,08:30 - 10:30,14,2-hour Symposium,Using mathematical and epidemiological models to identify the drivers of,Marc J.M. Bonten; Netherlands); Sarah Tschudin Sutter; Switzerland),S0423,09:30,,"Modelling the evolution of resistance Erida Gjini 
(Lisbon, Portugal)"
11 April 2025,SY154,08:30 - 10:30,14,2-hour Symposium,Using mathematical and epidemiological models to identify the drivers of,Marc J.M. Bonten; Netherlands); Sarah Tschudin Sutter; Switzerland),S0424,10:00,,"Assessing the associations of microbiome and socio-
demographic dynamics on AMR Katariina Pärnänen 
(Helsinki, Finland)"
11 April 2025,EW157,08:30 - 10:30,15,Educational Session,Endemic mycoses and mycetoma: underdiagnosed and underreported fungal,Ana Alastruey-Izquierdo; Spain); Rita Oladele; Nigeria),W0433,08:30,,"Advances and gaps in the diagnosis and treatment of 
histoplasmosis Diego Rodrigues Falci (Porto Alegre, 
Brazil)"
11 April 2025,EW157,08:30 - 10:30,15,Educational Session,Endemic mycoses and mycetoma: underdiagnosed and underreported fungal,Ana Alastruey-Izquierdo; Spain); Rita Oladele; Nigeria),W0434,08:50,Paracoccidioidomycosis:,"an update on diagnostic 
challenges Beatriz L. Gomez (Bogota, Colombia)"
11 April 2025,EW157,08:30 - 10:30,15,Educational Session,Endemic mycoses and mycetoma: underdiagnosed and underreported fungal,Ana Alastruey-Izquierdo; Spain); Rita Oladele; Nigeria),W0435,09:10,,"What is new in Talaromycosis Brown Lottie (London, 
United Kingdom)"
11 April 2025,EW157,08:30 - 10:30,15,Educational Session,Endemic mycoses and mycetoma: underdiagnosed and underreported fungal,Ana Alastruey-Izquierdo; Spain); Rita Oladele; Nigeria),W0436,09:30,Mycetoma:,"treatment challenges of a unique 
neglected tropical disease Borna Nyaoke-Anoke 
(Nairobi, Kenya)"
11 April 2025,EW155,08:30 - 10:30,2,Educational Session,An update on arboviral disease challenges,Misa Korva; Slovenia); Anna Papa-Konidari; Greece),W155,08:30,- 10:30,"Hall 2
Educational Session
An update on arboviral disease challenges
Chairs Misa Korva (Ljubljana, Slovenia)"
11 April 2025,EW155,08:30 - 10:30,2,Educational Session,An update on arboviral disease challenges,Misa Korva; Slovenia); Anna Papa-Konidari; Greece),W0425,08:30,,"The global epidemiology of arboviral diseases Chantal 
B.E.M. Reusken (Bilthoven, Netherlands)"
11 April 2025,EW155,08:30 - 10:30,2,Educational Session,An update on arboviral disease challenges,Misa Korva; Slovenia); Anna Papa-Konidari; Greece),W0426,08:50,,"Arboviral diseases transmitted by mosquitoes Luisa 
Barzon (Padua, Italy)"
11 April 2025,EW155,08:30 - 10:30,2,Educational Session,An update on arboviral disease challenges,Misa Korva; Slovenia); Anna Papa-Konidari; Greece),W0427,09:10,,"Aboviral diseases transmitted by ticks Joanna Maria 
Zajkowska (Białystok, Poland)"
11 April 2025,EW155,08:30 - 10:30,2,Educational Session,An update on arboviral disease challenges,Misa Korva; Slovenia); Anna Papa-Konidari; Greece),W0428,09:30,,"Arboviral diseases transmitted by sandflies Rémi 
Charrel (Marseille, France)"
11 April 2025,SY150,08:30 - 10:30,3,2-hour Symposium,Faecal microbiota transplantation and live biotherapeutic products: scientific,Lindsey Ann Edwards; United Kingdom); Ed J. Kuijper; Netherlands),S0406,09:00,What to check? –,"An attempt at evidence-based 
donor screening Elisabeth Terveer (Leiden, Netherlands)"
11 April 2025,SY150,08:30 - 10:30,3,2-hour Symposium,Faecal microbiota transplantation and live biotherapeutic products: scientific,Lindsey Ann Edwards; United Kingdom); Ed J. Kuijper; Netherlands),S0407,09:30,What are the right bugs –,"Developing LBPs out of 
FMTs Lena Biehl (Cologne, Germany)"
11 April 2025,SY150,08:30 - 10:30,3,2-hour Symposium,Faecal microbiota transplantation and live biotherapeutic products: scientific,Lindsey Ann Edwards; United Kingdom); Ed J. Kuijper; Netherlands),S0408,10:00,What’s up next? –,"Hot LBP candidates Ilan Youngster 
(Beer Yaakov, Israel)"
11 April 2025,SY151,08:30 - 10:30,4,2-hour Symposium,Using mathematical and epidemiological models to identify the drivers of,Michele Bartoletti; Italy); Pilar Retamar Gentil; Spain),Y151,08:30,- 10:30,"Hall 4
2-hour Symposium
News in endocarditis care
Chairs Michele Bartoletti (Milan, Italy)"
11 April 2025,SY151,08:30 - 10:30,4,2-hour Symposium,Using mathematical and epidemiological models to identify the drivers of,Michele Bartoletti; Italy); Pilar Retamar Gentil; Spain),S0409,08:30,Endocarditis guidelines: what is new?,"Siegbert Rieg 
(Freiburg, Germany)"
11 April 2025,SY151,08:30 - 10:30,4,2-hour Symposium,Using mathematical and epidemiological models to identify the drivers of,Michele Bartoletti; Italy); Pilar Retamar Gentil; Spain),S0410,09:00,,"Oral therapy and outpatient care Laura Escolà-Vergé 
(Barcelona, Spain)"
11 April 2025,SY151,08:30 - 10:30,4,2-hour Symposium,Using mathematical and epidemiological models to identify the drivers of,Michele Bartoletti; Italy); Pilar Retamar Gentil; Spain),S0411,09:30,PK/,"PD aspects of endocarditis antibiotic 
therapy Fekade Bruck Sime (Brisbane, Australia)"
11 April 2025,SY151,08:30 - 10:30,4,2-hour Symposium,Using mathematical and epidemiological models to identify the drivers of,Michele Bartoletti; Italy); Pilar Retamar Gentil; Spain),S0412,10:00,The Endocarditis Team:,"there is no way to work 
alone Barbara Hasse (Zurich, Switzerland)"
11 April 2025,SY151,08:30 - 10:30,4,2-hour Symposium,Using mathematical and epidemiological models to identify the drivers of,Michele Bartoletti; Italy); Pilar Retamar Gentil; Spain),S0422,09:00,,"Inferring the determinants of AMR dynamics across 
bacterial pathogens Lulla Opatowski (Paris, France)"
11 April 2025,SY151,08:30 - 10:30,4,2-hour Symposium,Using mathematical and epidemiological models to identify the drivers of,Michele Bartoletti; Italy); Pilar Retamar Gentil; Spain),S0423,09:30,,"Modelling the evolution of resistance Erida Gjini 
(Lisbon, Portugal)"
11 April 2025,SY151,08:30 - 10:30,4,2-hour Symposium,Using mathematical and epidemiological models to identify the drivers of,Michele Bartoletti; Italy); Pilar Retamar Gentil; Spain),S0424,10:00,,"Assessing the associations of microbiome and socio-
demographic dynamics on AMR Katariina Pärnänen 
(Helsinki, Finland)"
11 April 2025,EW157,08:30 - 10:30,15,Educational Session,Endemic mycoses and mycetoma: underdiagnosed and underreported fungal,Ana Alastruey-Izquierdo; Spain); Rita Oladele; Nigeria),W0433,08:30,,"Advances and gaps in the diagnosis and treatment of 
histoplasmosis Diego Rodrigues Falci (Porto Alegre, 
Brazil)"
11 April 2025,EW157,08:30 - 10:30,15,Educational Session,Endemic mycoses and mycetoma: underdiagnosed and underreported fungal,Ana Alastruey-Izquierdo; Spain); Rita Oladele; Nigeria),W0434,08:50,Paracoccidioidomycosis:,"an update on diagnostic 
challenges Beatriz L. Gomez (Bogota, Colombia)"
11 April 2025,EW157,08:30 - 10:30,15,Educational Session,Endemic mycoses and mycetoma: underdiagnosed and underreported fungal,Ana Alastruey-Izquierdo; Spain); Rita Oladele; Nigeria),W0435,09:10,,"What is new in Talaromycosis Brown Lottie (London, 
United Kingdom)"
11 April 2025,EW157,08:30 - 10:30,15,Educational Session,Endemic mycoses and mycetoma: underdiagnosed and underreported fungal,Ana Alastruey-Izquierdo; Spain); Rita Oladele; Nigeria),W0436,09:30,Mycetoma:,"treatment challenges of a unique 
neglected tropical disease Borna Nyaoke-Anoke 
(Nairobi, Kenya)"
11 April 2025,EW155,08:30 - 10:30,2,Educational Session,An update on arboviral disease challenges,Misa Korva; Slovenia); Anna Papa-Konidari; Greece),W155,08:30,- 10:30,"Hall 2
Educational Session
An update on arboviral disease challenges
Chairs Misa Korva (Ljubljana, Slovenia)"
11 April 2025,EW155,08:30 - 10:30,2,Educational Session,An update on arboviral disease challenges,Misa Korva; Slovenia); Anna Papa-Konidari; Greece),W0425,08:30,,"The global epidemiology of arboviral diseases Chantal 
B.E.M. Reusken (Bilthoven, Netherlands)"
11 April 2025,EW155,08:30 - 10:30,2,Educational Session,An update on arboviral disease challenges,Misa Korva; Slovenia); Anna Papa-Konidari; Greece),W0426,08:50,,"Arboviral diseases transmitted by mosquitoes Luisa 
Barzon (Padua, Italy)"
11 April 2025,EW155,08:30 - 10:30,2,Educational Session,An update on arboviral disease challenges,Misa Korva; Slovenia); Anna Papa-Konidari; Greece),W0427,09:10,,"Aboviral diseases transmitted by ticks Joanna Maria 
Zajkowska (Białystok, Poland)"
11 April 2025,EW155,08:30 - 10:30,2,Educational Session,An update on arboviral disease challenges,Misa Korva; Slovenia); Anna Papa-Konidari; Greece),W0428,09:30,,"Arboviral diseases transmitted by sandflies Rémi 
Charrel (Marseille, France)"
11 April 2025,SY150,08:30 - 10:30,3,2-hour Symposium,Faecal microbiota transplantation and live biotherapeutic products: scientific,Lindsey Ann Edwards; United Kingdom); Ed J. Kuijper; Netherlands),S0406,09:00,What to check? –,"An attempt at evidence-based 
donor screening Elisabeth Terveer (Leiden, Netherlands)"
11 April 2025,SY150,08:30 - 10:30,3,2-hour Symposium,Faecal microbiota transplantation and live biotherapeutic products: scientific,Lindsey Ann Edwards; United Kingdom); Ed J. Kuijper; Netherlands),S0407,09:30,What are the right bugs –,"Developing LBPs out of 
FMTs Lena Biehl (Cologne, Germany)"
11 April 2025,SY150,08:30 - 10:30,3,2-hour Symposium,Faecal microbiota transplantation and live biotherapeutic products: scientific,Lindsey Ann Edwards; United Kingdom); Ed J. Kuijper; Netherlands),S0408,10:00,What’s up next? –,"Hot LBP candidates Ilan Youngster 
(Beer Yaakov, Israel)"
11 April 2025,SY151,08:30 - 10:30,4,2-hour Symposium,News in endocarditis care,Michele Bartoletti; Italy); Pilar Retamar Gentil; Spain),Y151,08:30,- 10:30,"Hall 4
2-hour Symposium
News in endocarditis care
Chairs Michele Bartoletti (Milan, Italy)"
11 April 2025,SY151,08:30 - 10:30,4,2-hour Symposium,News in endocarditis care,Michele Bartoletti; Italy); Pilar Retamar Gentil; Spain),S0409,08:30,Endocarditis guidelines: what is new?,"Siegbert Rieg 
(Freiburg, Germany)"
11 April 2025,SY151,08:30 - 10:30,4,2-hour Symposium,News in endocarditis care,Michele Bartoletti; Italy); Pilar Retamar Gentil; Spain),S0410,09:00,,"Oral therapy and outpatient care Laura Escolà-Vergé 
(Barcelona, Spain)"
11 April 2025,SY151,08:30 - 10:30,4,2-hour Symposium,News in endocarditis care,Michele Bartoletti; Italy); Pilar Retamar Gentil; Spain),S0411,09:30,PK/,"PD aspects of endocarditis antibiotic 
therapy Fekade Bruck Sime (Brisbane, Australia)"
11 April 2025,SY151,08:30 - 10:30,4,2-hour Symposium,News in endocarditis care,Michele Bartoletti; Italy); Pilar Retamar Gentil; Spain),S0412,10:00,The Endocarditis Team:,"there is no way to work 
alone Barbara Hasse (Zurich, Switzerland)"
11 April 2025,ME165,11:00 - 12:00,12,Meet-the-Expert,How to use citizen science for public health,,M0450,11:00,,"Anna Noel-Storr (Leamington Spa, United Kingdom)"
11 April 2025,ME165,11:00 - 12:00,12,Meet-the-Expert,How to use citizen science for public health,,M0451,11:12,,"Jani Sormunen (Turku, Finland)"
11 April 2025,SY164,11:00 - 12:00,15,ePoster Flash Session,"C. diff  challenges: insights into treatment, monitoring, and infection",Lior Nesher; Israel); Michelle Yong; Australia),Y164,11:00,- 12:00,"Hall 15
1-hour Symposium
dsDNA virus infections in immunocompromised patients
Chairs Lior Nesher (Beersheba, Israel)"
11 April 2025,SY164,11:00 - 12:00,15,ePoster Flash Session,"C. diff  challenges: insights into treatment, monitoring, and infection",Lior Nesher; Israel); Michelle Yong; Australia),O167,11:00,- 12:00,"Arena 1
Open Forum
Vaccine rollout in low resource settings
Chair Asma Nasim (Karachi, Pakistan)"
11 April 2025,SY164,11:00 - 12:00,15,ePoster Flash Session,"C. diff  challenges: insights into treatment, monitoring, and infection",Lior Nesher; Israel); Michelle Yong; Australia),F0454,11:00,,"Typhoid vaccine roll out Nginache Nampota 
(Baltimore, United States)"
11 April 2025,SY164,11:00 - 12:00,15,ePoster Flash Session,"C. diff  challenges: insights into treatment, monitoring, and infection",Lior Nesher; Israel); Michelle Yong; Australia),F0456,11:20,,"The story of COVID-19 vaccines in LMIC Paul Adepoju 
(Perton, United Kingdom)"
11 April 2025,SY164,11:00 - 12:00,15,ePoster Flash Session,"C. diff  challenges: insights into treatment, monitoring, and infection",Lior Nesher; Israel); Michelle Yong; Australia),E0883,11:06,,"Evaluation of CRS3123 compared to vancomycin for 
the treatment of Clostridioides difficile  infection 
(CDI)"
11 April 2025,ME165,11:00 - 12:00,12,Meet-the-Expert,How to use citizen science for public health,,M0450,11:00,,"Anna Noel-Storr (Leamington Spa, United Kingdom)"
11 April 2025,ME165,11:00 - 12:00,12,Meet-the-Expert,How to use citizen science for public health,,M0451,11:12,,"Jani Sormunen (Turku, Finland)"
11 April 2025,SY164,11:00 - 12:00,15,ePoster Flash Session,Bugs breaking the blood-brain barrier,Lior Nesher; Israel); Michelle Yong; Australia),Y164,11:00,- 12:00,"Hall 15
1-hour Symposium
dsDNA virus infections in immunocompromised patients
Chairs Lior Nesher (Beersheba, Israel)"
11 April 2025,SY164,11:00 - 12:00,15,ePoster Flash Session,Bugs breaking the blood-brain barrier,Lior Nesher; Israel); Michelle Yong; Australia),O167,11:00,- 12:00,"Arena 1
Open Forum
Vaccine rollout in low resource settings
Chair Asma Nasim (Karachi, Pakistan)"
11 April 2025,SY164,11:00 - 12:00,15,ePoster Flash Session,Bugs breaking the blood-brain barrier,Lior Nesher; Israel); Michelle Yong; Australia),F0454,11:00,,"Typhoid vaccine roll out Nginache Nampota 
(Baltimore, United States)"
11 April 2025,SY164,11:00 - 12:00,15,ePoster Flash Session,Bugs breaking the blood-brain barrier,Lior Nesher; Israel); Michelle Yong; Australia),F0456,11:20,,"The story of COVID-19 vaccines in LMIC Paul Adepoju 
(Perton, United Kingdom)"
11 April 2025,SY164,11:00 - 12:00,15,ePoster Flash Session,Bugs breaking the blood-brain barrier,Lior Nesher; Israel); Michelle Yong; Australia),E0883,11:06,,"Evaluation of CRS3123 compared to vancomycin for 
the treatment of Clostridioides difficile  infection 
(CDI)"
11 April 2025,SY164,11:00 - 12:00,15,ePoster Flash Session,Bugs breaking the blood-brain barrier,Lior Nesher; Israel); Michelle Yong; Australia),E0887,11:30,,"Phase 3 study of oral gepotidacin for the treatment of 
uncomplicated urinary tract infection in Japanese 
ESCMID Global 2025 - Programme
female participants (EAGLE-J)"
11 April 2025,SY164,11:00 - 12:00,15,ePoster Flash Session,Bugs breaking the blood-brain barrier,Lior Nesher; Israel); Michelle Yong; Australia),E0891,11:48,,"Investigator-driven randomised controlled trial of 
cefiderocol versus standard therapy for healthcare-
associated and hospital-acquired gram-negative 
bacterial bloodstream Infections (BSI)"
11 April 2025,SY164,11:00 - 12:00,15,ePoster Flash Session,Bugs breaking the blood-brain barrier,Lior Nesher; Israel); Michelle Yong; Australia),F124,11:00,- 12:00,"Arena 3
ePoster Flash Session
Thinking outside the box in urinary tract infection
Chair Özlem Kurt Azap (Ankara, Türkiye)"
11 April 2025,SY164,11:00 - 12:00,15,ePoster Flash Session,Bugs breaking the blood-brain barrier,Lior Nesher; Israel); Michelle Yong; Australia),F125,11:00,- 12:00,"Arena 4
ePoster Flash Session
Bugs breaking the blood-brain barrier
Chair Markus Zeitlinger (Vienna, Austria)"
11 April 2025,KN158,11:00 - 12:00,1,ePoster Flash Session,Bugs breaking the blood-brain barrier,Emmanuelle Cambau; France); Kathryn Holt; United Kingdom),K0437,11:00,,"Stewart T. Cole (Paris, France)"
11 April 2025,KN158,11:00 - 12:00,1,ePoster Flash Session,Bugs breaking the blood-brain barrier,Emmanuelle Cambau; France); Kathryn Holt; United Kingdom),E0891,11:48,,"Investigator-driven randomised controlled trial of 
cefiderocol versus standard therapy for healthcare-
associated and hospital-acquired gram-negative 
bacterial bloodstream Infections (BSI)"
11 April 2025,KN158,11:00 - 12:00,1,ePoster Flash Session,Bugs breaking the blood-brain barrier,Emmanuelle Cambau; France); Kathryn Holt; United Kingdom),F124,11:00,- 12:00,"Arena 3
ePoster Flash Session
Thinking outside the box in urinary tract infection
Chair Özlem Kurt Azap (Ankara, Türkiye)"
11 April 2025,KN158,11:00 - 12:00,1,ePoster Flash Session,Bugs breaking the blood-brain barrier,Emmanuelle Cambau; France); Kathryn Holt; United Kingdom),F125,11:00,- 12:00,"Arena 4
ePoster Flash Session
Bugs breaking the blood-brain barrier
Chair Markus Zeitlinger (Vienna, Austria)"
11 April 2025,KN158,11:00 - 12:00,1,,,Emmanuelle Cambau; France); Kathryn Holt; United Kingdom),K0437,11:00,,"Stewart T. Cole (Paris, France)"
11 April 2025,SY162,11:00 - 12:00,11,,,Lucy Catteau; Belgium); Priya Nori; United States),Y162,11:00,- 12:00,"Hall 11
1-hour Symposium
Antimicrobial stewardship across the lifespan from paediatrics to geriatrics
Chairs Lucy Catteau (Brussels, Belgium)"
11 April 2025,SY162,11:00 - 12:00,11,,,Lucy Catteau; Belgium); Priya Nori; United States),S0444,11:00,,"Antimicrobial Stewardship in paediatrics across 
different settings Taylor Morrisette (Charleston, 
United States)"
11 April 2025,SY162,11:00 - 12:00,11,,,Lucy Catteau; Belgium); Priya Nori; United States),S0445,11:30,Stewardship in geriatrics:,"an exceedingly important 
target Dafna Yahav (Ramat-Gan, Israel)"
11 April 2025,ME166,11:00 - 12:00,13,Meet-the-Expert,Implementing AI in microbiological diagnostics: practical steps and quality,,M0452,11:00,,"Oliver Nolte (Zürich, Switzerland)"
11 April 2025,ME166,11:00 - 12:00,13,Meet-the-Expert,Implementing AI in microbiological diagnostics: practical steps and quality,,M0453,11:12,,"Jennifer Dien Bard (Los Angeles, United States)"
11 April 2025,SY163,11:00 - 12:00,14,,,Benedikt Huttner; Switzerland); Mirfin Mpundu; Zambia),Y163,11:00,- 12:00,"Hall 14
1-hour Symposium
People-centred approach to strengthening the AMR response at primary care
Chairs Benedikt Huttner (Geneva, Switzerland)"
11 April 2025,SY163,11:00 - 12:00,14,,,Benedikt Huttner; Switzerland); Mirfin Mpundu; Zambia),S0446,11:00,Implementation of WHO’,"s people-centred 
interventions Nienke Van De sanDe Bruinsma 
(Geneva, Switzerland)"
11 April 2025,SY163,11:00 - 12:00,14,,,Benedikt Huttner; Switzerland); Mirfin Mpundu; Zambia),S0447,11:30,,"Opportunities for strengthening AMR interventions in 
primary healthcare Sholpan Kaliyeva (Karaganda City, 
Kazakhstan)"
11 April 2025,OS122,11:00 - 12:00,16,1-hour Oral Session,Serious games - a serious business,Christian Kraef; Denmark); Galadriel Pellejero-Sagastizábal; Spain); O0878  The development process; impact and; implementation of an educational VR-module in; infection prevention and control for medical students; and healthcare workers in The Netherlands. A.; Tostmann*; Netherlands); O. Coenen-; Bouwman; B. Schippers; F. Luk; M. Graner; F. Van; Hoek; N. Stikkelbroeck; M. Dronkers; O0879  Impact of Professional Background on Performance; in ToREIMC: A Gamified Medical Knowledge; Platform A. Blanco-Di Matteo*; Spain); M.; Morante Ruiz; M. Riesgo Magaña; M. Martín García; O0880  Serious games and storytelling to enhance; adolescents' capabilities for decision-making; regarding meningococcal vaccination: a monocenter; study T. Morris*; France); S. Essalim; K.; Atroune; V. Ronat; M. Moulin; R. Eichel; E. Botelho-; Nevers; A. Gagneux-Brunon; O0881  ‘The Sepsis Olympics': Raising awareness of the; Sepsis 6 care bundle in an Irish Hospital through a; clinical challenge game. C. Uhomoibhi*; Ireland); K. Costelloe; J. Harte; N. Power; E. De Barra; O0882  Improvement of learners' confidence in antibiotic management by an interdisciplinary annual multi-; centred webinar A. Friedrichs*; Germany); E.; Kramme; T. Koch; J. Jochum; A. Van Der Linde; H.; Gerth; F. Jahn; A. Neubert,S122,11:00,- 12:00,"Hall 16
1-hour Oral Session
Serious games - a serious business
Chairs Christian Kraef (Copenhagen, Denmark)"
11 April 2025,SY159,11:00 - 12:00,2,,,Daniela Maric; Serbia); Mojca Maticic; Slovenia),Y159,11:00,- 12:00,"Hall 2
1-hour Symposium
Beat the cancer by beating the infections
Chairs Daniela Maric (Novi Sad, Serbia)"
11 April 2025,SY159,11:00 - 12:00,2,,,Daniela Maric; Serbia); Mojca Maticic; Slovenia),S0438,11:00,Prevention of infection-associated cancer:,"learning 
from each other Catharina Alberts (Amsterdam, 
Netherlands)"
11 April 2025,SY159,11:00 - 12:00,2,,,Daniela Maric; Serbia); Mojca Maticic; Slovenia),S0439,11:30,Test and treat early to prevent cancer:,"hepatitis B and 
hepatitis C Francesco Negro (Geneva, Switzerland)"
11 April 2025,SY160,11:00 - 12:00,4,,,Agnes Hajdu; Hungary); Iris K. Minichmayr; Austria),S0440,11:00,The dosing perspective:,"towards individualised 
treatment strategies Thomas Tängdén (Uppsala, 
Sweden)"
11 April 2025,SY160,11:00 - 12:00,4,,,Agnes Hajdu; Hungary); Iris K. Minichmayr; Austria),S0441,11:30,The infection control perspective:,"advancing patient-
centred approaches Alessia Savoldi (Verona, Italy)"
11 April 2025,SY161,11:00 - 12:00,5,,,Andreas H. Groll; Germany); Adilia Warris; United Kingdom),S0442,11:00,,"Emerging fungal infections in immunocompromised 
and geographically exposed children Laura Ferreras-
Antolin (London, United Kingdom)"
11 April 2025,SY161,11:00 - 12:00,5,,,Andreas H. Groll; Germany); Adilia Warris; United Kingdom),S0443,11:30,,"Best available treatments and options for children in 
resource-limited settings Fabianne Carlesse (Sao 
Paulo, Brazil)"
11 April 2025,OS118,11:00 - 12:00,6,1-hour Oral Session,Plasmids as a powerful tool of antibiotic resistance spread,,S118,11:00,- 12:00,"Hall 6
1-hour Oral Session
Plasmids as a powerful tool of antibiotic resistance spread
Chair Monika Dolejska (Pilsen, Czech Republic)"
11 April 2025,SY162,11:00 - 12:00,11,,,Lucy Catteau; Belgium); Priya Nori; United States),Y162,11:00,- 12:00,"Hall 11
1-hour Symposium
Antimicrobial stewardship across the lifespan from paediatrics to geriatrics
Chairs Lucy Catteau (Brussels, Belgium)"
11 April 2025,SY162,11:00 - 12:00,11,,,Lucy Catteau; Belgium); Priya Nori; United States),S0444,11:00,,"Antimicrobial Stewardship in paediatrics across 
different settings Taylor Morrisette (Charleston, 
United States)"
11 April 2025,SY162,11:00 - 12:00,11,,,Lucy Catteau; Belgium); Priya Nori; United States),S0445,11:30,Stewardship in geriatrics:,"an exceedingly important 
target Dafna Yahav (Ramat-Gan, Israel)"
11 April 2025,ME166,11:00 - 12:00,13,Meet-the-Expert,Implementing AI in microbiological diagnostics: practical steps and quality,,M0452,11:00,,"Oliver Nolte (Zürich, Switzerland)"
11 April 2025,ME166,11:00 - 12:00,13,Meet-the-Expert,Implementing AI in microbiological diagnostics: practical steps and quality,,M0453,11:12,,"Jennifer Dien Bard (Los Angeles, United States)"
11 April 2025,SY163,11:00 - 12:00,14,,,Benedikt Huttner; Switzerland); Mirfin Mpundu; Zambia),Y163,11:00,- 12:00,"Hall 14
1-hour Symposium
People-centred approach to strengthening the AMR response at primary care
Chairs Benedikt Huttner (Geneva, Switzerland)"
11 April 2025,SY163,11:00 - 12:00,14,,,Benedikt Huttner; Switzerland); Mirfin Mpundu; Zambia),S0446,11:00,Implementation of WHO’,"s people-centred 
interventions Nienke Van De sanDe Bruinsma 
(Geneva, Switzerland)"
11 April 2025,SY163,11:00 - 12:00,14,,,Benedikt Huttner; Switzerland); Mirfin Mpundu; Zambia),S0447,11:30,,"Opportunities for strengthening AMR interventions in 
primary healthcare Sholpan Kaliyeva (Karaganda City, 
Kazakhstan)"
11 April 2025,OS122,11:00 - 12:00,16,1-hour Oral Session,Serious games - a serious business,Christian Kraef; Denmark); Galadriel Pellejero-Sagastizábal; Spain); O0878  The development process; impact and; implementation of an educational VR-module in; infection prevention and control for medical students; and healthcare workers in The Netherlands. A.; Tostmann*; Netherlands); O. Coenen-; Bouwman; B. Schippers; F. Luk; M. Graner; F. Van; Hoek; N. Stikkelbroeck; M. Dronkers; O0879  Impact of Professional Background on Performance; in ToREIMC: A Gamified Medical Knowledge; Platform A. Blanco-Di Matteo*; Spain); M.; Morante Ruiz; M. Riesgo Magaña; M. Martín García; O0880  Serious games and storytelling to enhance; adolescents' capabilities for decision-making; regarding meningococcal vaccination: a monocenter; study T. Morris*; France); S. Essalim; K.; Atroune; V. Ronat; M. Moulin; R. Eichel; E. Botelho-; Nevers; A. Gagneux-Brunon; O0881  ‘The Sepsis Olympics': Raising awareness of the; Sepsis 6 care bundle in an Irish Hospital through a; clinical challenge game. C. Uhomoibhi*; Ireland); K. Costelloe; J. Harte; N. Power; E. De Barra; O0882  Improvement of learners' confidence in antibiotic management by an interdisciplinary annual multi-; centred webinar A. Friedrichs*; Germany); E.; Kramme; T. Koch; J. Jochum; A. Van Der Linde; H.; Gerth; F. Jahn; A. Neubert,S122,11:00,- 12:00,"Hall 16
1-hour Oral Session
Serious games - a serious business
Chairs Christian Kraef (Copenhagen, Denmark)"
11 April 2025,SY159,11:00 - 12:00,2,,,Daniela Maric; Serbia); Mojca Maticic; Slovenia),Y159,11:00,- 12:00,"Hall 2
1-hour Symposium
Beat the cancer by beating the infections
Chairs Daniela Maric (Novi Sad, Serbia)"
11 April 2025,SY159,11:00 - 12:00,2,,,Daniela Maric; Serbia); Mojca Maticic; Slovenia),S0438,11:00,Prevention of infection-associated cancer:,"learning 
from each other Catharina Alberts (Amsterdam, 
Netherlands)"
11 April 2025,SY159,11:00 - 12:00,2,,,Daniela Maric; Serbia); Mojca Maticic; Slovenia),S0439,11:30,Test and treat early to prevent cancer:,"hepatitis B and 
hepatitis C Francesco Negro (Geneva, Switzerland)"
11 April 2025,SY160,11:00 - 12:00,4,,,Agnes Hajdu; Hungary); Iris K. Minichmayr; Austria),S0440,11:00,The dosing perspective:,"towards individualised 
treatment strategies Thomas Tängdén (Uppsala, 
Sweden)"
11 April 2025,SY160,11:00 - 12:00,4,,,Agnes Hajdu; Hungary); Iris K. Minichmayr; Austria),S0441,11:30,The infection control perspective:,"advancing patient-
centred approaches Alessia Savoldi (Verona, Italy)"
11 April 2025,SY161,11:00 - 12:00,5,,,Andreas H. Groll; Germany); Adilia Warris; United Kingdom),S0442,11:00,,"Emerging fungal infections in immunocompromised 
and geographically exposed children Laura Ferreras-
Antolin (London, United Kingdom)"
11 April 2025,SY161,11:00 - 12:00,5,,,Andreas H. Groll; Germany); Adilia Warris; United Kingdom),S0443,11:30,,"Best available treatments and options for children in 
resource-limited settings Fabianne Carlesse (Sao 
Paulo, Brazil)"
11 April 2025,OS118,11:00 - 12:00,6,1-hour Oral Session,Plasmids as a powerful tool of antibiotic resistance spread,,S118,11:00,- 12:00,"Hall 6
1-hour Oral Session
Plasmids as a powerful tool of antibiotic resistance spread
Chair Monika Dolejska (Pilsen, Czech Republic)"
11 April 2025,OS119,11:00 - 12:00,7,,,Claus Moser; Denmark); Matthaios Papadimitriou Olivgeris; Switzerland); O0863  A Case of Persistent Legionella micdadei  Aortitis with; Endocarditis: Diagnostic and Therapeutic; Challenges V. Zwart*; Netherlands); E.; Kayabasi; H. De Groot; R. Bentvelsen; O0864  Management and Prognosis of Vascular Endograft; Infections: Case Series N. Scarpulla*; Italy); F.; Patauner; L. Bertolino; R. Andini; A.M.C. Peluso; R.; Gallo; E. Durante-Mangoni; O0865  Fungal frenzy: handling an uncommon etiology in; prosthetic valve endocarditis I. Cafarella*; Italy); R. Gallo; F. Patauner; F. Luciano; L. Bertolino; A.M.C. Peluso; F. Boccia; R. Zampino; E. Durante-; Mangoni; O0866  Successful Use of Oritavancin as Consolidation; Therapy for Infective Endocarditis Caused by; Enterococcus  spp.: Experience from Seven Cases in a; Referral Center F. Frondizi*; Italy); G.M.; Leanza; F. Catania; F. Sangiorgi; M. Chiuchiarelli; B.; Andriolo; L. Vahedi; B. Liguoro; F. Giovannenze; E.; Taddei; G. Scoppettuolo; C. Torti; O0867  Clinical Features and Outcomes of Gram-Negative; Bacterial Endocarditis: A Case Series from a; University Hospital G. Oliva*; Italy); F.; Giovannenze; G.M. Leanza; F. Frondizi; M.; Chiuchiarelli; B. Liguoro; B. Andriolo; E. Taddei; G.; Scoppettuolo; C. Torti,S119,11:00,- 12:00,"Hall 7
1-hour Case Session
Looking inside endovascular infections
Chairs Claus Moser (Copenhagen, Denmark)"
11 April 2025,OS120,11:00 - 12:00,8,1-hour Oral Session,Exploring Host-Pathogen Interactions and Immune Dynamics in Bacterial,Giovanni Delogu; Italy); Simon Foster; United Kingdom); O0868  Bacteria and host responses in both mice and human; lung organoid model revealed the role of a novel; plasmid pvirhs1 in hypervirulent Carbapenem-; resistant Klebsiella pneumoniae Y. Zhang*; China); W. Liu; K. Lin; L. Chen; J. Wu; N. Jiang; O0869  Presence and role of hypervirulence-associated; markers in Klebsiella pneumoniae  groups based on; LD50 value in mouse septic model A. Avdeeva*; (Saint-Petersburg; Russian Federation); D. Kandina; E. Podvysotskaia; P. Chulkova; M. Velizhanina; J.; Sopova; V. Lomonosova; V. Galushka; A.; Afinogenova; V. Shapovalova; O. Sulian; I. Ageevets; V. Ageevets; S. Sidorenko; O0870  Meta-transcriptomic Insights into Host-Pathogen; Interactions in Necrotizing Soft Tissue Infections; Using Differential Analysis T. Vashist*; India); N. Rana; D. Nair; A. Angrup; V. Sharma; C.; Tandup; P. Ray; A. Arora; O0871  Unveiling the hidden virulence of Acinetobacter; baumannii : how the lipooligosaccharide core; modulates immune responses and enhances; interferon-￿ production Y.T. Lee*; Taiwan; China); Y.C. Wang; O0872  Platelets drive neutrophil-mediated; neuroinflammation in tuberculous meningitis K.; Skolimowska*; United Kingdom); R.; Wilkinson; J.S. Friedland; D. Kirwan; T. Reid; D. De; Swardt; D.L.W. Chong; J. Kutschenreuter; M. Saeed; A. Davis; S. Wasserman; R. Goliath; Q. Kakana; P.; Renner; M. Panchoo; C. Stek; R. Johnson; M.; Maxebengula,S120,11:00,- 12:00,"Hall 8
1-hour Oral Session
Exploring Host-Pathogen Interactions and Immune Dynamics in Bacterial 
Virulence
Chairs Giovanni Delogu (Rome, Italy)"
11 April 2025,OS121,11:00 - 12:00,9,1-hour Oral Session,Shaping the future of IPC - digitalisation of surveillance,Diamantis Plachouras; Sweden); Maaike S.M. Van Mourik; Netherlands),S121,11:00,- 12:00,"Hall 9
1-hour Oral Session
Shaping the future of IPC - digitalisation of surveillance
Chairs Diamantis Plachouras (Solna, Sweden)"
11 April 2025,OS119,11:00 - 12:00,7,,,Claus Moser; Denmark); Matthaios Papadimitriou Olivgeris; Switzerland); O0863  A Case of Persistent Legionella micdadei  Aortitis with; Endocarditis: Diagnostic and Therapeutic; Challenges V. Zwart*; Netherlands); E.; Kayabasi; H. De Groot; R. Bentvelsen; O0864  Management and Prognosis of Vascular Endograft; Infections: Case Series N. Scarpulla*; Italy); F.; Patauner; L. Bertolino; R. Andini; A.M.C. Peluso; R.; Gallo; E. Durante-Mangoni; O0865  Fungal frenzy: handling an uncommon etiology in; prosthetic valve endocarditis I. Cafarella*; Italy); R. Gallo; F. Patauner; F. Luciano; L. Bertolino; A.M.C. Peluso; F. Boccia; R. Zampino; E. Durante-; Mangoni; O0866  Successful Use of Oritavancin as Consolidation; Therapy for Infective Endocarditis Caused by; Enterococcus  spp.: Experience from Seven Cases in a; Referral Center F. Frondizi*; Italy); G.M.; Leanza; F. Catania; F. Sangiorgi; M. Chiuchiarelli; B.; Andriolo; L. Vahedi; B. Liguoro; F. Giovannenze; E.; Taddei; G. Scoppettuolo; C. Torti; O0867  Clinical Features and Outcomes of Gram-Negative; Bacterial Endocarditis: A Case Series from a; University Hospital G. Oliva*; Italy); F.; Giovannenze; G.M. Leanza; F. Frondizi; M.; Chiuchiarelli; B. Liguoro; B. Andriolo; E. Taddei; G.; Scoppettuolo; C. Torti,S119,11:00,- 12:00,"Hall 7
1-hour Case Session
Looking inside endovascular infections
Chairs Claus Moser (Copenhagen, Denmark)"
11 April 2025,OS120,11:00 - 12:00,8,1-hour Oral Session,Exploring Host-Pathogen Interactions and Immune Dynamics in Bacterial,Giovanni Delogu; Italy); Simon Foster; United Kingdom); O0868  Bacteria and host responses in both mice and human; lung organoid model revealed the role of a novel; plasmid pvirhs1 in hypervirulent Carbapenem-; resistant Klebsiella pneumoniae Y. Zhang*; China); W. Liu; K. Lin; L. Chen; J. Wu; N. Jiang; O0869  Presence and role of hypervirulence-associated; markers in Klebsiella pneumoniae  groups based on; LD50 value in mouse septic model A. Avdeeva*; (Saint-Petersburg; Russian Federation); D. Kandina; E. Podvysotskaia; P. Chulkova; M. Velizhanina; J.; Sopova; V. Lomonosova; V. Galushka; A.; Afinogenova; V. Shapovalova; O. Sulian; I. Ageevets; V. Ageevets; S. Sidorenko; O0870  Meta-transcriptomic Insights into Host-Pathogen; Interactions in Necrotizing Soft Tissue Infections; Using Differential Analysis T. Vashist*; India); N. Rana; D. Nair; A. Angrup; V. Sharma; C.; Tandup; P. Ray; A. Arora; O0871  Unveiling the hidden virulence of Acinetobacter; baumannii : how the lipooligosaccharide core; modulates immune responses and enhances; interferon-￿ production Y.T. Lee*; Taiwan; China); Y.C. Wang; O0872  Platelets drive neutrophil-mediated; neuroinflammation in tuberculous meningitis K.; Skolimowska*; United Kingdom); R.; Wilkinson; J.S. Friedland; D. Kirwan; T. Reid; D. De; Swardt; D.L.W. Chong; J. Kutschenreuter; M. Saeed; A. Davis; S. Wasserman; R. Goliath; Q. Kakana; P.; Renner; M. Panchoo; C. Stek; R. Johnson; M.; Maxebengula,S120,11:00,- 12:00,"Hall 8
1-hour Oral Session
Exploring Host-Pathogen Interactions and Immune Dynamics in Bacterial 
Virulence
Chairs Giovanni Delogu (Rome, Italy)"
11 April 2025,OS121,11:00 - 12:00,9,1-hour Oral Session,Shaping the future of IPC - digitalisation of surveillance,Diamantis Plachouras; Sweden); Maaike S.M. Van Mourik; Netherlands),S121,11:00,- 12:00,"Hall 9
1-hour Oral Session
Shaping the future of IPC - digitalisation of surveillance
Chairs Diamantis Plachouras (Solna, Sweden)"
11 April 2025,OS121,11:00 - 12:00,9,1-hour Oral Session,Shaping the future of IPC - digitalisation of surveillance,Diamantis Plachouras; Sweden); Maaike S.M. Van Mourik; Netherlands),F132,13:30,- 14:30,"Arena 2
ePoster Flash Session
Difficult-to-treat cases in the immunocompromised
Chair Nicolas Mueller (Zurich, Switzerland)"
11 April 2025,OS121,11:00 - 12:00,9,1-hour Oral Session,Shaping the future of IPC - digitalisation of surveillance,Diamantis Plachouras; Sweden); Maaike S.M. Van Mourik; Netherlands),F133,13:30,- 14:30,"Arena 3
ePoster Flash Session
Viral infections in special populations
Chair Federico Garcia (Granada, Spain)"
11 April 2025,OS121,11:00 - 12:00,9,1-hour Oral Session,Shaping the future of IPC - digitalisation of surveillance,Diamantis Plachouras; Sweden); Maaike S.M. Van Mourik; Netherlands),F132,13:30,- 14:30,"Arena 2
ePoster Flash Session
Difficult-to-treat cases in the immunocompromised
Chair Nicolas Mueller (Zurich, Switzerland)"
11 April 2025,OS121,11:00 - 12:00,9,1-hour Oral Session,Shaping the future of IPC - digitalisation of surveillance,Diamantis Plachouras; Sweden); Maaike S.M. Van Mourik; Netherlands),F133,13:30,- 14:30,"Arena 3
ePoster Flash Session
Viral infections in special populations
Chair Federico Garcia (Granada, Spain)"
11 April 2025,OS121,11:00 - 12:00,9,1-hour Oral Session,Shaping the future of IPC - digitalisation of surveillance,Diamantis Plachouras; Sweden); Maaike S.M. Van Mourik; Netherlands),F134,13:30,- 14:30,"Arena 4
ePoster Flash Session
Infection Controller's Daily
Chair Cansu Cimen (Oldenburg, Germany)"
11 April 2025,EW174,13:30 - 15:30,11,Educational Session,Best practices and emerging strategies in the management of ventilator- and,Fusun Can; Türkiye); Jeroen Schouten; Netherlands),W174,13:30,- 15:30,"Hall 11
Educational Session
Best practices and emerging strategies in the management of ventilator- and 
healthcare-associated pneumonia
Chairs Fusun Can (Istanbul, Türkiye)"
11 April 2025,EW174,13:30 - 15:30,11,Educational Session,Best practices and emerging strategies in the management of ventilator- and,Fusun Can; Türkiye); Jeroen Schouten; Netherlands),W0481,13:30,,"Artificial Intelligence to predict VAP Miia Jansson 
(Oulu, Finland)"
11 April 2025,EW174,13:30 - 15:30,11,Educational Session,Best practices and emerging strategies in the management of ventilator- and,Fusun Can; Türkiye); Jeroen Schouten; Netherlands),W0482,13:50,,"Metagenomic approach to VAP diagnosis Jacques Schrenzel (Geneva, Switzerland)"
11 April 2025,EW174,13:30 - 15:30,11,Educational Session,Best practices and emerging strategies in the management of ventilator- and,Fusun Can; Türkiye); Jeroen Schouten; Netherlands),W0484,14:30,,"Optimising antibiotic therapy in VAP Pinyo 
Rattanaumpawan (Bangkok, Thailand)"
11 April 2025,SY170,13:30 - 15:30,13,2-hour Symposium,Novel strategies for eliminating the ‘worst films ever’,Elisa Borghi; Italy); Markus Zeitlinger; Austria),S0467,14:30,PK/,"PD-based optimisation of antibiotic treatments to 
suppress resistance in dynamic biofilm models Maria 
Dolores Macia Romero (Palma De Mallorca, Spain)"
11 April 2025,SY171,13:30 - 15:30,14,2-hour Symposium,Enhancing efficiency and reducing cost in microbiological diagnostics using,Mauricio Farfan; Chile); Chiara Minotti; Switzerland),Y171,13:30,- 15:30,"Hall 14
2-hour Symposium
Enhancing efficiency and reducing cost in microbiological diagnostics using 
pool testing
Chairs Mauricio Farfan (Santiago, Chile)"
11 April 2025,SY171,13:30 - 15:30,14,2-hour Symposium,Enhancing efficiency and reducing cost in microbiological diagnostics using,Mauricio Farfan; Chile); Chiara Minotti; Switzerland),S0469,13:30,,"Congenital cytomegalovirus detection by pool testing 
in saliva Giannina Izquierdo (Santiago, Chile)"
11 April 2025,SY171,13:30 - 15:30,14,2-hour Symposium,Enhancing efficiency and reducing cost in microbiological diagnostics using,Mauricio Farfan; Chile); Chiara Minotti; Switzerland),S0470,14:00,,"Detection of blood-corne pathogens in asymptomatic 
blood donors by pool testing Patricia Alvarez (Rio De 
Janeiro, Brazil)"
11 April 2025,SY171,13:30 - 15:30,14,2-hour Symposium,Enhancing efficiency and reducing cost in microbiological diagnostics using,Mauricio Farfan; Chile); Chiara Minotti; Switzerland),S0471,14:30,,"Large-scale pooled testing to increase rapid 
molecular diagnostic test coverage for 
tuberculosis Melissa Sander (Bamenda, Cameroon)"
11 April 2025,OS130,13:30 - 14:30,16,1-hour Oral Session,Advances in fungal diagnostics,,S130,13:30,- 14:30,"Hall 16
1-hour Oral Session
Advances in fungal diagnostics
Chair Sarah Delliere (Paris, France)"
11 April 2025,OS130,13:30 - 14:30,16,1-hour Oral Session,Advances in fungal diagnostics,,F134,13:30,- 14:30,"Arena 4
ePoster Flash Session
Infection Controller's Daily
Chair Cansu Cimen (Oldenburg, Germany)"
11 April 2025,EW174,13:30 - 15:30,11,Educational Session,Best practices and emerging strategies in the management of ventilator- and,Fusun Can; Türkiye); Jeroen Schouten; Netherlands),W174,13:30,- 15:30,"Hall 11
Educational Session
Best practices and emerging strategies in the management of ventilator- and 
healthcare-associated pneumonia
Chairs Fusun Can (Istanbul, Türkiye)"
11 April 2025,EW174,13:30 - 15:30,11,Educational Session,Best practices and emerging strategies in the management of ventilator- and,Fusun Can; Türkiye); Jeroen Schouten; Netherlands),W0481,13:30,,"Artificial Intelligence to predict VAP Miia Jansson 
(Oulu, Finland)"
11 April 2025,EW174,13:30 - 15:30,11,Educational Session,Best practices and emerging strategies in the management of ventilator- and,Fusun Can; Türkiye); Jeroen Schouten; Netherlands),W0482,13:50,,"Metagenomic approach to VAP diagnosis Jacques Schrenzel (Geneva, Switzerland)"
11 April 2025,EW174,13:30 - 15:30,11,Educational Session,Best practices and emerging strategies in the management of ventilator- and,Fusun Can; Türkiye); Jeroen Schouten; Netherlands),W0484,14:30,,"Optimising antibiotic therapy in VAP Pinyo 
Rattanaumpawan (Bangkok, Thailand)"
11 April 2025,SY170,13:30 - 15:30,13,2-hour Symposium,Novel strategies for eliminating the ‘worst films ever’,Elisa Borghi; Italy); Markus Zeitlinger; Austria),S0467,14:30,PK/,"PD-based optimisation of antibiotic treatments to 
suppress resistance in dynamic biofilm models Maria 
Dolores Macia Romero (Palma De Mallorca, Spain)"
11 April 2025,SY171,13:30 - 15:30,14,2-hour Symposium,Enhancing efficiency and reducing cost in microbiological diagnostics using,Mauricio Farfan; Chile); Chiara Minotti; Switzerland),Y171,13:30,- 15:30,"Hall 14
2-hour Symposium
Enhancing efficiency and reducing cost in microbiological diagnostics using 
pool testing
Chairs Mauricio Farfan (Santiago, Chile)"
11 April 2025,SY171,13:30 - 15:30,14,2-hour Symposium,Enhancing efficiency and reducing cost in microbiological diagnostics using,Mauricio Farfan; Chile); Chiara Minotti; Switzerland),S0469,13:30,,"Congenital cytomegalovirus detection by pool testing 
in saliva Giannina Izquierdo (Santiago, Chile)"
11 April 2025,SY171,13:30 - 15:30,14,2-hour Symposium,Enhancing efficiency and reducing cost in microbiological diagnostics using,Mauricio Farfan; Chile); Chiara Minotti; Switzerland),S0470,14:00,,"Detection of blood-corne pathogens in asymptomatic 
blood donors by pool testing Patricia Alvarez (Rio De 
Janeiro, Brazil)"
11 April 2025,SY171,13:30 - 15:30,14,2-hour Symposium,Enhancing efficiency and reducing cost in microbiological diagnostics using,Mauricio Farfan; Chile); Chiara Minotti; Switzerland),S0471,14:30,,"Large-scale pooled testing to increase rapid 
molecular diagnostic test coverage for 
tuberculosis Melissa Sander (Bamenda, Cameroon)"
11 April 2025,OS130,13:30 - 14:30,16,1-hour Oral Session,Advances in fungal diagnostics,,S130,13:30,- 14:30,"Hall 16
1-hour Oral Session
Advances in fungal diagnostics
Chair Sarah Delliere (Paris, France)"
11 April 2025,SY168,13:30 - 15:30,2,2-hour Symposium,Staphylococcus aureus : its expansion dynamics and interactions with its pals,,S0457,13:30,,"S. aureus  and its special relationship to S. 
epidermidis  Andreas Peschel (Tübingen, Germany)"
11 April 2025,SY168,13:30 - 15:30,2,2-hour Symposium,Staphylococcus aureus : its expansion dynamics and interactions with its pals,,S0458,14:00,,"Computational and in vitro  evaluation of probiotic 
treatments for nasal S. aureus  decolonization Silvio 
Daniel Brugger (Zurich, Switzerland)"
11 April 2025,SY168,13:30 - 15:30,2,2-hour Symposium,Staphylococcus aureus : its expansion dynamics and interactions with its pals,,S0459,14:30,,"Clonal population expansion of S. aureus  occurs due 
to escape from a finite number of intraphagocyte 
niches Simon Foster (Sheffield, United Kingdom)"
11 April 2025,SY168,13:30 - 15:30,2,2-hour Symposium,Staphylococcus aureus : its expansion dynamics and interactions with its pals,,S0460,15:00,,"How bacteriophages and pathogenicity islands drive 
the evolution of S. aureus  John Chen (Singapore, 
Singapore)"
11 April 2025,EW172,13:30 - 15:30,3,Educational Session,Beyond the gift of life: viral infection during pregnancy,Gülsen Özkaya Sahin; Sweden); Simona Ruta; Romania),W0474,13:50,RSV and Influenza during pregnancy:,"management 
and outcome Monika Redlberger-Fritz (Vienna, 
Austria)"
11 April 2025,SY169,13:30 - 15:30,4,2-hour Symposium,"Molecular epidemiology, resistance mechanisms and management of Gram-",Agnes Maria Sonnevend; Hungary); Kyriaki Xanthopoulou; Germany),S0461,13:30,,"Globally emerging resistance patterns of 
Enterobacterales Sasheela Ponnampalavanar (Kuala 
Lumpur, Malaysia)"
11 April 2025,SY169,13:30 - 15:30,4,2-hour Symposium,"Molecular epidemiology, resistance mechanisms and management of Gram-",Agnes Maria Sonnevend; Hungary); Kyriaki Xanthopoulou; Germany),S0462,14:00,Non-fermenters still important globally:,"a review of 
spread and resistance Anupa Thampy (Vellore, India)"
11 April 2025,SY169,13:30 - 15:30,4,2-hour Symposium,"Molecular epidemiology, resistance mechanisms and management of Gram-",Agnes Maria Sonnevend; Hungary); Kyriaki Xanthopoulou; Germany),S0463,14:30,,"Innovative rapid diagnostic methodologies for Gram-
negative pathogens Laurent Dortet (Le Kremlin-Bicêtre, France)"
11 April 2025,EW173,13:30 - 15:30,5,Educational Session,Tropical dermatology: a case-based approach,Pedro Legua; Peru); Bobbi Pritt; United States),W0477,13:30,Parasitic diseases:,"dermatological manifestations in 
the tropics Kirti Sabnis (India)"
11 April 2025,EW173,13:30 - 15:30,5,Educational Session,Tropical dermatology: a case-based approach,Pedro Legua; Peru); Bobbi Pritt; United States),W0478,13:50,,"Madura foot and other implantation mycoses M 
Ramam (New Delhi, India)"
11 April 2025,EW173,13:30 - 15:30,5,Educational Session,Tropical dermatology: a case-based approach,Pedro Legua; Peru); Bobbi Pritt; United States),W0479,14:10,,"Mycobacteria Francisco Bravo (Lima, Peru)"
11 April 2025,EW173,13:30 - 15:30,5,Educational Session,Tropical dermatology: a case-based approach,Pedro Legua; Peru); Bobbi Pritt; United States),W0480,14:30,,"Approach to rash in the returning traveller Frank O. D. 
Pettersen (Oslo, Norway)"
11 April 2025,OS127,13:30 - 14:30,6,1-hour Oral Session,"The good, the bad and the itchy: update on STIs",,,,,
11 April 2025,OS129,13:30 - 14:30,7,1-hour Oral Session,Biofilm biology and control,Margherita Cacaci; Italy); Laura Escolà-Vergé; Spain); O0930  Influence of non-coding small RNA00203 in biofilm; cells of Acinetobacter baumannii : Transcriptomic and; phenotypic D. Gebrelibanos*; China); P.; Leung; A.M. Shenkutie; F. Chow; O0931  Sub-MIC antibiotic effects on Pseudomonas; aeruginosa  biofilm streamer formation A. Di Claudio*; (Pieve Emanuele; Italy); R. Rusconi; E. Secchi; G.; Savorana; ESCMID Global 2025 - Programme; O0938  Combined use of; 3)-￿-D-glucan and PCR in oral; wash for Pneumocystis jirovecii  pneumonia diagnosis; in non-HIV population A. Falcó Roget*; Spain); A. Falcó-Roget; A. Albasanz-Puig; A.B. Pérez; S. Serradell; A. Guillén; E. Revilla; I. Los-Arcos; O. Len; I. Ruiz-Camps; M.T. Martín-Gómez; O0939  Iron levels in bronchoalveolar lavage fluid of; hematological patients with suspected invasive; pulmonary aspergillosis and their association with 12-; week mortality: a retrospective cohort study H.; Lamberink*; Netherlands); J. Heijmans; A. Wagemakers; K. Van Dijk,S129,13:30,- 14:30,"Hall 7
1-hour Oral Session
Biofilm biology and control
Chairs Margherita Cacaci (Rome, Italy)"
11 April 2025,SY168,13:30 - 15:30,2,2-hour Symposium,Staphylococcus aureus : its expansion dynamics and interactions with its pals,,S0457,13:30,,"S. aureus  and its special relationship to S. 
epidermidis  Andreas Peschel (Tübingen, Germany)"
11 April 2025,SY168,13:30 - 15:30,2,2-hour Symposium,Staphylococcus aureus : its expansion dynamics and interactions with its pals,,S0458,14:00,,"Computational and in vitro  evaluation of probiotic 
treatments for nasal S. aureus  decolonization Silvio 
Daniel Brugger (Zurich, Switzerland)"
11 April 2025,SY168,13:30 - 15:30,2,2-hour Symposium,Staphylococcus aureus : its expansion dynamics and interactions with its pals,,S0459,14:30,,"Clonal population expansion of S. aureus  occurs due 
to escape from a finite number of intraphagocyte 
niches Simon Foster (Sheffield, United Kingdom)"
11 April 2025,SY168,13:30 - 15:30,2,2-hour Symposium,Staphylococcus aureus : its expansion dynamics and interactions with its pals,,S0460,15:00,,"How bacteriophages and pathogenicity islands drive 
the evolution of S. aureus  John Chen (Singapore, 
Singapore)"
11 April 2025,EW172,13:30 - 15:30,3,Educational Session,Beyond the gift of life: viral infection during pregnancy,Gülsen Özkaya Sahin; Sweden); Simona Ruta; Romania),W0474,13:50,RSV and Influenza during pregnancy:,"management 
and outcome Monika Redlberger-Fritz (Vienna, 
Austria)"
11 April 2025,SY169,13:30 - 15:30,4,2-hour Symposium,"Molecular epidemiology, resistance mechanisms and management of Gram-",Agnes Maria Sonnevend; Hungary); Kyriaki Xanthopoulou; Germany),S0461,13:30,,"Globally emerging resistance patterns of 
Enterobacterales Sasheela Ponnampalavanar (Kuala 
Lumpur, Malaysia)"
11 April 2025,SY169,13:30 - 15:30,4,2-hour Symposium,"Molecular epidemiology, resistance mechanisms and management of Gram-",Agnes Maria Sonnevend; Hungary); Kyriaki Xanthopoulou; Germany),S0462,14:00,Non-fermenters still important globally:,"a review of 
spread and resistance Anupa Thampy (Vellore, India)"
11 April 2025,SY169,13:30 - 15:30,4,2-hour Symposium,"Molecular epidemiology, resistance mechanisms and management of Gram-",Agnes Maria Sonnevend; Hungary); Kyriaki Xanthopoulou; Germany),S0463,14:30,,"Innovative rapid diagnostic methodologies for Gram-
negative pathogens Laurent Dortet (Le Kremlin-Bicêtre, France)"
11 April 2025,EW173,13:30 - 15:30,5,Educational Session,Tropical dermatology: a case-based approach,Pedro Legua; Peru); Bobbi Pritt; United States),W0477,13:30,Parasitic diseases:,"dermatological manifestations in 
the tropics Kirti Sabnis (India)"
11 April 2025,EW173,13:30 - 15:30,5,Educational Session,Tropical dermatology: a case-based approach,Pedro Legua; Peru); Bobbi Pritt; United States),W0478,13:50,,"Madura foot and other implantation mycoses M 
Ramam (New Delhi, India)"
11 April 2025,EW173,13:30 - 15:30,5,Educational Session,Tropical dermatology: a case-based approach,Pedro Legua; Peru); Bobbi Pritt; United States),W0479,14:10,,"Mycobacteria Francisco Bravo (Lima, Peru)"
11 April 2025,EW173,13:30 - 15:30,5,Educational Session,Tropical dermatology: a case-based approach,Pedro Legua; Peru); Bobbi Pritt; United States),W0480,14:30,,"Approach to rash in the returning traveller Frank O. D. 
Pettersen (Oslo, Norway)"
11 April 2025,OS127,13:30 - 14:30,6,1-hour Oral Session,"The good, the bad and the itchy: update on STIs",,,,,
11 April 2025,OS129,13:30 - 14:30,7,1-hour Oral Session,Biofilm biology and control,Margherita Cacaci; Italy); Laura Escolà-Vergé; Spain); O0930  Influence of non-coding small RNA00203 in biofilm; cells of Acinetobacter baumannii : Transcriptomic and; phenotypic D. Gebrelibanos*; China); P.; Leung; A.M. Shenkutie; F. Chow; O0931  Sub-MIC antibiotic effects on Pseudomonas; aeruginosa  biofilm streamer formation A. Di Claudio*; (Pieve Emanuele; Italy); R. Rusconi; E. Secchi; G.; Savorana; ESCMID Global 2025 - Programme; O0932  Regulation of Novel Genes and Their Downstream; Functions in the AI-2-Mediated Quorum Sensing; System of Klebsiella pneumoniae X. Chu*; China); Q. Yang; O0933  Exploring structural differences in biofilms of smooth; and rough Mycobacterium abscessus  clinical strains; through confocal laser scanning microscopy C.; Maria*; Spain); M. Cano-Fernández; J.; Esteban; P. López-Roa; A. Ruedas-López; M.C.; Muñoz-Egea; O0934  Antibacterial and biofilm eradication of mupirocin-; loaded nano-emulsions Z. Najmi*; Italy); A.C.; Scalia; A. Cochis; J. De Souza Nunes; J. Alkorta; L.; Rimondini; D. Dupin,S129,13:30,- 14:30,"Hall 7
1-hour Oral Session
Biofilm biology and control
Chairs Margherita Cacaci (Rome, Italy)"
11 April 2025,OS126,13:30 - 15:30,8,,,Luisa Barzon; Italy); Karin Stiasny; Austria); O0910  Epidemiological and clinical features of mpox; during the clade Ib outbreak in South-Kivu; Democratic Republic of the Congo: a prospective; cohort study I. Brosius*; Belgium); E.; Hasivirwe Vakaniaki; S. Sabiti Nundu; L.; Liesenborghs; P. Mbala-Kingebeni; G. Mukari; P.; Munganga; J.C. Tshomba; E. De Vos; E. Bangwen; Y. Mujula; A. Tsoumanis; C. Van Dijck; A. Alengo; L.; Mutimba-Mambo; F. Mweshi Kumbana; J.; Babingwa Muunga; D. Mazambi Mambo; J.; Wakilongo Zangilwa; S. Bilembo Kitwanda; S.; Houben; N. Hoff; J.C. Makangara-Cigolo; E.; Kinganda-Lusamaki; M. Peeters; A. Rimoin; J.; Kindrachuck; N. Low; P. Katoto; E. Bwenge; Malembaka; J.H. Amuasi; O. Tshiani; R. Kojan; D.; Muamba Kambaj; C. Kacita; D. Mukadi-Bamuleka; S. Ahuka-Mundeke; K. Vercauteren; T. Wawina-; Bokalanga; J.J. Muyembe-Tamfum; O0911  Tracing the origin; spread and molecular evolution; of Dengue type 1 cases occurred in Northern Italy in; 2023 G. Romano*; Italy); G. Ferrari; A.M.G.; Pitrolo; F. Rovida; A. Piralla; F. Baldanti; O0912  Dengue Country Risk Estimation: Vector Suitability; and Imported Activity 2024. M. Torres Portillo*; (Toronto; Canada); K. Williams; R. Lababidi; A.; Thomas; K. Khan; O0913  Rat HEV in humans in Germany: presence but low; detection rate; a screening study 2022 - 2023 L.; Mueller*; Germany); M.L. Schmidt; T.; Schwarz; T.D. Best; T. Bleicker; J. Panajotov; J.; Jansen; J. Melchert; T. Mauno; C. Drosten; R.; Johne; V.M. Corman; O0914  Emergence of new enterovirus D68 lineage in; Europe in 2023 associated with distinct amino acid; substitutions in VP1 protein A. Hirvonen*; Finland); C.K. Johannesen; P. Simmonds; T.K.; Fischer; H. Harvala; K.S.M. Benschop; O0915  Health-economic impacts of chikungunya; vaccination in 34 countries J. Zhou*; United; Kingdom); N. Salant; D. Smith; D. Hollingsworth; K.; Pouwels; S. Radoykova; J. Lord; K. French; O0916  Clinical importance of a new tick-borne flaviviridae; virus; Alongshan Virus: retrospective serologic and; molecular study in Switzerland F. Tagini*; Switzerland); O. Opota; A. Eggermann; A. Coste; G.; Greub; O0917  From Trade Routes to Transmission Routes: Risk; Assessment of Japanese Encephalitis Outbreak in; Pakistan under China-Pakistan Economic Corridor; Using One Health Approach S. Ahmad*; Finland); O0918  Building a screening protocol for the detection of; Orthobunyavirus oropoucheense infection G.; Gagliardi*; Italy); D. Mileto; A. Mancon; L.; Morelli; M. Cutrera; A. Cavallo; A. Rizzo; V. Micheli; A. Lombardi; A. DolciO0919  Substantial viral diversity in bats and rodents from; East Africa: insights into conservation; recombination; and co-circulation D. Wang*; (Shenzhen; China),,,,
11 April 2025,OS128,13:30 - 14:30,9,1-hour Oral Session,AI Aiding AMS,Marlieke De Kraker; Switzerland); Bhanu Sinha; Netherlands); O0925  Using natural language processing to understand; free-text antibiotic prescriptions A. Martin*; (Middlesbrough; United Kingdom); L. Christopher; O0926  Enhancing Antimicrobial Stewardship Through; Collaboration Between an Intelligent System and; Infectious Disease Experts H.M. Wei*; Taiwan; China); Y.L. Hsu; Y.W. Chang; I.C. Chen; K.P.; Hwang; O0927  Augmented Intelligence in Infectious Diseases; as an antimicrobial stewardship tool for early; antibiotic discontinuation in suspected lower; respiratory tract infections J.L. Lim*; Singapore); P.Z.B. Cherng; P.M. Chlebicki; L.S.C. Gan; S.Y. Thien; S.L.S. Tang; L.X.T. Lee; Y.C.D. Yii; P.Y.; Zhou; Y. Wang; S.J. Chung; L.H.A. Kwa; O0928  Virtual antimicrobial stewardship ward rounds:; predicting antibiotic course stopping decisions in; hospitals using machine learning K. Yuan*; United Kingdom); J. Wei; C.H. Yoon; Q. Gu; W. Walker; T. Zhu; D. Eyre; O0929  Prospective evaluation of a machine learning-based; decision support system for intravenous-to-oral; antibiotic switching. W. Bolton*; United; Kingdom); R. Wilson; P. Georgiou; A. Holmes; T.M.; Rawson; M. Gilchrist; ESCMID Global 2025 - Programme; O0932  Regulation of Novel Genes and Their Downstream; Functions in the AI-2-Mediated Quorum Sensing; System of Klebsiella pneumoniae X. Chu*; China); Q. Yang; O0933  Exploring structural differences in biofilms of smooth; and rough Mycobacterium abscessus  clinical strains; through confocal laser scanning microscopy C.; Maria*; Spain); M. Cano-Fernández; J.; Esteban; P. López-Roa; A. Ruedas-López; M.C.; Muñoz-Egea; O0934  Antibacterial and biofilm eradication of mupirocin-; loaded nano-emulsions Z. Najmi*; Italy); A.C.; Scalia; A. Cochis; J. De Souza Nunes; J. Alkorta; L.; Rimondini; D. Dupin,S128,13:30,- 14:30,"Hall 9
1-hour Oral Session
AI Aiding AMS
Chairs Marlieke De Kraker (Geneva, Switzerland)"
11 April 2025,OS126,13:30 - 15:30,8,,,Luisa Barzon; Italy); Karin Stiasny; Austria); O0910  Epidemiological and clinical features of mpox; during the clade Ib outbreak in South-Kivu; Democratic Republic of the Congo: a prospective; cohort study I. Brosius*; Belgium); E.; Hasivirwe Vakaniaki; S. Sabiti Nundu; L.; Liesenborghs; P. Mbala-Kingebeni; G. Mukari; P.; Munganga; J.C. Tshomba; E. De Vos; E. Bangwen; Y. Mujula; A. Tsoumanis; C. Van Dijck; A. Alengo; L.; Mutimba-Mambo; F. Mweshi Kumbana; J.; Babingwa Muunga; D. Mazambi Mambo; J.; Wakilongo Zangilwa; S. Bilembo Kitwanda; S.; Houben; N. Hoff; J.C. Makangara-Cigolo; E.; Kinganda-Lusamaki; M. Peeters; A. Rimoin; J.; Kindrachuck; N. Low; P. Katoto; E. Bwenge; Malembaka; J.H. Amuasi; O. Tshiani; R. Kojan; D.; Muamba Kambaj; C. Kacita; D. Mukadi-Bamuleka; S. Ahuka-Mundeke; K. Vercauteren; T. Wawina-; Bokalanga; J.J. Muyembe-Tamfum; O0911  Tracing the origin; spread and molecular evolution; of Dengue type 1 cases occurred in Northern Italy in; 2023 G. Romano*; Italy); G. Ferrari; A.M.G.; Pitrolo; F. Rovida; A. Piralla; F. Baldanti; O0912  Dengue Country Risk Estimation: Vector Suitability; and Imported Activity 2024. M. Torres Portillo*; (Toronto; Canada); K. Williams; R. Lababidi; A.; Thomas; K. Khan; O0913  Rat HEV in humans in Germany: presence but low; detection rate; a screening study 2022 - 2023 L.; Mueller*; Germany); M.L. Schmidt; T.; Schwarz; T.D. Best; T. Bleicker; J. Panajotov; J.; Jansen; J. Melchert; T. Mauno; C. Drosten; R.; Johne; V.M. Corman; O0914  Emergence of new enterovirus D68 lineage in; Europe in 2023 associated with distinct amino acid; substitutions in VP1 protein A. Hirvonen*; Finland); C.K. Johannesen; P. Simmonds; T.K.; Fischer; H. Harvala; K.S.M. Benschop; O0915  Health-economic impacts of chikungunya; vaccination in 34 countries J. Zhou*; United; Kingdom); N. Salant; D. Smith; D. Hollingsworth; K.; Pouwels; S. Radoykova; J. Lord; K. French; O0916  Clinical importance of a new tick-borne flaviviridae; virus; Alongshan Virus: retrospective serologic and; molecular study in Switzerland F. Tagini*; Switzerland); O. Opota; A. Eggermann; A. Coste; G.; Greub; O0917  From Trade Routes to Transmission Routes: Risk; Assessment of Japanese Encephalitis Outbreak in; Pakistan under China-Pakistan Economic Corridor; Using One Health Approach S. Ahmad*; Finland); O0918  Building a screening protocol for the detection of; Orthobunyavirus oropoucheense infection G.; Gagliardi*; Italy); D. Mileto; A. Mancon; L.; Morelli; M. Cutrera; A. Cavallo; A. Rizzo; V. Micheli; A. Lombardi; A. DolciO0919  Substantial viral diversity in bats and rodents from; East Africa: insights into conservation; recombination; and co-circulation D. Wang*; (Shenzhen; China),,,,
11 April 2025,OS128,13:30 - 14:30,9,1-hour Oral Session,AI Aiding AMS,Marlieke De Kraker; Switzerland); Bhanu Sinha; Netherlands); O0925  Using natural language processing to understand; free-text antibiotic prescriptions A. Martin*; (Middlesbrough; United Kingdom); L. Christopher; O0926  Enhancing Antimicrobial Stewardship Through; Collaboration Between an Intelligent System and; Infectious Disease Experts H.M. Wei*; Taiwan; China); Y.L. Hsu; Y.W. Chang; I.C. Chen; K.P.; Hwang; O0927  Augmented Intelligence in Infectious Diseases; as an antimicrobial stewardship tool for early; antibiotic discontinuation in suspected lower; respiratory tract infections J.L. Lim*; Singapore); P.Z.B. Cherng; P.M. Chlebicki; L.S.C. Gan; S.Y. Thien; S.L.S. Tang; L.X.T. Lee; Y.C.D. Yii; P.Y.; Zhou; Y. Wang; S.J. Chung; L.H.A. Kwa; O0928  Virtual antimicrobial stewardship ward rounds:; predicting antibiotic course stopping decisions in; hospitals using machine learning K. Yuan*; United Kingdom); J. Wei; C.H. Yoon; Q. Gu; W. Walker; T. Zhu; D. Eyre; O0929  Prospective evaluation of a machine learning-based; decision support system for intravenous-to-oral; antibiotic switching. W. Bolton*; United; Kingdom); R. Wilson; P. Georgiou; A. Holmes; T.M.; Rawson; M. Gilchrist,S128,13:30,- 14:30,"Hall 9
1-hour Oral Session
AI Aiding AMS
Chairs Marlieke De Kraker (Geneva, Switzerland)"
